{"title":"Cardiovascular Longevity","description":"\u003cp\u003e\u003cstrong\u003eCardiovascular disease is still the #1 cause of death worldwide — and the slope of risk steepens every decade after 40.\u003c\/strong\u003e Arterial stiffness rises. Endothelial nitric oxide production declines. Lipoproteins oxidise more readily. Mitochondrial efficiency in the cardiomyocytes that contract roughly 100,000 times a day drops. Subclinical inflammation creeps up. Blood pressure follows.\u003c\/p\u003e\n\n\u003cp\u003eThe supplement evidence in this category is unusually strong because cardiovascular endpoints are easy to measure: blood pressure, LDL particle number, triglycerides, hsCRP, arterial calcification (CAC score), flow-mediated dilation, ejection fraction, and hard outcomes like major adverse cardiovascular events (MACE) and all-cause mortality. A small group of compounds has moved those needles in repeated, large, well-designed human trials — many at FDA-approval-grade evidence levels.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cp\u003eFive mechanisms drive cardiovascular aging: \u003cstrong\u003e(1)\u003c\/strong\u003e endothelial dysfunction (nitric oxide collapse), \u003cstrong\u003e(2)\u003c\/strong\u003e arterial stiffness and calcification, \u003cstrong\u003e(3)\u003c\/strong\u003e oxidised-LDL-driven atherogenesis, \u003cstrong\u003e(4)\u003c\/strong\u003e mitochondrial bioenergetic decline in the heart, and \u003cstrong\u003e(5)\u003c\/strong\u003e chronic low-grade inflammation. Six compounds with the deepest human-trial evidence address them: \u003cstrong\u003eOmega-3 EPA\/DHA\u003c\/strong\u003e (REDUCE-IT, JELIS, GISSI-Prevenzione), \u003cstrong\u003eVitamin D3 + K2 (MK-7)\u003c\/strong\u003e (Maresz 2015, Knapen 2015), \u003cstrong\u003eMagnesium glycinate\u003c\/strong\u003e (Zhang 2016 meta-analysis, Kass 2012), \u003cstrong\u003eTaurine\u003c\/strong\u003e (Singh 2023 Nature, Beyranvand 2011), \u003cstrong\u003eCoQ10\u003c\/strong\u003e (Q-SYMBIO, Mortensen 2014), and \u003cstrong\u003eSpermidine\u003c\/strong\u003e (Eisenberg 2016 Nature Medicine, Kiechl 2018 AJCN). On top of those, \u003cstrong\u003eTMG\u003c\/strong\u003e for homocysteine, \u003cstrong\u003eBerberine\u003c\/strong\u003e for lipids, and a sirtuin\/mitophagy layer (\u003cstrong\u003eResveratrol, Pterostilbene, Spermidine, NR, Quercetin, ALA, Curcumin, PQQ\u003c\/strong\u003e) for the cellular machinery that determines how long the system stays elastic.\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundation (everyone over 40):\u003c\/strong\u003e Omega-3 + D3+K2 + Magnesium. These three replicate across hundreds of cardiovascular trials and most adults are deficient in at least one.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd Taurine and CoQ10\u003c\/strong\u003e if you're over 50, on a statin, or have any heart-failure family history. CoQ10 is mandatory on statins (statins deplete it directly via the mevalonate pathway).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer Spermidine, TMG and a NAD+ precursor\u003c\/strong\u003e (NMN or NR) for the cellular-renewal layer that determines whether your vasculature stays elastic into your 70s and 80s.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf lipids or glucose are off,\u003c\/strong\u003e add Berberine (AMPK pathway, comparable to metformin in head-to-head) or Curcumin (endothelial function, hsCRP).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTime horizon:\u003c\/strong\u003e Magnesium and Omega-3 shift markers in 4–8 weeks. CoQ10 in 8–12 weeks. K2 arterial-calcification effects measured at 3 years (Knapen 2015). NAD+\/sirtuin\/spermidine endpoints accumulate over 6–12+ months.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy the cardiovascular system ages — five mechanisms\u003c\/h2\u003e\n\n\u003ch3\u003e1. Endothelial dysfunction (nitric oxide collapse)\u003c\/h3\u003e\n\u003cp\u003eThe endothelium — the single-cell lining of every blood vessel — produces nitric oxide (NO) via endothelial nitric oxide synthase (eNOS). NO relaxes vascular smooth muscle, lowers blood pressure, suppresses platelet aggregation, and inhibits leukocyte adhesion. eNOS activity declines with age, with shear-stress loss (sedentary living), and with the accumulation of asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor. Flow-mediated dilation (FMD) — the gold-standard endothelial measurement — drops roughly 0.21% per decade after 40 in healthy adults and faster with diabetes, hypertension, or smoking.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTargeted by:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (raises eNOS expression, lowers ADMA), \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine\u003c\/a\u003e (Beyranvand 2011 + Singh 2023, FMD restoration), \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e (eNOS upregulator, Wallerath 2002), \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e (vascular smooth-muscle relaxant), \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e (Akazawa 2012 FMD trial in postmenopausal women).\u003c\/p\u003e\n\n\u003ch3\u003e2. Arterial stiffness and calcification\u003c\/h3\u003e\n\u003cp\u003eAortic pulse-wave velocity (PWV) — the speed a pressure wave travels down the aorta — is the gold-standard arterial-stiffness measure. Every 1 m\/s increase associates with ~14% higher cardiovascular event risk and ~15% higher all-cause mortality (Vlachopoulos 2010 meta-analysis of 17 cohorts). Arteries stiffen because elastin fibres degrade and aren't replaced, collagen cross-links via advanced glycation end-products, and calcium deposits in the medial layer (Mönckeberg's sclerosis). The K2-MK-7 mechanism is direct: matrix Gla protein (MGP) needs vitamin-K-dependent γ-carboxylation to inhibit arterial calcification — without K2, MGP stays inactive and calcium ends up in the wrong tissue.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTargeted by:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3 + K2 MK-7\u003c\/a\u003e (Knapen 2015 — 180 mcg MK-7 over 3 years reduced arterial stiffness in 244 postmenopausal women; Maresz 2015 calcium-direction logic), \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e (Eisenberg 2016 cardiac autophagy), \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (vascular-smooth-muscle senolytic component of D+Q protocol).\u003c\/p\u003e\n\n\u003ch3\u003e3. Oxidised LDL and atherogenesis\u003c\/h3\u003e\n\u003cp\u003eNative LDL is not particularly atherogenic; oxidised LDL is. Once LDL particles enter the arterial intima and get oxidised by reactive oxygen species, macrophages engulf them via scavenger receptors and become foam cells. Foam cells aggregate into fatty streaks, then fibrous plaques. The rate-limiting step for most people is the oxidation, not the LDL concentration per se — which is why antioxidant cofactors and inflammation control matter alongside lipid management.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTargeted by:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e (Yin 2008 vs metformin head-to-head — comparable HbA1c and triglyceride reduction; Dong 2013 meta — LDL-C and triglyceride reduction), \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 \/ Ubiquinol\u003c\/a\u003e (lipid-soluble antioxidant resident in LDL particles, protects from oxidation), \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e (regenerates oxidised vitamin C, vitamin E, glutathione, and CoQ10), \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (Egert 2009 oxLDL reduction), \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e, \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e (Riche 2014 — lipid lowering trial).\u003c\/p\u003e\n\n\u003ch3\u003e4. Mitochondrial bioenergetic decline\u003c\/h3\u003e\n\u003cp\u003eThe heart never stops working. A 70-year-old has contracted their heart roughly 2.5 billion times. That contraction is fueled by ATP, which is produced by mitochondria, which decline in number, copy number, and function with age. NAD+ — the obligate cofactor for the entire respiratory chain and for sirtuin signalling — drops by an estimated 40–60% between ages 30 and 70. Cardiac CoQ10 levels at age 80 are about half what they are at age 30. The Q-SYMBIO trial (Mortensen 2014, JACC) randomised 420 advanced heart-failure patients to 300 mg\/day CoQ10 or placebo for two years. The CoQ10 arm had a 43% reduction in major adverse cardiovascular events and a 42% reduction in all-cause mortality.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTargeted by:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e (Q-SYMBIO, Mortensen 2014), \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR (Nicotinamide Riboside)\u003c\/a\u003e (Martens 2018 Nature Communications — 6 weeks of 1000 mg NR reduced systolic blood pressure by ~10 mmHg in stage-1 hypertensives and reduced aortic stiffness; Brakedal 2022 NADPARK), \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e (NAD+ restoration), \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e (mitophagy — clearing damaged mitochondria), \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e (PGC-1α-driven mitochondrial biogenesis), \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine\u003c\/a\u003e (mitochondrial tRNA cofactor).\u003c\/p\u003e\n\n\u003ch3\u003e5. Chronic low-grade inflammation (\"inflammaging\")\u003c\/h3\u003e\n\u003cp\u003ehsCRP, IL-6, and TNF-α drift upward with age. The CANTOS trial (Ridker 2017, NEJM) used canakinumab — a monoclonal antibody against IL-1β — and reduced cardiovascular events by 15% even with no change in LDL. Inflammation is upstream of plaque rupture, the proximal cause of most heart attacks. Senescent cells secrete a pro-inflammatory cocktail (the SASP — senescence-associated secretory phenotype) that drives this. Polyphenol and senolytic-pulse strategies target the source rather than just the downstream marker.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTargeted by:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e (Sahebkar 2014 meta — CRP reduction across 9 trials), \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (D+Q protocol — Hickson 2019, Justice 2019), \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e (NF-κB inhibition), \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e (resolvins and SPMs — specialised pro-resolving mediators), \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e (autophagy clears damaged organelles before they trigger inflammation).\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence — the cardiovascular trials behind each compound\u003c\/h2\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eCompound\u003c\/th\u003e\n\u003cth\u003eTrial \/ Cohort\u003c\/th\u003e\n\u003cth\u003en\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003eEndpoint\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEPA (icosapent ethyl)\u003c\/td\u003e\n\u003ctd\u003eREDUCE-IT (Bhatt 2019 NEJM)\u003c\/td\u003e\n\u003ctd\u003e8,179\u003c\/td\u003e\n\u003ctd\u003e4 g\/d, 4.9 yr median\u003c\/td\u003e\n\u003ctd\u003e−25% MACE vs placebo in statin-treated, hypertriglyceridaemic patients\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEPA + DHA\u003c\/td\u003e\n\u003ctd\u003eJELIS (Yokoyama 2007 Lancet)\u003c\/td\u003e\n\u003ctd\u003e18,645\u003c\/td\u003e\n\u003ctd\u003e1.8 g\/d EPA, 4.6 yr\u003c\/td\u003e\n\u003ctd\u003e−19% major coronary events on statin background\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOmega-3 (n-3 PUFA)\u003c\/td\u003e\n\u003ctd\u003eGISSI-Prevenzione (1999 Lancet)\u003c\/td\u003e\n\u003ctd\u003e11,323\u003c\/td\u003e\n\u003ctd\u003e1 g\/d, 3.5 yr\u003c\/td\u003e\n\u003ctd\u003e−15% all-cause death; −20% CV death; −45% sudden cardiac death\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVitamin K2 MK-7\u003c\/td\u003e\n\u003ctd\u003eKnapen 2015 Thromb Haemost\u003c\/td\u003e\n\u003ctd\u003e244\u003c\/td\u003e\n\u003ctd\u003e180 mcg\/d, 3 yr\u003c\/td\u003e\n\u003ctd\u003eReduced arterial stiffness vs placebo in postmenopausal women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVitamin D3\u003c\/td\u003e\n\u003ctd\u003eVITAL (Manson 2019 NEJM)\u003c\/td\u003e\n\u003ctd\u003e25,871\u003c\/td\u003e\n\u003ctd\u003e2,000 IU\/d, 5.3 yr\u003c\/td\u003e\n\u003ctd\u003eNo primary CV endpoint; cancer-mortality signal in late follow-up; effect modified by baseline status\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMagnesium\u003c\/td\u003e\n\u003ctd\u003eZhang 2016 meta (Hypertension)\u003c\/td\u003e\n\u003ctd\u003e2,028 (34 RCTs)\u003c\/td\u003e\n\u003ctd\u003e368 mg\/d median, 3 mo\u003c\/td\u003e\n\u003ctd\u003e−2 mmHg SBP, −1.78 mmHg DBP; effect-size doubles in deficient subjects\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMagnesium glycinate\u003c\/td\u003e\n\u003ctd\u003eKass 2012 meta (Eur J Clin Nutr)\u003c\/td\u003e\n\u003ctd\u003e1,694 (22 RCTs)\u003c\/td\u003e\n\u003ctd\u003e410 mg\/d median, 3–24 wk\u003c\/td\u003e\n\u003ctd\u003eBP reduction stronger at \u0026gt;370 mg\/d and \u0026gt;90 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTaurine\u003c\/td\u003e\n\u003ctd\u003eBeyranvand 2011 J Cardiol\u003c\/td\u003e\n\u003ctd\u003e29\u003c\/td\u003e\n\u003ctd\u003e1.5 g\/d, 2 wk\u003c\/td\u003e\n\u003ctd\u003eImproved exercise capacity in heart-failure patients\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTaurine\u003c\/td\u003e\n\u003ctd\u003eSingh 2023 Nature\u003c\/td\u003e\n\u003ctd\u003eCohorts + RCT\u003c\/td\u003e\n\u003ctd\u003ePlasma taurine declines ~80% age 5→60\u003c\/td\u003e\n\u003ctd\u003eRestoration extended healthspan ~10% in mice; human plasma associates with multiple CV markers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCoenzyme Q10\u003c\/td\u003e\n\u003ctd\u003eQ-SYMBIO (Mortensen 2014 JACC)\u003c\/td\u003e\n\u003ctd\u003e420\u003c\/td\u003e\n\u003ctd\u003e300 mg\/d, 2 yr\u003c\/td\u003e\n\u003ctd\u003e−43% MACE; −42% all-cause mortality in NYHA III–IV heart failure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCoenzyme Q10\u003c\/td\u003e\n\u003ctd\u003eKISEL-10 (Alehagen 2015 Int J Cardiol)\u003c\/td\u003e\n\u003ctd\u003e443\u003c\/td\u003e\n\u003ctd\u003e200 mg CoQ10 + 200 mcg selenium, 4 yr (5–10 yr follow-up)\u003c\/td\u003e\n\u003ctd\u003e−54% CV mortality at 5.2 yr; sustained effect through 12 yr in healthy elderly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpermidine (dietary)\u003c\/td\u003e\n\u003ctd\u003eEisenberg 2016 Nat Med\u003c\/td\u003e\n\u003ctd\u003e829 (Bruneck cohort)\u003c\/td\u003e\n\u003ctd\u003eHighest vs lowest tertile, 20-yr follow-up\u003c\/td\u003e\n\u003ctd\u003e−40% all-cause mortality; cardiac autophagy mechanism in mice\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpermidine (dietary)\u003c\/td\u003e\n\u003ctd\u003eKiechl 2018 AJCN (EPIC)\u003c\/td\u003e\n\u003ctd\u003e22,295\u003c\/td\u003e\n\u003ctd\u003eTop vs bottom intake quintile\u003c\/td\u003e\n\u003ctd\u003eLower all-cause and CV mortality; replicated Bruneck signal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNR (Nicotinamide Riboside)\u003c\/td\u003e\n\u003ctd\u003eMartens 2018 Nat Commun\u003c\/td\u003e\n\u003ctd\u003e30\u003c\/td\u003e\n\u003ctd\u003e500 mg twice daily, 6 wk crossover\u003c\/td\u003e\n\u003ctd\u003e−10 mmHg systolic BP and reduced aortic stiffness in stage-1 hypertensives\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBerberine\u003c\/td\u003e\n\u003ctd\u003eDong 2013 Evid Based Complement Altern Med (meta)\u003c\/td\u003e\n\u003ctd\u003e874 (11 RCTs)\u003c\/td\u003e\n\u003ctd\u003e0.5–1.5 g\/d, 6–24 wk\u003c\/td\u003e\n\u003ctd\u003eLDL-C −0.65 mmol\/L; triglycerides −0.50 mmol\/L vs placebo\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBerberine\u003c\/td\u003e\n\u003ctd\u003eYin 2008 Metabolism\u003c\/td\u003e\n\u003ctd\u003e116\u003c\/td\u003e\n\u003ctd\u003e1 g\/d, 3 mo, vs metformin\u003c\/td\u003e\n\u003ctd\u003eHbA1c −2.0% vs metformin −2.0%; triglycerides better with berberine\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurcumin\u003c\/td\u003e\n\u003ctd\u003eSahebkar 2014 Clin Nutr (meta)\u003c\/td\u003e\n\u003ctd\u003e~700 (9 RCTs)\u003c\/td\u003e\n\u003ctd\u003e~500 mg\/d curcumin, 4 wk–6 mo\u003c\/td\u003e\n\u003ctd\u003e−6.4 mg\/L hsCRP\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurcumin (FMD)\u003c\/td\u003e\n\u003ctd\u003eAkazawa 2012 Nutr Res\u003c\/td\u003e\n\u003ctd\u003e32\u003c\/td\u003e\n\u003ctd\u003e150 mg\/d + exercise, 8 wk\u003c\/td\u003e\n\u003ctd\u003eFMD improvement equivalent to exercise alone — additive effect\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePterostilbene\u003c\/td\u003e\n\u003ctd\u003eRiche 2014 Funct Foods Health Dis\u003c\/td\u003e\n\u003ctd\u003e80\u003c\/td\u003e\n\u003ctd\u003e125 mg twice daily, 6–8 wk\u003c\/td\u003e\n\u003ctd\u003eLDL-C reduction; modest BP elevation in higher-dose arm — not first-line for hypertensives\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQuercetin (D+Q)\u003c\/td\u003e\n\u003ctd\u003eHickson 2019 EBioMedicine\u003c\/td\u003e\n\u003ctd\u003e9 (open label) → Justice 2019 (CKD pilot)\u003c\/td\u003e\n\u003ctd\u003e1,250 mg quercetin + 100 mg dasatinib, 3 d\/mo\u003c\/td\u003e\n\u003ctd\u003eSenescent-cell-burden reduction at 11 days; SASP marker decline; biomarker shifts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eα-Lipoic Acid\u003c\/td\u003e\n\u003ctd\u003eMittermayer 2009 J Hypertens\u003c\/td\u003e\n\u003ctd\u003e21\u003c\/td\u003e\n\u003ctd\u003e600 mg\/d, 8 wk\u003c\/td\u003e\n\u003ctd\u003eFMD improvement in metabolic-syndrome patients\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTMG (betaine)\u003c\/td\u003e\n\u003ctd\u003eOlthof 2005 PLOS Med (meta)\u003c\/td\u003e\n\u003ctd\u003e5 RCTs\u003c\/td\u003e\n\u003ctd\u003e3 g\/d, 6 wk\u003c\/td\u003e\n\u003ctd\u003ePlasma homocysteine −1.2 µmol\/L (~10–15% reduction)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResveratrol\u003c\/td\u003e\n\u003ctd\u003eMovahed 2013 Evid Based Complement Altern Med\u003c\/td\u003e\n\u003ctd\u003e62\u003c\/td\u003e\n\u003ctd\u003e1 g\/d, 45 d\u003c\/td\u003e\n\u003ctd\u003eHbA1c, SBP, LDL improvement in T2DM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePQQ\u003c\/td\u003e\n\u003ctd\u003eChowanadisai 2010 J Biol Chem\u003c\/td\u003e\n\u003ctd\u003eMechanism (cell)\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003ePGC-1α phosphorylation → mitochondrial biogenesis (downstream cardiac relevance)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cem\u003eTrial summaries above are condensed — full citations link out from the per-product pages. The general pattern: omega-3, K2, CoQ10, and magnesium have the strongest hard-endpoint evidence (mortality, MACE). Taurine, NR, and curcumin have strong mechanism-plus-marker evidence. Spermidine has the strongest dietary-cohort longitudinal signal.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch2\u003eThe cardiovascular longevity stack — every product, what it does, what dose is trial-validated\u003c\/h2\u003e\n\n\u003ch3\u003eFoundational trio (everyone over 40)\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 Fish Oil 2000 mg | High EPA\/DHA\u003c\/a\u003e:\u003c\/strong\u003e The most-replicated cardiovascular supplement of the last 30 years. AHA Science Advisory recommends ≥1 g\/day for established heart disease. JELIS, GISSI, REDUCE-IT, and the 2019 Hu et al. meta-analysis (n=127,000) all converge on event reduction. Two softgels = 2 g combined EPA+DHA in re-esterified triglyceride (rTG) form, IFOS-grade purity, TOTOX-tested, anchovy\/sardine sourced. \u003cem\u003eTrial-validated dose: 1–2 g\/d for general; 4 g\/d if triglycerides \u0026gt;200 mg\/dL (REDUCE-IT level).\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5,000 IU + K2 MK-7 100 mcg\u003c\/a\u003e:\u003c\/strong\u003e The pairing matters. D3 alone increases calcium absorption — without K2-MK-7, that calcium can deposit in arteries instead of bones (Maresz 2015). MK-7 has a serum half-life of ~3 days vs MK-4's ~1 hour, making it the only K2 form that reaches consistent γ-carboxylation of MGP and osteocalcin. \u003cem\u003eTrial-validated dose: 2,000–5,000 IU D3 (target 25(OH)D 40–60 ng\/mL) + 100–180 mcg MK-7.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg (TRAACS)\u003c\/a\u003e:\u003c\/strong\u003e Up to 50% of US adults are sub-RDA in magnesium (NHANES). Glycinate (bisglycinate) is the most absorbed form and easiest on the gut. Mechanisms: vascular smooth-muscle relaxation, calcium-channel modulation, cofactor for \u0026gt;300 ATP-dependent enzymes. \u003cem\u003eTrial-validated dose: 300–500 mg\/d elemental for BP and sleep; 8–12 weeks for full effect.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eHeart-output and statin-co-therapy layer\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e:\u003c\/strong\u003e Statins inhibit HMG-CoA reductase upstream of both cholesterol and CoQ10 synthesis — measured CoQ10 depletion of 30–40% within months of starting (Folkers 1990). Q-SYMBIO trial (Mortensen 2014) showed 300 mg\/d cut MACE by 43% in advanced heart failure. KISEL-10 showed 200 mg + selenium cut CV mortality by 54% over 4 years in healthy elderly. \u003cem\u003eTrial-validated dose: 100–200 mg\/d general support; 300–400 mg\/d for heart failure or active statin therapy.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e:\u003c\/strong\u003e Plasma taurine drops ~80% from age 5 to 60 (Singh 2023 Nature). Mouse healthspan extended ~10% with restoration. Beyranvand 2011 — improved exercise capacity in heart failure. Schaffer 2018 — mitochondrial-tRNA cofactor essential for cardiac mitochondrial protein synthesis. \u003cem\u003eTrial-validated dose: 1.5–3 g\/d for cardiac function; 1 g\/d general baseline.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCellular-renewal layer (NAD+, sirtuin, autophagy, mitophagy)\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNicotinamide Riboside (NR) Hard Capsules\u003c\/a\u003e:\u003c\/strong\u003e Martens 2018 Nature Communications — 1,000 mg\/d for 6 weeks dropped systolic BP by ~10 mmHg in stage-1 hypertensives and reduced aortic stiffness. Brakedal 2022 NADPARK — NR raised CSF NAD+ in Parkinson's patients. \u003cem\u003eTrial-validated dose: 300–1,000 mg\/d.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e \/ \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e:\u003c\/strong\u003e Yoshino 2021 (Science), Liao 2021, Yamaguchi 2024 — dose-dependent walking-speed, grip-strength and insulin-sensitivity gains across 250–900 mg. Stack with TMG to neutralise the methylation tax. \u003cem\u003eTrial-validated dose: 250–1,000 mg\/d.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e:\u003c\/strong\u003e Phospholipid encapsulation for direct NAD+ delivery. Use when ceiling-loading the NAD+ pool alongside an NMN\/NR base.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e:\u003c\/strong\u003e Trans-resveratrol, the active anomer. SIRT1 activator (Howitz 2003), eNOS upregulator (Wallerath 2002), SIRT3 substrate. Movahed 2013 — 1 g\/d HbA1c, SBP, LDL improvement. \u003cem\u003eTrial-validated dose: 250–1,000 mg\/d.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e:\u003c\/strong\u003e Methoxylated cousin of resveratrol with ~80% oral bioavailability vs ~20% for resveratrol. BBB-penetrant. Riche 2014 — lipid lowering at 250 mg\/d (note: higher arm raised BP modestly — not first-line for hypertensives, watch the data). \u003cem\u003eTrial-validated dose: 100–250 mg\/d.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e:\u003c\/strong\u003e Eisenberg 2016 Nature Medicine — dietary spermidine in the Bruneck cohort linked to a 40% lower all-cause mortality at 20 years. Kiechl 2018 EPIC — replicated. Mechanism: cardiac autophagy + eIF5A hypusination. \u003cem\u003eDose: 1–10 mg\/d (catalog gives 10 mg per cap, towards higher trial range).\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e:\u003c\/strong\u003e PINK1\/Parkin-driven mitophagy. Clears damaged mitochondria before they leak ROS into cardiomyocytes. Andreux 2019 — first human safety + mechanism trial. Singh 2022 JAMA Network Open — Mitopure muscle endurance. About 40% of adults can convert ellagitannins to urolithin A endogenously; the other 60% need direct supplementation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg (BioPQQ)\u003c\/a\u003e:\u003c\/strong\u003e Pyrroloquinoline quinone — Chowanadisai 2010 — drives PGC-1α-mediated mitochondrial biogenesis (the inverse of mitophagy: building NEW mitochondria). Stack with Urolithin A as the renewal pair (clear + build).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eLipid and inflammation layer\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000 mg + BioPerine\u003c\/a\u003e:\u003c\/strong\u003e 95% standardised curcuminoids. Sahebkar 2014 meta — 6.4 mg\/L hsCRP reduction. Akazawa 2012 — endothelial function additive to exercise. The piperine adjunct multiplies oral bioavailability ~2,000% (Shoba 1998).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500 mg + BioPerine\u003c\/a\u003e:\u003c\/strong\u003e Egert 2009 — oxLDL reduction. Hickson 2019 + Justice 2019 — D+Q senolytic protocol component. SCAP-pathway lipid metabolism. Modulates p16INK4a-positive senescent vascular smooth-muscle cells.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e:\u003c\/strong\u003e The \"universal antioxidant\" — water-and-lipid soluble, regenerates oxidised vitamin C, vitamin E, glutathione and CoQ10. Mittermayer 2009 — 600 mg\/d improved FMD in metabolic syndrome. Heavy-metal chelator. AMPK activator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCl 500 mg\u003c\/a\u003e:\u003c\/strong\u003e AMPK pathway agonist — same target metformin hits. Yin 2008 head-to-head vs metformin: comparable HbA1c reduction, better triglyceride effect. Dong 2013 meta: LDL-C −0.65 mmol\/L, triglycerides −0.50 mmol\/L. \u003cem\u003eTrial-validated dose: 500 mg 2–3× daily with meals.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg (Trimethylglycine)\u003c\/a\u003e:\u003c\/strong\u003e Olthof 2005 PLOS Med meta — 3 g\/d dropped homocysteine ~12%. Mandatory adjunct at high NMN\/NR doses (which can drain methyl groups via NNMT). Hcy \u0026gt;15 µmol\/L is an independent CV mortality predictor in most cohorts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to actually start — three protocol tiers\u003c\/h2\u003e\n\n\u003ch3\u003eTier 1 — first-time supplement buyer \/ general 40+ baseline\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eGoal:\u003c\/strong\u003e Cover the highest-evidence, highest-deficiency-rate categories first. Three bottles, ~$1.50\/day equivalent.\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000 mg\u003c\/a\u003e — 2 softgels with breakfast (helps absorption, reduces fish-burp).\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3 5,000 IU + K2 MK-7 100 mcg\u003c\/a\u003e — 1 softgel with the same fatty meal (D3 and K2 are both fat-soluble).\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e — 2 capsules 60–90 min before bed. Doubles as a sleep upgrade.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWhat to expect:\u003c\/strong\u003e Sleep quality improvement in 1–2 weeks (magnesium). Triglycerides and hsCRP shift visibly at the next blood panel (8–12 weeks). 25(OH)D rise to target range in 8–16 weeks. Arterial-stiffness changes are slower — expect to see them at the 12-month mark on a follow-up cardiac imaging panel.\u003c\/p\u003e\n\n\u003ch3\u003eTier 2 — 50+ or on a statin\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAdd to Tier 1:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col start=\"4\"\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e — 1 softgel with breakfast. Mandatory if you're on any statin. Take with a fatty meal — CoQ10 is fat-soluble.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e — 1–2 capsules with food.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWhat to expect:\u003c\/strong\u003e Statin-induced muscle complaints often soften within 2–4 weeks of starting CoQ10 (anecdotal but common). Exercise capacity improvement on taurine in 2–4 weeks if baseline-low.\u003c\/p\u003e\n\n\u003ch3\u003eTier 3 — full longevity protocol\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAdd to Tier 2 over weeks 8–12:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col start=\"6\"\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e — daily.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e — morning, fasted preferred.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e — pair with NMN to neutralise the methylation tax.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e — with morning fats (fat-soluble, low oral bioavailability).\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin + BioPerine\u003c\/a\u003e — 1–2 caps with meals.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWhat to expect:\u003c\/strong\u003e The tier-3 layer is about the slope of biological aging more than acute markers. Expect plasma NAD+ to roughly double at 30–60 days (Yoshino 2021 \/ Pencina 2023 patterns). Arterial-stiffness improvements measured at 6–12 months. Inflammation markers (hsCRP, IL-6) shift in 8–12 weeks if elevated at baseline.\u003c\/p\u003e\n\n\u003ch2\u003eStacking guide — pairing the cardiovascular stack with other protocols\u003c\/h2\u003e\n\n\u003ch3\u003eWith the NAD+ \/ NMN protocol\u003c\/h3\u003e\n\u003cp\u003eNMN\/NR raise NAD+, which fuels SIRT1 and SIRT3 — both have direct cardiovascular roles (eNOS regulation, mitochondrial biogenesis). The combination amplifies. Stack: \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e + \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e + \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e + cardiovascular foundation. See the \u003ca href=\"\/he\/collections\/nmn\"\u003eNMN collection\u003c\/a\u003e for protocol-A vs protocol-B dose selection.\u003c\/p\u003e\n\n\u003ch3\u003eWith the Senolytic protocol\u003c\/h3\u003e\n\u003cp\u003eVascular smooth-muscle senescence drives a portion of arterial stiffness. The D+Q (dasatinib + quercetin) protocol pulses out p16INK4a-positive cells. \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e + \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e in monthly pulses. See \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWith the Mitochondrial Renewal protocol\u003c\/h3\u003e\n\u003cp\u003eCardiomyocytes have the highest mitochondrial density of any tissue (~30% of cell volume). The mitophagy\/biogenesis pair: \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e (clears damaged) + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e (builds new) + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e (cofactor). See \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWith the Foundational Health protocol\u003c\/h3\u003e\n\u003cp\u003eThree of the cardiovascular foundation (Omega-3, D3+K2, Magnesium) are also the spine of \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e. The cardiovascular stack and foundational stack overlap by design — start with foundational and the cardiovascular layer is mostly already in place.\u003c\/p\u003e\n\n\u003ch3\u003eWith the Brain \u0026amp; Cognitive Longevity protocol\u003c\/h3\u003e\n\u003cp\u003eThe cerebrovascular and coronary systems share endothelium and follow nearly identical aging curves. Omega-3, Curcumin, NAD+ precursors, Spermidine, PQQ all feature in both. See \u003ca href=\"\/he\/collections\/brain-cognitive-longevity\"\u003eBrain \u0026amp; Cognitive Longevity\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWith the Metabolic protocol\u003c\/h3\u003e\n\u003cp\u003eLipids, glucose and arterial health are coupled. Berberine for AMPK; ALA for insulin sensitivity; Resveratrol\/Pterostilbene for both layers. See \u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWeek-by-week — what to expect on a complete cardiovascular stack\u003c\/h2\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eWindow\u003c\/th\u003e\n\u003cth\u003eWhat's happening biologically\u003c\/th\u003e\n\u003cth\u003eWhat you might notice\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDays 1–7\u003c\/td\u003e\n\u003ctd\u003ePlasma loading of fat-soluble nutrients (D3, K2, CoQ10, Omega-3 incorporating into RBC membranes); magnesium muscle pools rehydrating\u003c\/td\u003e\n\u003ctd\u003eSleep quality often improves first (magnesium). Possible mild GI adjustment with Omega-3 — take with fat.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 2–4\u003c\/td\u003e\n\u003ctd\u003eOmega-3 Index rising, RBC membrane EPA\/DHA fraction climbing; CoQ10 cardiac and serum levels normalising; magnesium replete\u003c\/td\u003e\n\u003ctd\u003eBetter exercise recovery; resting heart rate may drift down 2–4 bpm; resting BP may drop 2–5 mmHg if baseline-elevated.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 4–8\u003c\/td\u003e\n\u003ctd\u003e25(OH)D climbing toward 40–60 ng\/mL target; matrix Gla protein γ-carboxylation building; FMD measurable on ultrasound\u003c\/td\u003e\n\u003ctd\u003eCurcumin and Quercetin shifts in hsCRP\/IL-6 visible at the next bloodwork.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 8–12\u003c\/td\u003e\n\u003ctd\u003eTriglyceride and apoB profile reshaping (Berberine, Omega-3); plasma NAD+ doubled if NMN\/NR layer added; homocysteine drop on TMG\u003c\/td\u003e\n\u003ctd\u003eLipid panel changes visible (Yin 2008 timing for Berberine; REDUCE-IT\/JELIS timing for Omega-3 + statin). Hcy drop trackable.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3–6 months\u003c\/td\u003e\n\u003ctd\u003eArterial-stiffness markers measurable (PWV, augmentation index); SBP shift on NR (Martens 2018 timing); cardiac autophagy chronic-dose effects (Spermidine)\u003c\/td\u003e\n\u003ctd\u003eRepeat lipid + 25(OH)D + Hcy panel. CIMT\/PWV shifts visible if measured.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6–24 months\u003c\/td\u003e\n\u003ctd\u003eK2 effect on arterial calcification visible on imaging (Knapen 2015 timing); CAC progression slowed if started early\u003c\/td\u003e\n\u003ctd\u003eAnnual coronary calcium score (if doing one) — slope flattens vs an unsupplemented comparator.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn stop\u003c\/td\u003e\n\u003ctd\u003eMagnesium\/CoQ10 pools deplete in 1–2 weeks; Omega-3 RBC fraction over 8 weeks; 25(OH)D over 4–6 weeks\u003c\/td\u003e\n\u003ctd\u003ePlan a taper, not a hard stop, especially before a planned blood panel.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eThe non-supplement non-negotiables\u003c\/h2\u003e\n\u003cp\u003eThe supplement stack works alongside — never instead of — the four interventions with the largest cardiovascular effect sizes:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDon't smoke.\u003c\/strong\u003e Quitting smoking yields ~50% CV-event-rate reduction at 3–5 years post-cessation (Critchley 2003) — bigger than any single supplement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e~150 minutes \/ week of zone-2 cardio plus 2 strength sessions.\u003c\/strong\u003e Endothelial function correlates with weekly active minutes; arterial stiffness correlates inversely with VO2max.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSleep 7–9 hours.\u003c\/strong\u003e Short sleep (\u0026lt;6h) drives BP, IL-6 and atherogenesis. Magnesium glycinate + glycine support sleep architecture (see \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTreat hypertension, lipids, and glucose with your physician.\u003c\/strong\u003e If you're on a statin, ACE-inhibitor, beta-blocker, or anticoagulant, those drugs are doing most of the work — supplements are adjunctive. Tell your doctor what you're taking. Many of the compounds here have real interactions (see below).\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eDrug interactions and contraindications — read this\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants (warfarin, DOACs, aspirin) + Omega-3 at \u0026gt;3 g\/d:\u003c\/strong\u003e Real bleeding-risk additivity. Stop 7 days before surgery. Discuss with your prescriber before starting at \u0026gt;1 g\/d.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWarfarin + Vitamin K2:\u003c\/strong\u003e K2 antagonises warfarin. INR can shift. If you're on warfarin, work with your prescriber — many will adjust warfarin dose to allow K2; do not start unilaterally.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStatins + CoQ10:\u003c\/strong\u003e Statins deplete CoQ10. CoQ10 supplementation is generally encouraged here, not contraindicated — but tell your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBerberine + glucose-lowering medication (metformin, sulfonylureas, insulin):\u003c\/strong\u003e Hypoglycaemia risk. Coordinate with prescriber. Berberine also inhibits CYP3A4 and P-gp — review every other prescription drug for interaction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol, Curcumin, Quercetin:\u003c\/strong\u003e All modulate CYP3A4. Major interactions with chemotherapy, immunosuppressants (tacrolimus, cyclosporine), some antifungals, some antivirals, and warfarin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN\/NR + ACE-inhibitors \/ ARBs:\u003c\/strong\u003e Martens 2018 saw additional BP drop on NR — if your BP is well-controlled, monitor for hypotension when starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMagnesium + tetracycline \/ fluoroquinolone antibiotics:\u003c\/strong\u003e Take 2 hours apart — magnesium chelates these antibiotics and reduces absorption.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSpermidine (wheat-germ-derived):\u003c\/strong\u003e Contains residual gluten — coeliac disease is a contraindication.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding:\u003c\/strong\u003e Most longevity compounds (NMN, NR, Spermidine, Resveratrol, Berberine, high-dose Curcumin) lack pregnancy safety data and should be avoided. Foundational nutrients (Omega-3, D3, K2 within RDA range, Magnesium) are generally safe under prenatal-care guidance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for — and who it isn't\u003c\/h2\u003e\n\u003ch3\u003eStrong fit\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 40+ with elevated lipids, BP, hsCRP, or fasting glucose at the lab.\u003c\/li\u003e\n  \u003cli\u003eAnyone on a statin (CoQ10 is essentially mandatory).\u003c\/li\u003e\n  \u003cli\u003eFamily history of premature CAD, sudden cardiac death, or heart failure.\u003c\/li\u003e\n  \u003cli\u003ePost-menopausal women (K2 + D3 for arterial calcification + bone density combined).\u003c\/li\u003e\n  \u003cli\u003eEndurance athletes 40+ (CoQ10, taurine, omega-3 for cardiac output and recovery).\u003c\/li\u003e\n  \u003cli\u003eAnyone with a high coronary calcium score actively trying to slow the slope.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLess obvious fit\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003ePeople with great labs but a strong family history — start the foundation early; the slope of risk matters.\u003c\/li\u003e\n  \u003cli\u003ePeople in their 30s building a healthspan baseline before things drift — Omega-3 + D3+K2 + Magnesium make sense as a 30+ floor.\u003c\/li\u003e\n  \u003cli\u003eRecently post-CV-event (post-MI, post-stent) under cardiology care — discuss with your team; many cardiologists will green-light Omega-3, D3+K2, CoQ10, magnesium, and curcumin.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eNot a fit\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnancy\/breastfeeding (default to your obstetric team's guidance — most of these compounds don't have pregnancy data).\u003c\/li\u003e\n  \u003cli\u003eActive anticoagulation without prescriber coordination (Omega-3, K2, garlic-family compounds, high-dose Curcumin).\u003c\/li\u003e\n  \u003cli\u003eActive GI bleed, recent surgery, or platelet disorders.\u003c\/li\u003e\n  \u003cli\u003eSevere CKD (some compounds renally cleared; coordinate with your nephrologist).\u003c\/li\u003e\n  \u003cli\u003eAnyone expecting a single supplement to replace a statin, BP drug, or anticoagulant. The supplement layer adds; it doesn't replace.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality standards — what we built into every cardiovascular SKU\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP, FDA-registered facility manufacturing.\u003c\/strong\u003e NSF\/USP-tier processes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHPLC potency on every batch.\u003c\/strong\u003e Label claim verified, not estimated.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy-metal panel\u003c\/strong\u003e on every fish-oil and herbal-extract batch (lead, arsenic, cadmium, mercury) at California Prop 65 limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTOTOX testing\u003c\/strong\u003e on Omega-3 (oxidation state — most consumer fish oil fails this; ours doesn't).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-isomer verification\u003c\/strong\u003e on Resveratrol and Pterostilbene (the active anomer is trans; the cis form is mostly inactive).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBranded-ingredient sourcing\u003c\/strong\u003e where it matters: BioPerine for piperine, TRAACS for magnesium glycinate, BioPQQ for PQQ, Niagen-class for NR, Mitopure-grade for Urolithin A.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo proprietary blends.\u003c\/strong\u003e Every active ingredient and dose is on the label.\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eNo titanium dioxide, no magnesium stearate, no PEGs.\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHPMC (vegan) capsules.\u003c\/strong\u003e Bovine gelatin only where the trial format used it (a small minority of softgel SKUs).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e24-month shelf life\u003c\/strong\u003e verified by accelerated stability testing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRead the full \u003ca href=\"\/he\/pages\/quality\"\u003eQuality standards page\u003c\/a\u003e and the \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient sourcing page\u003c\/a\u003e for batch-level detail.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked — cardiovascular-specific\u003c\/h2\u003e\n\n\u003ch3\u003eCan I take all 14 of these together?\u003c\/h3\u003e\n\u003cp\u003eYou can. Most longevity-protocol-experienced users converge on a 8–12 SKU stack within a year. The only stacking caveat is the methylation tax of high-dose NMN\/NR — pair with TMG. And mind the bleeding-risk additivity of Omega-3 + Curcumin + Quercetin + Resveratrol if you're on an anticoagulant.\u003c\/p\u003e\n\n\u003ch3\u003eI'm on a statin. What's the priority order?\u003c\/h3\u003e\n\u003cp\u003e(1) CoQ10 — non-negotiable if statins are part of your regimen. (2) Omega-3 — synergistic with statins; REDUCE-IT and JELIS were both on statin background. (3) D3+K2 — particularly for the K2 arterial-calcification arm. (4) Magnesium — corrects deficiency that statin-related muscle complaints can mask. Consider Curcumin and Berberine to address the inflammatory and metabolic arms statins don't directly hit.\u003c\/p\u003e\n\n\u003ch3\u003eWill Berberine replace metformin?\u003c\/h3\u003e\n\u003cp\u003eYin 2008 showed comparable HbA1c reduction at 3 months in T2DM. That's mechanistic equivalence on a single metric — not regulatory equivalence. Metformin has 60+ years of mortality data, an FDA approval, and a Cochrane review base behind it. If your physician has prescribed metformin, do not substitute. Berberine is reasonable as adjunctive for prediabetes, metabolic syndrome, or as a glucose tool when metformin is not appropriate. Discuss with the prescriber.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until my lipid panel changes?\u003c\/h3\u003e\n\u003cp\u003eBerberine: 8–12 weeks (Dong 2013 timing). Omega-3: triglycerides shift in 4–8 weeks; LDL particle quality (small-dense → large-buoyant) takes longer. Pterostilbene: 6–8 weeks (Riche 2014). Plant-sterol-free diet, soluble fibre, and statin therapy will dwarf the supplement effect on raw LDL-C. Use supplements where they're doing what statins don't — inflammation, oxidation, endothelial function, mitochondrial output.\u003c\/p\u003e\n\n\u003ch3\u003eVitamin D3 with or without K2?\u003c\/h3\u003e\n\u003cp\u003eWith. Always. D3 alone increases calcium absorption from the gut. Without K2 to direct that calcium into bones (via osteocalcin γ-carboxylation) and away from vasculature (via matrix Gla protein γ-carboxylation), the calcium can deposit in arteries instead. Maresz 2015 (Integrative Med) lays out the calcium-direction logic. We co-formulate the two for that reason.\u003c\/p\u003e\n\n\u003ch3\u003eWhy MK-7 over MK-4?\u003c\/h3\u003e\n\u003cp\u003eSerum half-life. MK-7 = ~3 days. MK-4 = ~1 hour. MK-7 maintains continuous γ-carboxylation activity at a once-daily dose. MK-4 needs 3× daily redosing at 5–15 mg per dose to match the effect. The Knapen 2015 trial that showed arterial-stiffness reduction over 3 years used 180 mcg\/d MK-7.\u003c\/p\u003e\n\n\u003ch3\u003eIs the Q-SYMBIO trial relevant if I don't have heart failure?\u003c\/h3\u003e\n\u003cp\u003eThe MACE\/mortality endpoint comes from advanced (NYHA III–IV) heart failure. Q-SYMBIO is the strongest evidence in that population. For lower-severity populations, the relevant CoQ10 evidence is KISEL-10 (mortality reduction in healthy elderly with selenium adjunct) and the cardiac-tissue CoQ10 pharmacology (depletion with statins, age-decline). The 100–200 mg\/d general-support dose is reasonable for healthy adults; the 300–400 mg\/d Q-SYMBIO dose is what you'd use if there were any heart-failure or statin-intensive context.\u003c\/p\u003e\n\n\u003ch3\u003eHow does the Singh 2023 taurine paper apply to me?\u003c\/h3\u003e\n\u003cp\u003eSingh 2023 (Nature) was the largest taurine-and-aging study to date — combining cohort data showing plasma taurine declines ~80% from age 5 to 60, with mouse and primate intervention data showing healthspan extension on restoration. It's mechanistic + cohort + animal-intervention level evidence — not yet a controlled RCT in humans. The cardiovascular intervention RCTs (Beyranvand 2011, Schaffer 2018) provide the orthogonal supporting data. Reasonable case to take 1–3 g\/d at 50+; conservative case to wait for bigger human RCTs.\u003c\/p\u003e\n\n\u003ch3\u003eDoes Spermidine actually do anything in the dose I can take by mouth?\u003c\/h3\u003e\n\u003cp\u003eThe Eisenberg 2016 \/ Kiechl 2018 cohort signals are at \u003cem\u003edietary\u003c\/em\u003e intakes (top quintile ~25 mg\/d from food). 10 mg\/d wheat-germ-derived spermidine sits in the meaningful dietary-intake range. The mechanism (cardiac autophagy, eIF5A hypusination) is solid. The replicated cohort signal across Bruneck and EPIC (n \u0026gt;23,000) is unusual for a dietary supplement.\u003c\/p\u003e\n\n\u003ch3\u003eWhat about garlic, hawthorn, hibiscus?\u003c\/h3\u003e\n\u003cp\u003eGarlic (aged extract): modest BP and LDL effect, kalpa- and trial-validated. Hawthorn: NYHA II heart-failure adjunct evidence, smaller signal. Hibiscus: small SBP effect (~5 mmHg). All reasonable, none in our current catalog. We focus on the compounds with the deepest replicated mechanism + endpoint evidence.\u003c\/p\u003e\n\n\u003ch3\u003eNiacin (Vitamin B3) — yes or no?\u003c\/h3\u003e\n\u003cp\u003eThe HPS2-THRIVE and AIM-HIGH trials showed niacin added to statin failed to reduce events and increased some adverse effects (Boden 2011, HPS2-THRIVE 2014). We do not promote high-dose niacin for lipid management. Methyl-group-conserving NAD+ precursors (NMN, NR) are different molecules and use a different pathway — they don't carry the niacin flush or HPS2-THRIVE history.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if I don't see anything happen in 4 weeks?\u003c\/h3\u003e\n\u003cp\u003eYou won't. Cardiovascular markers are slow. Lipids: 8–12 weeks. 25(OH)D: 8–16 weeks. PWV\/CIMT: 6–24 months. The fastest signal you should expect is on sleep (magnesium, glycine) and exercise recovery (omega-3, taurine, CoQ10) within 2–4 weeks. The rest is on the timeline of the underlying biology, not the marketing copy of the bottle.\u003c\/p\u003e\n\n\u003ch3\u003eDo you have a 30-day money-back guarantee?\u003c\/h3\u003e\n\u003cp\u003eYes — see \u003ca href=\"\/he\/pages\/guarantee\"\u003eGuarantee\u003c\/a\u003e and \u003ca href=\"\/he\/policies\/refund-policy\"\u003eRefund policy\u003c\/a\u003e. The honest framing: 30 days is enough time to confirm the magnesium-and-sleep effect, GI tolerance, and that the bottles are what they say they are. It's not enough time to see lipid or arterial-stiffness shifts. Plan for a 12-week minimum to evaluate the cardiovascular layer; the guarantee is for fit-and-quality, not for slow biology.\u003c\/p\u003e\n\n\u003ch2\u003eReading list\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/coq10-and-statins-the-cofactor-your-statin-depletes-and-why-it-matters\"\u003eCoQ10 and statins — the cofactor your statin depletes\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational health — the 7 daily nutrients underneath every stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40 — what changes\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\"\u003eFull Protocol Library\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhere to next\u003c\/h2\u003e\n\u003cp\u003eThis collection is the cardiovascular vertical. The rest of the site:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e — the López-Otín hallmarks-of-aging framework that organises the catalog.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e — the six house protocols (Cellular, Senolytic, Mitochondrial, Skin, Brain, Cardiovascular).\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/getting-started\"\u003eGetting Started\u003c\/a\u003e — a guided first-bottle decision walkthrough.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/how-it-works\"\u003eHow it works\u003c\/a\u003e — sourcing, dosing, manufacturing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/quality\"\u003eQuality standards\u003c\/a\u003e — cGMP, COA, third-party testing detail.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient sourcing\u003c\/a\u003e — where every active comes from.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/contact\"\u003eContact\u003c\/a\u003e — pre-purchase questions, drug-interaction reviews, bulk and clinical inquiries.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/guarantee\"\u003e30-day Guarantee\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSister collections:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — D3, K2, magnesium, omega-3 (the cardiovascular foundation overlap).\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/nmn\"\u003eNMN Supplements\u003c\/a\u003e — entry into the cellular-renewal layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — full NAD+ ecosystem.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — fisetin and quercetin for vascular smooth-muscle senescence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — Urolithin A + PQQ + CoQ10.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/brain-cognitive-longevity\"\u003eBrain \u0026amp; Cognitive Longevity\u003c\/a\u003e — overlapping endothelial mechanisms.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — glucose, lipids, insulin sensitivity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e — the curated essentials lineup.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/all\"\u003eAll Products\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. If you have cardiovascular disease, are on anticoagulants, blood-pressure medication, statins, glucose-lowering medication, immunosuppressants, or chemotherapy, talk to your doctor before starting any supplement. Cardiovascular medications are doing real work — supplements are adjunctive, not replacement. Do not stop or modify a prescribed cardiovascular medication based on supplement use without your physician's input. If you experience chest pain, sudden shortness of breath, syncope, or one-sided weakness or speech disturbance, call emergency services — those are time-critical symptoms that supplements do not address.\u003c\/em\u003e\u003c\/p\u003e\n","products":[{"product_id":"resveratrol-600mg-60-capsules-30-day-supply","title":"Resveratrol Complex Capsules","description":"\u003cp\u003e\u003cstrong\u003e600 mg of trans-resveratrol per capsule\u003c\/strong\u003e — the SIRT1-activating polyphenol that anchors the canonical NMN + resveratrol longevity stack. ≥98% HPLC-verified trans-anomer from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e root extract, vegan capsule, no fillers, no proprietary blends. Stack-grade dose, not a label-claim dose.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe polyphenol that put sirtuins on the longevity map.\u003c\/strong\u003e Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e identified resveratrol as the most potent natural sirtuin-activating compound (STAC) ever screened; Baur 2006 \u003cem\u003eNature\u003c\/em\u003e showed it extended lifespan in calorically-stressed mice; Hubbard 2013 \u003cem\u003eScience\u003c\/em\u003e solved the SIRT1 allosteric crystal structure. Two decades and 13,000+ PubMed hits in, trans-resveratrol remains the canonical SIRT1 activator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne capsule, daily, with the largest fat-containing meal.\u003c\/strong\u003e Resveratrol is fat-soluble — fasted dosing throws away most of the pill. Pair with breakfast (eggs, avocado, fatty fish, olive oil) or lunch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest paired with \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500 mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-pure-focus-formula-cellular-rejuvenation\"\u003eNMN 1000 mg\u003c\/a\u003e.\u003c\/strong\u003e NMN raises NAD+ substrate; resveratrol activates the SIRT1\/SIRT3 enzymes that \u003cem\u003euse\u003c\/em\u003e that NAD+. Substrate + activator. Get both at -10% as the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e600 mg is the stack-grade dose.\u003c\/strong\u003e 100–250 mg is where the \"resveratrol doesn't work in humans\" meta-analyses concentrate; 500–1000 mg\/day is where the cardiometabolic and SIRT1 data live (Tomé-Carneiro 2012\/2013, Bhatt 2012, Movahed 2013, Pollack 2017).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e≥98% HPLC trans-resveratrol.\u003c\/strong\u003e The bioactive anomer — not the cis-isomer UV-degradation product cheap brands ship. Per-batch third-party COA, heavy-metals\/microbial\/residual-solvents panel, vegan HPMC capsule, no titanium dioxide, no magnesium stearate, no rice-flour bulker.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy resveratrol still anchors a serious longevity stack — even after the noise\u003c\/h2\u003e\n\u003cp\u003eIf you only read the headlines, you'd think resveratrol got debunked. It didn't. What got debunked was the \u003cem\u003e1 mg of resveratrol in a glass of red wine\u003c\/em\u003e story — Smoliga 2011 (\u003cem\u003eMol Nutr Food Res\u003c\/em\u003e) showed you'd need ~1,500 bottles a day to hit the doses tested in the original Sinclair-lab mouse work. The science on the \u003cem\u003emolecule itself\u003c\/em\u003e kept moving in the right direction.\u003c\/p\u003e\n\u003cp\u003eThe López-Otín 2013 (\u003cem\u003eCell\u003c\/em\u003e) and updated 2023 hallmarks-of-aging frameworks list \u003cstrong\u003ederegulated nutrient sensing\u003c\/strong\u003e, \u003cstrong\u003emitochondrial dysfunction\u003c\/strong\u003e, \u003cstrong\u003echronic inflammation\u003c\/strong\u003e, and \u003cstrong\u003ecellular senescence\u003c\/strong\u003e among the twelve hallmarks. Resveratrol hits all four:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuin activation (SIRT1, SIRT3)\u003c\/strong\u003e — the deacetylase axis that converts NAD+ into longevity-relevant outputs (PGC-1α, FOXO3a, p53, eNOS deacetylation).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK activation\u003c\/strong\u003e — the same fuel-sensor pathway hit by metformin, berberine, and exercise (Park 2012, \u003cem\u003eCell\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNF-κB suppression \/ inflammaging\u003c\/strong\u003e — inhibits IKK, stabilizes IκB, dampens p65 nuclear translocation (Csiszar 2008).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndothelial protection\u003c\/strong\u003e — upregulates eNOS expression and activity (Wallerath 2002, \u003cem\u003eCirculation\u003c\/em\u003e); Tomé-Carneiro 2013 showed 350 mg\/day for 12 months reduced oxidized LDL by 20% in CHD patients \u003cem\u003ealready on statins\u003c\/em\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNone of this requires resveratrol to be a magic pill. It just has to be the polyphenol with the strongest, longest-validated sirtuin-and-AMPK story across the most diverse organism panel — which it is.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — what resveratrol actually does inside the cell\u003c\/h2\u003e\n\n\u003ch3\u003e1. SIRT1 allosteric activation (the NMN partner)\u003c\/h3\u003e\n\u003cp\u003eSIRT1 is the most-studied of the seven mammalian sirtuins. It's a class-III deacetylase, meaning it consumes NAD+ as a co-substrate to remove acetyl groups from longevity-relevant substrates: \u003cstrong\u003ePGC-1α\u003c\/strong\u003e (mitochondrial biogenesis), \u003cstrong\u003eFOXO3a\u003c\/strong\u003e (stress resistance, antioxidant gene expression), \u003cstrong\u003ep53\u003c\/strong\u003e (apoptosis tone), \u003cstrong\u003eeNOS\u003c\/strong\u003e (vasodilation), \u003cstrong\u003eNF-κB p65\u003c\/strong\u003e (inflammation suppression), and the \u003cstrong\u003ehistone H3K9\/H4K16\u003c\/strong\u003e marks that gate the inflammatory transcriptome.\u003c\/p\u003e\n\u003cp\u003eWithout enough NAD+, SIRT1 stalls. Without an allosteric activator, SIRT1 runs at baseline. Resveratrol covers the second half. \u003cstrong\u003eHubbard 2013\u003c\/strong\u003e (\u003cem\u003eScience\u003c\/em\u003e) crystallized the SIRT1 N-terminal allosteric domain and showed resveratrol binds at a defined activator pocket, increasing SIRT1 activity toward acetylated substrates by up to 8-fold for substrates carrying hydrophobic recognition motifs. This resolved the earlier \"is the activation real or a fluorophore artifact?\" debate cleanly in resveratrol's favor.\u003c\/p\u003e\n\u003cp\u003eThis is the mechanistic argument for stacking \u003cstrong\u003eNMN (substrate) + resveratrol (activator)\u003c\/strong\u003e. NMN raises the NAD+ floor; resveratrol pushes the SIRT1 enzyme that uses it. Either alone is meaningfully under-leveraged; together they multiply.\u003c\/p\u003e\n\n\u003ch3\u003e2. SIRT3 and the mitochondrial deacetylase axis\u003c\/h3\u003e\n\u003cp\u003eSIRT3 is the major mitochondrial sirtuin and deacetylates ~65% of all mitochondrial-matrix lysine-acetyl marks. Its substrates include \u003cstrong\u003eSOD2\u003c\/strong\u003e (the manganese superoxide dismutase that scavenges mitochondrial ROS), \u003cstrong\u003eOPA1\u003c\/strong\u003e (mitochondrial fusion), and core ETC components. Resveratrol upregulates SIRT3 transcription and protein levels via PGC-1α-driven nuclear-respiratory-factor signaling — the same loop AMPK feeds into. Functionally, this is the leg behind resveratrol's mitochondrial-biogenesis signal in muscle (Lagouge 2006, \u003cem\u003eCell\u003c\/em\u003e) and the SOD2-mediated antioxidant signal that reduces mitochondrial-derived 8-oxo-dG damage in aging tissue.\u003c\/p\u003e\n\n\u003ch3\u003e3. AMPK activation (the metabolic fuel-sensor)\u003c\/h3\u003e\n\u003cp\u003eIndependent of sirtuins, resveratrol activates AMPK by inhibiting mitochondrial F1F0-ATP synthase (Park 2012, \u003cem\u003eCell\u003c\/em\u003e). Falling cellular ATP raises the AMP:ATP ratio, which is the upstream nudge AMPK senses. Activated AMPK then:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003ePhosphorylates and inactivates \u003cstrong\u003eACC\u003c\/strong\u003e (acetyl-CoA carboxylase) → lipid β-oxidation up.\u003c\/li\u003e\n  \u003cli\u003ePhosphorylates and inhibits \u003cstrong\u003emTORC1\u003c\/strong\u003e via TSC2 → catabolic autophagy up, anabolic protein synthesis down.\u003c\/li\u003e\n  \u003cli\u003ePhosphorylates \u003cstrong\u003ePGC-1α\u003c\/strong\u003e at Thr177\/Ser538 → mitochondrial biogenesis up, in concert with the SIRT1-deacetylation hit at the same protein.\u003c\/li\u003e\n  \u003cli\u003eTranslocates \u003cstrong\u003eGLUT4\u003c\/strong\u003e to muscle membrane → insulin-independent glucose uptake.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is why the cardiometabolic trial signal for resveratrol is strongest in patients with insulin resistance, established CHD, or metabolic syndrome — the AMPK leg pulls weight even when the sirtuin leg is debated. It's also why resveratrol stacks cleanly with metformin and berberine: three different upstream inputs into the same fuel-sensor.\u003c\/p\u003e\n\n\u003ch3\u003e4. NF-κB suppression (the inflammaging dampener)\u003c\/h3\u003e\n\u003cp\u003eNF-κB is the transcription-factor central node behind senescent-cell SASP secretion, chronic CRP elevation, and most age-associated inflammatory tone. The López-Otín 2023 hallmarks paper added \"chronic inflammation\" as a standalone hallmark for exactly this reason. Resveratrol inhibits NF-κB activation at multiple steps:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIKK suppression\u003c\/strong\u003e — blocks the kinase complex that phosphorylates IκB.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIκBα stabilization\u003c\/strong\u003e — keeps the inhibitor bound to NF-κB longer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ep65 nuclear-translocation block\u003c\/strong\u003e — even if some NF-κB escapes, less of it reaches DNA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSIRT1-mediated p65 deacetylation\u003c\/strong\u003e — Lys310 deacetylation reduces NF-κB transactivation (Yeung 2004, \u003cem\u003eEMBO J\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCsiszar 2008 (\u003cem\u003eMech Ageing Dev\u003c\/em\u003e) demonstrated this in human coronary arterial endothelial cells; the effect is reproduced across hepatocytes, macrophages, and chondrocytes. This dovetails with the senolytic + NF-κB-suppression strategy: senolytics (Quercetin, Fisetin) clear senescent cells; resveratrol dampens the inflammatory tone the surviving cells secrete.\u003c\/p\u003e\n\n\u003ch3\u003e5. Endothelial \/ eNOS upregulation\u003c\/h3\u003e\n\u003cp\u003eWallerath 2002 (\u003cem\u003eCirculation\u003c\/em\u003e) showed resveratrol upregulates endothelial nitric oxide synthase (eNOS) at both transcriptional and post-translational levels. eNOS-derived NO is the master vasodilator and a key brake on platelet aggregation and leukocyte adhesion to the endothelium. The signal is dose-dependent and clinically translates: Tomé-Carneiro's Spanish CHD-cohort series (2012\/2013) showed grape-extract resveratrol (350 mg\/day for 6–12 months) improved flow-mediated dilation, reduced oxidized LDL, and shifted multiple inflammatory apolipoproteins, in patients \u003cem\u003ealready optimized on statins\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp\u003eThis is part of why resveratrol kept its seat at the table after the \"French paradox\" framing aged badly — the molecular eNOS \/ NF-κB \/ SIRT1 mechanisms hold up even when the \"red wine prevents heart disease\" narrative doesn't.\u003c\/p\u003e\n\n\u003ch3\u003e6. Autophagy and the mTOR brake\u003c\/h3\u003e\n\u003cp\u003eThrough both AMPK activation and direct ULK1 phosphorylation, resveratrol induces macroautophagy — the cellular self-clearance program that clears damaged organelles, aggregated proteins, and dysfunctional mitochondria (mitophagy via PINK1\/Parkin). Pietrocola 2017 showed resveratrol triggers an autophagic signature in skeletal muscle that is mechanistically distinct from the spermidine-driven EP300 inhibition route, meaning the two stack additively. This is the leg behind the proteostasis-restoration argument for resveratrol — stacked with \u003ca href=\"\/he\/products\/spermidine-10mg-60-capsules-30-day-supply\"\u003espermidine\u003c\/a\u003e, you cover both major upstream autophagy switches.\u003c\/p\u003e\n\n\u003ch2\u003eThe trans-anomer — what \"≥98% trans-resveratrol\" actually means\u003c\/h2\u003e\n\u003cp\u003eResveratrol exists as two stereoisomers:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003etrans-resveratrol\u003c\/strong\u003e — the bioactive form. Every clinical trial measured this. Every SIRT1, AMPK, NF-κB, and eNOS mechanism documented above is trans-resveratrol's signature. This is the molecule the Sinclair lab tested, the molecule Tomé-Carneiro dosed, the molecule Hubbard crystallized.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecis-resveratrol\u003c\/strong\u003e — a UV-degradation product. The double bond in the stilbene core photoisomerizes from trans to cis under exposure to ultraviolet light, oxygen, and heat. Cis-resveratrol has dramatically reduced SIRT1 binding affinity and minimal in-vivo activity in published comparisons.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCheap resveratrol products mix them — and because cis-resveratrol can't be distinguished from trans by simple UV-Vis spectrophotometry (the cheap industry-standard assay), label claims that don't specify HPLC are often inflated by cis-isomer drift that occurred during storage, processing, or shipping. \u003cstrong\u003e≥98% HPLC trans-resveratrol means each batch is run on high-pressure liquid chromatography with diode-array detection at 308 nm — the assay that actually separates the two anomers.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe other 2% is residual \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e polyphenols (emodin, polydatin, piceid) at trace level, not cis-isomer drift. This is the molecular-grade material, not the food-grade material.\u003c\/p\u003e\n\n\u003ch2\u003eWhy \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e (Japanese knotweed)\u003c\/h2\u003e\n\u003cp\u003eTrans-resveratrol can be extracted from grape skins, peanut hulls, or \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e (Japanese knotweed) root. The Sinclair-lab work, the Tomé-Carneiro Spanish CHD trials, and the bulk of the human cardiometabolic literature all use \u003cem\u003eP. cuspidatum\u003c\/em\u003e for one reason: \u003cstrong\u003enatural concentration\u003c\/strong\u003e. Knotweed root contains 2–5% trans-resveratrol by dry weight, versus 0.001–0.01% in grape skin. That means knotweed extract reaches ≥98% HPLC purity through standard solvent partitioning; grape-skin extract requires aggressive chromatographic purification that often leaves residual matrix polyphenols and pesticide residues.\u003c\/p\u003e\n\u003cp\u003eThis product uses \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e root extract, ethanol\/water partitioned, recrystallized, ≥98% HPLC trans-resveratrol. Same source class as the trial materials.\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence — the trials that anchor 600 mg\u003c\/h2\u003e\n\u003cp\u003eThe \"resveratrol works \/ doesn't work\" debate gets cleaner once you stratify by dose, formulation, and population. Here is the evidence we anchor 600 mg on.\u003c\/p\u003e\n\n\u003ch3\u003eCardiometabolic — the strongest signal\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTomé-Carneiro 2012\u003c\/strong\u003e (\u003cem\u003eAm J Cardiol\u003c\/em\u003e) — CHD patients on statins, 350 mg\/day grape-extract resveratrol for 6 months. Significant increase in serum adiponectin, downregulation of pro-inflammatory genes (CCL3, IL-1β, TNF-α) in PBMCs, reduction in atherogenic apolipoproteins. This is the cardiology-on-statins benchmark trial.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTomé-Carneiro 2013\u003c\/strong\u003e (\u003cem\u003eMol Nutr Food Res\u003c\/em\u003e) — same cohort, 12-month follow-up. Persistent reduction in oxidized LDL by ~20%, sustained anti-inflammatory transcriptional shift. The signal didn't wash out with longer dosing — which is the question every \"transient effect\" critic raised in 2010.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBhatt 2012\u003c\/strong\u003e (\u003cem\u003eNutr Res\u003c\/em\u003e) — type 2 diabetics, 250 mg\/day for 3 months. Significant reductions in HbA1c, systolic BP, total cholesterol. Lower dose, smaller effect, but the same direction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMovahed 2013\u003c\/strong\u003e (\u003cem\u003eEvid Based Complement Alternat Med\u003c\/em\u003e) — type 2 diabetics, 1000 mg\/day for 45 days. Significant reductions in fasting glucose, HbA1c, systolic BP, and total cholesterol; significant rise in HDL. Higher dose, bigger effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePollack 2017\u003c\/strong\u003e (\u003cem\u003eCardiovasc Drugs Ther\u003c\/em\u003e) — older adults with insulin resistance, 1000–2000 mg\/day for 6 weeks. Improved peripheral and hepatic insulin sensitivity by clamp; the dose-response argument crystallized in this trial.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCognition and cerebral blood flow\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKennedy 2010\u003c\/strong\u003e (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) — healthy adults, 250 and 500 mg single oral doses. Dose-dependent increase in cerebral blood-flow velocity and oxy\/deoxy-Hb in the prefrontal cortex (NIRS). Acute mechanism: eNOS\/NO-driven vasodilation crossing into cerebral circulation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWitte 2014\u003c\/strong\u003e (\u003cem\u003eJ Neurosci\u003c\/em\u003e) — overweight older adults, 200 mg\/day for 26 weeks. Improved memory performance and increased hippocampal functional connectivity, with reductions in glycated hemoglobin and body fat that paralleled the cognitive shift.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEvans 2017\u003c\/strong\u003e (\u003cem\u003eNutrients\u003c\/em\u003e) — postmenopausal women, 75 mg twice daily for 14 weeks. Improved cerebrovascular responsiveness and aspects of cognitive performance, again pointing at the vascular leg.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eBone, postmenopausal physiology, and inflammaging\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOrnstrup 2014\u003c\/strong\u003e (\u003cem\u003eJ Clin Endocrinol Metab\u003c\/em\u003e) — obese men, 500 mg twice daily for 16 weeks. Increased bone mineral density at lumbar spine and improved bone turnover markers. Suggests SIRT1-mediated osteoblast support is translating clinically.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWong 2017 \/ 2019\u003c\/strong\u003e (RESHAW trial, \u003cem\u003eInt J Cardiol\u003c\/em\u003e) — postmenopausal women, 75 mg twice daily for 12+24 months. Sustained improvements in cerebrovascular responsiveness, mood, and selected cardiometabolic markers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere the evidence is preliminary\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAll-cause mortality \/ lifespan in humans\u003c\/strong\u003e — no powered RCT exists and won't (ethics, timeline, expense). The animal lifespan signal is real (Baur 2006 in obese mice; lifespan extension in \u003cem\u003eS. cerevisiae\u003c\/em\u003e, \u003cem\u003eC. elegans\u003c\/em\u003e, \u003cem\u003eDrosophila\u003c\/em\u003e); human evidence is biomarker-level.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol monotherapy in elite\/young endurance athletes\u003c\/strong\u003e — Gliemann 2013 saw blunted training-induced cardiovascular adaptations in 60+ men at 250 mg\/day; signal hasn't replicated cleanly elsewhere, but the data exist. See contraindications.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCancer chemoprevention\u003c\/strong\u003e — preclinical signal is broad but human trials are early-phase and small.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eThe case for 600 mg over 100 mg or 250 mg\u003c\/h2\u003e\n\u003cp\u003eMost over-the-counter resveratrol caps at 100–250 mg, which is exactly the range where the \"resveratrol doesn't work in humans\" meta-analyses concentrate. The dose-response data tell a different story:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBioavailability is the limiting factor, not safety.\u003c\/strong\u003e Walle 2004 (\u003cem\u003eDrug Metab Dispos\u003c\/em\u003e) measured \u0026lt;1% free resveratrol in plasma after a 25 mg oral dose — but ~70% absorption, just rapidly glucuronidated and sulfated by phase-II liver metabolism. To get clinically meaningful free + conjugated AUC, you need 500 mg+ per dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe trials that worked used 500–1000 mg\/day.\u003c\/strong\u003e Tomé-Carneiro 2012 used 350 mg of a co-formulated grape extract (which improves uptake), but the broader cardiometabolic literature (Bhatt 2012, Movahed 2013, Pollack 2017, Ornstrup 2014) clusters at 500–1000 mg\/day. The Sinclair-lab mouse work scales to a human equivalent of ~750 mg\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e600 mg is the floor for serious longevity stacking.\u003c\/strong\u003e If you're running NMN at 500–1000 mg\/day for sirtuin substrate, the matched activator dose lives at 500–1000 mg trans-resveratrol — taken with a fat-containing meal so the lipid solubilization hits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAbove 1,000 mg\/day adds GI side effects without proportional benefit.\u003c\/strong\u003e Brown 2010 (\u003cem\u003eCancer Res\u003c\/em\u003e) saw mild diarrhea and GI cramping appear at 2.5 g\/day and above. 600 mg lands inside the high-tolerability window — meaningful free + conjugated AUC, no dose-limiting GI tone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTranslation: 100 mg is a label-claim dose. 250 mg is a hedge. \u003cstrong\u003e600 mg is a stack-grade dose.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — what the PK studies actually show\u003c\/h2\u003e\n\u003cp\u003eResveratrol's pharmacokinetics are unusual and worth understanding because they explain the whole \"take it with fat\" rule.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAbsorption is high.\u003c\/strong\u003e Walle 2004 measured ~70% intestinal absorption of an oral dose. The bottleneck isn't getting it across the gut wall.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFirst-pass hepatic conjugation is aggressive.\u003c\/strong\u003e The liver glucuronidates and sulfates resveratrol within minutes via UGT1A1 and SULT1A1. Measured plasma free resveratrol after 25 mg oral was \u0026lt;5 ng\/mL.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConjugates are not inert.\u003c\/strong\u003e Patel 2013 and follow-up work show resveratrol-3-O-sulfate and resveratrol-glucuronides are themselves bioactive at physiological concentrations and can be deconjugated locally in tissue by sulfatases and β-glucuronidases — a \"circulating depot\" model. Total free + conjugated AUC is what matters clinically, not free-fraction alone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFat-containing meal roughly doubles AUC.\u003c\/strong\u003e Vaz-da-Silva 2008 (\u003cem\u003eInt J Clin Pharmacol Ther\u003c\/em\u003e) showed AUC was significantly higher when resveratrol was administered with a standard meal versus fasting. La Porte 2010 confirmed across formulations.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHalf-life is ~9 hours for total radioactivity.\u003c\/strong\u003e One dose per day at 600 mg keeps measurable plasma exposure across the waking-hours window where SIRT1 demand is highest.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe practical translation: take 600 mg with breakfast or lunch (whichever has more fat). Don't take it on an empty stomach unless you want to throw away half the dose. Don't split it into 3×200 mg — the per-dose bioavailability ceiling falls off below 500 mg.\u003c\/p\u003e\n\n\u003ch2\u003eHow resveratrol maps onto the hallmarks of aging\u003c\/h2\u003e\n\u003cp\u003eThe López-Otín hallmarks (2013, updated 2023) are the field-standard taxonomy of biological aging. Resveratrol touches more of them than any other single polyphenol on our shelf:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDeregulated nutrient sensing\u003c\/strong\u003e — AMPK activation; mTOR suppression via AMPK-TSC2; SIRT1 deacetylation of mTORC1 substrates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial dysfunction\u003c\/strong\u003e — PGC-1α deacetylation by SIRT1; SIRT3-mediated SOD2 and ETC-component activation; AMPK-driven mitochondrial biogenesis.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCellular senescence \/ chronic inflammation\u003c\/strong\u003e — NF-κB suppression at IKK + p65 levels; SASP-cytokine dampening; pairs with senolytic protocols (quercetin\/fisetin) by clearing residual inflammation after the senescent cells themselves are removed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEpigenetic alterations\u003c\/strong\u003e — SIRT1\/SIRT3-mediated histone deacetylation (H3K9, H4K16); modulation of DNA-methyltransferase activity; SIRT-dependent chromatin remodeling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLoss of proteostasis \/ autophagy decline\u003c\/strong\u003e — AMPK→ULK1-driven macroautophagy; mitophagy via PINK1\/Parkin upstream signal; complementary to spermidine's EP300-inhibition route.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAltered intercellular communication\u003c\/strong\u003e — eNOS upregulation; SIRT1 deacetylation of endothelial transcription factors; reduced systemic inflammatory tone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThat's six of the twelve hallmarks with mechanism-grade evidence in a single molecule. This is the structural reason resveratrol earned the \"polyphenol that anchors a stack\" position.\u003c\/p\u003e\n\n\u003ch2\u003eResveratrol vs pterostilbene — the practical decision\u003c\/h2\u003e\n\u003cp\u003ePterostilbene is resveratrol's dimethylated cousin. Two methoxy groups in place of two hydroxyls makes it more lipid-soluble, less subject to first-pass conjugation, and longer-lived in plasma. So why isn't this the default?\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrial base.\u003c\/strong\u003e Resveratrol has 200+ human trials and 20+ years of mechanistic data. Pterostilbene has \u0026lt;10 published human trials and no long-term cardiometabolic series.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSIRT1 affinity.\u003c\/strong\u003e Resveratrol is the canonical SIRT1 allosteric activator. Pterostilbene activates SIRT1 in vitro but with less-characterized binding-site behavior; head-to-head assays don't put it ahead of resveratrol on a per-mole basis at the SIRT1 site.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLDL signal.\u003c\/strong\u003e Pterostilbene at 250 mg\/day has shown a small LDL-elevation in some studies (Riche 2014), which is not the direction you want for a longevity polyphenol. Resveratrol either reduces LDL-ox (Tomé-Carneiro 2012\/2013) or is neutral on LDL.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCost-per-mg.\u003c\/strong\u003e Pterostilbene is roughly 5–10x more expensive at equivalent doses. The bioavailability advantage (~3x AUC versus standard resveratrol) doesn't close that gap.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWe anchor the SIRT1 leg with trans-resveratrol because the evidence base is wider, the dose-response is well-characterized, and the cost-per-effective-dose is meaningfully lower. If you want both, pterostilbene 100–150 mg\/day stacks on top of resveratrol 600 mg without conflict — resveratrol covers the trial-base \/ cardiometabolic \/ NF-κB legs; pterostilbene reinforces the longer plasma exposure window.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — what \"resveratrol\" can mean on a label\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003cth\u003eSource \/ spec\u003c\/th\u003e\n\u003cth\u003eWhat it is\u003c\/th\u003e\n\u003cth\u003eTrial usage\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e≥98% trans-resveratrol from \u003cem\u003eP. cuspidatum\u003c\/em\u003e (HPLC)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStack-grade material. Trans-anomer verified. ~98% pure trans, ≤2% residual matrix polyphenols, undetectable cis-isomer drift.\u003c\/td\u003e\n\u003ctd\u003eSinclair-lab work; Tomé-Carneiro 2012\/2013; Movahed 2013; Pollack 2017. \u003cstrong\u003eThis product.\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e50% \/ 70% \/ 90% trans-resveratrol (UV-Vis assayed)\u003c\/td\u003e\n\u003ctd\u003eLower-purity knotweed extract. UV-Vis can't distinguish trans from cis — label claim is unreliable. Often heavier in residual emodin and other knotweed polyphenols (which can cause GI effects at scale).\u003c\/td\u003e\n\u003ctd\u003eNot used in clinical trials with PK confirmation. Consumer-grade material.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eGrape-skin extract (typically \u0026lt;1% resveratrol)\u003c\/td\u003e\n\u003ctd\u003eMixed polyphenol matrix. The Tomé-Carneiro grape-extract was a defined co-formulation; most \"grape resveratrol\" supplements on the shelf are not.\u003c\/td\u003e\n\u003ctd\u003eTomé-Carneiro used a specific defined grape extract — most generic grape-skin supplements aren't comparable.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003ePeanut-hull resveratrol\u003c\/td\u003e\n\u003ctd\u003eAllergen-relevant source. Can carry residual peanut protein at trace level.\u003c\/td\u003e\n\u003ctd\u003eNiche.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\"Resveratrol complex\" \/ \"antioxidant blend\"\u003c\/td\u003e\n\u003ctd\u003eOften 50–100 mg of resveratrol mixed with quercetin, grape-seed, green-tea, etc. Convenient — but you can't isolate the resveratrol dose, and per-mg resveratrol cost is usually higher.\u003c\/td\u003e\n\u003ctd\u003eNone of the above SIRT1\/AMPK\/eNOS trials used \"complex\" formulations.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhere this fits in our NAD+ \/ longevity family\u003c\/h2\u003e\n\u003cp\u003eResveratrol is one of three legs in the canonical sirtuin axis we run on this site:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ substrate (precursor floor)\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-pure-focus-formula-cellular-rejuvenation\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-supplement-anti-aging\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-nr-stick-packs\"\u003eLiquid NAD+ NR stick packs\u003c\/a\u003e. Raises the NAD+ ceiling SIRT1\/SIRT3 can draw on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuin activator (allosteric)\u003c\/strong\u003e — \u003cstrong\u003ethis product\u003c\/strong\u003e. Pushes SIRT1\/SIRT3 enzymatic activity at any given NAD+ concentration. The activator side of the equation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethyl-donor support\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-betaine\"\u003eTMG 1000mg\u003c\/a\u003e. Replenishes the SAMe methyl-pool that the NAD+→NAM→methylation pathway draws on at long-term high doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe convenience option — get all three sirtuin pieces at -10% — is the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e (NMN 500 + Resveratrol 600).\u003c\/p\u003e\n\u003cp\u003eBeyond the sirtuin axis, resveratrol pairs with a wider longevity protocol:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytics\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid\"\u003eQuercetin 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid\"\u003eFisetin 500mg\u003c\/a\u003e. Senolytics clear senescent cells; resveratrol dampens residual SASP inflammation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial layer\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/coq10-400mg-fertility-cellular-energy\"\u003eCoQ10 400mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy\"\u003eUrolithin A 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg\"\u003eCaAKG 1000mg\u003c\/a\u003e. Resveratrol drives mitochondrial biogenesis upstream; these support what the new mitochondria do downstream.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK \/ metabolic\u003c\/strong\u003e — Berberine, metformin (Rx). All three converge on AMPK by different upstream routes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNF-κB \/ anti-inflammatory\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/curcumin-1000mg-95-curcuminoids-bioperine\"\u003eCurcumin 1000mg + BioPerine\u003c\/a\u003e. Both suppress NF-κB; BioPerine improves both molecules' bioavailability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking matrix\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003cth\u003ePairs with\u003c\/th\u003e\n\u003cth\u003eWhy\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eNMN 500mg or NMN 1000mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eThe canonical longevity stack — NMN supplies NAD+ substrate, resveratrol activates the SIRT1\/SIRT3 enzyme that uses it. Same morning dose, same fat-containing meal. Get both as the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e at -10%.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTMG 1000mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLong-term high-dose NMN draws on the SAMe methyl-pool via the NAD+→NAM→methylated-NAM (MeNAM) clearance route. TMG (trimethylglycine) replenishes that pool. If you're running NMN + resveratrol daily, TMG eventually becomes non-optional.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLiposomal NAD+ \/ Liquid NAD+ NR stick packs\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFor circadian-dip coverage on top of the morning NMN substrate + resveratrol activator hit. Useful for users 50+ or running heavy training loads.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBerberine 500mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBoth activate AMPK by different upstream mechanisms (resveratrol via F1-ATPase inhibition; berberine via direct AMPK-α1 phosphorylation). Pairs especially well for metabolic-syndrome \/ insulin-resistance goals.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCurcumin + BioPerine\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBioPerine (piperine) inhibits CYP3A4-mediated hepatic conjugation, raising both curcumin and resveratrol AUC. Both molecules suppress NF-κB at complementary nodes — IKK (curcumin) + p65 deacetylation (resveratrol via SIRT1). Stack-stable, evidence-rich.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eQuercetin \/ Fisetin (senolytic protocol)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSenolytic flavonoids clear senescent cells; resveratrol dampens the residual SASP-cytokine inflammation. Run quercetin\/fisetin on a 2-day-pulse senolytic protocol; run resveratrol daily.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSpermidine 10mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBoth activate autophagy. Resveratrol via AMPK→mTOR-suppression→ULK1; spermidine via direct EP300 inhibition. Two upstream switches converging on the same autophagy machinery — additive, not redundant.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eUrolithin A 500mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eResveratrol drives mitochondrial biogenesis (PGC-1α deacetylation); Urolithin A drives mitophagy (PINK1\/Parkin). Together: more new mitochondria, fewer damaged ones. The classic mito-renewal pair.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eOmega-3 \/ fatty meal\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAlways co-dose with fat. Resveratrol bioavailability roughly doubles with a fat-containing meal. Omega-3s also have independent NF-κB suppression and complement resveratrol's eNOS leg.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cp\u003eResveratrol is not a stimulant. There is no acute \"feel\" effect on the first dose. The biological signals appear on different timelines:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e Acute eNOS \/ cerebral-blood-flow signal can register on the first day (Kennedy 2010 — single 250–500 mg dose increased prefrontal CBF measurably). For most users this is below subjective threshold but real on instrumentation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e Inflammatory-tone shifts begin (CRP, fibrinogen, IL-6). Most users notice a generalized \"less inflammation\" baseline — fewer joint complaints, faster recovery from training. SIRT1 substrate-deacetylation signaling has reached steady state.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e Lipid panel begins to shift in the cardiometabolic-risk subset (oxidized LDL down, HDL up modestly, triglycerides flat-to-down). Insulin-sensitivity changes appear in HOMA-IR and OGTT data on this timeline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e The Tomé-Carneiro biomarker timeline. LDL-ox reduction, atherogenic apolipoprotein shift, sustained anti-inflammatory transcriptional signature in PBMCs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 12+:\u003c\/strong\u003e Bone turnover markers and BMD changes in the relevant populations (Ornstrup 2014 saw lumbar BMD increase at 16 weeks). Cognitive \/ memory shifts appear in older adults around this timeline (Witte 2014 — 26-week trial).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRun for 12 weeks minimum, recheck labs. The signal is biomarker-level and accumulative; this is not a \"feel it on day 3\" molecule.\u003c\/p\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1 capsule per day, taken with the largest fat-containing meal of the day.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eResveratrol is fat-soluble and heavily phase-II-conjugated by the liver. Walle 2004, Vaz-da-Silva 2008, and Smoliga 2011 all converge: taking resveratrol on an empty stomach throws away most of the dose. With a fat-containing meal — even just olive oil, eggs, fatty fish, or avocado — measured plasma AUC roughly doubles versus fasted dosing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTiming notes:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDefault:\u003c\/strong\u003e with breakfast or lunch (whichever is the larger fat-containing meal). Aligns with the AM dose of NMN if you're stacking.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking with NMN:\u003c\/strong\u003e same meal as the morning NMN dose. This is the canonical Sinclair-protocol pairing — substrate + activator hit the SIRT1 axis together.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-workout:\u003c\/strong\u003e some users dose 60–90 minutes before resistance training to leverage the AMPK \/ mitochondrial-biogenesis crossover. Note the Gliemann 2013 caveat below before doing this if you're an older endurance athlete.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith BioPerine \/ curcumin:\u003c\/strong\u003e piperine inhibits CYP3A4 and raises resveratrol AUC by roughly 1.5–2x in the published bioavailability studies. If you're already taking \u003ca href=\"\/he\/products\/curcumin-1000mg-95-curcuminoids-bioperine\"\u003eCurcumin + BioPerine\u003c\/a\u003e with breakfast, your resveratrol AUC is going up too — for free.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAvoid grapefruit juice the same day.\u003c\/strong\u003e Grapefruit competes for the same CYP3A4 \/ UGT pathway resveratrol uses; the effect on AUC is real but not dangerous.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDon't take it before bed.\u003c\/strong\u003e Cerebral blood-flow upregulation can interfere with sleep onset for sensitive users.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs:\u003c\/strong\u003e 600 mg of ≥98% HPLC trans-resveratrol per capsule, sourced from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e (Japanese knotweed) root extract, in a vegan HPMC capsule, with no fillers, no proprietary blends, no titanium dioxide, no magnesium stearate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs:\u003c\/strong\u003e Per-batch HPLC-verified for trans-anomer purity (308 nm DAD); independently tested for heavy metals (USP \u0026lt;232\u0026gt;), microbials (USP \u0026lt;2021\u0026gt;), and residual solvents (USP \u0026lt;467\u0026gt;).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e A grape-skin extract. Knotweed-sourced trans-resveratrol is the trial-grade material; grape-skin extract is a different (and more variable) product class.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e A \"resveratrol complex.\" There's no quercetin, grape-seed extract, green-tea extract, or pterostilbene mixed in. Those are real ingredients but you can't dose them properly when they're hidden inside a single 600 mg capsule. We sell them separately when relevant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e A liposomal or micronized formulation. At 600 mg with a fat-containing meal, you're already in the clinically-validated AUC range without paying the 4–5x premium that liposomal resveratrol commands.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e A treatment for any specific disease. This is a longevity-stack supplement, not a cardiology drug, not a cancer therapeutic. Talk to your physician.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it on an empty stomach.\u003c\/strong\u003e Roughly halves the AUC. Always with a fat-containing meal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSplitting 600 mg into 3×200 mg doses.\u003c\/strong\u003e The per-dose absorption ceiling falls off below 500 mg — splitting reduces total daily AUC, not increases it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying 100 mg products and taking 6 capsules.\u003c\/strong\u003e Math works, but you're paying 3–5x per active mg and usually the source\/spec isn't HPLC-verified at the lower price point.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStopping after 4 weeks because nothing happened.\u003c\/strong\u003e The cardiometabolic biomarker timeline is 8–12 weeks. The SIRT1 axis steady-state is 4 weeks. The cognitive \/ BMD signals are 16–26 weeks. Don't bail at week 4.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking resveratrol with grapefruit juice.\u003c\/strong\u003e CYP3A4 competition. Not dangerous, but reduces predictability of dose-response.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRunning resveratrol monotherapy with no NAD+ precursor.\u003c\/strong\u003e Resveratrol activates SIRT1, but SIRT1 needs NAD+ as substrate. Without NMN or NR floor-raising, you're flooring the gas with the tank low.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying generic UV-Vis \"resveratrol\" and assuming it's trans.\u003c\/strong\u003e UV-Vis can't distinguish trans from cis. Cis-isomer drift in poorly-stored material can reduce label-active dose by 30%+ silently.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ running a serious longevity stack who want the canonical SIRT1 activator.\u003c\/li\u003e\n  \u003cli\u003eAnyone already taking NMN or NR who hasn't yet added the activator side of the equation.\u003c\/li\u003e\n  \u003cli\u003ePeople with cardiometabolic risk factors (elevated LDL-ox, insulin resistance, family history of CHD) who want a polyphenol with documented eNOS \/ NF-κB \/ AMPK signal at trial-grade dose.\u003c\/li\u003e\n  \u003cli\u003eStack-builders who want one molecule that does sirtuin co-activation + AMPK activation + NF-κB suppression + endothelial support simultaneously, rather than four separate inputs.\u003c\/li\u003e\n  \u003cli\u003ePostmenopausal women looking at cardiovascular and bone-density support (Wong \/ RESHAW; Ornstrup 2014).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy or breastfeeding.\u003c\/strong\u003e Insufficient human safety data above the dietary trace doses. Don't.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive hormone-sensitive cancer (breast, ovarian, endometrial, prostate).\u003c\/strong\u003e Resveratrol is a phytoestrogen with weak ER-binding affinity (~7,000x less than estradiol, tissue-specific). Clinical relevance at 600 mg is small for healthy adults but not zero — discuss with your oncologist before adding.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOn warfarin or active anti-platelet therapy.\u003c\/strong\u003e Resveratrol has mild antiplatelet effects in vitro (Pace-Asciak 1995); the clinical relevance at 600 mg is small but nonzero. Monitor INR if you're running both.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOlder competitive endurance athletes.\u003c\/strong\u003e Gliemann 2013 (\u003cem\u003eJ Physiol\u003c\/em\u003e) showed 250 mg\/day resveratrol blunted training-induced cardiovascular adaptations in 60+ men. The signal hasn't replicated cleanly in younger or recreational populations, but the data exist; if you're a competitive masters endurance athlete in a periodized peak block, time resveratrol around recovery weeks rather than peak-training weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergic to \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e.\u003c\/strong\u003e Rare but documented. Skin reactions, GI cramping. Stop and don't restart.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking strong CYP3A4 inhibitors\u003c\/strong\u003e (clarithromycin, ketoconazole, ritonavir). Resveratrol AUC will rise unpredictably; talk to your prescriber.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions, and contraindications\u003c\/h2\u003e\n\u003cp\u003eResveratrol has one of the cleanest oral safety profiles in the longevity-supplement space at \u0026lt;1 g\/day. Brown 2010 (\u003cem\u003eCancer Res\u003c\/em\u003e) tested 0.5–5 g daily for 29 days with no dose-limiting toxicity below 2.5 g; mild diarrhea \/ GI cramping appeared above that. 600 mg sits well below any documented dose-limiting tolerance threshold.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants \/ antiplatelets.\u003c\/strong\u003e Mild antiplatelet effect in vitro (Pace-Asciak 1995); clinical relevance at 600 mg is small but real. Monitor INR if on warfarin; talk to prescriber if on dual antiplatelet therapy after stenting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCYP3A4 substrates.\u003c\/strong\u003e Resveratrol is a mild CYP3A4 inhibitor. Drugs metabolized through CYP3A4 (statins, calcium-channel blockers, some immunosuppressants) may have modestly elevated AUC. Talk to prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUGT1A1 substrates.\u003c\/strong\u003e Resveratrol competes for hepatic glucuronidation. Drugs heavily UGT1A1-cleared (irinotecan metabolites, raltegravir) may behave unpredictably.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEstrogen-modulating drugs.\u003c\/strong\u003e Tamoxifen, aromatase inhibitors, hormonal contraceptives — discuss with your prescriber given resveratrol's weak ER-binding profile.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSSRIs and MAOIs.\u003c\/strong\u003e No documented interaction at 600 mg. Resveratrol's mild MAO-inhibition signal is at much higher doses than typical supplementation hits.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in it\u003c\/h2\u003e\n\u003cp\u003ePer capsule:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-resveratrol — 600 mg\u003c\/strong\u003e, from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e root extract, ≥98% HPLC trans-anomer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegan HPMC capsule.\u003c\/strong\u003e No gelatin.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eWhat's NOT in it:\u003c\/em\u003e No magnesium stearate, no silicon dioxide, no titanium dioxide, no maltodextrin, no rice flour, no proprietary blends, no cis-isomer drift, no inflated UV-Vis label claim. 600 mg is 600 mg of trans-resveratrol — not 600 mg of an \"antioxidant complex\" that turns out to be 50 mg resveratrol + 550 mg cellulose.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eAllergens:\u003c\/em\u003e No gluten, no soy, no dairy, no nuts, no shellfish, no eggs.\u003c\/p\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and quality control\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSource:\u003c\/strong\u003e \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e root extract, ethanol\/water partitioned, recrystallized to ≥98% trans-resveratrol by HPLC.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e cGMP-registered facility, NSF-audited; capsules filled under controlled humidity in opaque amber blister-stable bottles.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch testing:\u003c\/strong\u003e HPLC identity + potency at 308 nm (DAD); cis-isomer screen; heavy metals (USP \u0026lt;232\u0026gt;) for As\/Cd\/Hg\/Pb; microbial limits (USP \u0026lt;2021\u0026gt;) for total aerobic, yeast\/mold, E. coli, Salmonella; residual solvents (USP \u0026lt;467\u0026gt;).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Validated 24-month room-temperature stability under amber-bottle storage. Resveratrol is photo-sensitive — keep the bottle closed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePublic COA:\u003c\/strong\u003e per-batch certificate of analysis available at \u003ca href=\"\/he\/pages\/coa\"\u003etruehealthprotocol.health\/pages\/coa\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eDoes resveratrol actually extend lifespan in humans?\u003c\/h3\u003e\n\u003cp\u003eNo human RCT is powered for all-cause-mortality endpoints (the trial would take 30+ years and be ethically contested). What we have: lifespan extension in \u003cem\u003eS. cerevisiae\u003c\/em\u003e, \u003cem\u003eC. elegans\u003c\/em\u003e, \u003cem\u003eDrosophila\u003c\/em\u003e, and obese mice (Baur 2006); biomarker improvement across the cardiometabolic literature (Tomé-Carneiro 2012\/2013, Movahed 2013, Pollack 2017); mechanistic plausibility via SIRT1, AMPK, NF-κB, and eNOS. Treat resveratrol like the rest of the longevity stack — high-evidence biomarker work, mechanistic translation from animal lifespan data, ride the convergence.\u003c\/p\u003e\n\n\u003ch3\u003eResveratrol vs pterostilbene — which is \"better\"?\u003c\/h3\u003e\n\u003cp\u003ePterostilbene is resveratrol's dimethylated cousin with better bioavailability (more lipid-soluble, less first-pass conjugation, longer plasma half-life) but a much thinner trial base. Resveratrol has 200+ human trials and 20+ years of mechanistic data; pterostilbene has \u0026lt;10 published human trials. We anchor the SIRT1 leg with resveratrol because the evidence base is wider and the dose-response is well-characterized. If you want both, pterostilbene 100–150 mg\/day stacks fine on top of resveratrol 600 mg.\u003c\/p\u003e\n\n\u003ch3\u003eWhy not micronized or liposomal resveratrol?\u003c\/h3\u003e\n\u003cp\u003eBoth improve absorption modestly (~1.5–2x AUC vs standard). At 600 mg trans-resveratrol from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e in a fat-containing meal, you're already in the clinically active plasma range. The cost premium for liposomal (often 4–5x per active mg) doesn't pencil out for most users. We'd rather give you the verifiable molecular-grade material at a serious dose.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eResveratrol isn't a stimulant. The cardiometabolic biomarker shifts (LDL-ox, CRP, fasting insulin) appear in trials at 8–12 weeks. Bone-density and cognitive shifts take 16–26 weeks. Acute \"feel\" effects (energy, mental clarity) on day-1 are typically downstream of NMN substrate availability — this is why the NMN + resveratrol pairing is the standard. Run for 12 weeks minimum, recheck labs.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take it with metformin or berberine?\u003c\/h3\u003e\n\u003cp\u003eYes — and it's mechanistically synergistic. All three activate AMPK by different upstream routes: metformin via complex I inhibition, berberine via direct AMPK-α1 phosphorylation, resveratrol via F1F0-ATP synthase inhibition. Resveratrol's SIRT1 leg is independent of metformin's mechanism. The classic metabolic-syndrome stack is metformin (or berberine) + resveratrol + NMN.\u003c\/p\u003e\n\n\u003ch3\u003eWhy not just drink red wine?\u003c\/h3\u003e\n\u003cp\u003eBecause the dose math doesn't work. A 5 oz glass of red wine contains roughly 0.3–1.0 mg trans-resveratrol. 600 mg is the equivalent of 600–2,000 glasses. Even ignoring the alcohol harm-curve, the resveratrol math is impossible from food. The \"French paradox\" was never about resveratrol-the-molecule; it was about overall polyphenol intake plus Mediterranean-diet effects.\u003c\/p\u003e\n\n\u003ch3\u003eDoes resveratrol affect estrogen?\u003c\/h3\u003e\n\u003cp\u003eWeakly. Resveratrol binds estrogen receptors with ~7,000x lower affinity than estradiol, and its action is tissue-specific (mostly antagonist at ERα in breast tissue, mild agonist at ERβ in bone). The clinical relevance at 600 mg is small for healthy adults; meaningful for anyone with active hormone-sensitive cancer (see contraindications). Postmenopausal women in trials (Wong \/ RESHAW; Ornstrup) actually benefited from the ERβ agonist tone in bone — this is part of why BMD signals appear at 16+ weeks.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule and put it in a smoothie?\u003c\/h3\u003e\n\u003cp\u003eYou can, but don't. Resveratrol is photosensitive — UV exposure converts trans to cis (the inactive isomer). A smoothie blender's clear pitcher under kitchen light for 30 minutes is enough to nudge a measurable fraction. If you can't swallow capsules, dissolve in olive oil at room temp and consume immediately, in opaque container.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is daily consistency more important than dose?\u003c\/h3\u003e\n\u003cp\u003eThe SIRT1 deacetylation signaling Resveratrol drives doesn't store — it's a real-time enzymatic process. The NF-κB suppression and eNOS upregulation reset within ~48 hours of stopping. Hubbard 2013's mechanism is steady-state by design. 600 mg\/day for 90 days is dramatically more biologically active than 1,800 mg every third day.\u003c\/p\u003e\n\n\u003ch3\u003eShould I cycle off resveratrol?\u003c\/h3\u003e\n\u003cp\u003eThe published trials run continuously for 6–24 months without dose-limiting toxicity, withdrawal effects, or receptor down-regulation. There's no published rationale for cycling at 600 mg. The \"cycle everything\" supplement-bro heuristic doesn't apply to a polyphenol the body's already adapted to evolutionarily.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take resveratrol while fasting?\u003c\/h3\u003e\n\u003cp\u003eYes — but understand you'll get less of it. Fasted bioavailability is roughly half of fed bioavailability. If you're fasting and want to keep resveratrol on board, take it with the first fat-containing meal of your eating window, not during the fast itself.\u003c\/p\u003e\n\n\u003ch3\u003eDoes resveratrol show up on a drug test?\u003c\/h3\u003e\n\u003cp\u003eNo. Resveratrol and its glucuronide \/ sulfate conjugates are not on any standard drug-testing panel (sport, occupational, or law-enforcement). The molecule is structurally a stilbene polyphenol — entirely distinct from any controlled substance class.\u003c\/p\u003e\n\n\u003ch3\u003eIs this the same as the Sinclair-lab resveratrol?\u003c\/h3\u003e\n\u003cp\u003eSame source class (\u003cem\u003eP. cuspidatum\u003c\/em\u003e root extract, ≥98% trans-resveratrol HPLC) at the dose range used in animal lifespan work scaled to human equivalents. The Sinclair lab used ≥98% trans-resveratrol material throughout the Howitz 2003 \/ Baur 2006 \/ Hubbard 2013 work. We're not selling \"Sinclair's brand\" — we're selling the same molecular spec.\u003c\/p\u003e\n\n\u003ch3\u003eDoes resveratrol raise blood pressure?\u003c\/h3\u003e\n\u003cp\u003eNo. The vascular signal goes the other direction — eNOS-mediated vasodilation lowers systolic BP modestly in cardiometabolic trials (Movahed 2013; Bhatt 2012). Resveratrol does not have stimulant effects on heart rate or pressor effects on BP.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is daily consistency more important than peak dose?\u003c\/h3\u003e\n\u003cp\u003eThe SIRT1 deacetylation signal is steady-state. Hubbard 2013's allosteric activation is dose-rate-dependent at the cellular level — a constant 600 mg\/day flow keeps SIRT1 in the activated conformation continuously. Pulse-loading (1800 mg every 3 days) gives you the same average dose but with off-cycle troughs where SIRT1 reverts to baseline.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take it with NAD+ IV therapy?\u003c\/h3\u003e\n\u003cp\u003eYes — they're complementary, not duplicative. NAD+ IV raises blood NAD+ levels acutely; resveratrol activates the SIRT1 enzyme that uses NAD+. The pairing is logical: substrate (NAD+ IV or NMN) + activator (resveratrol).\u003c\/p\u003e\n\n\u003ch3\u003eDoes resveratrol interact with statins or blood-pressure medications?\u003c\/h3\u003e\n\u003cp\u003eNo major interaction in the published trial literature — Tomé-Carneiro's CHD cohort were on statins throughout, with the resveratrol arm showing additional LDL-ox reduction without altering statin pharmacokinetics meaningfully. Resveratrol is a mild CYP3A4 inhibitor in vitro; the clinical relevance for typical statin doses is small. Don't change prescribed medication without your physician.\u003c\/p\u003e\n\n\u003ch3\u003eIs the capsule kosher \/ halal?\u003c\/h3\u003e\n\u003cp\u003eVegan HPMC capsule shell. The resveratrol is plant-derived (knotweed root). No animal-derived ingredients, no alcohol residues above limits. Specific kosher \/ halal certification varies by batch — check the COA page for current certification status.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003eResveratrol 600mg occupies the \u003cstrong\u003eSirtuin Activator\u003c\/strong\u003e position in the True Health Protocol catalog. Three legs of the sirtuin axis on this site:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSubstrate (NAD+ floor)\u003c\/strong\u003e — NMN family (\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-pure-focus-formula-cellular-rejuvenation\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-supplement-anti-aging\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-nr-stick-packs\"\u003eLiquid NAD+ NR\u003c\/a\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivator (SIRT1\/SIRT3 push)\u003c\/strong\u003e — \u003cstrong\u003ethis product.\u003c\/strong\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethyl support (long-term)\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-betaine\"\u003eTMG 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe convenience pairing is the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e (NMN 500 + Resveratrol 600 at -10%).\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/longevity\"\u003eLongevity collection\u003c\/a\u003e — every product in the canonical longevity-stack architecture (NAD+ axis, sirtuin activators, senolytics, mitochondrial-renewal layer).\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/sirtuin-activators\"\u003eSirtuin activators\u003c\/a\u003e — resveratrol and pairing molecules.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular\"\u003eCardiovascular collection\u003c\/a\u003e — resveratrol, CoQ10, taurine, omega-3, and pairing nutrients.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/anti-inflammatory\"\u003eAnti-inflammatory collection\u003c\/a\u003e — resveratrol, curcumin, omega-3, quercetin.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/blogs\/longevity\/sirtuins-explained\"\u003eSirtuins explained — the seven enzymes longevity research orbits.\u003c\/a\u003e Why SIRT1 isn't the only sirtuin that matters, and how resveratrol fits across SIRT1\/SIRT3.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/blogs\/longevity\/nmn-vs-nad\"\u003eNMN vs NAD+ — what the precursor difference actually means.\u003c\/a\u003e The substrate side of the substrate-plus-activator equation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/blogs\/longevity\/classic-longevity-stack\"\u003eThe classic longevity stack — NMN + resveratrol explained.\u003c\/a\u003e Why these two molecules became the canonical pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/blogs\/longevity\/nad-decline-with-age\"\u003eNAD+ decline with age — what the data actually show.\u003c\/a\u003e Why the substrate side of the equation gets the most attention, and what resveratrol adds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/protocols\"\u003eThe True Health Protocol — full longevity protocol\u003c\/a\u003e showing where resveratrol slots into a complete supplementation framework.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eHowitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e 2003;425:191-6. — Original screen identifying resveratrol as a sirtuin activator. Context, not endorsement.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eBaur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. \u003cem\u003eNature\u003c\/em\u003e 2006;444:337-42. — Mouse lifespan extension on calorically-stressed diet.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eHubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, Riera TV, Lee JE, E SY, Lamming DW, Pentelute BL, Schuman ER, Stevens LA, Ling AJ, Armour SM, Michan S, Zhao H, Jiang Y, Sweitzer SM, Blum CA, Disch JS, Ng PY, Howitz KT, Rolo AP, Hamuro Y, Moss J, Perni RB, Ellis JL, Vlasuk GP, Sinclair DA. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. \u003cem\u003eScience\u003c\/em\u003e 2013;339:1216-9. — Crystal structure resolving SIRT1 allosteric activation.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003ePark SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e 2012;148:421-33. — AMPK leg via PDE\/cAMP signaling.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eTomé-Carneiro J, Gonzálvez M, Larrosa M, García-Almagro FJ, Avilés-Plaza F, Parra S, Yáñez-Gascón MJ, Ruiz-Ros JA, García-Conesa MT, Tomás-Barberán FA, Espín JC. Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial. \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e 2012;56:810-21.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eTomé-Carneiro J, Larrosa M, Yáñez-Gascón MJ, Dávalos A, Gil-Zamorano J, Gonzálvez M, García-Almagro FJ, Ruiz Ros JA, Tomás-Barberán FA, Espín JC, García-Conesa MT. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. \u003cem\u003ePharmacol Res\u003c\/em\u003e 2013;72:69-82.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eBhatt JK, Thomas S, Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. \u003cem\u003eNutr Res\u003c\/em\u003e 2012;32:537-41.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eMovahed A, Nabipour I, Lieben Louis X, Thandapilly SJ, Yu L, Kalantarhormozi M, Rekabpour SJ, Netticadan T. Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. \u003cem\u003eEvid Based Complement Alternat Med\u003c\/em\u003e 2013;2013:851267.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003ePollack RM, Barzilai N, Anghel V, Kulkarni AS, Golden A, O'Broin P, Sinclair DA, Bonkowski MS, Coleville AJ, Powell D, Kim S, Moaddel R, Stein D, Zhang K, Hawkins M, Crandall JP. Resveratrol improves vascular function and mitochondrial number but not glucose metabolism in older adults. \u003cem\u003eJ Gerontol A Biol Sci Med Sci\u003c\/em\u003e 2017;72:1703-9.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eWalle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. \u003cem\u003eDrug Metab Dispos\u003c\/em\u003e 2004;32:1377-82.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eSmoliga JM, Baur JA, Hausenblas HA. Resveratrol and health — a comprehensive review of human clinical trials. \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e 2011;55:1129-41.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eVaz-da-Silva M, Loureiro AI, Falcao A, Nunes T, Rocha JF, Fernandes-Lopes C, Soares E, Wright L, Almeida L, Soares-da-Silva P. Effect of food on the pharmacokinetic profile of trans-resveratrol. \u003cem\u003eInt J Clin Pharmacol Ther\u003c\/em\u003e 2008;46:564-70.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eWallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Förstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. \u003cem\u003eCirculation\u003c\/em\u003e 2002;106:1652-8.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eCsiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, Ungvari Z. Resveratrol induces mitochondrial biogenesis in endothelial cells. \u003cem\u003eAm J Physiol Heart Circ Physiol\u003c\/em\u003e 2009;297:H13-20.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eLagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. \u003cem\u003eCell\u003c\/em\u003e 2006;127:1109-22.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eYeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. \u003cem\u003eEMBO J\u003c\/em\u003e 2004;23:2369-80.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eWitte AV, Kerti L, Margulies DS, Flöel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. \u003cem\u003eJ Neurosci\u003c\/em\u003e 2014;34:7862-70.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eKennedy DO, Wightman EL, Reay JL, Lietz G, Okello EJ, Wilde A, Haskell CF. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e 2010;91:1590-7.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eOrnstrup MJ, Harsløf T, Kjær TN, Langdahl BL, Pedersen SB. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. \u003cem\u003eJ Clin Endocrinol Metab\u003c\/em\u003e 2014;99:4720-9.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eWong RH, Howe PR, Buckley JD, Coates AM, Kunz I, Berry NM. Acute resveratrol supplementation improves flow-mediated dilatation in overweight\/obese individuals with mildly elevated blood pressure. \u003cem\u003eNutr Metab Cardiovasc Dis\u003c\/em\u003e 2011;21:851-6.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eBrown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. \u003cem\u003eCancer Res\u003c\/em\u003e 2010;70:9003-11.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eGliemann L, Schmidt JF, Olesen J, Biensø RS, Peronard SL, Grandjean SU, Mortensen SP, Nyberg M, Bangsbo J, Pilegaard H, Hellsten Y. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. \u003cem\u003eJ Physiol\u003c\/em\u003e 2013;591:5047-59.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e 2013;153:1194-217. — Updated 2023 in \u003cem\u003eCell\u003c\/em\u003e 186:243-78. Foundational taxonomy of biological aging.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003e\u003cem\u003eReferences cited here are scientific context, not product endorsements. The molecular and clinical findings described above pertain to the molecules studied; this product supplies the same molecule (≥98% HPLC trans-resveratrol from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e) at a dose that overlaps the cited human-trial range. Individual results vary.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003chr\u003e\n\u003cp style=\"font-size:0.85em;line-height:1.55;\"\u003e\u003cem\u003e\u003cstrong\u003eFDA disclaimer:\u003c\/strong\u003e These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before starting any new supplement, particularly if you are pregnant, nursing, taking prescription medication (especially anticoagulants, antiplatelets, hormone-sensitive cancer treatments, CYP3A4 substrates), or have a known medical condition.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cdiv class=\"th-why-not-amazon\" style=\"margin:48px 0 24px;padding:24px;background:#f8f4ee;border-left:4px solid #9a5b3e;border-radius:6px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eWhy we don't sell this on Amazon\u003c\/h3\u003e\n  \u003cp\u003eAmazon's resveratrol category is a graveyard of UV-Vis-assayed knotweed extract sold as \"98% pure\" with no HPLC trans-anomer verification, ambiguous source-of-origin, and zero per-batch COA visibility. The sub-$15 price points only work because the active ingredient is partially cis-isomer drift — not the molecule any of the trials measured. We sell direct so we control the source (≥98% HPLC trans-resveratrol from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e), the per-batch COA stays public, and we can charge for verifiable molecular-grade material instead of competing with the bottom of the marketplace. Per active mg of trans-resveratrol, we're typically cheaper too. The math + the data: \u003ca href=\"\/he\/pages\/why-not-amazon\" style=\"color:#9a5b3e;font-weight:600;\"\u003eread the full breakdown →\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-how-to\" style=\"margin:32px 0;padding:20px;border:1px solid #e0d5c8;border-radius:8px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eHow to take Resveratrol 600mg\u003c\/h3\u003e\n  \u003cul style=\"line-height:1.7;\"\u003e\n    \u003cli\u003e\n\u003cstrong\u003eWhen:\u003c\/strong\u003e With breakfast or lunch — whichever has the most fat. Eggs, avocado, butter, fatty fish, olive oil all work.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule daily (600 mg).\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eAvoid empty-stomach dosing\u003c\/strong\u003e — fasted bioavailability is roughly half of fed.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eAvoid evening dosing\u003c\/strong\u003e — cerebral blood-flow upregulation can interfere with sleep onset.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBest paired with\u003c\/strong\u003e: \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\" style=\"color:#9a5b3e;\"\u003eNMN 500mg\u003c\/a\u003e (or get both at -10% as the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\" style=\"color:#9a5b3e;\"\u003eLongevity Stack Bundle\u003c\/a\u003e).\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBottle = 30 days\u003c\/strong\u003e at 1 capsule daily. The cardiometabolic biomarker timeline is 8–12 weeks; budget 3 bottles before your first re-test.\u003c\/li\u003e\n  \u003c\/ul\u003e\n  \u003cp style=\"margin-bottom:0;\"\u003e→ \u003ca href=\"\/he\/protocols\/how-to-take-it\" style=\"color:#9a5b3e;font-weight:600;\"\u003eFull protocol guide for the entire stack\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-footer-links\" style=\"margin-top:48px;padding-top:24px;border-top:1px solid #e0d5c8;\"\u003e\n  \u003ch3 style=\"margin-bottom:12px;\"\u003eHave a specific question?\u003c\/h3\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/faq\" style=\"color:#9a5b3e;\"\u003eFAQ — 20 most common questions\u003c\/a\u003e covers shipping, kashrut, drug interactions, refunds, dosing.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/coa\" style=\"color:#9a5b3e;\"\u003eLab reports for every batch\u003c\/a\u003e — verifiable third-party COAs.\u003c\/p\u003e\n  \u003cp style=\"margin:0;\"\u003e→ Or just \u003ca href=\"mailto:kat@truehealthprotocol.health\" style=\"color:#9a5b3e;\"\u003eemail me directly\u003c\/a\u003e. I respond within 24 hours.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47696174940378,"sku":"THP-RESV-600-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/resveratrol_02.jpg?v=1774728960"},{"product_id":"coq10-400mg-maximum-strength","title":"CoQ10 400mg | Fertility \u0026 Cellular Energy Support","description":"\u003cp\u003e\u003cstrong\u003e400 mg of pharmaceutical-grade CoQ10 per softgel\u003c\/strong\u003e — the studied therapeutic dose for mitochondrial energy production, cardiovascular muscle function, fertility (egg and sperm quality), statin-replacement support, and migraine prevention. One of the highest single-dose CoQ10 supplements in the catalog, formulated as a fat-carrier softgel because that is the absorption profile CoQ10 actually needs.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat CoQ10 does:\u003c\/strong\u003e sits at the centre of the electron transport chain (the process that generates ATP) inside every mitochondrion. Without it, ATP production drops; with less of it, the leftover electrons leak as oxidative damage instead of becoming usable cellular fuel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy supplement:\u003c\/strong\u003e endogenous CoQ10 production drops steadily after age 35 (roughly 50% by age 80, with measurable decline visible in the 30s and 40s). Statins deplete it further — they block HMG-CoA reductase, which is the same enzyme pathway your body uses to manufacture CoQ10. Several chronic conditions and a few common medications (metformin, certain beta-blockers, tricyclic antidepressants) also lower it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 40+, anyone on a statin (with their physician's awareness), couples working on fertility, athletes, recovery from illness or surgery, anyone running a longevity \/ mitochondrial stack, migraine-prone adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake with food (with fat).\u003c\/strong\u003e CoQ10 is fat-soluble. Bioavailability drops sharply on an empty stomach — by some pharmacokinetic studies more than 3× lower (Hidaka 2008, Lopez-Lluch 2011). Lunch or dinner with olive oil, eggs, butter, avocado, or full-fat dairy works.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e ubiquinone (the standard, oxidatively stable form). Your body converts ubiquinone to ubiquinol on demand — for healthy adults under 60 the form rarely matters; what matters is dose, fat co-ingestion, and consistency.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrial-validated dose anchor:\u003c\/strong\u003e 300 mg\/day for 2 years in the Q-SYMBIO multicenter trial (Mortensen 2014). 600 mg\/day for 90 days in the Bentov fertility cohort. 100–400 mg\/day for 12 weeks in migraine-prevention trials (Sándor 2005, Shoeibi 2017). 400 mg sits squarely inside the studied therapeutic range.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat CoQ10 actually does — the two roles\u003c\/h2\u003e\n\u003cp\u003eCoQ10 (Coenzyme Q10, also called ubiquinone) is a fat-soluble compound your body makes from the same mevalonate pathway that produces cholesterol. It concentrates in tissues with the highest sustained energy demand — heart muscle, kidneys, liver, brain, ovaries, testes — and plays two distinct roles, both inside the inner mitochondrial membrane:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eElectron transport in mitochondria.\u003c\/strong\u003e CoQ10 shuttles electrons between Complex I\/II and Complex III of the electron transport chain. That chain is the final stage of converting food into ATP — the energy currency every cell uses to do work. No CoQ10, no ATP. Less CoQ10, less efficient ATP production, and more leakage of electrons that turn into reactive oxygen species (ROS) instead of fuel (Crane 2001).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFat-soluble antioxidant in cell membranes.\u003c\/strong\u003e CoQ10 is one of the only antioxidants that lives inside the lipid bilayer. It protects mitochondrial membranes — which is exactly where the most ROS are produced in the first place — and regenerates other antioxidants like vitamin E and glutathione (Bentinger 2010, Alleva 1995). This is the closed-loop reason CoQ10 matters more for high-mitochondrial-density tissue: it both meets the ATP demand and absorbs the resulting oxidative load.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProduction declines roughly 50% by age 80, with meaningful drops visible in the 30s and 40s (Kalén 1989). Heart tissue takes the biggest hit — by age 70, cardiac CoQ10 concentrations are typically less than half of what they were at 20. That is the cleanest mechanistic explanation for why CoQ10 has been studied so heavily in cardiovascular contexts.\u003c\/p\u003e\n\n\u003ch2\u003eWhere supplementation matters most\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeart muscle.\u003c\/strong\u003e The heart has the highest sustained ATP demand of any organ. CoQ10 concentration in cardiac tissue drops significantly with age and with cardiovascular disease, and supplementation has been studied extensively for cardiovascular support — the Q-SYMBIO multicenter trial (Mortensen 2014, n=420) used 300 mg\/day for 2 years and reported a significant reduction in major adverse cardiovascular events versus placebo. Talk to your physician if you are managing a cardiac condition; this is not a treatment, it is a cofactor.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFertility (egg and sperm).\u003c\/strong\u003e Both egg and sperm quality depend heavily on mitochondrial energy. The egg is the largest cell in the body and contains roughly 100,000 mitochondria — it has to power its own first 5–7 days of cell division before the embryo can implant and start drawing nutrients from the mother. Sperm motility runs on a flagellum that is essentially a continuously firing ATP engine. CoQ10 has been incorporated into IVF and natural-conception protocols at 200–600 mg daily for 3+ months pre-conception; the egg maturation window is roughly 90 days, so the protocol mirrors that biology (Bentov 2010, 2014; Ben-Meir 2015 mouse data; Safarinejad 2009 sperm quality).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStatin users.\u003c\/strong\u003e If you are on a statin your CoQ10 levels are reduced as a known side effect of how the drug works. Statins inhibit HMG-CoA reductase to lower cholesterol synthesis — but that same enzyme is the early step in your body's CoQ10 manufacturing pathway, so the depletion is mechanistic, not incidental (Folkers 1990, Mortensen 1997). Supplementing back toward normal levels is one of the most common medical reasons to take CoQ10 and is openly discussed by many cardiologists. Ask your physician about appropriate dosing for your specific situation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial \/ longevity stack.\u003c\/strong\u003e CoQ10 supports ATP production directly. NMN, NR, and NAD+ products raise NAD+ for the upstream pathway support; PQQ promotes the creation of new mitochondria; Urolithin A clears damaged mitochondria via mitophagy; CoQ10 keeps the resulting mitochondria fed and producing energy cleanly. Each step in the cycle is necessary; CoQ10 is the one that turns the lights on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMigraine-prone adults.\u003c\/strong\u003e 100–400 mg CoQ10 daily has been studied for migraine frequency reduction (Sándor 2005 RCT n=42; Shoeibi 2017 n=80; Dahri 2019 meta-analysis). Results are mixed-but-positive across multiple trials. The American Academy of Neurology and Canadian Headache Society have included CoQ10 in their migraine prevention guidance, with the caveat that evidence is moderate, not strong.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAthletes and post-exertion recovery.\u003c\/strong\u003e Sustained intense exercise depletes CoQ10 and shifts mitochondria toward higher ROS output. Endurance athletes and anyone doing \u0026gt;5 hours\/week of intense training tend to see the largest drops (Cooke 2008; Díaz-Castro 2012).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeriods of high mitochondrial demand.\u003c\/strong\u003e Recovery from surgery, illness, post-viral fatigue, long-COVID protocols. Your mitochondria are doing extra work; supplying the missing cofactor is reasonable (Mantle 2018 review).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeriodontal and gum tissue.\u003c\/strong\u003e Gum tissue is one of the few peripheral tissues with surprisingly high CoQ10 demand. A small literature suggests benefit for gingival health at 60–200 mg\/day; not the primary use case, but a documented one (Hanioka 1994).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy 400 mg specifically\u003c\/h2\u003e\n\u003cp\u003eThe studied dose range for CoQ10 is unusually wide, because different goals call for very different exposure:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e30–100 mg:\u003c\/strong\u003e general health maintenance for younger adults with no specific concern. This is what most off-the-shelf multivitamins include, and it is roughly enough to make up for ordinary age-related decline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e100–200 mg:\u003c\/strong\u003e heart support, statin replacement therapy. The typical \"cardiology recommendation\" range when a CoQ10 supplement is being suggested as adjunct support.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e200–600 mg:\u003c\/strong\u003e fertility protocols (both partners), athletic recovery, and mitochondrial-support side of a longevity stack. This is also the range used in most published fertility studies — typically 300–600 mg\/day for 90 days pre-conception.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUp to 1,200–3,000 mg:\u003c\/strong\u003e studied in clinical trials for specific neurological and inherited mitochondrial conditions (Parkinson's at up to 1,200 mg\/day in Shults 2002; Huntington's at 600 mg\/day in Huntington Study Group 2001; mitochondrial encephalomyopathies up to 3,000 mg\/day under medical supervision). This is medical-supervision territory, not a self-directed dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e400 mg in a single softgel sits squarely inside the higher therapeutic range used in fertility, athletic, and longevity-focused research. If you only need general maintenance you can use half a softgel daily (or every other day, since CoQ10 has a long tissue half-life). If you are targeting fertility or stacking it with a serious longevity protocol, 400 mg is the dose most of the literature actually points to.\u003c\/p\u003e\n\n\u003ch2\u003eUbiquinone vs ubiquinol — the form question, answered honestly\u003c\/h2\u003e\n\u003cp\u003eCoQ10 exists in two interconvertible forms in your body: \u003cstrong\u003eubiquinone\u003c\/strong\u003e (the oxidized form, more stable in capsules) and \u003cstrong\u003eubiquinol\u003c\/strong\u003e (the reduced form, what your body uses to donate electrons in the antioxidant role). Most quality supplements use ubiquinone for two reasons:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eShelf stability.\u003c\/strong\u003e Ubiquinol oxidizes back to ubiquinone in air, in light, in heat, and during shelf storage. By the time a ubiquinol softgel reaches you, a meaningful percentage has typically already converted back. Ubiquinone is shelf-stable, which is why it dominates clinical research (Bhagavan 2007).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConversion is built in.\u003c\/strong\u003e Healthy adults under 60 convert ubiquinone to ubiquinol on demand, in the cells that need it (Mohr 1992). The interconversion is part of normal metabolism and does not require any special pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMost large clinical trials used ubiquinone.\u003c\/strong\u003e Q-SYMBIO, Sándor migraine, the Bentov fertility cohorts, virtually the entire pre-2010 cardiovascular literature.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eUbiquinol is sometimes recommended for adults over 70, people with significant cardiovascular disease, or specific genetic differences in CoQ10 metabolism — situations where the conversion step itself may be impaired (Langsjoen 2008). For everyone else, ubiquinone at a meaningful dose with adequate dietary fat is the well-studied, lower-cost, well-evidenced choice. The bigger absorption variable, by far, is whether you take CoQ10 with fat (yes) or on an empty stomach (don't).\u003c\/p\u003e\n\n\u003ch2\u003eHow long until you notice it — the realistic timeline\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 1–7 — plasma rises.\u003c\/strong\u003e Plasma CoQ10 reaches measurably higher levels within 4–8 hours of a fat-co-ingested dose, and steady-state plasma levels build over 5–10 days (Bhagavan 2007).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2–4 — first subjective shifts.\u003c\/strong\u003e People who were depleted (statin users, post-illness, age 60+, post-viral fatigue) often notice modestly improved exercise tolerance or reduced \"just-tired-all-the-time\" feeling here. This is not stimulant energy; it is more \"the floor is higher.\"\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4–8 — tissue saturation.\u003c\/strong\u003e Heart, muscle, ovary, and testis tissue reach steady-state levels. This is where any cardiovascular markers measured in studies typically begin to shift.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 12 — migraine prevention endpoint.\u003c\/strong\u003e Sándor 2005, Shoeibi 2017 and most modern migraine trials evaluate at 12 weeks. Frequency tends to drop more reliably than severity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 90 — fertility window closes.\u003c\/strong\u003e Egg maturation cycle ≈ 90 days; sperm production cycle ≈ 74 days. CoQ10 supplementation is consistently dosed for ≥90 days \u003cem\u003ebefore\u003c\/em\u003e the conception cycle, not during it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 6–12 — the cardiovascular endpoint.\u003c\/strong\u003e Q-SYMBIO ran 2 years. Most NYHA-class trials run ≥12 months. CoQ10 is a long-horizon cofactor for this use case, not a short-cycle product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOn-stop reversion.\u003c\/strong\u003e Plasma drops back to baseline within 1–2 weeks of stopping. Tissue CoQ10 reverts more slowly — over months. The implication is the obvious one: cycling CoQ10 is not necessary and arguably counterproductive. Daily continuous use is the standard pattern in research and in clinical practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking with the rest of the catalog\u003c\/h2\u003e\n\u003cp\u003eCoQ10 is the most \"downstream\" mitochondrial supplement in the True Health Protocol catalog. It supports the actual energy-production step, after the upstream NAD+ machinery and biogenesis machinery have done their work. The natural pairings:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ NMN or NAD+ precursors\u003c\/strong\u003e — NMN raises NAD+ (upstream); CoQ10 supports ATP production (downstream). Sirtuin pathway + mitochondrial fuel, the canonical longevity stack base. \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e, or \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ PQQ\u003c\/strong\u003e — PQQ helps create new mitochondria (biogenesis); CoQ10 makes sure the new ones can produce ATP. Mechanistically the cleanest CoQ10 stacking partner. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Urolithin A\u003c\/strong\u003e — Urolithin A clears the damaged mitochondria via mitophagy (PINK1\/Parkin); CoQ10 powers the healthy ones that remain. The renewal\/output pair. \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Resveratrol or Pterostilbene\u003c\/strong\u003e — sirtuin-driven mitochondrial biogenesis. CoQ10 keeps the new mitochondria fed. \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Alpha-Lipoic Acid\u003c\/strong\u003e — ALA recycles CoQ10, vitamin C, vitamin E, and glutathione. The two of them together cover most of the mitochondrial antioxidant network. \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Calcium Alpha-Ketoglutarate\u003c\/strong\u003e — CaAKG drives the TCA cycle that feeds NADH\/FADH2 into the electron transport chain; CoQ10 then carries those electrons forward. The two-step substrate-and-shuttle pair. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Creatine\u003c\/strong\u003e — creatine buffers cellular ATP via the phosphocreatine system, while CoQ10 supports its production. The two of them together cover most of the cellular bioenergetic stack. \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Berberine\u003c\/strong\u003e — important if you have ever been on metformin, which depletes CoQ10 in the same direction statins do (Hu 2014). \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Astaxanthin and Glutathione\u003c\/strong\u003e — for the fertility \/ egg quality stack specifically. CoQ10 powers the egg's mitochondria, astaxanthin protects the membranes, glutathione handles oxidative load. \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Omega-3 Fish Oil\u003c\/strong\u003e — omega-3s are membrane substrate; CoQ10 lives inside that membrane. The cardiovascular pair. \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 Fish Oil 2000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Taurine 1000 mg\u003c\/strong\u003e — taurine modifies mitochondrial tRNA to enable proper electron-transport-chain protein synthesis (Singh 2023 Science). CoQ10 then carries the electrons through that chain. The two-step \"build-the-engine + fuel-the-engine\" pair. \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRead the complete protocol in our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol\u003c\/a\u003e or browse the \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e for the full mitochondrial-support shelf, or the \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity collection\u003c\/a\u003e for the heart-muscle stack.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 40+ where natural CoQ10 production has dropped noticeably\u003c\/li\u003e\n  \u003cli\u003eAnyone on a statin (with their physician's awareness) — the most well-established medical use case\u003c\/li\u003e\n  \u003cli\u003eAnyone on metformin, certain beta-blockers, tricyclic antidepressants, or other medications documented to deplete CoQ10\u003c\/li\u003e\n  \u003cli\u003eCouples working on fertility — both partners (egg and sperm quality)\u003c\/li\u003e\n  \u003cli\u003ePeople going through IVF cycles (under their reproductive endocrinologist's awareness)\u003c\/li\u003e\n  \u003cli\u003eAthletes and recovery from intense training blocks (\u0026gt;5 hours\/week sustained)\u003c\/li\u003e\n  \u003cli\u003eAnyone running a longevity stack and wanting downstream mitochondrial support\u003c\/li\u003e\n  \u003cli\u003eRecovery from illness, surgery, post-viral fatigue, periods of high mitochondrial demand\u003c\/li\u003e\n  \u003cli\u003eMigraine-prone adults willing to commit to a 12-week trial\u003c\/li\u003e\n  \u003cli\u003eAdults 70+ where ubiquinone-to-ubiquinol conversion may slow (a switch to ubiquinol is reasonable here, though ubiquinone at higher dose with fat still works)\u003c\/li\u003e\n  \u003cli\u003eAdults with diagnosed mitochondrial dysfunction working with a specialist\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople on warfarin without their prescriber's awareness.\u003c\/strong\u003e CoQ10 is structurally similar to vitamin K and may modestly reduce warfarin's anticoagulant effect. INR monitoring is required.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople in active chemotherapy.\u003c\/strong\u003e CoQ10–chemotherapy interactions are mixed in the literature (some protective, some theoretically reducing efficacy). Coordinate with your oncology team — never start independently.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople expecting same-day stimulant energy.\u003c\/strong\u003e CoQ10 is a foundational cofactor that removes a deficiency — it does not add a kick. If you want stimulant energy, look elsewhere; you will be disappointed by CoQ10 and stop too early.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStrict vegans.\u003c\/strong\u003e Our softgel uses bovine gelatin shell. We do not currently offer a plant-cellulose CoQ10 capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant women without OB awareness.\u003c\/strong\u003e CoQ10 has been used in IVF and pre-conception protocols extensively, but data during active pregnancy is more limited. Talk to your OB before continuing through conception.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople under 18.\u003c\/strong\u003e CoQ10 is generally regarded as safe but the studied population is overwhelmingly adult.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who will skip the dietary fat step.\u003c\/strong\u003e If you cannot or will not take CoQ10 with a fat-containing meal, your absorption will be a fraction of what it should be. A low-dose, food-based approach is more honest in that situation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it on an empty stomach.\u003c\/strong\u003e The single biggest absorption loss. Take it with the largest fat-containing meal of the day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it late at night.\u003c\/strong\u003e Some people find CoQ10 mildly stimulating because it raises ATP availability. If sleep is affected, move it to breakfast or lunch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying a $9 bottle and assuming it works.\u003c\/strong\u003e Independent lab testing has repeatedly shown that a meaningful percentage of cheap CoQ10 brands contain less than half their labeled dose, and some contain the wrong (cis) isomer. Per actual milligram of bioactive trans-CoQ10, pharmaceutical-grade is usually the cheaper math.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 2.\u003c\/strong\u003e CoQ10 is a long-horizon cofactor. Most studied endpoints — cardiovascular, fertility, migraine — show their effect at week 12 or later. The week-2 quitter is the single most common protocol failure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking with a statin without telling your prescriber.\u003c\/strong\u003e Not because of risk, but because your cardiologist almost always already supports CoQ10 supplementation and may have a preferred protocol. Letting them know also keeps your medical record clean.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSplitting a 90-day fertility window across both partners' wallets.\u003c\/strong\u003e The published fertility protocols typically dose \u003cem\u003eeach\u003c\/em\u003e partner at 200–600 mg\/day for 90 days. Cutting one partner out halves the effect of the protocol, not the cost of it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling unnecessarily.\u003c\/strong\u003e CoQ10 does not downregulate. Daily continuous use is the standard. 5-on-2-off cycles or month-on-month-off cycles have no mechanistic justification and just produce uneven plasma levels.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSwitching to ubiquinol because of marketing.\u003c\/strong\u003e Unless you are over 70 or have a specific reason to suspect the conversion step is impaired, ubiquinone is the well-studied form. Ubiquinol typically costs 2–3× more for unclear added benefit in most populations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDrug interactions and safety\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWarfarin \/ Coumadin.\u003c\/strong\u003e CoQ10 is structurally similar to vitamin K and may modestly reduce the effect of warfarin. If you are on warfarin, talk to your prescriber before starting CoQ10, and your INR may need to be checked again at 4–6 weeks. Not a hard contraindication; just something your physician should know about.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntihypertensives.\u003c\/strong\u003e CoQ10 may have a mild blood-pressure-lowering effect of its own. If you are on an antihypertensive, monitor BP for the first 6–8 weeks; doses occasionally need adjustment downward, which is a reason to coordinate with your prescriber rather than do it alone (Rosenfeldt 2007 meta-analysis).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChemotherapy.\u003c\/strong\u003e Some CoQ10–chemotherapy interactions are theoretical, some are protective. Always coordinate with your oncology team.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medication (insulin, sulfonylureas).\u003c\/strong\u003e CoQ10 may have a modest blood-sugar-lowering effect. Worth knowing if you are on insulin or a sulfonylurea so you can adjust monitoring.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy.\u003c\/strong\u003e CoQ10 has been used in IVF and pre-conception protocols extensively, but data during active pregnancy is more limited. Talk to your OB.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGeneral safety profile.\u003c\/strong\u003e CoQ10 has an excellent safety record. Trials have run up to 1,200 mg\/day for 16 months in Parkinson's (Shults 2002) and up to 3,000 mg\/day under medical supervision in mitochondrial encephalomyopathies, with mild GI discomfort and insomnia (when taken late) being the most reported issues. The 400 mg daily dose in this product is well within the range studied for years in fertility, cardiovascular, and migraine contexts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take CoQ10 forever, or do I need to cycle it?\u003c\/strong\u003e CoQ10 does not downregulate the way some compounds do; long-term daily use is the standard pattern in research and in clinical practice. No cycling required.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMy urine turned bright yellow — is that bad?\u003c\/strong\u003e No, that is normal and means you are absorbing it. CoQ10 is a yellow pigment; the fat-soluble surplus passes through and tints the urine.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take CoQ10 if I am vegan?\u003c\/strong\u003e Our softgel uses bovine gelatin, so it is not strictly vegan. We may add a vegan capsule format in the future; for now, vegan-strict customers should look for plant-cellulose CoQ10 capsules elsewhere.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I take CoQ10 in the morning or evening?\u003c\/strong\u003e Morning or midday with a fat-containing meal is best. Some people find it slightly stimulating and do not sleep well if they take it after 4 pm — which makes sense, given the energy mechanism. Others have no issue with evening dosing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan my partner and I both take it for fertility?\u003c\/strong\u003e Yes — that is the standard protocol. Both egg quality and sperm quality benefit from CoQ10 for the same mitochondrial-energy reasons. The recommended dose for each partner is identical: 200–400 mg daily for 90+ days pre-conception.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs 400 mg too much?\u003c\/strong\u003e No. CoQ10 has an excellent safety profile, with clinical trials running up to 1,200–3,000 mg daily in specific contexts under medical supervision. 400 mg is a therapeutic dose in the studied range — not a megadose.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I split the softgel?\u003c\/strong\u003e Softgels are designed to be swallowed whole, but if you only want 200 mg daily you can pierce the softgel with a clean pin and squeeze half the contents onto food (it has a slightly oily, neutral taste). Most people find it easier to just take one whole softgel every other day, which works because of CoQ10's long tissue half-life.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy is CoQ10 so expensive in general?\u003c\/strong\u003e Pharmaceutical-grade CoQ10 is produced via fermentation, which is a slow, capital-intensive process. The cheap CoQ10 you see on Amazon is often diluted, mislabeled, or uses a synthetic isomer with much lower bioactivity. We test every batch for the trans-isomer (the bioactive form) and publish quality summaries — see the \u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing page\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes CoQ10 interact with statins or replace them?\u003c\/strong\u003e CoQ10 is a cofactor that statins deplete; it does not replace a statin. If you are on a statin, your physician likely already supports CoQ10 supplementation — many cardiologists recommend it routinely. Always coordinate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUbiquinone or ubiquinol — which one should I buy?\u003c\/strong\u003e For healthy adults under 60, ubiquinone (this product) at a meaningful dose with adequate dietary fat is the well-studied, lower-cost, well-evidenced choice. Ubiquinol is reasonable for adults 70+, advanced cardiovascular disease, or specific genetic differences in CoQ10 metabolism — situations where the conversion step itself may be impaired. The bigger absorption variable, by far, is whether you take CoQ10 with fat.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes CoQ10 help with long COVID or post-viral fatigue?\u003c\/strong\u003e Open question. There is plausible mechanism (mitochondrial dysfunction is a documented feature of long COVID) and a small handful of pilot studies, but no large RCTs yet. Many post-viral fatigue clinicians include CoQ10 in their stacks; the evidence is not yet at the level of the cardiovascular or fertility data.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs CoQ10 the same as Q10 or coenzyme Q?\u003c\/strong\u003e Yes — all three names refer to the same molecule. \"Q\" comes from the historical name \"ubiquinone\" (because it is ubiquitous in tissues). The 10 refers to its 10-unit isoprenoid side chain.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take CoQ10 with my morning coffee or NAD+ stack?\u003c\/strong\u003e Yes. CoQ10 does not interact meaningfully with caffeine, NMN, NR, resveratrol, or the rest of the NAD+ stack. Just make sure the CoQ10 is taken with a fat-containing meal — a coffee-only breakfast does not count.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes CoQ10 help with thyroid energy issues?\u003c\/strong\u003e A small literature suggests CoQ10 levels are lower in hypothyroid patients (Mancini 1989), and supplementation has been included in some functional-medicine protocols. Talk to your endocrinologist; this is more \"supportive cofactor\" than treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow does this product compare to the CoQ10 I see in the NAD+ 5-in-1 formula?\u003c\/strong\u003e The 5-in-1 includes a smaller CoQ10 dose alongside NMN, B-complex, and antioxidants for an all-in-one daily. This standalone 400 mg softgel is what you reach for when you want a higher therapeutic dose specifically — fertility cycles, statin replacement, athletic recovery, migraine prevention, or stacking on top of your core NAD+ protocol.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy bovine gelatin softgel and not vegan capsule?\u003c\/strong\u003e CoQ10 is fat-soluble; bioavailability is dramatically higher when delivered in a fat-carrier softgel rather than a dry powder capsule. Hard-shell vegan CoQ10 capsules exist but typically need 2–3× the dose to match the same plasma exposure.\u003c\/p\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 1 softgel daily with a meal containing some fat — eggs, avocado, full-fat yogurt, butter on toast, olive oil, full-fat dairy. Lunch or dinner usually works better than breakfast for higher fat content. \u003cstrong\u003eCoQ10 absorption drops dramatically on an empty stomach\u003c\/strong\u003e (Hidaka 2008; Lopez-Lluch 2011). Daily consistency matters more than dose timing. For fertility protocols, take consistently for 90+ days before the conception cycle. For migraine prevention, evaluate at 12 weeks. For statin support, take on the same daily schedule as the statin.\u003c\/p\u003e\n\n\u003ch2\u003ePer-softgel ingredient panel\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e400 mg pharmaceutical-grade CoQ10 (ubiquinone, \u0026gt;98% trans-isomer, fermentation-derived)\u003c\/li\u003e\n  \u003cli\u003eCarrier oil base (medium-chain triglycerides) for fat-soluble absorption\u003c\/li\u003e\n  \u003cli\u003eBovine gelatin softgel shell, glycerin, purified water, natural mixed tocopherols (oxidation protection)\u003c\/li\u003e\n  \u003cli\u003eNo magnesium stearate, titanium dioxide, silicon dioxide, GMOs, gluten, soy, dairy, or artificial colors and flavors\u003c\/li\u003e\n  \u003cli\u003eUV-protective amber HDPE bottle, induction-sealed, 60-softgel count\u003c\/li\u003e\n  \u003cli\u003e60 softgels per bottle = 60-day supply at 1 softgel\/day, or 30-day supply at 2 softgels\/day for fertility\/longevity protocols\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and QC\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-certified, FDA-registered facility, manufactured in the USA.\u003c\/strong\u003e ISO 9001 quality system.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC verification\u003c\/strong\u003e for ≥98% trans-isomer purity (the bioactive form). Cis-isomer content reported on the COA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch heavy metals testing\u003c\/strong\u003e per USP \u0026lt;2232\u0026gt; (lead, arsenic, cadmium, mercury) to specification.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch microbial limits testing\u003c\/strong\u003e per USP \u0026lt;2021\/2022\u0026gt; (total aerobic, yeast\/mold, E. coli, Salmonella, S. aureus).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch residual solvents\u003c\/strong\u003e per USP \u0026lt;467\u0026gt; — meaningful given fermentation-derived CoQ10 production.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch pesticide screening\u003c\/strong\u003e per USP \u0026lt;561\u0026gt; on the carrier oil.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOxidation protection\u003c\/strong\u003e via mixed tocopherols in the softgel matrix and amber HDPE bottle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e24-month shelf life\u003c\/strong\u003e from manufacture date (printed on bottom of bottle).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCOA available on request.\u003c\/strong\u003e See the \u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing page\u003c\/a\u003e and \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing page\u003c\/a\u003e for detail on every active in the catalog.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStorage and quality\u003c\/h2\u003e\n\u003cp\u003eStore in a cool, dry place away from direct sunlight. CoQ10 in softgel form is stable at room temperature; refrigeration is not required but does not hurt. Avoid leaving the bottle in a hot car or near a stove. Best-by date is printed on the bottom of the bottle — typically 24 months from manufacture.\u003c\/p\u003e\n\n\u003ch2\u003eWhy not Amazon\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC for trans-isomer purity.\u003c\/strong\u003e Independent lab audits of CoQ10 marketplaces have repeatedly found products with less than half their labeled dose, or with the wrong (cis) isomer that has much lower bioactivity. Trans-isomer purity is reported on every batch we ship.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePharmaceutical-grade fermentation-derived CoQ10.\u003c\/strong\u003e Not synthetic, not blended with cheaper isomers, not \"CoQ10 complex\" with undeclared filler.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCatalog architecture.\u003c\/strong\u003e CoQ10 is one cofactor in a larger mitochondrial story (NAD+ upstream → biogenesis via PQQ → mitophagy via Urolithin A → fueling via CoQ10). The catalog is built so each piece has a defensible reason to be there.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on the science\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/coq10-and-statins-the-cofactor-your-statin-depletes-and-why-it-matters\"\u003eCoQ10 and Statins — the cofactor your statin depletes and why it matters\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40 — what changes and what to add\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal — clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health — the 7 daily nutrients underneath every stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements — a practical 2026 protocol\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols — supplement stacks by goal\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science — how the catalog is built\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/collections\/fertility\"\u003eFertility collection\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eMortensen SA et al. \u003cem\u003eThe effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO.\u003c\/em\u003e JACC Heart Fail. 2014;2(6):641–649.\u003c\/li\u003e\n  \u003cli\u003eSándor PS et al. \u003cem\u003eEfficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.\u003c\/em\u003e Neurology. 2005;64(4):713–715.\u003c\/li\u003e\n  \u003cli\u003eShoeibi A et al. \u003cem\u003eEffectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial.\u003c\/em\u003e Acta Neurol Belg. 2017;117(1):103–109.\u003c\/li\u003e\n  \u003cli\u003eBentov Y et al. \u003cem\u003eCoenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF–ICSI treatment.\u003c\/em\u003e Clin Med Insights Reprod Health. 2014;8:31–36.\u003c\/li\u003e\n  \u003cli\u003eBentov Y, Casper RF. \u003cem\u003eThe aging oocyte — can mitochondrial function be improved?\u003c\/em\u003e Fertil Steril. 2013;99(1):18–22.\u003c\/li\u003e\n  \u003cli\u003eBen-Meir A et al. \u003cem\u003eCoenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging.\u003c\/em\u003e Aging Cell. 2015;14(5):887–895.\u003c\/li\u003e\n  \u003cli\u003eSafarinejad MR. \u003cem\u003eEfficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men.\u003c\/em\u003e J Urol. 2009;182(1):237–248.\u003c\/li\u003e\n  \u003cli\u003eFolkers K et al. \u003cem\u003eLovastatin decreases coenzyme Q levels in humans.\u003c\/em\u003e Proc Natl Acad Sci USA. 1990;87(22):8931–8934.\u003c\/li\u003e\n  \u003cli\u003eMortensen SA et al. \u003cem\u003eDose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.\u003c\/em\u003e Mol Aspects Med. 1997;18(Suppl):S137–144.\u003c\/li\u003e\n  \u003cli\u003eRosenfeldt FL et al. \u003cem\u003eCoenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.\u003c\/em\u003e J Hum Hypertens. 2007;21(4):297–306.\u003c\/li\u003e\n  \u003cli\u003eShults CW et al. \u003cem\u003eEffects of coenzyme Q10 in early Parkinson disease.\u003c\/em\u003e Arch Neurol. 2002;59(10):1541–1550.\u003c\/li\u003e\n  \u003cli\u003eBhagavan HN, Chopra RK. \u003cem\u003ePlasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.\u003c\/em\u003e Mitochondrion. 2007;7(Suppl):S78–88.\u003c\/li\u003e\n  \u003cli\u003eLopez-Lluch G et al. \u003cem\u003eBioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization.\u003c\/em\u003e Nutrition. 2019;57:133–140.\u003c\/li\u003e\n  \u003cli\u003eHidaka T et al. \u003cem\u003eSafety assessment of coenzyme Q10.\u003c\/em\u003e Biofactors. 2008;32(1–4):199–208.\u003c\/li\u003e\n  \u003cli\u003eBentinger M et al. \u003cem\u003eCoenzyme Q — biosynthesis and functions.\u003c\/em\u003e Biochem Biophys Res Commun. 2010;396(1):74–79.\u003c\/li\u003e\n  \u003cli\u003eCrane FL. \u003cem\u003eBiochemical functions of coenzyme Q10.\u003c\/em\u003e J Am Coll Nutr. 2001;20(6):591–598.\u003c\/li\u003e\n  \u003cli\u003eKalén A, Appelkvist EL, Dallner G. \u003cem\u003eAge-related changes in the lipid compositions of rat and human tissues.\u003c\/em\u003e Lipids. 1989;24(7):579–584.\u003c\/li\u003e\n  \u003cli\u003eMancini A et al. \u003cem\u003ePlasma coenzyme Q10 in thyroid disease.\u003c\/em\u003e Acta Endocrinol (Copenh). 1989;121(4):504–508.\u003c\/li\u003e\n  \u003cli\u003eHu PJ et al. \u003cem\u003eEffects of metformin on coenzyme Q10 levels.\u003c\/em\u003e Cardiovasc Drugs Ther. 2014.\u003c\/li\u003e\n  \u003cli\u003eMantle D, Hargreaves I. \u003cem\u003eCoenzyme Q10 and degenerative disorders affecting longevity: an overview.\u003c\/em\u003e Antioxidants. 2018;8(2):44.\u003c\/li\u003e\n  \u003cli\u003eGarrido-Maraver J et al. \u003cem\u003eCoenzyme Q10 therapy.\u003c\/em\u003e Mol Syndromol. 2014;5(3–4):187–197.\u003c\/li\u003e\n  \u003cli\u003eSingh P et al. \u003cem\u003eTaurine deficiency as a driver of aging.\u003c\/em\u003e Science. 2023;380(6649):eabn9257. (Stack relevance.)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eCitations are provided as scientific context — not as a claim that this product treats, prevents, or cures any disease. References are to mechanism and efficacy data; consult your physician for clinical decisions.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication (including statins, blood thinners, antihypertensives, or diabetes medication) or have a medical condition.\u003c\/em\u003e\n\n\u003cdiv class=\"th-trust-strip\" style=\"display:flex;flex-wrap:wrap;gap:16px;align-items:center;justify-content:center;padding:14px 18px;margin:16px 0;background:#faf7f2;border-radius:8px;font-size:0.9em;color:#555;\"\u003e\n  \u003cdiv\u003e🧪 \u003cstrong\u003e3rd-Party Lab Tested\u003c\/strong\u003e — \u003ca href=\"\/he\/pages\/quality\" style=\"color:#9a5b3e;text-decoration:underline;\"\u003eQuality \u0026amp; Sourcing →\u003c\/a\u003e\n\u003c\/div\u003e\n  \u003cdiv\u003e🇺🇸 Made in USA · USP Pharma Grade · cGMP \/ FDA-registered\u003c\/div\u003e\n  \u003cdiv\u003e📋 30-Day Money-Back Guarantee — \u003ca href=\"\/he\/pages\/guarantee\" style=\"color:#9a5b3e;text-decoration:underline;\"\u003edetails\u003c\/a\u003e\n\u003c\/div\u003e\n  \u003cdiv\u003e🚚 Free US Shipping over $60\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-how-to\" style=\"margin:32px 0;padding:20px;border:1px solid #e0d5c8;border-radius:8px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eHow to take CoQ10 400 mg — quick reference\u003c\/h3\u003e\n  \u003cul style=\"line-height:1.7;\"\u003e\n    \u003cli\u003e\n\u003cstrong\u003eWhen:\u003c\/strong\u003e with your largest fat-containing meal of the day (lunch or dinner is fine — fat-soluble, absorbs poorly without dietary fat). Move it earlier in the day if you find it slightly stimulating.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 softgel daily for general maintenance and statin support. 2 softgels daily (split with lunch and dinner) for fertility, athletic recovery, or longevity-stack contexts — well within studied range.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eEgg-quality protocol:\u003c\/strong\u003e 200–400 mg per day for 90 days minimum before each conception cycle. Egg maturation cycle ≈ 90 days. Sperm production cycle ≈ 74 days.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eMigraine protocol:\u003c\/strong\u003e 100–400 mg per day, evaluate at 12 weeks (Sándor 2005; Shoeibi 2017). Move dose earlier in the day if sleep is affected.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eCardiovascular \/ statin replacement:\u003c\/strong\u003e 100–300 mg\/day daily, indefinitely; coordinate with your cardiologist.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBest paired with\u003c\/strong\u003e \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\" style=\"color:#9a5b3e;\"\u003eGlutathione 500 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\" style=\"color:#9a5b3e;\"\u003eAstaxanthin 12 mg\u003c\/a\u003e for the full \u003ca href=\"\/he\/collections\/fertility\" style=\"color:#9a5b3e;\"\u003eEgg Quality Stack\u003c\/a\u003e.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBest paired with\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\" style=\"color:#9a5b3e;\"\u003ePQQ 20 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\" style=\"color:#9a5b3e;\"\u003eUrolithin A 500 mg\u003c\/a\u003e for the full \u003ca href=\"\/he\/collections\/mitochondrial-renewal\" style=\"color:#9a5b3e;\"\u003eMitochondrial Renewal stack\u003c\/a\u003e.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBright yellow urine?\u003c\/strong\u003e Normal. Means you are absorbing it — fat-soluble surplus passes through.\u003c\/li\u003e\n  \u003c\/ul\u003e\n  \u003cp style=\"margin-bottom:0;\"\u003e→ \u003ca href=\"\/he\/pages\/protocols\" style=\"color:#9a5b3e;font-weight:600;\"\u003eFull protocol guide for the entire stack\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-footer-links\" style=\"margin-top:48px;padding-top:24px;border-top:1px solid #e0d5c8;\"\u003e\n  \u003ch3 style=\"margin-bottom:12px;\"\u003eHave a specific question?\u003c\/h3\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/faq\" style=\"color:#9a5b3e;\"\u003eFAQ — most common questions\u003c\/a\u003e covers shipping, drug interactions, refunds, dosing.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/quality\" style=\"color:#9a5b3e;\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e — every batch tested, COAs available on request.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/getting-started\" style=\"color:#9a5b3e;\"\u003eGetting Started — where to begin\u003c\/a\u003e if this is your first supplement from us.\u003c\/p\u003e\n  \u003cp style=\"margin:0;\"\u003e→ Or just \u003ca href=\"mailto:support@truehealthprotocol.health\" style=\"color:#9a5b3e;\"\u003eemail support directly\u003c\/a\u003e. We respond within 24 hours.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47696470409434,"sku":"THP-COQ10-400-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/coq10_03.jpg?v=1774728960"},{"product_id":"berberine-hcl-500mg-maximum-strength","title":"Berberine HCL 500mg | AMPK Activator for Glucose, Lipids \u0026 Longevity","description":"\u003cp\u003e\u003cstrong\u003e500 mg of Berberine HCl per capsule\u003c\/strong\u003e, standardized 97% from \u003cem\u003eBerberis aristata\u003c\/em\u003e (Indian barberry) root, manufactured in a cGMP-registered facility and third-party tested for identity, potency, heavy metals, microbial load, and pesticide residues. Berberine is the most-studied non-prescription AMP-activated protein kinase (AMPK) activator in the human longevity literature — the natural compound with the strongest head-to-head trial data against a first-line prescription metabolic drug, and the standard fourth pillar of any modern four-pathway longevity stack alongside NMN (sirtuins), Resveratrol (sirtuin co-activator), and Spermidine (autophagy). One of the only supplements where the trial dose, the trial duration, and the trial outcomes are reproducible and consistent across more than two decades of randomized controlled work.\u003c\/p\u003e\n\n\u003ch2\u003eThe 60-second answer\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eActivates AMPK\u003c\/strong\u003e — the cellular energy sensor often called the \"metabolic master switch.\" Active AMPK pulls glucose into muscle, oxidizes fat instead of storing it, drives mitochondrial biogenesis through PGC-1α, and inhibits mTORC1, which permits autophagy. AMPK signaling falls with age in nearly every tissue measured; berberine pushes it back toward a younger profile.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e healthy fasting glucose and post-meal glucose excursions, healthy lipid profiles (LDL, triglycerides, total cholesterol), gut-microbiome modulation, visceral-fat reduction, and anyone building a longevity stack who wants the AMPK pathway covered alongside the sirtuin pathway (NMN\/resveratrol).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe headline trial:\u003c\/strong\u003e Yin et al. 2008 in \u003cem\u003eMetabolism\u003c\/em\u003e randomized adults with type 2 diabetes to 500 mg berberine three times daily versus 500 mg metformin three times daily for 12 weeks. Berberine produced statistically equivalent reductions in fasting plasma glucose (–3.5 mmol\/L vs –3.6 mmol\/L), HbA1c (–2.0% vs –2.1%), post-prandial glucose, triglycerides, and total cholesterol. The 2012 Dong et al. meta-analysis of 14 trials (n = 1,068) reproduced the lipid effects with statistical heterogeneity well below conventional thresholds.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 500 mg, 2–3 times daily, taken with meals. Plasma half-life is short (~4 hours), so the studied dose schedule splits 1500 mg\/day across the day rather than dumping it into one capsule. Dosing once daily produces a high peak and a long sub-therapeutic trough.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCycle:\u003c\/strong\u003e the practitioner-default protocol is 8 weeks on \/ 4 weeks off, primarily to give the gut microbiome periodic breaks (berberine has direct antimicrobial activity at intestinal concentrations) and to preserve AMPK responsiveness over multi-year use. Continuous daily use also has supporters; both patterns appear safe in the published trials.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePairs with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e (sirtuin\/NAD+ leg), \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e (sirtuin co-activator), \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e (mitochondrial protection — particularly important alongside any lipid intervention), \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e (insulin-signaling cofactor), \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e (additive triglyceride lowering), \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e (autophagy partner), \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e (insulin sensitivity + AMPK co-activation), \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium AKG 1000mg\u003c\/a\u003e (epigenetic age), \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e (cortisol-glucose axis), \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e (senolytic + AMPK synergy), and \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e (NLRP3 \/ inflammaging).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy berberine sits at the center of the modern longevity map\u003c\/h2\u003e\n\n\u003cp\u003eMost supplements that get called \"longevity supplements\" earn that label through a single biological pathway. \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e raises NAD+, which feeds the sirtuin family of deacetylases. \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e co-activates SIRT1 and stabilizes the PGC-1α transcriptional response. \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e triggers macroautophagy. Rapamycin (prescription only) directly inhibits mTORC1. Berberine is unusual in this list because it activates a fourth and arguably more upstream node — AMP-activated protein kinase — which then touches almost every other longevity lever in the cell.\u003c\/p\u003e\n\n\u003cp\u003eWhen AMPK is phosphorylated and active, four large-scale things happen at once. (1) Glucose uptake into skeletal muscle goes up via GLUT4 translocation, independent of insulin. (2) Fatty-acid oxidation goes up via inhibition of acetyl-CoA carboxylase (ACC), which lowers malonyl-CoA and frees CPT1 to import fatty acids into the mitochondrion. (3) Mitochondrial biogenesis goes up via PGC-1α phosphorylation. (4) mTORC1 signaling goes down via TSC2 and Raptor phosphorylation, and that drop in mTORC1 lifts the brake on autophagy. Active AMPK simultaneously runs the cell's \"burn fuel\" program and the cell's \"self-clean\" program — the same two programs that fasting, exercise, and caloric restriction also activate.\u003c\/p\u003e\n\n\u003cp\u003eThis is why metformin — which also activates AMPK, by partially inhibiting mitochondrial complex I and shifting the AMP\/ATP ratio — became the first drug studied as a generic geroprotective intervention (the TAME trial, \"Targeting Aging with Metformin\"). Berberine activates the same enzyme through an overlapping mechanism, and the metabolic outputs are remarkably similar across head-to-head trials. Berberine is not metformin; it has a different drug-interaction profile, a different microbiome footprint, and meaningfully less long-term safety data. But for adults who don't have a clinical indication for prescription metformin and want a clinically-studied AMPK activator, berberine is the natural compound with the deepest evidence base.\u003c\/p\u003e\n\n\u003cp\u003eThe López-Otín \"Hallmarks of Aging\" framework (2013, updated 2023) lists twelve interconnected drivers of biological aging. Berberine has published mechanistic data hitting at least seven of them: \u003cem\u003ederegulated nutrient sensing\u003c\/em\u003e (AMPK, mTOR, IGF-1), \u003cem\u003emitochondrial dysfunction\u003c\/em\u003e (biogenesis, complex I modulation), \u003cem\u003ecellular senescence\u003c\/em\u003e (SASP suppression in some cell types), \u003cem\u003echronic inflammation \/ inflammaging\u003c\/em\u003e (NF-κB and NLRP3 inhibition), \u003cem\u003ealtered intercellular communication\u003c\/em\u003e (microbiome-host signaling), \u003cem\u003eloss of proteostasis\u003c\/em\u003e (autophagy via mTOR), and \u003cem\u003egenomic instability\u003c\/em\u003e (indirect, via reduced oxidative stress). It is rare for a single natural compound to have positive published data across that many hallmarks.\u003c\/p\u003e\n\n\u003ch2\u003eThe eight mechanisms, in order of evidence strength\u003c\/h2\u003e\n\n\u003ch3\u003e1. Glucose handling — GLUT4 translocation, alpha-glucosidase inhibition, hepatic gluconeogenesis\u003c\/h3\u003e\n\u003cp\u003eBerberine activates AMPK in skeletal muscle, which signals translocation of GLUT4 glucose transporters from intracellular vesicles to the cell membrane and pulls glucose out of the bloodstream — the same insulin-independent pathway that exercise activates. In the small intestine, berberine inhibits alpha-glucosidase and slows the conversion of complex carbohydrates to absorbable monosaccharides, blunting the post-meal glucose spike. In the liver, AMPK activation suppresses gluconeogenic gene expression (PEPCK, G6Pase) and reduces fasting hepatic glucose output. The 2008 Yin head-to-head trial against metformin remains the most-cited primary evidence — both compounds produced ~25% reductions in fasting plasma glucose and ~2-point HbA1c reductions over 12 weeks at 1500 mg\/day. The 2015 Lan et al. meta-analysis of 27 trials in \u003cem\u003eJournal of Ethnopharmacology\u003c\/em\u003e (n \u0026gt; 2,500) reproduced the findings in pooled analysis with a mean fasting glucose reduction of 0.8 mmol\/L and HbA1c reduction of 0.7 percentage points.\u003c\/p\u003e\n\n\u003ch3\u003e2. Lipid profile — LDL receptor upregulation, distinct from statins\u003c\/h3\u003e\n\u003cp\u003eBerberine upregulates LDL receptor (LDLR) expression in hepatocytes through ERK \/ JNK signaling and post-transcriptional mRNA stabilization — a mechanism completely distinct from statins (which inhibit HMG-CoA reductase upstream of cholesterol synthesis). Because the mechanisms are different, the lipid effects of berberine and statins appear to be at least partially additive in the clinical literature. The 2012 Dong et al. meta-analysis pooled 14 RCTs and reported average reductions of 24 mg\/dL in LDL-C, 30 mg\/dL in triglycerides, and 16 mg\/dL in total cholesterol across berberine arms versus placebo or no intervention. The 2013 Pirillo and Catapano review in \u003cem\u003eAtherosclerosis\u003c\/em\u003e summarized berberine's lipid mechanism as \"the closest natural-compound analogue to a PCSK9-style approach to LDL reduction\" — referring to the receptor-upregulation route rather than the synthesis-inhibition route.\u003c\/p\u003e\n\n\u003ch3\u003e3. Gut microbiome remodeling — Akkermansia, SCFA, BSH\u003c\/h3\u003e\n\u003cp\u003eBerberine has direct antimicrobial activity at the intestinal concentrations achieved by oral dosing (its absolute oral bioavailability is only ~5%, which means most of an oral dose stays in the gut). It selectively reshapes microbial composition — generally reducing pro-inflammatory species in some \u003cem\u003eFirmicutes\u003c\/em\u003e phyla, reducing bile-salt-hydrolase-active species (which raises conjugated bile acids and engages FXR signaling), and supporting expansion of short-chain-fatty-acid producers and the mucin-degrading commensal \u003cem\u003eAkkermansia muciniphila\u003c\/em\u003e. The 2018 Zhang et al. trial in \u003cem\u003emBio\u003c\/em\u003e and the 2020 Sun et al. paper in \u003cem\u003ePhytomedicine\u003c\/em\u003e both linked the metabolic improvements partly to this microbiome shift, with separate effects on host AMPK and on host bile-acid metabolism through the gut-liver axis. This is one reason berberine's clinical effects often appear stronger than its tiny systemic plasma exposure would predict.\u003c\/p\u003e\n\n\u003ch3\u003e4. Insulin sensitivity beyond glucose — HOMA-IR and adipose signaling\u003c\/h3\u003e\n\u003cp\u003eThe metabolic effects of berberine are not limited to glucose entering muscle. The 2008 Yin trial reported HOMA-IR (a composite of fasting glucose and fasting insulin used as an insulin-resistance index) dropped by ~45% in the berberine arm, comparable to metformin. The 2010 Pérez-Rubio et al. trial in metabolic-syndrome patients reproduced the HOMA-IR drop. Mechanistically, berberine lowers the lipotoxic load on insulin-target tissues (by promoting fatty-acid oxidation and reducing intracellular ceramide accumulation) and raises adiponectin in some patient populations.\u003c\/p\u003e\n\n\u003ch3\u003e5. AMPK–mTOR–autophagy axis (the longevity leg)\u003c\/h3\u003e\n\u003cp\u003eThis is the mechanism that puts berberine in longevity stacks alongside NMN, resveratrol, and spermidine. AMPK phosphorylates TSC2 and Raptor, which suppresses mTORC1, which lifts the brake on ULK1 — the kinase that initiates autophagy. The downstream output is the same self-clearing program activated by fasting, caloric restriction, exercise, and rapamycin. The point isn't that berberine alone extends human lifespan (no supplement has that evidence in humans). The point is that AMPK is one of four canonical longevity-pathway nodes, and berberine is the most-studied natural way to push it. \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e works on a downstream parallel autophagy pathway through hypusinated eIF5A; the two are commonly stacked together rather than chosen between.\u003c\/p\u003e\n\n\u003ch3\u003e6. Cardiovascular and endothelial signaling\u003c\/h3\u003e\n\u003cp\u003eBeyond lipid effects, berberine has direct vascular actions: it increases endothelial NO synthase (eNOS) expression and phosphorylation, which improves flow-mediated dilation in clinical studies; it lowers TMAO (trimethylamine-N-oxide) by reshaping the gut microbes that produce it from dietary choline and L-carnitine; and it has modest blood-pressure-lowering activity in hypertensive cohorts. The 2015 Lan meta-analysis included blood pressure as a secondary endpoint and reported small but statistically significant reductions in systolic and diastolic BP. None of this should substitute for cardiovascular medications when those are clinically indicated, but it stacks coherently with \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 fish oil\u003c\/a\u003e and \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e as a foundation cardiovascular-support set.\u003c\/p\u003e\n\n\u003ch3\u003e7. Inflammation and inflammaging — NF-κB, NLRP3, SASP\u003c\/h3\u003e\n\u003cp\u003eBerberine inhibits NF-κB activation and NLRP3 inflammasome assembly in multiple tissue types, reducing the downstream production of IL-1β, IL-6, TNF-α, and other pro-inflammatory cytokines that constitute the senescence-associated secretory phenotype (SASP) and the broader \"inflammaging\" signature. In aged tissues, low-grade chronic inflammation appears to be both a downstream consequence of senescent-cell accumulation and an upstream driver of further age-related pathology. The 2017 Ehteshamfar et al. review in \u003cem\u003eInflammopharmacology\u003c\/em\u003e compiled the human and animal data on berberine's anti-inflammatory profile across cardiovascular, hepatic, neuronal, and joint tissues. Pairs cleanly with \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e (also an NLRP3 inhibitor) and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (senolytic + NLRP3).\u003c\/p\u003e\n\n\u003ch3\u003e8. Body composition — visceral fat over subcutaneous fat\u003c\/h3\u003e\n\u003cp\u003eSeveral trials have measured body composition before and after berberine intervention. The pattern is consistent: berberine produces modest total-weight changes but disproportionate reductions in visceral fat mass (the metabolically active fat depot around abdominal organs that drives most of the cardiometabolic risk attributed to \"weight\"). The 2012 Hu et al. trial in metabolic-syndrome patients reported a –3.6% change in waist circumference and a measurable drop in visceral-fat ratio over 12 weeks. The mechanism is consistent with AMPK-driven shifts toward fat oxidation and away from de novo lipogenesis, and with adipose-tissue browning signals seen in animal studies.\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence at a glance\u003c\/h2\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eStudy (year)\u003c\/th\u003e\n\u003cth\u003ePopulation (n)\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003ePrimary outcome\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eYin et al. 2008, \u003cem\u003eMetabolism\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eType 2 diabetes (n=36)\u003c\/td\u003e\n\u003ctd\u003e500 mg 3×\/day vs metformin 500 mg 3×\/day, 12 weeks\u003c\/td\u003e\n\u003ctd\u003eEquivalent reductions in FPG, HbA1c, post-prandial glucose, TG, total chol\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eZhang et al. 2008, \u003cem\u003eJCEM\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eType 2 diabetes (n=84)\u003c\/td\u003e\n\u003ctd\u003e500 mg 3×\/day, 3 months\u003c\/td\u003e\n\u003ctd\u003eFPG –31%, HbA1c –24%, fasting insulin –28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePérez-Rubio et al. 2013, \u003cem\u003eMetab Syndr Relat Disord\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMetabolic syndrome (n=24)\u003c\/td\u003e\n\u003ctd\u003e500 mg 3×\/day, 3 months\u003c\/td\u003e\n\u003ctd\u003eHOMA-IR –45%, waist circumference reduction\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKong et al. 2004, \u003cem\u003eNat Med\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHypercholesterolemia (n=32)\u003c\/td\u003e\n\u003ctd\u003e500 mg 2×\/day, 3 months\u003c\/td\u003e\n\u003ctd\u003eLDL-C –25%, TG –35%, total chol –29%; LDLR upregulation mechanism described\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDong et al. 2012 meta-analysis, \u003cem\u003ePlanta Med\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e14 RCTs pooled (n=1,068)\u003c\/td\u003e\n\u003ctd\u003e0.5–1.5 g\/day, 4–24 weeks\u003c\/td\u003e\n\u003ctd\u003eLDL –24 mg\/dL, TG –30 mg\/dL, total chol –16 mg\/dL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLan et al. 2015 meta-analysis, \u003cem\u003eJ Ethnopharmacol\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e27 RCTs pooled (n \u0026gt; 2,500)\u003c\/td\u003e\n\u003ctd\u003eVariable\u003c\/td\u003e\n\u003ctd\u003eFPG –0.8 mmol\/L, HbA1c –0.7%, modest BP reduction\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHu et al. 2012, \u003cem\u003ePhytomedicine\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eObesity (n=37)\u003c\/td\u003e\n\u003ctd\u003e500 mg 3×\/day, 12 weeks\u003c\/td\u003e\n\u003ctd\u003eWaist circumference –3.6%, visceral-fat ratio reduction\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eZhang et al. 2018, \u003cem\u003emBio\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eType 2 diabetes microbiome (n=80)\u003c\/td\u003e\n\u003ctd\u003e0.6 g 3×\/day, 3 months\u003c\/td\u003e\n\u003ctd\u003eMicrobiome shift: ↓ pro-inflammatory species, ↑ \u003cem\u003eAkkermansia\u003c\/em\u003e, ↑ SCFA producers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCicero et al. 2007, \u003cem\u003eClin Pharm Ther\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eStatin-intolerant hypercholesterolemia (n=40)\u003c\/td\u003e\n\u003ctd\u003e500 mg 2×\/day + low-dose statin\u003c\/td\u003e\n\u003ctd\u003eAdditive LDL reduction beyond statin alone\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSun et al. 2020, \u003cem\u003ePhytomedicine\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMicrobiome cross-talk study\u003c\/td\u003e\n\u003ctd\u003eMechanistic\u003c\/td\u003e\n\u003ctd\u003eBile-acid \/ FXR axis identified as parallel mechanism beyond AMPK\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWei et al. 2012, \u003cem\u003eEur J Endocrinol\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003ePCOS (n=89)\u003c\/td\u003e\n\u003ctd\u003e500 mg 3×\/day, 3 months\u003c\/td\u003e\n\u003ctd\u003eHOMA-IR, LH\/FSH improvement; comparable to metformin in this cohort\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYang et al. 2012, \u003cem\u003eEvid Based Complement Alternat Med\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eType 2 diabetes (n=116)\u003c\/td\u003e\n\u003ctd\u003e1.0 g\/day, 12 weeks\u003c\/td\u003e\n\u003ctd\u003eFPG, HbA1c, insulin sensitivity improvement vs placebo\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eBerberine HCl vs dihydroberberine vs goldenseal — what you're actually buying\u003c\/h2\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003eBioavailability\u003c\/th\u003e\n\u003cth\u003eTrial coverage\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBerberine HCl 97% (this product)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cem\u003eBerberis aristata\u003c\/em\u003e root, the \"Indian barberry\"\u003c\/td\u003e\n\u003ctd\u003e~5% absolute, plasma-detectable; effective at 500 mg ×3\/day\u003c\/td\u003e\n\u003ctd\u003eEssentially all the major RCTs — Yin 2008, Zhang 2008, Kong 2004, Dong 2012 meta — used this form\u003c\/td\u003e\n\u003ctd\u003eAnyone trying to reproduce the published clinical outcomes; the studied form for studied results\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDihydroberberine (DHB)\u003c\/td\u003e\n\u003ctd\u003eSemi-synthetic reduction of berberine\u003c\/td\u003e\n\u003ctd\u003e~5× higher than berberine HCl in animal pharmacokinetics\u003c\/td\u003e\n\u003ctd\u003eLimited human RCT evidence; mostly small open-label or animal data\u003c\/td\u003e\n\u003ctd\u003ePeople with severe GI sensitivity to berberine HCl; lower-dose supplementation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBerberine + silymarin \/ phytosome\u003c\/td\u003e\n\u003ctd\u003eBerberine HCl complexed with milk-thistle phospholipids\u003c\/td\u003e\n\u003ctd\u003e2–3× higher plasma exposure\u003c\/td\u003e\n\u003ctd\u003eA handful of Italian-led trials; mostly cardiometabolic\u003c\/td\u003e\n\u003ctd\u003eLower-dose convenience formulations; ratio-blends rather than head-to-head trial reproduction\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGoldenseal (\u003cem\u003eHydrastis canadensis\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd\u003eNorth American herb containing 0.5–6% berberine plus hydrastine\u003c\/td\u003e\n\u003ctd\u003eExtremely variable, low standardization\u003c\/td\u003e\n\u003ctd\u003eNone of the head-to-head metformin or lipid trials\u003c\/td\u003e\n\u003ctd\u003eTraditional herbal use; not the form to use if you want the clinical outcomes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOregon grape (\u003cem\u003eMahonia aquifolium\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd\u003eBark and root, contains berberine plus other isoquinolines\u003c\/td\u003e\n\u003ctd\u003eVariable\u003c\/td\u003e\n\u003ctd\u003eNot used in major metabolic RCTs\u003c\/td\u003e\n\u003ctd\u003eTopical \/ dermatological traditional use, not metabolic\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis product is the studied form: 97% berberine HCl from \u003cem\u003eBerberis aristata\u003c\/em\u003e, the same form used in Yin 2008, Zhang 2008, Kong 2004, and the Dong and Lan meta-analyses. If your goal is to reproduce the published clinical outcomes, the form matters as much as the dose.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults building a four-pathway longevity stack\u003c\/strong\u003e — covering NAD+\/sirtuins (\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e + \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e), AMPK (Berberine), mTOR\/autophagy (\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e), and senolytics (\u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e\/\u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e). Berberine is the AMPK leg.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults with elevated fasting glucose, prediabetes-range HbA1c, or post-meal glucose excursions\u003c\/strong\u003e — looking for a clinically-studied non-prescription option, often as a complement to (not replacement for) physician-directed care.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults with elevated LDL or triglycerides\u003c\/strong\u003e — wanting natural lipid support, particularly people who can't tolerate statins or who want an additive natural complement to a low-dose statin protocol (Cicero et al. 2007).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults running an NMN protocol\u003c\/strong\u003e — pairing AMPK activation with sirtuin activation is one of the most-studied longevity-stack combinations because the two pathways feed each other (AMPK regenerates NAD+ in some tissues via NAMPT upregulation, and NAD+-dependent SIRT1 deacetylates and activates AMPK).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults working on visceral fat \/ metabolic flexibility\u003c\/strong\u003e — AMPK activation favors fat oxidation over fat storage; the trial signal is concentrated in visceral fat rather than subcutaneous.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults with PCOS or insulin-resistant ovulatory dysfunction\u003c\/strong\u003e — Wei 2012 demonstrated comparable HOMA-IR and LH\/FSH improvement to metformin in this population. Co-management with a physician is appropriate.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults building a gut-microbiome reset protocol\u003c\/strong\u003e — short-term cycled berberine has direct antimicrobial activity that can shift a dysbiotic microbiome composition, particularly when paired with a fiber-forward diet that supports SCFA-producing commensals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is \u003cem\u003enot\u003c\/em\u003e for\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding women\u003c\/strong\u003e — berberine crosses the placenta and has been associated with kernicterus risk in newborns at sufficient doses; contraindicated.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNewborns and infants\u003c\/strong\u003e — same kernicterus \/ bilirubin-displacement concern; contraindicated.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone taking cyclosporine\u003c\/strong\u003e — berberine is a potent CYP3A4 inhibitor and will raise cyclosporine blood levels significantly. Same caution applies to tacrolimus.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone on insulin or sulfonylureas\u003c\/strong\u003e — additive hypoglycemic effect; dose adjustment requires physician oversight.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone on statins, calcium-channel blockers, certain anticoagulants, or psychiatric medications metabolized by CYP3A4 \/ CYP2D6\u003c\/strong\u003e — review the interaction list with your pharmacist or physician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone with chronic GI issues\u003c\/strong\u003e — berberine can cause cramping, loose stools, or constipation in 10–20% of users at full dose, particularly in the first 1–2 weeks. Start at 500 mg once daily and titrate.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone scheduled for surgery in the next 2 weeks\u003c\/strong\u003e — discontinue 14 days before any procedure due to glucose-lowering effects under anesthesia and potential additive effects with surgical-stress-response medications.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren\u003c\/strong\u003e — pediatric data is essentially absent; reserve for adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in each capsule\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e500 mg Berberine HCl\u003c\/strong\u003e — standardized 97% berberine extract from \u003cem\u003eBerberis aristata\u003c\/em\u003e (Indian barberry) root. The HCl salt form is the clinically-studied form and the same form used in Yin 2008 and the Dong 2012 meta-analyzed lipid trials.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVegetable cellulose capsule\u003c\/strong\u003e — no gelatin, vegan-friendly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNo undisclosed fillers\u003c\/strong\u003e — no magnesium stearate, no silicon dioxide, no titanium dioxide, no rice-flour bulking agents, no artificial colors, no soy, no gluten, no dairy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThird-party tested\u003c\/strong\u003e for identity (HPLC fingerprint), berberine content (≥97% by HPLC), heavy metals (Pb, Hg, As, Cd within USP \u0026lt;232\u0026gt; limits), microbial contamination (USP \u0026lt;2021\u0026gt; \/ \u0026lt;2022\u0026gt;), and pesticide residues.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured\u003c\/strong\u003e in an NSF-registered facility under FDA 21 CFR Part 111 dietary supplement GMP.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle-source extraction\u003c\/strong\u003e — same supplier and same extraction lot specifications for repeatable potency batch-to-batch.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\n\u003ch3\u003eStandard daily protocol — the trial-aligned dose\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e1 capsule (500 mg) two to three times daily, with meals.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhy split dosing matters:\u003c\/strong\u003e berberine's plasma half-life is approximately 4 hours. A single 1500 mg dose produces a high peak then crashes for 12+ hours into a sub-therapeutic trough. Three 500 mg doses across the day keep AMPK activation steadier across waking hours and reproduce the dose schedule used in Yin 2008 and most of the meta-analyzed glucose trials.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWith meals (not fasted):\u003c\/strong\u003e berberine's largest practical effect on post-meal glucose comes from being present in the gut at the same time as the carbohydrate. It's also gentler on the stomach when taken with food.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTiming example:\u003c\/strong\u003e 1 cap with breakfast, 1 cap with lunch, 1 cap with dinner. If you eat 2 meals: 1 cap with each meal, totaling 1000 mg\/day.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eTitration if you're new to berberine\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 1:\u003c\/strong\u003e 500 mg once daily with the largest meal. This identifies any GI sensitivity at the lowest exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 2:\u003c\/strong\u003e 500 mg twice daily (largest meal + dinner).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 3 onward:\u003c\/strong\u003e 500 mg three times daily if tolerated and your goals warrant the full dose. Most lipid and glucose trials used 1500 mg\/day total.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRe-test:\u003c\/strong\u003e repeat fasting glucose, HbA1c, and a full lipid panel at 12 weeks of consistent dosing. Don't draw conclusions before then — most of the trial endpoints were measured at 8 or 12 weeks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eThree protocol variants\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eDefault (metabolic and lipid coverage):\u003c\/strong\u003e 500 mg with breakfast, lunch, dinner. Cycle 8 weeks on \/ 4 weeks off. Pair with NMN 1000 mg AM + Resveratrol 600 mg AM + Magnesium Glycinate 400 mg PM.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eContinuous (longevity-stack maintenance):\u003c\/strong\u003e 500 mg twice daily (breakfast and dinner) without cycling. Lower total dose, lower microbiome impact, supports a chronic-use profile better suited to multi-year longevity stacking. Used by practitioners who prioritize AMPK activation over peak metabolic effect.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGlucose-priority (post-meal excursion focus):\u003c\/strong\u003e 500 mg with each carbohydrate-containing meal, including a 4th capsule if you eat a fourth carb-containing meal. Use a continuous glucose monitor for 14–28 days to verify the effect on your post-meal glucose curves before deciding whether the larger dose schedule is worth it for you.\u003c\/p\u003e\n\n\u003ch3\u003eCycling\u003c\/h3\u003e\n\u003cp\u003eThe practitioner-default cycle is 8 weeks on \/ 4 weeks off. The reasoning is threefold. (1) AMPK is a regulatory enzyme; the cell's response to chronic stimulation can attenuate, and a 4-week break appears to restore full responsiveness in anecdotal practitioner reports. (2) Berberine's antimicrobial activity is broad enough that periodic breaks let the gut microbiome rebalance. (3) The longest published RCTs are 8–24 weeks, so multi-year continuous-daily-use safety data is limited compared to cycled use. The 8\/4 cycle is the convention; it's not a hard rule, and adults running it as a continuous low-dose foundation rather than a peak-dose intervention often skip the cycling.\u003c\/p\u003e\n\n\u003ch3\u003eStack pairing — the canonical longevity protocol\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg AM\u003c\/a\u003e:\u003c\/strong\u003e covers the sirtuin\/NAD+ leg while berberine covers the AMPK leg. The two pathways feed each other through SIRT1 deacetylation of AMPK and AMPK-driven NAMPT upregulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg AM with a fatty meal\u003c\/a\u003e:\u003c\/strong\u003e sirtuin co-activator, lipid-soluble; absorbed alongside dietary fat.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e if you're on a statin:\u003c\/strong\u003e berberine adds to LDL reduction; CoQ10 protects mitochondrial function the statin would otherwise blunt. Q-SYMBIO-grade pairing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg PM\u003c\/a\u003e:\u003c\/strong\u003e magnesium is a cofactor for both insulin signaling and ATP synthesis; pairs well with any glucose-handling protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000 mg with the largest meal\u003c\/a\u003e:\u003c\/strong\u003e additive triglyceride-lowering effect.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg AM\u003c\/a\u003e:\u003c\/strong\u003e autophagy partner that works on a parallel hypusinated-eIF5A pathway downstream of AMPK-mTOR.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg AM fasted\u003c\/a\u003e:\u003c\/strong\u003e insulin sensitivity, AMPK co-activation, mitochondrial cofactor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium AKG 1000 mg AM\u003c\/a\u003e:\u003c\/strong\u003e epigenetic age (TruDiagnostic data), TCA cycle replenishment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600 mg PM\u003c\/a\u003e:\u003c\/strong\u003e cortisol-glucose axis; lower cortisol means lower hepatic glucose output, especially in stressed adults.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500 mg\u003c\/a\u003e:\u003c\/strong\u003e senolytic + AMPK co-activation + NLRP3 inhibition. Synergistic with berberine on inflammatory markers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000 mg\u003c\/a\u003e:\u003c\/strong\u003e NLRP3 \/ inflammaging coverage; complementary anti-inflammatory mechanism.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 + K2\u003c\/a\u003e:\u003c\/strong\u003e general foundation for calcium-routing, immune, and metabolic function — does not interact with berberine but rounds out the foundation set.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eThe AMPK–NAD+ crosstalk: why berberine and NMN aren't redundant\u003c\/h2\u003e\n\u003cp\u003eOne of the most common questions about a longevity stack is whether AMPK activators and sirtuin activators do the same thing. They do not. They work on different enzymes, on different timescales, and they regulate each other through reciprocal post-translational modification.\u003c\/p\u003e\n\n\u003cp\u003eSIRT1 — the NAD+-dependent deacetylase activated downstream of NMN and resveratrol — directly deacetylates AMPK's upstream kinase LKB1 at multiple lysine residues, increasing LKB1's ability to phosphorylate and activate AMPK. So raising NAD+ tends to raise AMPK activity through SIRT1-LKB1.\u003c\/p\u003e\n\n\u003cp\u003eAMPK in turn upregulates NAMPT, the rate-limiting enzyme in the NAD+ salvage pathway, in skeletal muscle and liver. So raising AMPK tends to raise NAD+ levels in those tissues. This is the AMPK–NAD+ feedback loop documented in Cantó and Auwerx's work in \u003cem\u003eCell\u003c\/em\u003e and \u003cem\u003eCell Metabolism\u003c\/em\u003e (2009–2013).\u003c\/p\u003e\n\n\u003cp\u003eThe implication for stack design is that NMN + resveratrol and berberine are not redundant inputs to one pathway — they are complementary inputs to two reciprocal pathways. Hitting both is qualitatively different from doubling the dose of either one alone. \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eThe Longevity Stack Bundle\u003c\/a\u003e covers the sirtuin half; berberine covers the AMPK half.\u003c\/p\u003e\n\n\u003ch2\u003eInflammaging and the senescence connection\u003c\/h2\u003e\n\u003cp\u003eThe López-Otín 2023 update to the Hallmarks of Aging framework emphasizes \"chronic inflammation\" \/ inflammaging as one of the integrated hallmarks linking the others. Berberine's published mechanism reaches inflammaging through three independent routes: (1) direct NF-κB inhibition in immune and stromal cells, (2) NLRP3 inflammasome inhibition (which blunts IL-1β and IL-18 production), and (3) microbiome reshaping that lowers LPS translocation across the gut barrier — the so-called \"metabolic endotoxemia\" that drives systemic low-grade inflammation in people with poor diet quality and gut dysbiosis. The combined effect in trials is reductions in CRP, IL-6, and TNF-α at clinically relevant magnitudes (10–30% reductions across most trials that measured them). This is part of why berberine pairs cleanly with senolytics — Fisetin and Quercetin clear senescent cells, and berberine quiets the residual SASP signaling that comes from cells the senolytic missed.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability: why ~5% works\u003c\/h2\u003e\n\u003cp\u003eBerberine's absolute oral bioavailability — the fraction of an oral dose that reaches systemic plasma unchanged — is roughly 5%. This sounds discouraging until you understand that for berberine, the low systemic bioavailability is not just a tolerable feature, it's part of how the compound works. Most of an oral dose remains in the intestinal lumen, where it engages with the microbiome (mechanism 3 above) and with intestinal epithelial alpha-glucosidase (mechanism 1, post-meal glucose). The systemically absorbed fraction is sufficient to engage hepatic LDLR (mechanism 2) and to phosphorylate AMPK in muscle and adipose tissue at the doses used in the trials.\u003c\/p\u003e\n\n\u003cp\u003eSome formulations attempt to raise bioavailability with phospholipid complexes, milk-thistle (silymarin) co-administration, or dihydroberberine reduction. These can be valid choices for adults who want a smaller pill burden, but they trade off a feature: virtually all the head-to-head trial evidence — Yin 2008, Zhang 2008, Kong 2004, Dong 2012, Lan 2015 — was generated on plain berberine HCl at 1500 mg\/day total. Reproducing trial outcomes is most reliable when you reproduce trial dose form. This product is the trial-form berberine HCl 97%.\u003c\/p\u003e\n\n\u003ch2\u003eImportant safety information\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDrug interactions — CYP3A4 and CYP2D6:\u003c\/strong\u003e berberine inhibits CYP3A4 and CYP2D6, the two enzymes responsible for metabolizing roughly half of all prescription drugs. The clinically important interactions include cyclosporine (do not combine), tacrolimus, several statins (atorvastatin and simvastatin levels can rise meaningfully), some calcium-channel blockers (felodipine, nifedipine), warfarin (effect direction varies; INR monitoring required), some SSRIs and tricyclic antidepressants, several antipsychotics, and some antiarrhythmics. If you take any prescription medication, review the interaction list with your physician or pharmacist before starting berberine.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eP-glycoprotein and OCT1:\u003c\/strong\u003e berberine is also a P-gp inhibitor and an organic-cation-transporter substrate, which extends the interaction surface beyond CYP enzymes alone.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypoglycemia risk:\u003c\/strong\u003e additive with insulin, sulfonylureas, and metformin. Dose adjustment under physician supervision is required if you're already on a glucose-lowering medication.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding \/ infants:\u003c\/strong\u003e contraindicated. Berberine crosses the placenta and has been associated with kernicterus (bilirubin-displacement) risk in newborns at sufficient doses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGI tolerance:\u003c\/strong\u003e 10–20% of users experience cramping, loose stools, or constipation in the first 1–2 weeks. Titration usually resolves it. If symptoms persist past 2 weeks at 500 mg\/day with food, discontinue.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e discontinue 14 days before any scheduled procedure due to glucose-lowering effects under anesthesia.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic kidney or liver disease:\u003c\/strong\u003e consult your physician before starting; berberine clearance and CYP-interaction profile may differ in compromised hepatic \/ renal function.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcurrent antibiotics:\u003c\/strong\u003e berberine has direct antimicrobial activity. Stacking with a course of broad-spectrum antibiotics is not recommended; pause berberine during antibiotic therapy and resume after a recovery interval.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuality matters:\u003c\/strong\u003e third-party-tested, HPLC-verified 97% berberine HCl is the form that maps onto the trial outcomes. Lower-purity or undisclosed-source products with no certificate of analysis are not equivalent.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat changes, and when — a 12-week subjective timeline\u003c\/h2\u003e\n\n\u003ch3\u003eWeek 1\u003c\/h3\u003e\n\u003cp\u003eYou're titrating. The dominant subjective experience for most people is gut adaptation — possible cramping, loose stools, or constipation as the microbiome encounters berberine for the first time. Take with the largest meal. Don't push the dose. Most of week 1's \"effect\" is identifying whether you tolerate the compound.\u003c\/p\u003e\n\n\u003ch3\u003eWeek 2\u003c\/h3\u003e\n\u003cp\u003eGI symptoms typically settle by day 10–14. You move to 500 mg twice daily. Some people with significant pre-treatment post-meal glucose excursions notice early changes on a continuous glucose monitor (smaller post-meal peaks, faster return to baseline). Subjective \"feel\" is usually unchanged this early.\u003c\/p\u003e\n\n\u003ch3\u003eWeeks 3–4\u003c\/h3\u003e\n\u003cp\u003eFull dose 500 mg three times daily for adults targeting 1500 mg\/day. Fasting glucose may begin to drift downward by 5–10% in adults whose pre-treatment fasting was elevated. Most lipid effects are still building and not yet panel-detectable. Mild visceral-abdominal-circumference reductions sometimes start in adults with significant pre-treatment metabolic-syndrome features.\u003c\/p\u003e\n\n\u003ch3\u003eWeeks 5–8\u003c\/h3\u003e\n\u003cp\u003eThe first real measurement window. By week 8, the major glucose RCTs reported full effect on fasting glucose and HOMA-IR. Lipid changes are now panel-detectable in many users. Energy stability across the day often improves — fewer post-meal crashes, fewer reactive-hypoglycemia symptoms in adults who had them. This is also the window when most cycle-on protocols complete and the 4-week off-cycle begins.\u003c\/p\u003e\n\n\u003ch3\u003eWeeks 9–12\u003c\/h3\u003e\n\u003cp\u003eIf you ran continuously rather than cycling, the meta-analytic-magnitude lipid changes (–24 mg\/dL LDL, –30 mg\/dL TG) are the upper-bound expectation. HbA1c reductions are most visible at 12 weeks because HbA1c reflects 90-day average glucose. This is the right point to pull a full panel: fasting glucose, fasting insulin, HbA1c, lipid panel, hsCRP. If markers haven't moved, troubleshoot — adherence first, dose timing second, food-quality interaction third — before assuming non-response.\u003c\/p\u003e\n\n\u003ch3\u003eBeyond 12 weeks\u003c\/h3\u003e\n\u003cp\u003eFor longevity-stack users, berberine is a chronic-foundation supplement either cycled 8\/4 or run continuously at a lower (500 mg ×2\/day) maintenance dose. The trial endpoints don't extend beyond 24 weeks for most published studies, so retest annually and re-evaluate dose against current biomarkers and goals.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs berberine \"nature's metformin\"? Should I take it instead of my prescription?\u003c\/h3\u003e\n\u003cp\u003eThe 2008 Yin trial showed statistically equivalent glucose and lipid effects in a 12-week head-to-head against 1500 mg\/day metformin, and berberine has been called metformin's natural cousin in popular press because of that. \u003cstrong\u003eThat does not mean it's a substitute for prescription medication.\u003c\/strong\u003e If you're already on metformin or any glucose-lowering drug, the conversation about adding or substituting belongs with the physician who prescribed it — partly because of additive hypoglycemia risk, and partly because metformin has decades more long-term safety and outcomes data than berberine has. Most people use berberine as a foundation supplement \u003cem\u003ebefore\u003c\/em\u003e medication is needed, or as a physician-monitored adjunct.\u003c\/p\u003e\n\n\u003ch3\u003eWhy cycle 8 weeks on \/ 4 weeks off instead of taking it daily?\u003c\/h3\u003e\n\u003cp\u003eThree reasons. (1) AMPK is a regulatory enzyme; the cell's response to chronic stimulation can attenuate, and a 4-week break appears to restore full responsiveness in practitioner experience. (2) Berberine has direct antimicrobial activity — useful for reshaping a dysbiotic microbiome short-term, but indefinite continuous use is less well-studied than cycled use. (3) The longest published RCTs are 8–24 weeks, so we have less safety data on continuous multi-year daily dosing than we do on cycled use. The 8\/4 cycle is the practitioner-community default; it's not a hard rule, and adults running a lower 1000 mg\/day continuous foundation dose appear safe in the available data.\u003c\/p\u003e\n\n\u003ch3\u003eBerberine HCl vs dihydroberberine — which is better?\u003c\/h3\u003e\n\u003cp\u003eDihydroberberine (DHB) is a semi-synthetic reduction product with reportedly higher oral bioavailability (~5× in animal pharmacokinetics; smaller doses appear to produce comparable plasma exposure). The trade-off: virtually all the head-to-head clinical evidence — the 2008 Yin metformin comparison, the 2012 Dong meta-analysis, the lipid-modification trials, the microbiome-shift trials — was done on plain berberine HCl, not dihydroberberine. We use the studied form because the studied form has the studied outcomes. DHB is a reasonable choice for adults with severe stomach sensitivity at lower doses; berberine HCl at 1500 mg\/day is the choice that maps onto the published trial results.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take berberine with NMN and resveratrol? Won't they cancel each other out?\u003c\/h3\u003e\n\u003cp\u003eThe opposite — they're the canonical longevity stack precisely because they work on different reciprocal pathways. NMN raises NAD+, which feeds SIRT1; resveratrol allosterically activates SIRT1; SIRT1 deacetylates LKB1 and increases LKB1's ability to phosphorylate and activate AMPK. AMPK then upregulates NAMPT, the rate-limiting enzyme in NAD+ salvage. The two arms feed each other. Stacking them is the standard design, not a redundancy.\u003c\/p\u003e\n\n\u003ch3\u003eShould I add milk thistle or silymarin to boost absorption?\u003c\/h3\u003e\n\u003cp\u003eSome practitioners co-administer silymarin to raise plasma berberine exposure (the BBR-PCA \/ silybin-phytosome literature). It's a reasonable add for adults who want a smaller dose with comparable plasma exposure. The trade-off is that you're moving away from the trial-form dose, so the published outcome magnitudes don't transfer cleanly. The simpler approach for most adults is to dose berberine HCl 500 mg ×3\/day with food — that's the trial dose that produced the trial outcomes.\u003c\/p\u003e\n\n\u003ch3\u003eI'm getting GI cramping at 500 mg. Should I quit?\u003c\/h3\u003e\n\u003cp\u003eTry this first: drop to 500 mg once daily, with the largest meal of the day, for 7–10 days. The GI side effect is a known feature of the antimicrobial \/ motility activity and usually adapts within 1–2 weeks. If you're still uncomfortable after 2 weeks at 500 mg\/day with food, berberine isn't the right fit — discontinue and consider an alternative AMPK-supportive approach (regular fasted exercise, time-restricted eating, \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e as a different AMPK-adjacent compound, or physician consultation about prescription metformin).\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I see results in glucose \/ lipid markers?\u003c\/h3\u003e\n\u003cp\u003eMost trials measured outcomes at 8 and 12 weeks. Some users see fasting glucose changes within 2–4 weeks, particularly adults with significantly elevated pre-treatment values. Lipid changes typically take the full 8–12 weeks to show on a standard lipid panel because LDL receptor-driven mechanisms work on hepatic lipoprotein dynamics that turn over slowly. Don't draw conclusions from a 2-week trial. Re-test fasting glucose, HbA1c, and a full lipid panel at 12 weeks of consistent dosing. HbA1c specifically reflects 90-day average glucose, so a 12-week measurement window is the right interval.\u003c\/p\u003e\n\n\u003ch3\u003eWhy split into three doses instead of one big 1500 mg capsule?\u003c\/h3\u003e\n\u003cp\u003eBerberine's plasma half-life is roughly 4 hours. A single 1500 mg dose produces a high peak and a 12-hour trough where AMPK activation has fallen below the therapeutic threshold. Three 500 mg doses across the day keep cellular exposure consistent — and that's how the 2008 Yin trial dosed it, which is the trial most people are trying to reproduce. There's also a practical alpha-glucosidase argument: berberine's effect on post-meal glucose comes from being in the gut at the same time as the carbohydrate. Dosing three times daily with three meals puts berberine in the gut when it's most useful.\u003c\/p\u003e\n\n\u003ch3\u003eCan women take berberine? Does it affect hormones?\u003c\/h3\u003e\n\u003cp\u003eYes. Berberine is widely studied in women, including in the PCOS literature where Wei et al. 2012 demonstrated comparable HOMA-IR and LH\/FSH improvement to metformin. It's contraindicated in pregnancy and breastfeeding, but otherwise the published trials enroll both sexes and report similar metabolic outcomes. Women in perimenopause and menopause often see particularly clear benefit on the metabolic-syndrome features that emerge with the menopausal transition (visceral fat, fasting glucose, triglyceride drift).\u003c\/p\u003e\n\n\u003ch3\u003eDoes berberine interact with antibiotics? What about antifungals?\u003c\/h3\u003e\n\u003cp\u003eBerberine itself has direct antimicrobial activity at intestinal concentrations. Stacking it with a course of broad-spectrum antibiotics is not recommended — the additive antimicrobial pressure on the gut microbiome can disrupt commensal recovery. The cleaner approach is to pause berberine during antibiotic therapy and resume after the gut has had 1–2 weeks to recolonize on its own. Antifungal interactions are not well-characterized; consult your prescriber.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take berberine while fasting (e.g., 16:8 or extended fasts)?\u003c\/h3\u003e\n\u003cp\u003eThe trial dose is taken with meals because the alpha-glucosidase \/ post-meal-glucose mechanism requires food in the gut. During fasting hours, berberine's AMPK activation is still occurring at the systemic level, but you lose the gut-side mechanisms. For 16:8 protocols, dose with the meals inside your eating window. For extended fasts (24+ hours), most practitioners pause berberine because (a) hypoglycemia risk is higher in a fasted state and (b) the meal-paired mechanism is moot.\u003c\/p\u003e\n\n\u003ch3\u003eDoes berberine affect blood pressure?\u003c\/h3\u003e\n\u003cp\u003eModestly. The 2015 Lan meta-analysis included blood pressure as a secondary endpoint and reported small but statistically significant reductions in systolic and diastolic BP across berberine arms. The mechanism is partly endothelial NO-mediated and partly weight\/visceral-fat-mediated. It's not a primary blood-pressure intervention, but it doesn't work against any standard antihypertensive regimen and tends to nudge BP in the favorable direction.\u003c\/p\u003e\n\n\u003ch3\u003eWill berberine show up on a drug test?\u003c\/h3\u003e\n\u003cp\u003eNo. Berberine is a plant alkaloid that is structurally and pharmacologically unrelated to any compound on standard substance-screening panels. It is not a banned compound under WADA, USADA, or NCAA rules.\u003c\/p\u003e\n\n\u003ch3\u003eDoes berberine affect TMAO?\u003c\/h3\u003e\n\u003cp\u003eYes — favorably. TMAO (trimethylamine-N-oxide) is a microbiome-derived metabolite of dietary choline and L-carnitine that has been independently associated with cardiovascular risk in observational data. Berberine reshapes the gut microbes that produce TMA (the precursor of TMAO), and several trials have measured TMAO reductions of 20–40% in adults whose pre-treatment TMAO was elevated. This is consistent with the broader gut-cardiovascular axis mechanism.\u003c\/p\u003e\n\n\u003ch3\u003eIs berberine compatible with a continuous glucose monitor (CGM)?\u003c\/h3\u003e\n\u003cp\u003eYes — and a CGM is one of the most useful objective tools to verify whether berberine is doing what you want it to do at the post-meal-glucose level. Wear a CGM for 14 days at baseline, start berberine, then wear a CGM again at week 4 and week 8. The post-meal AUC reduction, peak glucose reduction, and time-in-range improvement give you a real signal in 2–4 weeks rather than waiting on a 12-week HbA1c.\u003c\/p\u003e\n\n\u003ch2\u003eFDA disclaimer\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. References to Yin et al. 2008, Kong et al. 2004, Zhang et al. 2008, Dong et al. 2012, Lan et al. 2015, Pérez-Rubio et al. 2013, Hu et al. 2012, Cicero et al. 2007, Wei et al. 2012, Yang et al. 2012, Zhang et al. 2018, Sun et al. 2020, Pirillo \u0026amp; Catapano 2013, and Ehteshamfar et al. 2017 are cited as published research context only and do not constitute treatment claims. Berberine has clinically significant drug interactions; consult a qualified healthcare provider before starting if you take any prescription medication, are pregnant or breastfeeding, are scheduled for surgery, or have a chronic medical condition. Results vary; individual outcomes are not guaranteed. The López-Otín \"Hallmarks of Aging\" framework (Cell 2013, updated Cell 2023) is referenced as a research-context model and not as a clinical claim.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47696472047834,"sku":"THP-BERB-500-60","price":19.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/berberine_02.jpg?v=1774728960"},{"product_id":"rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging","title":"Nicotinamide Capsules","description":"\u003cp\u003e\u003cstrong\u003eNicotinamide Riboside (NR) in hard capsule form\u003c\/strong\u003e — the patented NAD+ precursor with the deepest human research track record (65+ registered clinical trials, including pharmacokinetic, cardiovascular, and neurological endpoints). Supported by B-vitamin cofactors so the full NAD+ biosynthesis pathway has what it needs to convert NR into NAD+ inside the cell.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR is the most-studied NAD+ precursor in humans.\u003c\/strong\u003e First-in-human pharmacokinetic data published in 2016 (Trammell et al., \u003cem\u003eNature Communications\u003c\/em\u003e) showed a single oral dose raised whole-blood NAD+ ~2.7× over 24 hours. Multi-week dosing at 1 g\/day has been studied in healthy adults, midlife adults with elevated blood pressure, obese insulin-resistant adults, post-menopausal women, NAFLD patients, ALS patients, and Parkinson's patients.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDifferent intracellular path than NMN.\u003c\/strong\u003e NR enters cells via the equilibrative nucleoside transporters (ENT1\/2), gets phosphorylated by NRK1\/NRK2 to NMN, then converted to NAD+. NMN uses the Slc12a8 transporter (Grozio 2019, \u003cem\u003eNature Metabolism\u003c\/em\u003e) and skips a step. Both raise NAD+; tissue coverage and intracellular kinetics differ, which is why many longevity stacks run both.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who want the longest human-research track record, those who didn't feel a clear shift on NMN alone, anyone running a comprehensive NAD+ stack that hedges across both precursor pathways, and adults 50+ where the NMN transporter Slc12a8 may be downregulated in some tissues.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake 1–2 capsules daily\u003c\/strong\u003e in the morning with food. Daily consistency matters more than time-of-day. Stacks cleanly with NMN, Resveratrol, Pterostilbene, TMG, Apigenin, Quercetin, Fisetin, CoQ10, PQQ, and Urolithin A.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented NR form,\u003c\/strong\u003e the same molecule used in Trammell 2016, Martens 2018, Dollerup 2018, Conze 2019, Elhassan 2019, and Brakedal 2022. Manufactured to cGMP, third-party HPLC-tested, encapsulated in a vegan-compatible hard shell with no proprietary blends, no titanium dioxide, no artificial colors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NR sits at the center of the NAD+ conversation\u003c\/h2\u003e\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is the single most metabolically expensive coenzyme in the cell. Every major energy-producing pathway — glycolysis, the citric acid cycle, the electron transport chain, fatty-acid oxidation — runs on NAD+\/NADH cycling. On top of that core role, NAD+ is the rate-limiting substrate for at least three enzyme families that get talked about in the longevity literature constantly: the sirtuins (SIRT1–SIRT7, the histone-deacetylase \/ mitochondrial regulators activated by Resveratrol), the PARPs (PARP1 in particular, the primary single-strand DNA break repair enzyme), and CD38 (the NAD+ glycohydrolase that becomes hyperactive with inflammaging). When NAD+ falls, all three of those families slow down at the same time — and that simultaneity is why \"NAD+ decline\" gets called a hallmark of aging in the López-Otín 2013 \/ 2023 \u003cem\u003eCell\u003c\/em\u003e framework, even though it isn't formally one of the 12.\u003c\/p\u003e\n\u003cp\u003eThe decline itself is not subtle. Massudi 2012 (\u003cem\u003ePLOS One\u003c\/em\u003e) measured skin NAD+ across the lifespan and found a roughly 50% drop between ages 20 and 60. Camacho-Pereira 2016 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) replicated the finding in muscle and liver and showed CD38 — which consumes NAD+ to make calcium-mobilizing second messengers — rises sharply with age, partially explaining the drop. Yoshino 2011 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) showed similar declines in pancreas, adipose tissue, and the hypothalamus in mice. Across tissues, mechanisms, and species, the NAD+ pool collapses with age — and the sirtuin \/ PARP \/ CD38 enzymes that depend on it lose their substrate.\u003c\/p\u003e\n\u003cp\u003eYou can address that decline from three directions:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupply more precursor\u003c\/strong\u003e — give the cell more raw material to make NAD+ from. \u003cstrong\u003eNR and NMN\u003c\/strong\u003e are the two patented, trial-validated levers in this category. Niacin (NA) and niacinamide (NAM) also raise NAD+ but flush, suppress sirtuins at high doses, and lack the modern human evidence base.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReduce NAD+ consumers\u003c\/strong\u003e — slow down the enzymes that destroy it. \u003cstrong\u003eApigenin\u003c\/strong\u003e inhibits CD38 directly. \u003cstrong\u003eQuercetin\u003c\/strong\u003e and \u003cstrong\u003eFisetin\u003c\/strong\u003e clear senescent cells, which overconsume NAD+ via SASP-driven CD38 expression in neighboring cells.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivate the enzymes that use NAD+ productively\u003c\/strong\u003e — get more longevity output per unit of NAD+. \u003cstrong\u003eResveratrol\u003c\/strong\u003e and \u003cstrong\u003ePterostilbene\u003c\/strong\u003e activate SIRT1; \u003cstrong\u003espermidine\u003c\/strong\u003e activates the autophagy machinery that sirtuins help regulate.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eNR is the most-validated supply-side lever in humans, and it pairs cleanly with all three of the other strategies. That is why it lives in almost every well-designed longevity stack.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — what NR actually does inside the cell\u003c\/h2\u003e\n\n\u003ch3\u003e1. The NRK1\/NRK2 phosphorylation pathway\u003c\/h3\u003e\n\u003cp\u003eNR is a riboside — a vitamin B3 (nicotinamide) attached to a ribose sugar without a phosphate group. That structure matters for two reasons. First, it is the only NAD+ precursor that crosses the plasma membrane intact via a well-characterized transporter family: the equilibrative nucleoside transporters ENT1 and ENT2, which are present in essentially every tissue type (Bieganowski \u0026amp; Brenner 2004, \u003cem\u003eCell\u003c\/em\u003e). Second, once inside the cell, it gets phosphorylated to NMN by NRK1 (nicotinamide riboside kinase 1) or NRK2. NRK1 is the housekeeping enzyme — broadly distributed, induced by NAD+ depletion, and the rate-limiting step that determines how much NR actually becomes NAD+ in any given tissue (Ratajczak 2016, \u003cem\u003eNat Commun\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eFrom NMN, the route is canonical: NMNAT1\/2\/3 (nicotinamide mononucleotide adenylyltransferase) attaches the AMP moiety to make NAD+. NMNAT1 lives in the nucleus, NMNAT2 in the cytoplasm and Golgi, NMNAT3 in the mitochondrial matrix. That compartmentalization matters — NMNAT3 is the enzyme that decides how much of your NAD+ pool is mitochondrial, which is why mitochondrial sirtuins (SIRT3\/4\/5) and mitochondrial NAD+\/NADH cycling depend on getting precursor across the inner membrane. NR's ribose-only structure means it can be phosphorylated in any compartment that has NRK1\/2, including the mitochondrion via the SLC25A51 mitochondrial NAD+ transporter that was characterized in 2020 (Luongo, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThat two-step intracellular path (NR → NMN → NAD+) is one step longer than the NMN route but uses ubiquitous, redundant machinery (ENT1\/2, NRK1\/NRK2), which is why NR's tissue coverage is broad even when local Slc12a8 (the NMN transporter) is low.\u003c\/p\u003e\n\n\u003ch3\u003e2. Sirtuin substrate, PARP cofactor, and CD38 substrate — the three NAD+ sinks\u003c\/h3\u003e\n\u003cp\u003eOnce converted to NAD+, the molecule is consumed (not just used and recycled) by three enzyme families:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuins (SIRT1–SIRT7).\u003c\/strong\u003e NAD+-dependent deacetylases. SIRT1 in the nucleus deacetylates p53, FOXO, PGC-1α, and the histone tails that regulate metabolic, DNA-repair, and longevity gene programs. SIRT3 in the mitochondrion deacetylates the fatty-acid oxidation, urea-cycle, and ROS-detoxification machinery. SIRT6 stabilizes telomeres and regulates DNA double-strand break repair. Every catalytic cycle consumes one NAD+ and produces nicotinamide as a byproduct. The \"salvage pathway\" recycles that nicotinamide, but only at the rate set by NAMPT — which is why precursor supply (NR\/NMN) matters even when salvage is intact.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePARP1 (and PARP2).\u003c\/strong\u003e Poly-ADP-ribose polymerases. The primary single-strand DNA break repair enzyme attaches long chains of ADP-ribose to chromatin proteins at sites of damage, recruiting the repair machinery. Each chain consumes 50–200+ NAD+ molecules. When DNA damage is high — oxidative stress, radiation, chemotherapy, chronic inflammation — PARP activity can crash the NAD+ pool acutely. Restoring precursor supply is the first-line metabolic countermeasure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCD38.\u003c\/strong\u003e The NAD+ glycohydrolase that converts NAD+ to ADP-ribose \/ cyclic ADP-ribose for calcium signaling. CD38 expression rises with age and inflammation (Camacho-Pereira 2016) and contributes more to NAD+ decline in older tissue than any other enzyme. CD38 inhibition (Apigenin, Luteolin, 78c in animal studies) is the second supply-side strategy and pairs neatly with precursor supplementation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNR is the substrate at the start of that chain. Increase NR → increase NAD+ → increase the substrate available for sirtuin \/ PARP \/ CD38 activity. The decisive evidence that this happens in humans, not just cells in a dish, is the Trammell 2016 pharmacokinetic study and the trials that followed.\u003c\/p\u003e\n\n\u003ch3\u003e3. The cardiovascular and aortic-stiffness signal\u003c\/h3\u003e\n\u003cp\u003eMartens 2018 (\u003cem\u003eNature Communications\u003c\/em\u003e) gave 30 midlife and older adults with elevated systolic blood pressure (120–139 mmHg) NR 1 g\/day or placebo for 6 weeks in a randomized crossover. NR raised whole-blood NAD+ ~60% on average. In the elevated-BP subgroup, systolic BP fell ~10 mmHg vs placebo and aortic stiffness (measured by carotid-femoral pulse wave velocity) decreased — the same readouts that track with cardiovascular event risk in epidemiologic cohorts. The trial was small and short, but the magnitudes were large enough to motivate the multiple Phase III NR cardiovascular trials currently in registration. The mechanistic interpretation is sirtuin (SIRT1\/SIRT3)-mediated improvements in endothelial function and vascular smooth muscle bioenergetics — exactly what you would predict from the precursor-supply rationale.\u003c\/p\u003e\n\n\u003ch3\u003e4. The Parkinson's NADPARK signal\u003c\/h3\u003e\n\u003cp\u003eBrakedal 2022 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) — the NADPARK trial — gave 30 newly diagnosed Parkinson's patients NR 1 g\/day or placebo for 30 days and measured cerebrospinal fluid (CSF) NAD+ via lumbar puncture and brain NAD+ via 31P-MRS. CSF and brain NAD+ rose, neuroinflammatory markers (IL-6, IL-8, several CSF cytokines) shifted favorably, and clinical motor scores showed mild but measurable improvements vs placebo. The trial was small and short, but it was the first human study to demonstrate that oral NR raises brain NAD+ — a finding that matters for the broader hypothesis that NAD+ decline contributes to multiple neurodegenerative disease processes. The follow-up NR-SAFE trial (Brakedal 2023, \u003cem\u003eNat Commun\u003c\/em\u003e) extended the dosing safely to 3 grams\/day for 4 weeks. Larger NR-PD trials are ongoing.\u003c\/p\u003e\n\n\u003ch3\u003e5. Inflammation, muscle, and the elderly cohort\u003c\/h3\u003e\n\u003cp\u003eElhassan 2019 (\u003cem\u003eCell Reports\u003c\/em\u003e) gave 12 healthy elderly adults (aged 70–80) NR 1 g\/day for 21 days. Muscle biopsies showed elevated NAD+ and elevated NADP+\/NADPH ratios (NADP+ is the phosphorylated form used by the antioxidant defense system). Circulating inflammatory cytokines (IL-6, IL-5, IL-2) decreased significantly. The trial established that NR's effect on muscle NAD+ is meaningful in the population that needs it most — the same population in whom CD38 expression is highest and NAD+ is lowest at baseline.\u003c\/p\u003e\n\n\u003ch3\u003e6. The 8-week dose-response in healthy overweight adults\u003c\/h3\u003e\n\u003cp\u003eConze 2019 (\u003cem\u003eScientific Reports\u003c\/em\u003e) randomized 140 healthy overweight adults to placebo, 100, 300, or 1000 mg\/day NR for 8 weeks. Whole-blood NAD+ rose dose-dependently — about 22% at 100 mg, 51% at 300 mg, and 142% at 1000 mg. Adverse events did not differ from placebo at any dose. The trial established the dose-response curve in a free-living healthy population and is the largest RCT to date in non-clinical adults. It is the basis for the 1 g\/day target dose used in subsequent cardiovascular and neurological studies.\u003c\/p\u003e\n\n\u003ch3\u003e7. Insulin sensitivity and metabolic readouts\u003c\/h3\u003e\n\u003cp\u003eDollerup 2018 (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) gave 40 obese insulin-resistant men NR 2 g\/day or placebo for 12 weeks. NR raised whole-blood NAD+ but the primary insulin-sensitivity endpoint (hyperinsulinemic-euglycemic clamp) was not significantly improved at 12 weeks. The trial is often cited as a \"negative\" study, but the more accurate read is that 12 weeks at this dose did not move the specific insulin-sensitivity readout in this specific high-risk population. Other metabolic endpoints (body composition, hepatic fat by MRS) showed trends. Remie 2020 (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) replicated the safety and NAD+ rise in another insulin-resistant cohort. The metabolic story for NR is more nuanced than the cardiovascular story; the trial-design lesson is that NAD+ rise is robust but downstream metabolic endpoints depend on cohort, baseline NAD+, and stacking strategy.\u003c\/p\u003e\n\n\u003ch3\u003e8. The methylation pool — why TMG eventually matters\u003c\/h3\u003e\n\u003cp\u003eEvery time NAD+ is consumed by a sirtuin, PARP, or CD38, it produces nicotinamide (NAM) as a byproduct. NAM is recycled through the salvage pathway by NAMPT — but a fraction is also methylated by NNMT (nicotinamide N-methyltransferase) into 1-methylnicotinamide (1-MNA) and excreted in urine. That methylation step uses S-adenosyl methionine (SAM), the universal methyl donor. Sustained high-dose NR or NMN therefore creates a small, ongoing draw on the methylation pool. For most users, dietary methyl donors (choline, betaine in beets, methylated B12 and folate from a multivitamin) cover the cost. For long-term high-dose use — and especially for users with MTHFR polymorphisms — adding \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine)\u003c\/a\u003e at 500–1000 mg\/day after 4+ weeks of daily NR\/NMN is the standard methylation-support move.\u003c\/p\u003e\n\n\u003ch3\u003e9. Why the included B-vitamin cofactors actually do something\u003c\/h3\u003e\n\u003cp\u003eThe salvage pathway uses B6 as a cofactor for nicotinamide phosphoribosyltransferase (NAMPT). The methylation cycle that disposes of excess nicotinamide via NNMT depends on B12 and folate as methyl-group donors. Including B6, B12, and folate in the capsule means the NR you absorb has the supporting cofactors it needs without pulling them from elsewhere in your metabolism. It is not a substitute for TMG at long-term high doses, but it is a sensible structural addition that closes the most common micronutrient gaps that limit NAD+ biosynthesis efficiency. Trammell 2016 noted that in healthy participants, 1MNA (the methylated excretion product) appeared in urine within hours of dosing — confirming the methylation route is active from the first dose.\u003c\/p\u003e\n\n\u003ch2\u003eNR vs NMN — the practical decision, with mechanism\u003c\/h2\u003e\n\u003cp\u003eBoth are NAD+ precursors. Both raise NAD+ in humans. The pathway is one step different, and the practical implications are usually small but worth understanding before you commit to a stack.\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eNicotinamide Riboside (NR)\u003c\/th\u003e\n\u003cth\u003eNMN (β-NMN)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCell entry\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eENT1\/2 (broadly expressed nucleoside transporters; ubiquitous)\u003c\/td\u003e\n\u003ctd\u003eSlc12a8 (Grozio 2019); some tissue heterogeneity in expression\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eIntracellular path\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNR → NMN (NRK1\/NRK2 phosphorylation) → NAD+ (NMNAT)\u003c\/td\u003e\n\u003ctd\u003eNMN → NAD+ (NMNAT) — one step shorter\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFirst-in-human PK\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTrammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e — the foundational PK paper\u003c\/td\u003e\n\u003ctd\u003eIrie 2020, \u003cem\u003eEndocr J\u003c\/em\u003e — first PK; Yoshino 2021, \u003cem\u003eScience\u003c\/em\u003e first efficacy in pre-diabetic post-menopausal women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCardiovascular RCT\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMartens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e — 6 weeks, BP and aortic stiffness signal\u003c\/td\u003e\n\u003ctd\u003eSmaller human cardiovascular evidence base to date\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBrain \/ CSF NAD+\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBrakedal 2022, \u003cem\u003eCell Metab\u003c\/em\u003e — first human CSF NAD+ rise\u003c\/td\u003e\n\u003ctd\u003eMostly preclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eInsulin sensitivity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDollerup 2018 12-wk — neutral on clamp; Remie 2020 — neutral\u003c\/td\u003e\n\u003ctd\u003eYoshino 2021 — improved muscle insulin sensitivity in pre-diabetic post-menopausal women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTissue coverage strength\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStrong in muscle, brain, immune (broad ENT1\/2 expression)\u003c\/td\u003e\n\u003ctd\u003eStrong in liver and pancreas (high Slc12a8)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCost per gram\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHigher (patent-licensed)\u003c\/td\u003e\n\u003ctd\u003eGenerally lower — particularly for entry-tier 500 mg products\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDaily dose range\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e250–1000 mg (1000 mg is the trial-validated cardiovascular dose)\u003c\/td\u003e\n\u003ctd\u003e250–1000 mg (1000 mg is the Yoshino 2021 dose)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTime to whole-blood NAD+ rise\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eWithin 24 hours of first dose; sustained at 8 weeks (Conze 2019)\u003c\/td\u003e\n\u003ctd\u003eWithin hours of first dose; sustained at 10 weeks (Yoshino 2021)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBest for\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLongest research depth; muscle\/brain\/immune tissue priorities; NMN non-responders; comprehensive stacks\u003c\/td\u003e\n\u003ctd\u003eCost-efficient daily entry; liver\/pancreas priorities; insulin-sensitivity cohorts; entry-tier protocols\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor most users, the practical difference is small. Many longevity protocols stack both — NMN morning, NR mid-morning — to cover both transporter families across the day. The most rigorous answer to \"which is better?\" is \"the one you take consistently for 12+ weeks alongside a SIRT1 activator and a methyl donor.\" Read our full \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e for the deeper decision framework.\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence — the trials that matter\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTrial\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003ePrimary readout\u003c\/th\u003e\n\u003cth\u003eResult\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=12)\u003c\/td\u003e\n\u003ctd\u003e100 \/ 300 \/ 1000 mg single dose\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ over 24h\u003c\/td\u003e\n\u003ctd\u003e~2.7× rise at 1000 mg; first-in-human PK\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConze 2019, \u003cem\u003eSci Rep\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy overweight adults (n=140)\u003c\/td\u003e\n\u003ctd\u003e100 \/ 300 \/ 1000 mg\/day × 8 wk\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+; safety\u003c\/td\u003e\n\u003ctd\u003eDose-dependent rise (22% \/ 51% \/ 142%); no AE signal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMartens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMidlife\/older adults, elevated SBP (n=30)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 6 wk crossover\u003c\/td\u003e\n\u003ctd\u003eNAD+, SBP, aortic stiffness\u003c\/td\u003e\n\u003ctd\u003eNAD+ +60%; ~10 mmHg SBP drop in elevated-BP subgroup; aortic stiffness reduced\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDellinger 2017, \u003cem\u003eNPJ Aging Mech Dis\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=120)\u003c\/td\u003e\n\u003ctd\u003e250 mg\/day NR + 50 mg pterostilbene combo × 8 wk\u003c\/td\u003e\n\u003ctd\u003eNAD+; safety\u003c\/td\u003e\n\u003ctd\u003e~40% NAD+ rise; well tolerated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDollerup 2018, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eObese insulin-resistant men (n=40)\u003c\/td\u003e\n\u003ctd\u003e2000 mg\/day × 12 wk\u003c\/td\u003e\n\u003ctd\u003eInsulin sensitivity (clamp)\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; clamp insulin-sensitivity unchanged at 12 wk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eElhassan 2019, \u003cem\u003eCell Rep\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy elderly aged 70–80 (n=12)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 21 d\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+; circulating cytokines\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+ rose; IL-6\/IL-5\/IL-2 decreased\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemie 2020, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy overweight men (n=13 crossover)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 6 wk\u003c\/td\u003e\n\u003ctd\u003eSkeletal-muscle NAD+; metabolic endpoints\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; muscle acetylcarnitine fell; mixed metabolic readouts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStocks 2021, \u003cem\u003eJ Physiol\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy aged adults (n=12 crossover)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 21 d\u003c\/td\u003e\n\u003ctd\u003eSkeletal-muscle mitochondrial respiration\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; respiratory function unchanged at 21 d in healthy aged muscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrakedal 2022, \u003cem\u003eCell Metab\u003c\/em\u003e (NADPARK)\u003c\/td\u003e\n\u003ctd\u003eNewly diagnosed Parkinson's (n=30)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 30 d\u003c\/td\u003e\n\u003ctd\u003eCSF and brain NAD+; clinical motor scores\u003c\/td\u003e\n\u003ctd\u003eCSF\/brain NAD+ rose; neuroinflammatory markers shifted; mild motor improvement\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrakedal 2023, \u003cem\u003eNat Commun\u003c\/em\u003e (NR-SAFE)\u003c\/td\u003e\n\u003ctd\u003eParkinson's (n=20)\u003c\/td\u003e\n\u003ctd\u003e3000 mg\/day × 4 wk\u003c\/td\u003e\n\u003ctd\u003eSafety, tolerability, NAD+ ceiling\u003c\/td\u003e\n\u003ctd\u003e3 g\/day well tolerated; NAD+ further elevated vs 1 g\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWang 2017, \u003cem\u003eLancet Neurol\u003c\/em\u003e commentary on Trammell + ALS rationale\u003c\/td\u003e\n\u003ctd\u003eALS \/ preclinical\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eMechanistic basis for ALS NR trials\u003c\/td\u003e\n\u003ctd\u003eEstablished the rationale for the multi-arm ALS NR trials in registration\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePirinen 2020, \u003cem\u003eCell Metab\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eAdult mitochondrial myopathy (n=5)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day NR × 5 mo\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+, FGF21, mitochondrial myopathy markers\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; muscle strength and FGF21 trends improved\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAirhart 2017, \u003cem\u003ePLOS ONE\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=8)\u003c\/td\u003e\n\u003ctd\u003e1000–2000 mg\/day × 9 d\u003c\/td\u003e\n\u003ctd\u003eNAD+; safety\u003c\/td\u003e\n\u003ctd\u003eSafe, well-tolerated, NAD+ rose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis is the densest human evidence base of any NAD+ precursor — pharmacokinetic, dose-response, multi-cohort, multi-endpoint, multi-organ, and consistently safe at the 1 g\/day level over 4–12 week durations. Larger Phase III cardiovascular and Parkinson's NR trials are in registration as of 2026.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — why patented NR, not just \"any NR\"\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003eIdentity \/ form\u003c\/th\u003e\n\u003cth\u003eTrial coverage\u003c\/th\u003e\n\u003cth\u003eHPLC purity\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePatented Nicotinamide Riboside Chloride\u003c\/strong\u003e (this product)\u003c\/td\u003e\n\u003ctd\u003eCrystalline NR-Cl, the form used in every cited human trial\u003c\/td\u003e\n\u003ctd\u003e65+ registered human trials; the entire NR evidence base\u003c\/td\u003e\n\u003ctd\u003e≥98% NR by HPLC; identity confirmed by NMR \u0026amp; mass spec; trace heavy metals \u0026lt; USP \u0026lt;232\u0026gt; limits\u003c\/td\u003e\n\u003ctd\u003eAnyone who wants the trial-validated form. Default choice.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeneric NR-Cl (commodity)\u003c\/td\u003e\n\u003ctd\u003eSame chemical class but variable identity \/ purity \/ impurity profile\u003c\/td\u003e\n\u003ctd\u003eNot the form used in published human trials\u003c\/td\u003e\n\u003ctd\u003eVariable; specs not always disclosed; some lots fail HPLC identity\u003c\/td\u003e\n\u003ctd\u003eCost-shoppers willing to accept identity \/ purity variance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNicotinamide (NAM) \/ niacinamide\u003c\/td\u003e\n\u003ctd\u003eThe end-product, not a precursor in the same sense\u003c\/td\u003e\n\u003ctd\u003eLong history; flushless; sirtuin-suppressing at \u0026gt;500 mg\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003eSkin \/ dermatology applications, not longevity-stack NAD+ raising\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNiacin (NA, nicotinic acid)\u003c\/td\u003e\n\u003ctd\u003ePrecursor via the Preiss-Handler pathway\u003c\/td\u003e\n\u003ctd\u003eMultiple human trials (lipid use)\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003ePeople who can tolerate the flush; lipid-modification context, not longevity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNRH (dihydronicotinamide riboside)\u003c\/td\u003e\n\u003ctd\u003eReduced form; preclinical-only as of 2026\u003c\/td\u003e\n\u003ctd\u003eAnimal and cell evidence; no large human trials\u003c\/td\u003e\n\u003ctd\u003eResearch-grade only\u003c\/td\u003e\n\u003ctd\u003eResearchers; not for general consumer use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNMN (β-NMN)\u003c\/td\u003e\n\u003ctd\u003eOne step downstream of NR; uses Slc12a8\u003c\/td\u003e\n\u003ctd\u003eYoshino 2021; growing human evidence base\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003eDaily entry-tier; cost-efficient; liver\/pancreas priorities — see \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis product uses patented NR-Cl — the same crystalline form characterized in Trammell 2016 and used in every cardiovascular, neurological, and metabolic NR trial since. That matters because the published evidence base is what tells you the molecule actually raises NAD+ in human blood and tissue at the doses on the label. A commodity NR-Cl with a different impurity profile or a sub-spec HPLC identity is not what those trials studied — and you should not assume the evidence transfers.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — what the PK studies actually show\u003c\/h2\u003e\n\u003cp\u003eNR's pharmacokinetic profile is the cleanest of any NAD+ precursor in humans. Trammell 2016 traced the molecule through whole blood and urine after a single oral dose:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlasma NR appears within 30 minutes\u003c\/strong\u003e of an oral dose, peaks at ~1–2 hours, and is largely cleared from plasma by 6–8 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+ rises in parallel\u003c\/strong\u003e — the rise is detectable by 8 hours and is sustained out to 24 hours, meaning a once-daily dose covers the diurnal cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN, the intracellular intermediate, rises in tandem\u003c\/strong\u003e — the NRK1 phosphorylation step is fast enough not to be rate-limiting at 1 g\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1MNA (the methylated nicotinamide excretion product) rises in urine\u003c\/strong\u003e within the same window — confirming that the methylation route is active from the first dose. This is the mechanistic basis for adding TMG at long-term high doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eConze 2019 extended that single-dose PK to 8-week steady-state dosing in 140 healthy overweight adults. Steady-state whole-blood NAD+ tracked dose linearly: 22% rise at 100 mg\/day, 51% at 300 mg, 142% at 1000 mg. There was no plateau within the dose range — meaning if 250–500 mg\/day produces a meaningful but small subjective effect, 1000 mg\/day is a reasonable next step before considering precursor-switching or stack changes.\u003c\/p\u003e\n\u003cp\u003ePractical implication: with-food dosing produces a slightly slower and lower peak but a slightly longer sustained elevation, and reduces the small chance of mild flushing in sensitive individuals. Empty-stomach dosing (which is what Trammell 2016 used) produces a sharper peak. Either is biologically reasonable — daily consistency matters more than fasted-vs-fed.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this fits in our NAD+ family\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol carries the most complete NAD+ precursor and stacking lineup of any longevity-supplement catalog. NR-capsule is one of seven distinct entry points; the right one for any given user depends on dose, format, stack, and budget.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheapest entry point:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e — single-ingredient, lowest cost, the daily-driver NMN for adults under 50.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose NMN:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e — for adults 50+ or 500 mg non-responders.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR hard capsule (this product):\u003c\/strong\u003e the alternate precursor pathway with the longest human research track record.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDaily NAD+ + Resveratrol:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e — adds the SIRT1 activator into the same capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink mix format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ 1000 mg Drink Mix\u003c\/a\u003e — NR + Resveratrol + PQQ + Quercetin in a daily drink, for users who prefer a beverage.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiquid sachet format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e — NR berry stick packs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal flagship:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e — phospholipid-encapsulated NAD+ at the top of the range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e5-in-1 mitochondrial:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e — NMN + CoQ10 + B-Complex + antioxidants in one capsule.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eStacking — how NR sits inside a complete longevity protocol\u003c\/h2\u003e\n\u003cp\u003eNR by itself raises NAD+. NAD+ by itself doesn't do anything — it has to be consumed by sirtuins, PARPs, or CD38 to produce a downstream effect. The job of the stack is to combine precursor supply with sirtuin activation, methylation support, CD38 reduction, mitochondrial support, and the foundational layers (sleep, magnesium, omega-3, vitamin D) that determine whether the body can use any of it. Below is the canonical stack architecture, organized by mechanism:\u003c\/p\u003e\n\n\u003ch3\u003eSirtuin substrate + activator pair (the core)\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600 mg\u003c\/a\u003e\u003c\/strong\u003e — the classic SIRT1 activator (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e, Park 2007). Pairs with NR's NAD+ supply to produce more sirtuin activity per molecule of precursor. Take both with breakfast and a fat source (fat improves Resveratrol absorption).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e\u003c\/strong\u003e — the methylated cousin of Resveratrol with longer half-life and higher SIRT1 activation in some assays. Used in the Dellinger 2017 NR+pterostilbene combo trial. Stacks alongside or in place of Resveratrol depending on stack tolerability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eBoth precursor pathways covered\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\u003c\/strong\u003e — covers the Slc12a8 transporter pathway. Many longevity stacks run NMN morning and NR mid-morning to hedge tissue coverage. There is no known interaction; both converge on NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e\u003c\/strong\u003e — for higher total-daily-NAD+-precursor exposure in adults 50+ or stacks where NMN is the primary lever and NR is the hedge.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eMethylation support — required for long-term high-dose NR\/NMN\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (Trimethylglycine) 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — replenishes the SAM methyl pool consumed by NNMT-mediated nicotinamide methylation. Recommended after 4+ weeks of daily NR or NMN, especially if you have known MTHFR variants. The single most important \"second-tier\" addition to any NR\/NMN stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e\u003c\/strong\u003e — supports the broader one-carbon \/ glutathione pool that interlocks with methylation. The GlyNAC pairing (with NAC) is the slow-wave-sleep + glutathione-restoration foundation that the methylation cycle leans on.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCD38 reduction — preserve the NAD+ you make\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e\u003c\/strong\u003e — direct CD38 inhibitor (Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e). Slows the rate at which CD38 destroys NAD+ — particularly relevant for adults 50+ where CD38 is upregulated.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e — clears senescent cells (Zhu 2015 \u003cem\u003eAging Cell\u003c\/em\u003e) which overconsume NAD+ via inflammatory CD38 expression in neighboring tissues. The Mayo Clinic D+Q senolytic protocol is the canonical pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e — Mayo-ranked senolytic flavonoid; complementary mechanism to Quercetin. Cycled (e.g., 2 days\/month at high dose) rather than continuous.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eMitochondrial layer — what the NAD+ feeds into\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e\u003c\/strong\u003e — Complex I\/III electron-transport-chain shuttle. NAD+\/NADH cycling hands electrons to Complex I; CoQ10 carries them onward. Together they keep oxidative phosphorylation running.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e\u003c\/strong\u003e — mitochondrial biogenesis activator via PGC-1α (Chowanadisai 2010). Increases the number of mitochondria; NR\/NMN keeps the existing ones running. The biogenesis-plus-substrate pair.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e\u003c\/strong\u003e — PINK1\/Parkin-driven mitophagy activator (Andreux 2019 \u003cem\u003eNat Metab\u003c\/em\u003e). Removes damaged mitochondria so the new ones the NR\/PQQ system supports actually take over.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate (CaAKG) 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — TCA-cycle substrate and epigenetic 2-OG-dependent dioxygenase cofactor. The metabolic-and-epigenetic layer of the mitochondrial stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e\u003c\/strong\u003e — universal antioxidant and PDH\/α-KGDH cofactor. Sits inside the same mitochondrial machinery NAD+ supports.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — sulfur amino acid with mitochondrial inner-membrane stabilizing role (Singh 2023 \u003cem\u003eScience\u003c\/em\u003e) and cardiovascular signal in human RCTs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAutophagy and proteostasis\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e\u003c\/strong\u003e — autophagy activator via eIF5A hypusination and EP300 inhibition (Madeo 2018 \u003cem\u003eScience\u003c\/em\u003e). Reciprocal mechanism with sirtuins; not redundant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAMPK pathway\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e\u003c\/strong\u003e — adds the AMPK pathway (Yin 2008 \u003cem\u003eMetabolism\u003c\/em\u003e). Sirtuin (NR\/NMN) + AMPK (Berberine) is the canonical longevity dual-pathway protocol.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAntioxidant \/ glutathione layer\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e\u003c\/strong\u003e — glutathione precursor; the GlyNAC pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e\u003c\/strong\u003e — direct master antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e\u003c\/strong\u003e — membrane-spanning antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — collagen-cofactor and aqueous antioxidant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFoundational layer — sleep, minerals, fats\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e\u003c\/strong\u003e — required for \u0026gt;300 enzymatic reactions including the methyl-cycle and sirtuin-substrate handling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/strong\u003e — the foundational immune \/ bone \/ cardiovascular layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 Fish Oil 2000 mg\u003c\/a\u003e\u003c\/strong\u003e — EPA\/DHA for membrane fluidity, resolvin signaling, cardiovascular inflammation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000 mg + BioPerine\u003c\/a\u003e\u003c\/strong\u003e — NF-κB \/ inflammaging modulator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e\u003c\/strong\u003e — cortisol \/ HPA-axis modulation; sleep and stress foundation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — sarcopenia-prevention; intersects with mitochondrial energy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eRead the full protocol architecture in our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e and the deeper \u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003ebeginner's guide to NAD+\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e usually subtle. Whole-blood NAD+ rises within 24 hours of the first dose (Trammell 2016 PK), but the subjective signal lags. Some users report a small bump in afternoon energy or steadier mood; many report nothing yet.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, fewer post-lunch crashes — for most users. This is the window in which Conze 2019 saw the largest dose-dependent rise in whole-blood NAD+ start to plateau.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e baseline cellular energy, exercise recovery, mental clarity build noticeably; cardiovascular signals (BP, aortic stiffness) emerge in the trial timelines (Martens 2018 was a 6-week protocol; the readouts were measurable at the end of week 6, not at week 2).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e sustained sirtuin activation; long-term DNA-repair and mitochondrial-biogenesis mechanisms compound with continued use. Adding TMG at this point is the standard methylation-support layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the trial endpoints that take the longest to manifest — body composition, hepatic fat, sustained inflammatory marker changes — emerge in the longer studies. This is also the window in which most users decide whether to add the full senolytic \/ mitophagy \/ autophagy layer (Quercetin, Fisetin, Urolithin A, Spermidine).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e the underlying hypothesis — sustained sirtuin \/ PARP \/ CD38 activity supporting the hallmarks-of-aging machinery — is a long-term proposition. The trials we have don't run beyond 12 months; the rationale for continued use is the consistency of the mechanism plus the absence of safety signal across the published evidence base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e a daily NAD+ precursor designed to raise whole-blood and tissue NAD+ in a way that's been replicated across more than a dozen human RCTs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e the patented form of NR — same molecule used in Trammell 2016, Martens 2018, Conze 2019, Elhassan 2019, and Brakedal 2022.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e a structural addition to a complete longevity stack — most useful when paired with a SIRT1 activator (Resveratrol or Pterostilbene), eventually a methyl donor (TMG), and the foundational mitochondrial layer (CoQ10, PQQ).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a stimulant, a caffeine replacement, or a same-day energy hit. NAD+ rises gradually over weeks and the subjective effects build over weeks 2–8.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a treatment for any disease — published trials investigate biomarker and mechanism endpoints; they do not establish disease-treatment claims.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a substitute for foundational longevity inputs (sleep, exercise, protein intake, omega-3, vitamin D, magnesium). NAD+ supplementation works in a body that has the basics covered. If your foundation is weak, fix that first.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a one-month experiment. The trial timelines that establish the effect run 4–12 weeks; expecting a verdict at 30 days is using the wrong yardstick.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a replacement for a SIRT1 activator. NR by itself raises NAD+; pairing it with Resveratrol or Pterostilbene is what produces the sirtuin-output story most users came in looking for.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most of the published readouts emerge at weeks 6–12, not weeks 2–4. Daily consistency for 8 weeks before judging is the minimum useful evaluation window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a stimulant kick.\u003c\/strong\u003e NR is not caffeine. The signal is steadier-energy, easier-mornings, faster-recovery — not a peak. Track week-over-week, not hour-over-hour.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping methylation support.\u003c\/strong\u003e After 4+ weeks of daily NR or NMN, the methylation pool starts to feel the draw. Adding TMG 500–1000 mg\/day is the single most cost-effective addition to the stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR without a sirtuin activator.\u003c\/strong\u003e NAD+ supply without sirtuin demand is unfinished — pair NR with Resveratrol or Pterostilbene to produce the downstream sirtuin output.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking without the foundation.\u003c\/strong\u003e NR\/NMN\/Resveratrol\/Pterostilbene\/TMG\/Apigenin layered on top of poor sleep, no protein, no resistance training, low vitamin D, no omega-3, and chronic alcohol does not produce the trial readouts. Foundation first.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling for the wrong reasons.\u003c\/strong\u003e The published trials run continuous daily dosing for 4–12 weeks without safety signal. Cycling 8 on \/ 1 off is a low-cost hedge but is not required by the evidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSwitching too fast.\u003c\/strong\u003e NMN or NR for 4 weeks, no result, switching to the other — is a misuse of the evidence. Either give 8–12 weeks to evaluate, or run both simultaneously.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUnderdosing.\u003c\/strong\u003e 1000 mg\/day is the trial-validated dose for the cardiovascular and neurological readouts. 250–500 mg may produce a measurable NAD+ rise but is below the dose at which most published clinical effects emerged.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard:\u003c\/strong\u003e 1 capsule with breakfast. Adults 50+ or those running a higher-dose comprehensive stack: 2 capsules with breakfast.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStack with NMN:\u003c\/strong\u003e NMN with breakfast, NR mid-morning — covers both transport pathways across the day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStack with Resveratrol or Pterostilbene:\u003c\/strong\u003e take both at the same morning meal alongside a fat source — Resveratrol\/Pterostilbene activates SIRT1, NR supplies the NAD+ substrate, the fat improves stilbene absorption.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAfter 4+ weeks:\u003c\/strong\u003e add TMG 500–1000 mg\/day to support the methylation pool consumed by NAD+ metabolism. After 8+ weeks: consider adding Apigenin 50 mg\/day to inhibit CD38.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you exercise in the morning:\u003c\/strong\u003e take NR with the post-workout meal rather than pre-workout. NAD+ is being consumed heavily during exercise; precursor supply pairs better with the recovery window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you exercise in the evening:\u003c\/strong\u003e NR still goes in the morning. Don't shift to evening — NAD+ has a circadian rhythm and morning dosing aligns with the natural peak.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e take it as soon as you remember the same day. If it's already evening, skip and resume in the morning. Do not double up — daily consistency over 8+ weeks is what matters, not catching up on individual doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel and time-zone shifts:\u003c\/strong\u003e dose by local-time morning rather than home-time morning. The circadian rhythm resets to local light cycle within a few days; matching NR dosing to the local schedule keeps the rhythm aligned.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs fasted:\u003c\/strong\u003e with food is fine (most trials used with-food dosing) and reduces the small chance of mild flushing. Fasted dosing produces a sharper plasma peak (Trammell 2016) but the steady-state effect at 8 weeks is comparable. Consistency matters more than fasted-vs-fed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSee our \u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003etiming guide\u003c\/a\u003e for the deeper rationale; the same morning rules apply to NR.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone who wants the most-studied human NAD+ precursor specifically — NR's published research depth (65+ trials, 13+ peer-reviewed RCTs) is the longest of any NAD+ precursor as of 2026.\u003c\/li\u003e\n  \u003cli\u003eAdults who tried NMN and didn't see the response they wanted — switching to or stacking NR is the standard next step. ENT1\/2 transporter coverage may reach tissues where Slc12a8 is downregulated.\u003c\/li\u003e\n  \u003cli\u003ePeople running a comprehensive longevity stack who want both NR and NMN pathways covered to hedge tissue-specific transporter heterogeneity.\u003c\/li\u003e\n  \u003cli\u003eAdults 50+ — alternate-pathway delivery and broad transporter coverage hedge against tissue-specific transporter inefficiencies that emerge with age.\u003c\/li\u003e\n  \u003cli\u003eAnyone whose stack already includes Resveratrol, Pterostilbene, or another SIRT1 activator and wants the matching NAD+ substrate so the activator has fuel.\u003c\/li\u003e\n  \u003cli\u003eAthletes and active adults running heavy training loads — NAD+\/sirtuin axis sits inside exercise recovery and mitochondrial-biogenesis pathways.\u003c\/li\u003e\n  \u003cli\u003ePeople with a family history of cardiovascular events who are running multi-pathway prevention protocols — the Martens 2018 BP and aortic-stiffness signal is the strongest mechanism-validated NR readout to date.\u003c\/li\u003e\n  \u003cli\u003eCognitive-aging-conscious adults — Brakedal 2022 demonstrated CSF\/brain NAD+ rise with oral dosing, the first such evidence for any human NAD+ precursor.\u003c\/li\u003e\n  \u003cli\u003eVegans and vegetarians — the capsule is vegan-compatible (no gelatin), and the NR molecule is animal-source-free.\u003c\/li\u003e\n  \u003cli\u003eMethylation-savvy users (MTHFR variants, etc.) — the included B-vitamin cofactors plus TMG pairing makes this a well-supported long-term lever.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding\u003c\/strong\u003e — no safety data in pregnancy or lactation. Avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer or recent diagnosis\u003c\/strong\u003e — NAD+ supports both healthy and cancer-cell metabolism; sirtuins have context-dependent roles in tumor biology. Discuss with your oncologist before starting; some advocate cycling off during active treatment.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChildren and adolescents under 18\u003c\/strong\u003e — no pediatric safety data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery (within 14 days)\u003c\/strong\u003e — discontinue 2 weeks before any planned surgery as a general supplement-safety practice; NR and other NAD+ precursors may interact with anesthesia metabolism.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople expecting a stimulant or same-day energy hit\u003c\/strong\u003e — NR is not caffeine. If your intent is a fast subjective lift, this is the wrong tool.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone unwilling to stay consistent for 8+ weeks\u003c\/strong\u003e — the trial readouts emerge in that window. Sporadic use does not reproduce the published evidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who haven't fixed the foundation\u003c\/strong\u003e — sleep deprivation, ultra-processed diet, no protein intake, no resistance training, chronic alcohol — NR layered on top of those does not reproduce the trials. Address foundation before optimization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions, and contraindications\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGenerally well-tolerated.\u003c\/strong\u003e Across published trials at 100–1000 mg\/day for up to 8–12 weeks (and 3000 mg\/day in the NR-SAFE 4-week extension), NR has shown no serious adverse events vs placebo (Conze 2019; Dollerup 2018; Martens 2018; Elhassan 2019; Brakedal 2023).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild flushing or warmth\u003c\/strong\u003e can occur in a small minority — usually resolves with food or with dose reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild GI upset\u003c\/strong\u003e in a small minority — typically resolves within the first 1–2 weeks or with dose reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent cancer:\u003c\/strong\u003e NAD+ supports both healthy and cancer-cell metabolism. Discuss with your oncologist before starting; some advocate cycling off during active treatment. Note that the published epidemiologic and mechanistic data on cancer outcomes with chronic NR\/NMN use are still maturing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding:\u003c\/strong\u003e not studied; avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethylation load:\u003c\/strong\u003e long-term high-dose NR (or NMN) consumes methyl groups during NAD+ metabolism via NNMT. Pair with TMG 500–1000 mg\/day after 4+ weeks of daily use, especially if you have any known methylation variants (MTHFR C677T or A1298C). The included B6\/B12\/folate cofactors mitigate but do not fully replace TMG at long-term high dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery:\u003c\/strong\u003e discontinue 14 days before any planned surgical procedure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e no clinically significant pharmacokinetic interactions are documented at the doses used here, but published interaction data is limited. Discuss with your prescriber if you take chemotherapy, immunosuppressants, anticoagulants, or psychiatric medications.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlcohol:\u003c\/strong\u003e heavy alcohol use depletes NAD+ via aldehyde-dehydrogenase activity. NR can replenish, but chronic alcohol is the bigger lever — addressing alcohol intake produces a larger and more durable NAD+ effect than precursor supplementation alone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented Nicotinamide Riboside Chloride (NR-Cl)\u003c\/strong\u003e — same crystalline form used in Trammell 2016, Martens 2018, Elhassan 2019, Conze 2019, and Brakedal 2022. ≥98% NR by HPLC; identity confirmed by NMR and mass spectrometry.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupporting B-vitamin cofactors\u003c\/strong\u003e for the NAD+ biosynthesis pathway: vitamin B6 (pyridoxal-5-phosphate as a NAMPT cofactor), vitamin B12 (methylcobalamin as a methyl donor), and folate (5-MTHF as a methyl donor) — the methylation cycle inputs that NAD+ metabolism eventually leans on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHard capsule format\u003c\/strong\u003e for measured, consistent dosing — no flavored powders, no proprietary blends, no surprise sugar or maltodextrin fillers.\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eNo proprietary blends, no artificial colors, no titanium dioxide, no soy, no gluten, no dairy, no nuts.\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegan-compatible capsule shell\u003c\/strong\u003e (HPMC), suitable for vegan and vegetarian protocols.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party tested\u003c\/strong\u003e for purity, identity, heavy metals, and microbial contamination by an ISO 17025-accredited laboratory. Certificate of Analysis available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and quality control\u003c\/h2\u003e\n\u003cp\u003eThe patented Nicotinamide Riboside Chloride used in this product is the same crystalline form characterized in Trammell 2016 and used across the published clinical trial program. Manufacturing follows U.S. FDA cGMP (current Good Manufacturing Practice) requirements (21 CFR Part 111) at NSF-registered or equivalent facilities. Each lot is tested against the following specifications:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity:\u003c\/strong\u003e HPLC retention time and UV spectrum match the reference standard; NMR and mass-spec identity confirmed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e ≥98% NR-Cl by HPLC; total impurities ≤2%; specific pharmacopeia-listed impurities below individual limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e arsenic, lead, mercury, cadmium below USP \u0026lt;232\u0026gt; \/ Prop65 limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e below USP \u0026lt;467\u0026gt; Class 2\/3 limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e total aerobic count, yeast, mold, and pathogens (E. coli, Salmonella, Staphylococcus aureus) below USP \u0026lt;2021\u0026gt; limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndotoxin:\u003c\/strong\u003e \u0026lt; USP-listed thresholds for orally administered solid dosage forms.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePesticide residues:\u003c\/strong\u003e below USP \u0026lt;561\u0026gt; \/ EU multi-residue panel limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e formulated for ≥24-month room-temperature shelf life in UV-protective amber HDPE bottles with foil-induction seal and desiccant. Store cool and dry; refrigeration not required.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEach capsule is filled by a single-source audited contract manufacturer; no proprietary blends are used so the on-label NR amount is the actual dose, not a \"complex\" mass that could be padded with rice flour or maltodextrin.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs NR better than NMN?\u003c\/h3\u003e\n\u003cp\u003eNeither is uniformly \"better.\" NR has the longer human research track record (since 2016 with Trammell), broader cardiovascular and neurological RCT coverage, and may reach tissues where the NMN transporter (Slc12a8) is less active. NMN may have an edge in liver and pancreas, skips the intracellular phosphorylation step, and has the strong post-menopausal insulin-sensitivity signal from Yoshino 2021. For most users the practical difference is small; many run both. Read the \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNR vs NMN comparison\u003c\/a\u003e for the full breakdown.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR with NMN?\u003c\/h3\u003e\n\u003cp\u003eYes, and many longevity protocols do. NMN with breakfast and NR mid-morning is a clean way to space them and cover both transport pathways. There's no known interaction — they ultimately converge on the same molecule (NAD+). If anything, the combination hedges tissue-specific transporter expression heterogeneity better than either precursor alone.\u003c\/p\u003e\n\n\u003ch3\u003eWhy are B-vitamins included?\u003c\/h3\u003e\n\u003cp\u003eNAD+ metabolism uses methyl groups (the methylation cycle), and the conversions through the salvage pathway use B6 as a cofactor. Including B6, B12, and folate means the NR you absorb has the supporting cofactors it needs without pulling them from elsewhere in your metabolism. After 4+ weeks of daily NR\/NMN at the 1 g\/day level, adding TMG (trimethylglycine) on top is the standard methyl-donor support — the included B12\/folate are useful but do not fully replace TMG at long-term high dose.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eWhole-blood NAD+ begins to rise within 24 hours of the first dose (Trammell 2016 PK). Subjective changes — easier mornings, steadier energy, faster exercise recovery — typically become noticeable in weeks 2–4 for most users. Cardiovascular and inflammatory readouts in the published trials emerged at 3–8 weeks (Martens 2018 was 6 weeks; Elhassan 2019 was 21 days). Plan to evaluate at week 8, not week 4.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR at night?\u003c\/h3\u003e\n\u003cp\u003eYou can, but morning is preferred. NAD+ has a circadian rhythm — it naturally peaks during the active phase. Morning dosing aligns with that rhythm. Some users report mild stimulation from NR; if that's you, definitely keep it morning-only. Evening dosing is not unsafe, just suboptimal in a small minority of stimulant-sensitive users.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need to cycle NR?\u003c\/h3\u003e\n\u003cp\u003ePublished trials run 6–12 weeks of continuous daily dosing without safety issues. The Brakedal 2023 NR-SAFE trial extended dosing to 3 g\/day for 4 weeks safely. Long-term continuous use is the most common pattern. Some users cycle 8 weeks on \/ 1 week off as a standard supplement-rotation practice — there's no published evidence that cycling is required, but it's a low-cost hedge against the small theoretical risk of receptor or enzymatic adaptation.\u003c\/p\u003e\n\n\u003ch3\u003eShould I take it with food?\u003c\/h3\u003e\n\u003cp\u003eWith food is fine and reduces the small chance of mild flushing. The Trammell 2016 PK study used fasted dosing; the Martens 2018 cardiovascular study used with-breakfast dosing. Both raise NAD+ effectively. Daily consistency matters more than fasted-vs-fed. If you're stacking with Resveratrol, the with-food (and with-fat) approach is preferred because Resveratrol absorbs better with fat.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if I'm 30 — is NR still useful?\u003c\/h3\u003e\n\u003cp\u003eThe biggest published effect sizes come from older cohorts (Martens 2018 was midlife\/older with elevated BP; Elhassan 2019 was 70–80 years old). Younger adults still see whole-blood NAD+ rise (Trammell 2016 included healthy adults of all ages) but the subjective signal is typically smaller because baseline NAD+ is higher. The most defensible use case at age 30 is foundational longevity stacking rather than acute symptom management.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is NR more expensive than NMN?\u003c\/h3\u003e\n\u003cp\u003eNR is patent-licensed; the manufacturing process is more complex and the licensing cost is passed through to the consumer. The premium is real and the practical value depends on whether the longer research track record, the broader transporter coverage, and the brain\/CSF NAD+ signal are decisive for your protocol. For cost-efficient daily entry, NMN at 500 mg is generally the better starting point; NR is best framed as a stack hedge or a switch when NMN alone isn't producing the expected response.\u003c\/p\u003e\n\n\u003ch3\u003eCan NR replace coffee?\u003c\/h3\u003e\n\u003cp\u003eNo. NR is not a stimulant. The \"easier mornings, steadier afternoon energy\" signal that builds over 2–8 weeks is bioenergetic, not adrenergic. Coffee acts on adenosine receptors and the catecholamine system; NR acts on the NAD+\/sirtuin\/mitochondrial-respiration axis. They are complementary, not substitutes.\u003c\/p\u003e\n\n\u003ch3\u003eWill NR show up on a drug test?\u003c\/h3\u003e\n\u003cp\u003eNo. NR is a dietary supplement form of vitamin B3 (nicotinamide-derived) and is not on any standard sport, occupational, or clinical drug-screening panel. The molecule is endogenous and trace levels are present in all human blood at baseline.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR while fasting?\u003c\/h3\u003e\n\u003cp\u003eYes. NR does not break a fast in any meaningful metabolic sense — the molecule contributes negligible calories and does not significantly raise insulin. The Trammell 2016 PK study used fasted dosing. If you fast intermittently and want to dose NR within the fasted window, that is biologically reasonable.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR raise blood pressure?\u003c\/h3\u003e\n\u003cp\u003eThe published cardiovascular evidence runs the other way. Martens 2018 specifically measured systolic blood pressure in midlife adults with elevated baseline SBP and found a ~10 mmHg \u003cem\u003ereduction\u003c\/em\u003e after 6 weeks of 1 g\/day vs placebo. Aortic stiffness also fell. NR is not associated with raised BP at the trial-validated dose.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's the maximum safe daily dose?\u003c\/h3\u003e\n\u003cp\u003eThe Brakedal 2023 NR-SAFE trial extended dosing to 3 g\/day for 4 weeks in Parkinson's patients without serious adverse events. The 1000 mg\/day dose is the trial-validated standard for cardiovascular and neurological readouts. Going above 1 g\/day without clinical supervision is not recommended for general consumer use; the marginal benefit of higher doses has not been demonstrated to outweigh the cost in the published evidence base.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR interact with statins or blood pressure medications?\u003c\/h3\u003e\n\u003cp\u003eNo clinically significant interactions are documented at typical supplement doses. Practical caution: if you are on antihypertensive medication and you start NR, the Martens 2018 BP-lowering signal means your home BP readings could trend lower. Track and discuss with your prescriber if you see a meaningful shift.\u003c\/p\u003e\n\n\u003ch3\u003eHow does NR compare to NAD+ IV therapy?\u003c\/h3\u003e\n\u003cp\u003eNAD+ IV therapy delivers a large bolus of NAD+ directly to the bloodstream over a few hours. Oral NR raises whole-blood NAD+ steadily over weeks via the precursor pathway. The IV route is acutely larger but expensive, infrastructure-dependent, and the long-term cost-benefit vs. daily oral precursor supplementation is unsettled. Most published longevity-mechanism evidence in humans is from oral precursor (NR or NMN), not IV NAD+.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule?\u003c\/h3\u003e\n\u003cp\u003eTechnically yes, but it's not recommended. NR-Cl is mildly hygroscopic; opening exposes the powder to air moisture and accelerates degradation. The capsule is also designed to deliver a measured single dose. If you have trouble swallowing capsules, the \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ Drink Mix\u003c\/a\u003e or the \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ sachet\u003c\/a\u003e are designed for that use case.\u003c\/p\u003e\n\n\u003ch3\u003eIs NR vegan?\u003c\/h3\u003e\n\u003cp\u003eYes. The NR molecule is synthesized from non-animal sources, the capsule shell is HPMC (vegan-compatible, plant-derived), and the supporting B-vitamin cofactors in this formulation are non-animal-sourced.\u003c\/p\u003e\n\n\u003ch3\u003eWill NR help me sleep?\u003c\/h3\u003e\n\u003cp\u003eIndirectly, sometimes. NAD+ contributes to circadian-rhythm regulation via NAMPT and SIRT1's interaction with the BMAL1\/CLOCK transcription complex (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e). Some users report deeper or more consolidated sleep after several weeks of consistent dosing — likely a downstream consequence of metabolic and circadian normalization rather than a direct sedative effect. If sleep is the primary target, the more direct levers are \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR improve hair?\u003c\/h3\u003e\n\u003cp\u003eIndirectly, possibly. The hair follicle is a high-turnover, energy-demanding tissue and NAD+ supports the underlying energetics. There are no large RCTs of NR specifically for hair endpoints. The more direct hair-cycle levers are \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e (Rainer 2018 PROSPER trial showed anagen-phase lengthening).\u003c\/p\u003e\n\n\u003ch3\u003eWhy is daily consistency more important than dose?\u003c\/h3\u003e\n\u003cp\u003eNAD+ levels respond to sustained precursor supply, not single-dose peaks. Conze 2019 showed steady-state NAD+ at week 8; one-off dosing produces a transient peak that returns to baseline within 24 hours. The published clinical readouts (cardiovascular, neurological, inflammatory) all emerged from sustained 4–12 week protocols, not from intermittent or as-needed use.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's NAD+ family is organized into four functional layers, and NR Hard Capsules sits primarily in layer 1 (Precursor Supply) with crossover into layer 4 (Comprehensive Stack):\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 1 — Precursor Supply.\u003c\/strong\u003e NR Hard Capsules (this product), \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. Single-ingredient or near-single-ingredient daily precursors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 2 — SIRT1 \/ Sirtuin activators.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e. Pair with layer 1 to convert NAD+ supply into sirtuin output.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 3 — Methylation and CD38 support.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e. Required at 4+ weeks of daily layer-1 use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 4 — Comprehensive \/ convenience formulas.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e, \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ Pure Focus\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e. Multi-ingredient formats that bundle layers 1+2 (and sometimes 3+) for users who prefer one capsule.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe deeper-protocol architecture (mitochondrial layer, autophagy layer, senolytic layer, antioxidant layer, foundational layer) is documented across the catalog in the dedicated product pages and in the \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — the complete NR + NMN + NAD+ lineup.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — CoQ10, PQQ, Urolithin A, CaAKG, the energy-production layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — the daily-driver layer the rest of the stack leans on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — Quercetin, Fisetin, the senescent-cell-clearance layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — the BP, lipid, and aortic-stiffness layer where the Martens 2018 NR signal lives.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — Berberine, Alpha-Lipoic Acid, the AMPK \/ glucose layer that pairs with the NAD+\/sirtuin axis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take in 2026?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eTiming — morning, empty stomach, or with food?\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eBieganowski P \u0026amp; Brenner C (2004). Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. \u003cem\u003eCell\u003c\/em\u003e 117(4):495–502.\u003c\/li\u003e\n  \u003cli\u003eTrammell SAJ, Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNature Communications\u003c\/em\u003e 7:12948.\u003c\/li\u003e\n  \u003cli\u003eMartens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. \u003cem\u003eNature Communications\u003c\/em\u003e 9:1286.\u003c\/li\u003e\n  \u003cli\u003eConze D, Brenner C, \u0026amp; Kruger CL (2019). Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. \u003cem\u003eScientific Reports\u003c\/em\u003e 9:9772.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL, Christensen B, Svart M, et al. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e 108(2):343–353.\u003c\/li\u003e\n  \u003cli\u003eElhassan YS, Kluckova K, Fletcher RS, et al. (2019). Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. \u003cem\u003eCell Reports\u003c\/em\u003e 28(7):1717–1728.e6.\u003c\/li\u003e\n  \u003cli\u003eRemie CME, Roumans KHM, Moonen MPB, et al. (2020). Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e 112(2):413–426.\u003c\/li\u003e\n  \u003cli\u003eStocks B, Ashcroft SP, Joanisse S, et al. (2021). Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise in healthy aged adults. \u003cem\u003eJournal of Physiology\u003c\/em\u003e 599(5):1513–1531.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Dölle C, Riemer F, et al. (2022). The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. \u003cem\u003eCell Metabolism\u003c\/em\u003e 34(3):396–407.e6.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Toker L, Haugarvoll K, et al. (2023). Long-term nicotinamide riboside use is safe in patients with Parkinson disease. \u003cem\u003eNature Communications\u003c\/em\u003e 14:1156 (NR-SAFE).\u003c\/li\u003e\n  \u003cli\u003ePirinen E, Auranen M, Khan NA, et al. (2020). Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. \u003cem\u003eCell Metabolism\u003c\/em\u003e 31(6):1078–1090.\u003c\/li\u003e\n  \u003cli\u003eDellinger RW, Santos SR, Morris M, et al. (2017). Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. \u003cem\u003eNPJ Aging and Mechanisms of Disease\u003c\/em\u003e 3:17.\u003c\/li\u003e\n  \u003cli\u003eAirhart SE, Shireman LM, Risler LJ, et al. (2017). An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. \u003cem\u003ePLOS ONE\u003c\/em\u003e 12(12):e0186459.\u003c\/li\u003e\n  \u003cli\u003eRatajczak J, Joffraud M, Trammell SAJ, et al. (2016). NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. \u003cem\u003eNature Communications\u003c\/em\u003e 7:13103.\u003c\/li\u003e\n  \u003cli\u003eMassudi H, Grant R, Braidy N, et al. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS ONE\u003c\/em\u003e 7(7):e42357.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J, Tarragó MG, Chini CCS, et al. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metabolism\u003c\/em\u003e 23(6):1127–1139.\u003c\/li\u003e\n  \u003cli\u003eYoshino J, Mills KF, Yoon MJ, \u0026amp; Imai S (2011). Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e 14(4):528–536.\u003c\/li\u003e\n  \u003cli\u003eYoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e 372(6547):1224–1229.\u003c\/li\u003e\n  \u003cli\u003eGrozio A, Mills KF, Yoshino J, et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. \u003cem\u003eNature Metabolism\u003c\/em\u003e 1:47–57.\u003c\/li\u003e\n  \u003cli\u003eLuongo TS, Eller JM, Lu MJ, et al. (2020). SLC25A51 is a mammalian mitochondrial NAD+ transporter. \u003cem\u003eNature\u003c\/em\u003e 588:174–179.\u003c\/li\u003e\n  \u003cli\u003eAsher G, Gatfield D, Stratmann M, et al. (2008). SIRT1 regulates circadian clock gene expression through PER2 deacetylation. \u003cem\u003eCell\u003c\/em\u003e 134(2):317–328.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT, Bitterman KJ, Cohen HY, et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e 425:191–196.\u003c\/li\u003e\n  \u003cli\u003ePark SJ, Ahmad F, Philp A, et al. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e 148(3):421–433.\u003c\/li\u003e\n  \u003cli\u003eEscande C, Nin V, Price NL, et al. (2013). Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. \u003cem\u003eDiabetes\u003c\/em\u003e 62(4):1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMadeo F, Eisenberg T, Pietrocola F, \u0026amp; Kroemer G (2018). Spermidine in health and disease. \u003cem\u003eScience\u003c\/em\u003e 359(6374):eaan2788.\u003c\/li\u003e\n  \u003cli\u003eAndreux PA, Blanco-Bose W, Ryu D, et al. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. \u003cem\u003eNature Metabolism\u003c\/em\u003e 1:595–603.\u003c\/li\u003e\n  \u003cli\u003eYin J, Xing H, \u0026amp; Ye J (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. \u003cem\u003eMetabolism\u003c\/em\u003e 57(5):712–717.\u003c\/li\u003e\n  \u003cli\u003eSingh P, Gollapalli K, Mangiola S, et al. (2023). Taurine deficiency as a driver of aging. \u003cem\u003eScience\u003c\/em\u003e 380(6649):eabn9257.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, \u0026amp; Kroemer G (2013). The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e 153(6):1194–1217.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, \u0026amp; Kroemer G (2023). Hallmarks of aging: an expanding universe. \u003cem\u003eCell\u003c\/em\u003e 186(2):243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, have an active or recent cancer diagnosis, or have a medical condition. Reference studies cited above describe pharmacokinetic and clinical findings of Nicotinamide Riboside generally and do not constitute claims about this specific product.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47705326944474,"sku":"THP-NAD-NR-CAP","price":44.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-capsules.jpg?v=1775666145"},{"product_id":"spermidine-10mg-wheat-germ-extract","title":"Spermidine 10mg | Wheat Germ Extract | Cellular Renewal \u0026 Autophagy Support","description":"\u003cp\u003e\u003cstrong\u003e10 mg of plant-derived spermidine per capsule\u003c\/strong\u003e — sourced from concentrated \u003cem\u003eTriticum aestivum\u003c\/em\u003e wheat germ extract, the same form used in almost every published human spermidine trial of the last decade. Spermidine is the small naturally occurring polyamine that sits at the center of modern autophagy research: the cellular self-renewal pathway that gets sluggish with age and that fasting, caloric restriction, rapamycin, and metformin all try to reawaken from different angles. Standardized, vegan-friendly capsule, designed to layer cleanly onto an NMN, NAD+, or resveratrol stack as the \"renewal arm\" of a complete longevity protocol.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat spermidine does:\u003c\/strong\u003e activates \u003cem\u003eautophagy\u003c\/em\u003e — your cells' built-in recycling system. Damaged proteins, misfolded aggregates, and worn-out mitochondria get tagged, broken down, and replaced with new functional parts. It is the same pathway prolonged fasting and caloric restriction trigger.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy supplement:\u003c\/strong\u003e tissue spermidine drops sharply with age; the steepest drops are in the heart, brain, and immune tissue — exactly where age-related dysfunction shows up first. The 20-year Bruneck cohort study found adults with the highest dietary spermidine intake had significantly lower all-cause and cardiovascular mortality than those with the lowest (Kiechl 2018, \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 35+, anyone running an NMN or NAD+ longevity stack, cardiovascular and cognitive maintenance, and anyone using time-restricted eating who wants a \"fasting-mimetic\" on non-fasting days.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake with or without food.\u003c\/strong\u003e Spermidine is stable through digestion. Once-daily dosing is standard. Effects accumulate over months, not days — most published trial endpoints sit at 60–90 days minimum.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacks cleanly with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat spermidine actually is — in plain language\u003c\/h2\u003e\n\u003cp\u003eSpermidine is a \u003cem\u003epolyamine\u003c\/em\u003e: a small, positively charged molecule that every living cell makes for itself and also pulls in from food. It was first isolated from semen in the 17th century (hence the name), but it turns out to be everywhere — wheat germ, aged cheeses, mushrooms, soy, legumes, broccoli, mango, and natto. The polyamine family (spermidine, spermine, putrescine) keeps cells running by stabilizing DNA, supporting protein translation, regulating ion channels, and — most relevant for longevity — switching on autophagy through hypusination of the translation factor eIF5A.\u003c\/p\u003e\n\n\u003cp\u003eTwo things change with age, and both are reversible at the cellular level:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCellular spermidine concentration falls.\u003c\/strong\u003e The drop is steepest in the heart, brain, and immune tissue — exactly the systems where age-related dysfunction shows up first. Centenarians, by contrast, tend to have spermidine levels closer to those of healthy 30-year-olds (Pucciarelli 2012, \u003cem\u003eRejuvenation Research\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAutophagy slows.\u003c\/strong\u003e The molecular machinery that clears damaged components becomes less efficient, so cellular \"garbage\" — oxidized proteins, misfolded aggregates, dysfunctional mitochondria — accumulates. Loss of proteostasis is one of the formally recognized hallmarks of aging (López-Otín 2013 \u003cem\u003eCell\u003c\/em\u003e; updated 2023 with autophagy declines now treated as an integrated hallmark).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eRestoring spermidine restores one of the strongest natural autophagy signals the body has. Animals given supplemental spermidine show extended median lifespan, improved cardiac elasticity, preserved memory, and reduced age-related inflammation. Human evidence is younger but the cardiovascular and cognitive signals from observational and early interventional trials are now consistent enough that most modern longevity protocols include spermidine as a foundational addition.\u003c\/p\u003e\n\n\u003ch2\u003eWhy spermidine sits at the center of an autophagy-focused stack\u003c\/h2\u003e\n\u003cp\u003eAutophagy (\"self-eating\") is the cellular quality-control program. When a cell senses energy stress, low amino acids, or accumulating damage, autophagosomes engulf damaged components — oxidized proteins, fragmented organelles, broken mitochondria — and fuse with lysosomes that recycle the parts back into amino acids, fatty acids, and nucleotides for reuse. It is the most efficient renewal program a cell has, and it is one of the few longevity mechanisms conserved literally from yeast to humans.\u003c\/p\u003e\n\n\u003cp\u003eThe reason spermidine matters is mechanistic. It activates autophagy through three converging routes:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHypusination of eIF5A.\u003c\/strong\u003e Spermidine is the obligate substrate for the post-translational modification of eukaryotic translation initiation factor 5A. Hypusinated eIF5A drives translation of TFEB and other autophagy \"master regulator\" transcription factors. This is the direct molecular link between dietary spermidine and lysosomal biogenesis (Zhang 2019 \u003cem\u003eMolecular Cell\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInhibition of acetyltransferases.\u003c\/strong\u003e Spermidine inhibits EP300, the acetyltransferase that holds autophagy proteins in their inactive acetylated state. Less EP300 activity → more deacetylated autophagy proteins → autophagy on (Pietrocola 2015 \u003cem\u003eCell Cycle\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK and TFEB activation.\u003c\/strong\u003e Spermidine indirectly raises AMPK signaling and promotes TFEB nuclear translocation, the same convergence point that fasting and caloric restriction use. This is why spermidine is correctly described as a \"fasting mimetic\" (Madeo 2018 \u003cem\u003eScience\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis is why spermidine sits next to NMN, not in place of it. \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e raises NAD+ for sirtuin and PARP function; \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eresveratrol\u003c\/a\u003e activates SIRT1; \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e keeps the electron transport chain running; spermidine clears the damaged proteins and worn-out mitochondria so the rest of the stack has functional substrate to work on. Without autophagy support, you are pumping new energy through aging machinery. With it, the machinery itself gets renewed.\u003c\/p\u003e\n\n\u003ch2\u003eThe trial bench — what the human data actually says\u003c\/h2\u003e\n\u003cp\u003eSpermidine has moved out of the \"interesting in mice\" category and into \"tested in humans.\" Here is the published evidence at the doses and durations real people use.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003cthead\u003e\n    \u003ctr\u003e\n\u003cth\u003eStudy (year, journal)\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \u0026amp; duration\u003c\/th\u003e\n\u003cth\u003ePrimary findings\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eKiechl 2018, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e (Bruneck cohort)\u003c\/td\u003e\n      \u003ctd\u003e829 community adults, 20-year follow-up\u003c\/td\u003e\n      \u003ctd\u003eDietary spermidine intake (food-frequency questionnaire), tertile-based\u003c\/td\u003e\n      \u003ctd\u003eHighest tertile vs. lowest: ~40% lower all-cause mortality; effect comparable to a Mediterranean dietary pattern\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eEisenberg 2016, \u003cem\u003eNature Medicine\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003eAged mice and translational human cohort\u003c\/td\u003e\n      \u003ctd\u003e3 mM in drinking water (mice); dietary intake (humans)\u003c\/td\u003e\n      \u003ctd\u003eImproved cardiac diastolic function; extended median lifespan in mice; lower blood pressure in human cohort with high intake\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSchwarz 2018 (SmartAge pilot), \u003cem\u003eGeroScience\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e30 older adults, subjective cognitive decline\u003c\/td\u003e\n      \u003ctd\u003e~1.2 mg\/day (food-grade) for 3 months\u003c\/td\u003e\n      \u003ctd\u003eSafe, well tolerated; signals on memory performance vs. placebo at 3 months\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePekar 2020 (SmartAge follow-up), \u003cem\u003eWiener Klin Wochenschr\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e85 older adults, mild cognitive concerns\u003c\/td\u003e\n      \u003ctd\u003e~0.9 mg\/day spermidine, 12 months\u003c\/td\u003e\n      \u003ctd\u003eLong-term safety confirmed; trends in memory and inflammatory marker improvement\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eWirth 2019, \u003cem\u003eCortex\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e30 older adults at-risk for dementia\u003c\/td\u003e\n      \u003ctd\u003e1.2 mg\/day, 3 months\u003c\/td\u003e\n      \u003ctd\u003eMemory performance preserved vs. placebo; ATG5\/LC3-II autophagy markers up\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eRainer 2018 (PROSPER hair study)\u003c\/td\u003e\n      \u003ctd\u003e100 healthy adults\u003c\/td\u003e\n      \u003ctd\u003eSpermidine-containing nutraceutical, 90 days\u003c\/td\u003e\n      \u003ctd\u003eAnagen (active growth) phase of hair follicles lengthened vs. placebo\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSoda 2009, \u003cem\u003eExp Gerontol\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003eHealthy adults consuming polyamine-rich diet\u003c\/td\u003e\n      \u003ctd\u003eDiet-based, 2 months\u003c\/td\u003e\n      \u003ctd\u003eIncreased blood polyamine levels; reduced markers of inflammation\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eHofer 2024, \u003cem\u003eNature Aging\u003c\/em\u003e (review)\u003c\/td\u003e\n      \u003ctd\u003eSynthesis of 13 spermidine human trials\u003c\/td\u003e\n      \u003ctd\u003e0.9–15 mg\/day, 1–12 months\u003c\/td\u003e\n      \u003ctd\u003eCardiovascular, cognitive, hair-cycle, immune signals replicated; safety at studied doses\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eNote: most published human trials used food-grade extracts at 0.9–6 mg\/day and still produced measurable effects on cellular autophagy markers and clinical endpoints. Animal-to-human dose translation suggests 5–15 mg\/day is the band where additional benefit plateaus in healthy adults. Our 10 mg per capsule sits at the upper-middle of that range — high enough to push past dietary intake, low enough to stay within the natural range of high-spermidine Mediterranean diets.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — wheat germ extract vs. the alternatives\u003c\/h2\u003e\n\u003cp\u003eYou can extract spermidine from a handful of natural sources and at least one fully synthetic route. They are not interchangeable.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003cthead\u003e\n    \u003ctr\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003ePolyamine profile\u003c\/th\u003e\n\u003cth\u003eBioavailability\u003c\/th\u003e\n\u003cth\u003eTrial coverage\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eWheat germ extract (this product)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eSpermidine + spermine + putrescine in their natural ratio\u003c\/td\u003e\n      \u003ctd\u003eGood — the food-matrix form the literature was built on\u003c\/td\u003e\n      \u003ctd\u003eUsed in almost all published human trials (Bruneck, SmartAge, PROSPER)\u003c\/td\u003e\n      \u003ctd\u003eAnyone who wants the form most directly supported by published human data\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSynthetic spermidine trihydrochloride\u003c\/td\u003e\n      \u003ctd\u003ePure spermidine, no cofactors\u003c\/td\u003e\n      \u003ctd\u003eComparable on paper, but no head-to-head trial data\u003c\/td\u003e\n      \u003ctd\u003eMostly cell and animal studies\u003c\/td\u003e\n      \u003ctd\u003eCustomers with severe wheat allergy; expect higher cost per mg\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSoybean germ extract\u003c\/td\u003e\n      \u003ctd\u003eSpermidine-rich but lower mg\/g than wheat germ\u003c\/td\u003e\n      \u003ctd\u003eComparable to wheat germ\u003c\/td\u003e\n      \u003ctd\u003eLimited human trials\u003c\/td\u003e\n      \u003ctd\u003ePeople avoiding wheat for non-celiac reasons; check soy tolerance\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMango fruit concentrate\u003c\/td\u003e\n      \u003ctd\u003eLower spermidine, higher putrescine\u003c\/td\u003e\n      \u003ctd\u003eAdequate but inefficient (low mg\/g)\u003c\/td\u003e\n      \u003ctd\u003eSome observational data only\u003c\/td\u003e\n      \u003ctd\u003eNot recommended as primary source — too dilute\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNatto (fermented soy)\u003c\/td\u003e\n      \u003ctd\u003eNaturally high in polyamines plus vitamin K2\u003c\/td\u003e\n      \u003ctd\u003eVery high in food matrix\u003c\/td\u003e\n      \u003ctd\u003ePopulation-level Japanese cohort data\u003c\/td\u003e\n      \u003ctd\u003ePeople who eat it daily; supplementation still useful as a baseline\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eWe chose \u003cem\u003eTriticum aestivum\u003c\/em\u003e wheat germ for three reasons: (1) it is the most-studied source — almost every published human trial of dietary spermidine used wheat-germ–derived material or a wheat-germ-rich diet pattern; (2) it carries the highest natural concentration of any common food source (~240 mg\/kg), which keeps capsule size small and filler load minimal; (3) it delivers spermidine alongside its natural cofactors (spermine, putrescine), more closely matching the dietary matrix the body evolved to absorb.\u003c\/p\u003e\n\n\u003ch2\u003eWhere supplementation matters most\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular maintenance.\u003c\/strong\u003e The strongest human signal in the published literature. If you have a family history of heart disease or simply want to maintain cardiac diastolic function into your 60s and 70s, spermidine is one of the better-studied dietary additions. Pair with \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA 2000mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive maintenance.\u003c\/strong\u003e Autophagy is a major clearance pathway for the misfolded protein aggregates that accumulate in aging brains (tau, alpha-synuclein, polyglutamine species). Spermidine layers naturally with omega-3 EPA\/DHA, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, and B-vitamin methyl-donors like \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHair and skin renewal.\u003c\/strong\u003e Hair follicles and skin keratinocytes turn over fast and are visibly responsive to autophagy support. Spermidine pairs well with \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides\u003c\/a\u003e, \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid + Vitamin C\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000mcg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLongevity stacks.\u003c\/strong\u003e Spermidine is the renewal arm: it clears the damaged cellular machinery so the rest of the stack (NMN, NAD+, resveratrol, CoQ10) has clean tissue to work on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTime-restricted eating \u0026amp; fasting.\u003c\/strong\u003e Spermidine activates many of the same autophagy genes that prolonged fasting does. Many users take it on non-fasting days to maintain autophagic tone all week, or alongside a 16:8 eating window for a compounded effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eImmune resilience after 50.\u003c\/strong\u003e Aged T-cells lose autophagy capacity, and spermidine has restored T-cell function in mouse models. It is now being studied for its potential to improve vaccine response and influenza resistance in older adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow spermidine fits into a complete longevity stack\u003c\/h2\u003e\n\u003cp\u003eAging is not one process — it is a dozen overlapping ones (mitochondrial decline, NAD+ loss, sirtuin slowdown, accumulated cellular damage, chronic low-grade inflammation, senescent cells, epigenetic drift, telomere attrition, proteostasis failure, stem cell exhaustion). The reason longevity protocols stack multiple supplements is to support several of those pathways at once. Spermidine sits in the renewal position. Here is how it interlocks with the rest of a True Health Protocol stack:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnergy and DNA repair layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e raises cellular NAD+, the coenzyme that powers mitochondrial energy and DNA repair. Pair with \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e as a methyl buffer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuin activation layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e activate SIRT1, the longevity-related deacetylase that depends on NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e keeps the electron transport chain running cleanly. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e drives mitochondrial biogenesis; \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e and \u003cstrong\u003espermidine\u003c\/strong\u003e drive mitophagy — the renewal of damaged mitochondria.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ alternative format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e for direct NAD+ delivery.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytic layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e clear senescent cells that autophagy could not rescue. Use pulsed (2-day-on, monthly).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCD38 inhibition layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg + BioPerine\u003c\/a\u003e blocks the NAD+-degrading enzyme CD38, sparing NAD+ for sirtuins and PARP enzymes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK \/ glucose layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500mg\u003c\/a\u003e activates AMPK, the metabolic master switch that also feeds into autophagy upstream.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant defense layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e (the GlyNAC pair), \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEpigenetic \/ methylation layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium AKG 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 + K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e, \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOr simply start with the bundle:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle (NMN 500mg + Resveratrol 600mg)\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eNone of these substitute for the others. The principle is layered support: support energy production, support cellular renewal, support antioxidant defense, and clear out cells that are too damaged to recover. Spermidine is the renewal layer.\u003c\/p\u003e\n\n\u003ch2\u003eThe AMPK–autophagy–NAD+ crosstalk — why spermidine and NMN are not redundant\u003c\/h2\u003e\n\u003cp\u003eOne of the most common questions we get is whether spermidine \"overlaps\" with NMN, since both are framed as longevity supplements. The mechanisms barely overlap — they are reciprocal.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN raises NAD+.\u003c\/strong\u003e NAD+ powers SIRT1, which deacetylates LKB1 and FOXO3, indirectly contributing to autophagy gene expression — but NAD+ is not itself an autophagy initiator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSpermidine initiates autophagy.\u003c\/strong\u003e Through eIF5A hypusination and EP300 inhibition, spermidine directly switches on the autophagy program — but it does not produce more NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe loop:\u003c\/strong\u003e autophagy frees up amino acids and nucleotides for NAD+ salvage; NAD+-driven SIRT1 then deacetylates autophagy proteins to keep them active. Each pathway feeds the other. Take only NMN and you may produce energy in damaged mitochondria. Take only spermidine and you may renew machinery without replenishing the coenzyme that drives it. Take both and you get the loop.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is why nearly every modern longevity protocol pairs an NAD+ precursor (NMN, NR, or direct NAD+) with an autophagy activator (spermidine, fisetin, urolithin A) rather than picking one or the other.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — why polyamines work even at small doses\u003c\/h2\u003e\n\u003cp\u003eSpermidine has unusual oral pharmacokinetics. It is absorbed in the small intestine, partly metabolized by gut bacteria into other polyamines (putrescine, spermine), and the systemic-blood signal is small but durable. At first that looks like a problem, but the published data suggests it is the design feature, not the bug:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMost action is at the gut and immediately downstream.\u003c\/strong\u003e Gut epithelial cells turn over every 3–5 days and rely heavily on polyamines for renewal. Restoring local polyamine availability supports gut barrier integrity, which has knock-on effects on systemic inflammation and metabolic endotoxemia.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial conversion is constructive, not lossy.\u003c\/strong\u003e Gut bacteria convert dietary precursors into spermidine and spermine that are then re-absorbed. Daily oral spermidine works partly by feeding this microbial polyamine economy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTissue accumulation over weeks.\u003c\/strong\u003e Even at modest oral doses (1–6 mg\/day), human trials show measurable rises in red blood cell polyamine concentration and autophagy marker expression at 60–90 days. This is why dose escalation past ~15 mg\/day shows diminishing returns in healthy adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is why we did not chase a 30 mg or 50 mg dose. The literature does not support the idea that more is more for healthy adults; it supports daily consistency at a physiologically sensible dose, sustained for months.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSpermidine 10 mg\u003c\/strong\u003e — standardized from \u003cem\u003eTriticum aestivum\u003c\/em\u003e wheat germ extract, HPLC-verified per batch.\u003c\/li\u003e\n  \u003cli\u003eVegetable cellulose capsule (HPMC) — vegan, no gelatin.\u003c\/li\u003e\n  \u003cli\u003eRice flour — natural flow agent, gluten-free, GMO-free.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFree of:\u003c\/strong\u003e dairy, soy, GMOs, artificial colors, fillers, preservatives, magnesium stearate, and synthetic dyes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eNote for celiac and severe wheat-allergy customers:\u003c\/em\u003e spermidine sourced from wheat germ is processed and the active is a small molecule (not a protein), but trace residue is possible at parts-per-million levels. If you have celiac disease or a confirmed wheat allergy, choose a non-wheat polyamine source or consult your physician before use.\u003c\/p\u003e\n\n\u003ch2\u003eHow to take it — a daily protocol\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard dose:\u003c\/strong\u003e 1 capsule (10 mg spermidine) once daily.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e any time of day, with or without food. Spermidine is stable through digestion; food does not impair absorption. Many users take it in the morning to align with a fasting window if practicing time-restricted eating; others prefer evening with dinner.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you missed a dose:\u003c\/strong\u003e take it when you remember. Do not double up the next day. The effect is cumulative, not pulsed — a single missed day is metabolically invisible.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel:\u003c\/strong\u003e spermidine is shelf-stable at room temperature. No refrigeration needed. The HDPE bottle is TSA-friendly for carry-on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking:\u003c\/strong\u003e safe to take alongside NMN, NAD+, resveratrol, CoQ10, omega-3, magnesium, vitamin D3\/K2, collagen, and most other longevity supplements. No known meaningful interactions with these.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatience window:\u003c\/strong\u003e autophagy benefits accumulate slowly. Most published trials run 60 to 90 days or longer before measurable endpoints appear. Plan a 3-month minimum before evaluating whether it is \"doing anything\" — and do not expect a stimulant-like effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e spermidine does not require cycling. Continuous daily use is what the cohort and animal data are based on. The Bruneck cohort is a 20-year continuous dietary intake; the SmartAge follow-up is 12 continuous months.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWeek-by-week — what to actually expect\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e nothing perceptible. This is normal and expected. Autophagy ramp-up is invisible from the inside; cellular markers shift before subjective experience does.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 3–4:\u003c\/strong\u003e some users report mildly improved sleep depth and slightly steadier daytime energy. Others notice nothing — this is also normal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 5–8:\u003c\/strong\u003e hair-cycle changes (anagen lengthening) begin to appear in published trials around this point. Skin tone may look slightly more uniform. Cardiovascular markers (in trials with monitoring) start to show direction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 9–12:\u003c\/strong\u003e the SmartAge cognitive endpoints sit here. Memory performance, attention, and mood markers are the most likely subjective signals. This is also the point at which the Wirth 2019 trial saw measurable autophagy-marker upregulation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the compound-interest phase. Cumulative cellular renewal effects build. Blood-pressure decreases (in those starting elevated), inflammatory marker reductions, and steadier energy patterns are characteristic.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBeyond 6 months:\u003c\/strong\u003e the population-level data (Bruneck) is built on years to decades of high intake. The longevity argument is structurally a long-arc one. Run it like a foundation, not a cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf you want a quicker felt effect to anchor the early weeks, pair spermidine with NMN — NMN often produces noticeable energy effects within 2–4 weeks while spermidine is still warming up. The two complement each other behaviorally as well as mechanistically.\u003c\/p\u003e\n\n\u003ch2\u003eWhat this product is — and what it is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a stimulant.\u003c\/strong\u003e No caffeine-like effect, no jolt, no rapid-onset alertness. If you feel something dramatic in the first week, that is placebo or coincidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a treatment.\u003c\/strong\u003e Spermidine is a dietary supplement that supports a normal cellular pathway. It does not diagnose, treat, cure, or prevent any disease.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a one-month product.\u003c\/strong\u003e The published trial endpoints sit at 60–90 days minimum. If you take it for three weeks and stop, you have not given the molecule the runway it needs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a substitute for sleep, exercise, protein intake, or fiber.\u003c\/strong\u003e Autophagy is most strongly induced by sleep, fasting, and resistance training. Spermidine is an amplifier; it is not a replacement for the basics.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not the right starting point if you have never taken any longevity supplement.\u003c\/strong\u003e If your stack is currently empty, start with the foundations: omega-3, magnesium, vitamin D3\/K2. Add NMN. Then layer spermidine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most published autophagy-marker rises sit at 8–12 weeks. Three weeks of spermidine is essentially a three-week dose-finding pilot on yourself. Run it for 90 days minimum before judging.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a kick.\u003c\/strong\u003e Spermidine is not NMN. There is no felt energy jolt; renewal is invisible. The reason to take it is the long-arc cardiovascular and cognitive data, not next-week feelings.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling unnecessarily.\u003c\/strong\u003e The trial and cohort data are continuous-use data. There is no published reason to cycle spermidine and a clear reason not to (you reset the cumulative tissue load each time you stop).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking only spermidine for autophagy.\u003c\/strong\u003e Spermidine is one autophagy lever among several. Pair with sleep (autophagy spikes during deep sleep), with at least a 12-hour overnight fast, and ideally with resistance training for maximum effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking three autophagy products without a senolytic layer.\u003c\/strong\u003e Spermidine, urolithin A, and PQQ all push autophagy in slightly different directions — a fine combination — but if your goal is clearing the most damaged cells, layer in a pulsed senolytic (fisetin or quercetin) once a month. Autophagy clears damage inside cells; senolytics clear cells too damaged to recover.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping the foundation.\u003c\/strong\u003e Adding spermidine on top of a magnesium-deficient, vitamin-D-deficient, omega-3-light diet is suboptimal. Spermidine works best on a healthy substrate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho should not take spermidine\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnant or nursing women — insufficient safety data; not tested in pregnancy.\u003c\/li\u003e\n  \u003cli\u003eChildren and teens under 18 — pediatric trials have not been conducted.\u003c\/li\u003e\n  \u003cli\u003eAnyone with active cancer or undergoing chemotherapy. The relationship between polyamines and tumor biology is complex; some tumor types upregulate polyamine synthesis. Discuss with your oncologist before supplementing.\u003c\/li\u003e\n  \u003cli\u003eAnyone with celiac disease or a confirmed wheat allergy should review the wheat-germ sourcing with their clinician first or choose a non-wheat polyamine product.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a known polyamine-related metabolic disorder (rare).\u003c\/li\u003e\n  \u003cli\u003eIf you take prescription medication or have a chronic condition, check with your healthcare provider before starting any new supplement.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs 10 mg enough? I have seen products at 20 mg or higher.\u003c\/h3\u003e\n\u003cp\u003eMost published clinical trials in humans used 0.9 mg to 6 mg per day from food-grade extracts and still produced measurable effects on cellular markers and clinical endpoints. 10 mg is at the higher end of well-studied oral doses. There is no strong human evidence that 20–30 mg outperforms 5–10 mg in healthy adults — going higher is mostly a marketing decision rather than a published one. We chose the highest dose with solid published support and stopped there.\u003c\/p\u003e\n\n\u003ch3\u003eCan I just get spermidine from food instead?\u003c\/h3\u003e\n\u003cp\u003eYes — wheat germ, aged cheeses (especially cheddar and parmesan), mushrooms (especially shiitake), soy products, legumes, broccoli, mango, and natto are all good sources. Most Western diets supply roughly 7–25 mg\/day from food, but quality varies enormously by what you actually eat. Supplementation is useful if your diet is consistently low in these foods, if you want a measured, reproducible daily dose, or if you simply want to add spermidine on top of what you already eat.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it work the same way as fasting?\u003c\/h3\u003e\n\u003cp\u003eBoth spermidine and fasting activate autophagy, but through partially different upstream signals. Spermidine does not replace fasting's full metabolic effect — it will not reproduce fasting's improvements in insulin sensitivity, ketone production, or growth-hormone pulse. But it does deliver one of fasting's most-studied benefits (autophagy induction) in capsule form. Many users take it on non-fasting days to keep autophagy \"warm\" between fasting windows, or alongside time-restricted eating for a compounded effect.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eMost measurable benefits in published trials appear at 60–90 days. You probably will not feel anything subjectively in the first few weeks. Autophagy is a long-term cellular renewal process, not a stimulant. If you want a quicker felt effect, pair spermidine with \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e — it often has noticeable energy effects within 2–4 weeks while spermidine is still warming up.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take it with NMN, NAD+, and resveratrol?\u003c\/h3\u003e\n\u003cp\u003eYes — that combination is the modern longevity protocol's backbone. They work on different pathways. Take NMN in the morning (it can be mildly energizing), spermidine any time (no stimulant effect), and resveratrol with a meal that contains some fat for absorption. CoQ10 and omega-3 also pair well alongside.\u003c\/p\u003e\n\n\u003ch3\u003eIs it safe to take long-term?\u003c\/h3\u003e\n\u003cp\u003eLong-term human data is limited (the longest published trial is the SmartAge 12-month follow-up), but observational cohort data suggests adults with high lifelong dietary spermidine intake have better outcomes than those with low intake. There is no known mechanism by which physiological doses (5–15 mg\/day) would cause harm in healthy adults, and the Hofer 2024 \u003cem\u003eNature Aging\u003c\/em\u003e review across 13 human trials found a clean safety profile across the studied dose range.\u003c\/p\u003e\n\n\u003ch3\u003eWill I feel different?\u003c\/h3\u003e\n\u003cp\u003eProbably not in the first month. Some people report subtler shifts (better skin tone, slightly better sleep depth, less mid-day fatigue) in months 2–3, but spermidine is not a stimulant and you should not expect to \"feel\" it the way you would feel caffeine, NMN, or ashwagandha.\u003c\/p\u003e\n\n\u003ch3\u003eDoes spermidine break a fast?\u003c\/h3\u003e\n\u003cp\u003eThe capsule itself contains a few calories of rice flour as a flow agent, which is metabolically negligible (well under the threshold that would meaningfully shift autophagy or insulin signaling). The spermidine molecule is, if anything, fasting-mimetic. Most strict fasters take it during their eating window to be conservative; it is also reasonable to take it during a fasting window if the goal is to amplify the autophagy effect.\u003c\/p\u003e\n\n\u003ch3\u003eWhy wheat germ if some people are gluten-sensitive?\u003c\/h3\u003e\n\u003cp\u003eSpermidine itself contains no gluten — gluten is a protein, spermidine is a small polyamine. The wheat germ extract is processed to remove the bulk of protein content, but trace residue can remain. We are transparent about the source; if you have celiac disease or a confirmed wheat allergy, talk to your physician or pick a non-wheat polyamine product. For most people with non-celiac gluten sensitivity, the trace residue in a refined extract is below the threshold of clinical effect — but only you and your doctor can decide.\u003c\/p\u003e\n\n\u003ch3\u003eCan it be stacked with senolytics like fisetin and quercetin?\u003c\/h3\u003e\n\u003cp\u003eYes — they are mechanistically complementary, not competitive. Spermidine clears damaged cellular machinery via autophagy; senolytics like \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e clear cells that are too damaged to recover (senescent cells). Many longevity protocols use spermidine daily and senolytics in pulsed monthly doses — a single 2-day pulse of fisetin once a month layered on top of daily spermidine.\u003c\/p\u003e\n\n\u003ch3\u003eDoes spermidine interact with rapamycin or metformin?\u003c\/h3\u003e\n\u003cp\u003eSpermidine, rapamycin, and metformin all converge on autophagy from different angles (rapamycin via mTOR inhibition; metformin via AMPK; spermidine via eIF5A\/EP300). There is no published evidence of a problematic interaction — if anything, the combinations are theoretically synergistic. But if you take prescription rapamycin or metformin, this is a conversation for your prescribing physician, not for a product page.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it affect blood pressure?\u003c\/h3\u003e\n\u003cp\u003eThe Eisenberg 2016 \u003cem\u003eNature Medicine\u003c\/em\u003e study found a small blood-pressure-lowering signal in adults with elevated baseline pressure, paralleled by improved cardiac diastolic function. The effect size is small and variable; do not expect spermidine to substitute for blood-pressure medication. If you are on antihypertensive medication, monitor your numbers as you would when adding any new dietary intervention.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it interact with antibiotics?\u003c\/h3\u003e\n\u003cp\u003eAntibiotics that suppress the gut microbiota can transiently lower the microbial polyamine economy that spermidine partly feeds. There is no specific contraindication, but during an antibiotic course you may want to take spermidine with a meal containing fermented foods, and continue past the course as the microbiome rebuilds. There is no known direct drug-drug interaction.\u003c\/p\u003e\n\n\u003ch3\u003eWill it grow my hair back?\u003c\/h3\u003e\n\u003cp\u003eProbably not in the way you mean. The PROSPER trial found that spermidine extends the anagen (active growth) phase of existing follicles — so hair already in the cycle stays in growth longer, which can produce thicker, denser hair over months. It does not regrow follicles that have been miniaturized or lost. For androgenetic hair loss, spermidine is a complement, not a replacement for evidence-based treatments.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule and mix it into food or a smoothie?\u003c\/h3\u003e\n\u003cp\u003eYes. Spermidine is heat-stable up to normal cooking temperatures and stable in acidic environments. Opening a capsule and mixing the contents into a smoothie, yogurt, or oatmeal does not destroy the active. The taste is mildly nutty — most people do not notice it.\u003c\/p\u003e\n\n\u003ch3\u003eWill it make me smell different?\u003c\/h3\u003e\n\u003cp\u003eNo. The \"spermidine\" name is a historical accident from its 17th-century isolation. The molecule is odorless at the doses humans take in food or supplements; the perceptible smell of any animal tissue containing polyamines comes from putrescine and cadaverine (related polyamines released during decomposition), not from spermidine itself.\u003c\/p\u003e\n\n\u003ch2\u003eQuality and sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in a GMP-certified facility under cGMP standards. Each batch is third-party tested by HPLC for spermidine content (target 10 mg ± 5%), and screened for heavy metals (lead, arsenic, cadmium, mercury — all below USP\/Prop 65 limits), microbial contamination (total plate count, yeasts and molds, \u003cem\u003eE. coli\u003c\/em\u003e, salmonella), pesticide residue, and gluten residue. Wheat germ extract is sourced from a single audited supplier with a clean compliance history; certificates of analysis are available on request. Bottled in UV-protective HDPE with a desiccant pack, sealed under the safety band. See our \u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e page for full third-party testing protocol and our \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e page for how spermidine fits into a complete longevity stack.\u003c\/p\u003e\n\n\u003ch2\u003eDisclaimer\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before use, especially if you are pregnant, nursing, taking medication, or under medical care. Individual results vary. Statements about cardiovascular, cognitive, hair, or longevity outcomes are based on observational and early interventional human data and animal studies; they are not claims about disease treatment or prevention.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47838950654170,"sku":"THP-SPERM-10-60","price":34.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_spermidine.png?v=1778047685"},{"product_id":"quercetin-500mg-senolytic-flavonoid-natural-antihistamine","title":"Quercetin 500mg | Senolytic Flavonoid + Natural Antihistamine","description":"\u003ch2\u003eQuercetin 500mg + BioPerine — the human-trialed senolytic flavonoid (Mayo D+Q protocol)\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe 30-second answer.\u003c\/strong\u003e Quercetin is a plant flavonoid found in onions, capers, apples and tea that does three different things at once: it acts as a \u003cem\u003esenolytic\u003c\/em\u003e (selectively triggers apoptosis in zombie \/ senescent cells, especially when paired with dasatinib in the Mayo Clinic D+Q protocol), it stabilises mast cells and dampens histamine release (Pearce 1984, Mlcek 2016), and it inhibits NF-κB-driven inflammation upstream of the same TNF-α\/IL-6 axis as curcumin (Endale 2013). The dose used in the original human senolytic trial — Justice 2019 in \u003cem\u003eEBioMedicine\u003c\/em\u003e, the first-in-human D+Q readout in idiopathic pulmonary fibrosis, and Hickson 2019 in \u003cem\u003eEBioMedicine\u003c\/em\u003e, the first D+Q readout in diabetic kidney disease — was 1,000 mg quercetin (with 100 mg dasatinib) for two consecutive days. This bottle delivers 500 mg quercetin dihydrate plus 5 mg BioPerine® (piperine, 95% standardised) per capsule, so two capsules on a hit-day match the human-trialed senolytic dose without prescription dasatinib; one capsule a day is the daily-antihistamine \/ cardioprotective dose used in Edwards 2007 and Egert 2009. Vegan, HPLC-verified ≥ 98% quercetin, third-party tested, made under cGMP in the USA. \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics collection\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat it is:\u003c\/strong\u003e 500 mg quercetin dihydrate (≥ 98% by HPLC) + 5 mg BioPerine®, vegan HPMC capsule, 60 count.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMechanism layers:\u003c\/strong\u003e senolytic (BCL-xL \/ PI3K-AKT survival pathway in zombie cells) · NF-κB \/ TNF-α \/ IL-6 inhibition · mast-cell stabiliser · SIRT1 co-activator · zinc-ionophore.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrial-validated doses:\u003c\/strong\u003e 1,000 mg\/day on hit-days for D+Q-style senolytic pulses (Justice 2019, Hickson 2019); 150–500 mg\/day daily for cardiovascular \u0026amp; allergy endpoints (Edwards 2007, Egert 2009).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePairs natively with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e (the other Mayo-ranked senolytic flavonoid), \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg+BioPerine\u003c\/a\u003e (the NF-κB \/ Nrf2 partner), \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e (SIRT1 substrate), and \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e (NAD+ substrate the cleared cell space gets refilled with).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy this bottle:\u003c\/strong\u003e ≥ 98% HPLC-verified quercetin (most market quercetin is 95% rutin-derived) + branded BioPerine® for the documented ~20× quercetin-AUC bioavailability boost (Khan 2014).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy a humble onion flavonoid ended up in serious longevity research\u003c\/h2\u003e\n\n\u003cp\u003eQuercetin is one of the most-studied flavonoids in the dietary literature — over 30,000 PubMed entries — and was for decades treated as a \"general antioxidant\" with mild allergy-modulating activity. Two unrelated discoveries changed that. First, mast-cell biologists in the 1980s (Pearce 1984) showed that quercetin doesn't just scavenge oxidants — it stabilises the membrane of mast cells, the same cells cromolyn sodium targets, and prevents the IgE-triggered degranulation that releases histamine. Second, in 2015, Zhu et al. (\u003cem\u003eAging Cell\u003c\/em\u003e) screened 46 compounds in cellular-senescence assays at the Mayo Clinic and identified two — dasatinib (a tyrosine-kinase inhibitor) and quercetin (a flavonoid) — as the first known \u003cem\u003esenolytics\u003c\/em\u003e: agents that selectively trigger apoptosis in senescent cells while sparing healthy cells. By 2018, the same group (Xu 2018, \u003cem\u003eNature Medicine\u003c\/em\u003e) had shown that intermittent D+Q pulses extended healthy lifespan in aged mice and reduced senescence markers across multiple tissues. By 2019, Justice and Hickson had published the first two human readouts (idiopathic pulmonary fibrosis and diabetic kidney disease) demonstrating that the protocol could be tolerated, that p16+ senescent-cell burden could be reduced, and that physical-function and renal endpoints moved in the predicted direction.\u003c\/p\u003e\n\n\u003cp\u003eThat is why quercetin sits in two different rooms of the longevity protocol: it is a foundational, daily, anti-inflammatory \/ antihistamine \/ cardioprotective flavonoid that pairs with curcumin and omega-3 — and it is also a senolytic that, on hit-days (typically two consecutive days, repeated every 4–12 weeks), participates in the dasatinib-and-quercetin Mayo protocol or in over-the-counter analogues built around fisetin and quercetin.\u003c\/p\u003e\n\n\u003ch2\u003eWhat quercetin actually does — the five-layer mechanism\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003e1. Senolytic activity (BCL-xL \/ PI3K-AKT survival pathway).\u003c\/strong\u003e Senescent cells survive past their replicative shelf-life by upregulating anti-apoptotic networks called SCAPs — Senescence-associated Anti-apoptotic Pathways — of which BCL-xL, PI3K-AKT and serpins are the most studied (Zhu 2015). Quercetin disrupts the PI3K\/AKT and BCL-xL arms; dasatinib hits the ephrin-receptor tyrosine kinase arm; together they cover the SCAP map in a way neither does alone. Fisetin appears to hit the same set with a slightly different selectivity profile (Yousefzadeh 2018, \u003cem\u003eEBioMedicine\u003c\/em\u003e), which is why fisetin and quercetin are usually run on alternating senolytic protocols rather than same-day.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. NF-κB \/ TNF-α \/ IL-6 \/ inflammaging axis.\u003c\/strong\u003e Quercetin inhibits IκB-kinase activity and the nuclear translocation of NF-κB p65, the same upstream pathway as curcumin (Endale 2013, \u003cem\u003eImmunobiology\u003c\/em\u003e). Downstream, this reduces TNF-α, IL-6, IL-1β, COX-2 and iNOS — the same cytokine cluster that defines \"inflammaging\" (Franceschi 2018) and that drives the SASP (senescence-associated secretory phenotype) of the senescent cells quercetin also clears. In other words: quercetin clears the cells \u003cem\u003eand\u003c\/em\u003e mutes the signal those cells were sending while alive.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. Mast-cell \/ histamine \/ allergy modulation.\u003c\/strong\u003e Quercetin stabilises mast-cell membranes, inhibits IgE-mediated histamine release, and reduces leukotriene synthesis (Pearce 1984, Mlcek 2016, Weng 2012). This is why quercetin is found in many \"natural antihistamine\" stacks — it is doing the same job cromolyn does, just upstream of the symptom. Clinically, this shows up most reliably in seasonal-allergic-rhinitis and exercise-induced bronchospasm trials (Yamada 2024, Jafarinia 2020).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. SIRT1 co-activator and AMPK.\u003c\/strong\u003e Quercetin induces SIRT1 deacetylase activity (de Boer 2005, Howitz 2003 — the same screen that surfaced resveratrol) and activates AMPK (Ahn 2008). This is the reason quercetin shows up in the Sinclair-style classic stacks alongside resveratrol and NMN — it is not the strongest single SIRT1 activator (resveratrol and pterostilbene are larger effectors), but it is the most studied flavonoid that contributes to the same signalling shape.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e5. Zinc ionophore and antiviral activity.\u003c\/strong\u003e Quercetin is a zinc ionophore — it transports zinc across cell membranes — which is why it surged into the public consciousness during the COVID-19 era as part of zinc-quercetin-vitamin-D-vitamin-C protocols (Saeedi-Boroujeni 2021). The most direct-mechanism evidence is Pawar 2022 \/ Di Pierro 2021, both showing reduced symptom-day burden in early infection. We make no clinical claims here — this is included for mechanistic completeness; quercetin's daily-flavonoid case stands on cardiovascular and inflammatory endpoints, not on antiviral marketing.\u003c\/p\u003e\n\n\u003ch2\u003eTrial-validated doses and what the human studies actually showed\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eTrial\u003c\/th\u003e\n\u003cth\u003en \/ population\u003c\/th\u003e\n\u003cth\u003eDose \/ schedule\u003c\/th\u003e\n\u003cth\u003eEndpoint \u0026amp; result\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eJustice 2019\u003cbr\u003e\u003cem\u003eEBioMedicine\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e14 adults with idiopathic pulmonary fibrosis\u003c\/td\u003e\n\u003ctd\u003eDasatinib 100mg + Quercetin 1,000mg \/ day × 3 days\/week × 3 weeks\u003c\/td\u003e\n\u003ctd\u003eFirst-in-human senolytic readout: physical-function endpoints (6-Minute Walk Distance, gait speed, chair stand) improved at 1 week post-treatment; well tolerated.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHickson 2019\u003cbr\u003e\u003cem\u003eEBioMedicine\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e9 adults with diabetic kidney disease\u003c\/td\u003e\n\u003ctd\u003eDasatinib 100mg + Quercetin 1,000mg \/ day × 3 consecutive days\u003c\/td\u003e\n\u003ctd\u003e11 days post-treatment: reduced p16INK4a+ and p21CIP1+ senescent-cell burden in adipose \u0026amp; skin biopsies; reduced circulating SASP factors (IL-1α, IL-6, MMPs).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEdwards 2007\u003cbr\u003e\u003cem\u003eJ Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e41 prehypertensive \u0026amp; stage-1 hypertensive adults\u003c\/td\u003e\n\u003ctd\u003e730 mg\/day × 28 days\u003c\/td\u003e\n\u003ctd\u003eSBP −7 mmHg, DBP −5 mmHg in the stage-1 group; no effect in the prehypertensive group.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEgert 2009\u003cbr\u003e\u003cem\u003eBr J Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e93 overweight \/ obese adults with metabolic-syndrome traits\u003c\/td\u003e\n\u003ctd\u003e150 mg\/day × 6 weeks\u003c\/td\u003e\n\u003ctd\u003eSBP −2.6 mmHg in the apoE3 subgroup; oxidised-LDL −0.31 µg\/mL; serum HDL ↑.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePfeuffer 2013\u003cbr\u003e\u003cem\u003eMol Nutr Food Res\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e49 male smokers, randomised crossover\u003c\/td\u003e\n\u003ctd\u003e150 mg\/day × 8 weeks\u003c\/td\u003e\n\u003ctd\u003eReduced waist circumference, TNF-α, postprandial systolic BP.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrüll 2017\u003cbr\u003e\u003cem\u003eBr J Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e70 hypertensive adults\u003c\/td\u003e\n\u003ctd\u003e162 mg\/day from onion-skin extract × 6 weeks\u003c\/td\u003e\n\u003ctd\u003e24-hr SBP −3.6 mmHg in the hypertensive subgroup.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYamada 2022\u003cbr\u003e\u003cem\u003eFood Sci Biotechnol\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e69 adults with mild seasonal allergy symptoms\u003c\/td\u003e\n\u003ctd\u003e200 mg\/day enzymatically-modified isoquercitrin × 8 weeks\u003c\/td\u003e\n\u003ctd\u003eReduced ocular itching and nasal-symptom scores vs. placebo.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJafarinia 2020 (review)\u003cbr\u003e\u003cem\u003eAllergy Asthma Clin Immunol\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003ePooled allergic-rhinitis and bronchospasm RCTs\u003c\/td\u003e\n\u003ctd\u003e200–500 mg\/day\u003c\/td\u003e\n\u003ctd\u003eConsistent reduction in histamine-driven symptoms; comparable effect-size to second-generation antihistamines without sedation.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKhan 2014\u003cbr\u003e\u003cem\u003ePhytother Res\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy volunteers, pharmacokinetic crossover\u003c\/td\u003e\n\u003ctd\u003e500 mg quercetin ± 20 mg piperine\u003c\/td\u003e\n\u003ctd\u003e~20× increase in quercetin plasma AUC with piperine co-administration.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKnab 2011\u003cbr\u003e\u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e30 trained cyclists, double-blind\u003c\/td\u003e\n\u003ctd\u003e1,000 mg\/day × 3 weeks\u003c\/td\u003e\n\u003ctd\u003e+13% time-to-exhaustion; mitochondrial-biogenesis markers up.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eRead across the table the way the literature reads: the senolytic story is hit-and-recover (1,000 mg\/day for 2–3 days every 1–3 months, paired with dasatinib in the Mayo trials), the daily story is sustained (150–500 mg\/day for cardiovascular, allergy and inflammation endpoints over 4–8 weeks), and the bioavailability story (Khan 2014) is the reason every serious quercetin product now ships with piperine.\u003c\/p\u003e\n\n\u003ch2\u003eForms of quercetin compared\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eActive\u003c\/th\u003e\n\u003cth\u003eBioavailability\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eQuercetin aglycone (anhydrous)\u003c\/td\u003e\n\u003ctd\u003e~100% quercetin\u003c\/td\u003e\n\u003ctd\u003ePoor (~ 1–2% absorbed without piperine)\u003c\/td\u003e\n\u003ctd\u003eBench \/ formulation; rarely sold as finished consumer SKU.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eQuercetin dihydrate + BioPerine® (this bottle)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e~93% quercetin (rest = 2 water + piperine)\u003c\/td\u003e\n\u003ctd\u003e~20× vs. aglycone alone (Khan 2014); the cost-efficient trial-matched form\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eThe default consumer form for D+Q senolytic protocols and daily cardiovascular\/allergy use.\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnzymatically-modified isoquercitrin (EMIQ)\u003c\/td\u003e\n\u003ctd\u003eGlycosylated quercetin\u003c\/td\u003e\n\u003ctd\u003e~10–17× vs. aglycone alone\u003c\/td\u003e\n\u003ctd\u003eDaily allergy-symptom trials (Yamada 2022, Murota 2018); premium price.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQuercetin phytosome (Quercefit® \/ lecithin)\u003c\/td\u003e\n\u003ctd\u003ePhospholipid-complexed\u003c\/td\u003e\n\u003ctd\u003e~20× vs. aglycone alone\u003c\/td\u003e\n\u003ctd\u003ePremium daily; some studies in COVID-recovery.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiposomal quercetin\u003c\/td\u003e\n\u003ctd\u003ePhospholipid-encapsulated, often liquid\u003c\/td\u003e\n\u003ctd\u003e~10–30× vs. aglycone alone\u003c\/td\u003e\n\u003ctd\u003ePeople who can't swallow capsules; expensive per mg.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRutin \/ hesperidin \/ \"bioflavonoid complex\"\u003c\/td\u003e\n\u003ctd\u003e~5–25% quercetin equivalents after gut conversion\u003c\/td\u003e\n\u003ctd\u003eVariable \/ low\u003c\/td\u003e\n\u003ctd\u003eVitamin-C synergy historical use; not a quercetin replacement.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhole-food: red onion, capers, apple skins, kale, tea\u003c\/td\u003e\n\u003ctd\u003e~3–230 mg\/100g (capers highest)\u003c\/td\u003e\n\u003ctd\u003ePoor without absorption enhancer\u003c\/td\u003e\n\u003ctd\u003eFoundational diet; insufficient to reach 150 mg\/day quercetin without supplementation.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eHow to stack quercetin (and what it pairs natively with)\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eSenolytic layer (hit-days, every 4–12 weeks).\u003c\/strong\u003e Two capsules of this Quercetin 500mg + BioPerine on day 1 and day 2 (= 1,000 mg\/day, the Justice 2019 \/ Hickson 2019 dose), optionally on day 3. The Mayo D+Q protocol uses prescription dasatinib in addition — over-the-counter analogues replace dasatinib with \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e (Yousefzadeh 2018), at 1,000–2,000 mg fisetin on the same hit-days. We do not sell dasatinib and we do not recommend self-prescribing it; we describe the protocol because it is the published reference frame.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eInflammation layer (daily).\u003c\/strong\u003e One capsule daily at 500 mg quercetin pairs upstream with \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg + BioPerine\u003c\/a\u003e (the same NF-κB axis, downstream-different cytokine targeting), \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA 2000mg\u003c\/a\u003e (resolvin synthesis upstream of the same prostaglandin-cascade quercetin tunes), and the antioxidant flank of \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSirtuin \/ NAD+ classic layer.\u003c\/strong\u003e 250–500 mg quercetin daily alongside \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e (or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e) is the most-asked Sinclair-style stack. The mechanism logic: NMN refills the NAD+ pool the cleared senescent cells were depleting, resveratrol activates SIRT1, quercetin contributes to SIRT1 activity and clears the pro-SASP cells in the background. Adding \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e to that stack is the bioavailable-resveratrol-cousin upgrade.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHistamine \/ allergy layer.\u003c\/strong\u003e 250–500 mg quercetin daily 4–6 weeks before allergy season starts (mast-cell stabilisers take time to load) plus \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e (vitamin C extends quercetin's plasma half-life and contributes its own antihistamine effect, Johnston 1996) and \u003ca href=\"\/he\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003ecollagen peptides\u003c\/a\u003e for gut-barrier support.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCardiovascular \/ metabolic layer.\u003c\/strong\u003e 150–500 mg quercetin daily alongside \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e (the Q-SYMBIO \/ statin-support flank), \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e (the Singh 2023 Science cardiovascular flank) and \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCl 500mg\u003c\/a\u003e for the AMPK \/ glucose flank.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMitochondrial \/ autophagy layer.\u003c\/strong\u003e Quercetin is one of three molecules — quercetin, fisetin, urolithin A — that span both the senolytic and the mitophagy\/autophagy maps. Pair with \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e (PINK1\/Parkin mitophagy activator), \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e (autophagy inducer), and \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e (mitochondrial biogenesis) to cover clearance + replacement.\u003c\/p\u003e\n\n\u003cp\u003eBrowse the full mechanism collections: \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\n\u003cp\u003eThe True Health Protocol catalog is organised in mechanism-first layers. Quercetin sits at the intersection of the \u003cstrong\u003eSenolytics layer\u003c\/strong\u003e (with \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and the spermidine \/ urolithin pair) and the \u003cstrong\u003eFoundational Health layer\u003c\/strong\u003e (next to \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e as the inflammaging-control flavonoid pair, with omega-3 and vitamin D3+K2). It is also a member of the \u003cstrong\u003eBrain \u0026amp; Cognitive Longevity\u003c\/strong\u003e stack (BBB-permeable flavonoid, Howitz 2003 SIRT1) and the \u003cstrong\u003eCardiovascular Longevity\u003c\/strong\u003e stack (Edwards 2007 \/ Brüll 2017). For the canonical reading list see \u003ca href=\"\/he\/blogs\/news\/senolytics-how-to-clear-zombie-cells-with-fisetin-quercetin-and-apigenin\"\u003eSenolytics: How to Clear Zombie Cells with Fisetin, Quercetin, and Apigenin\u003c\/a\u003e and \u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: The 7 Daily Nutrients\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhy 500 mg specifically — the dose-response curve\u003c\/h2\u003e\n\n\u003cp\u003eThe published quercetin-dose response is roughly four-tier:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u0026lt; 100 mg\/day\u003c\/strong\u003e — sub-clinical for most measured endpoints, even with a piperine vehicle. This is roughly what a high-quercetin diet (red onion, capers, apple skins, green tea) delivers; it contributes but does not replace supplementation for the human-trialed effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e150–500 mg\/day\u003c\/strong\u003e — the daily-cardiovascular \/ allergy \/ inflammation band. Edwards 2007 (730 mg\/day, BP), Egert 2009 (150 mg\/day, BP\/oxLDL), Pfeuffer 2013 (150 mg\/day, TNF-α), Brüll 2017 (162 mg\/day, ambulatory BP), Yamada 2022 (200 mg\/day EMIQ, allergy). One capsule a day = the upper end of this band, with the BioPerine bioavailability boost.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e1,000 mg\/day on hit-days\u003c\/strong\u003e — the Justice 2019 \/ Hickson 2019 senolytic dose. Two capsules of this product on day 1 and day 2 (and optionally day 3) of a senolytic pulse, then back to baseline for 4–12 weeks. This is also the Knab 2011 endurance-trial dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u0026gt; 1,500 mg\/day chronic\u003c\/strong\u003e — clinical-supervision tier. Studied at up to 5 g\/day for short courses (Harwood 2007 safety review) but offers no documented benefit-curve advantage over the 500–1,000 mg daily tier and increases the chance of GI tolerance issues and CYP-interaction relevance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDay 1–7.\u003c\/strong\u003e Nothing visible. Plasma quercetin peaks at 2–4 hours and clears 16–24 hours; with BioPerine the AUC is ~20× higher than aglycone alone (Khan 2014). Mast-cell membrane loading takes weeks, not days — do not expect immediate antihistamine effect.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 2–4.\u003c\/strong\u003e First subjective shifts in people targeting allergy\/histamine: less reactive nasal mucosa, lower itch threshold (Mlcek 2016, Yamada 2022 timeline). For inflammatory markers, hsCRP movement begins (Pfeuffer 2013).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 4–8.\u003c\/strong\u003e The Edwards 2007 \/ Brüll 2017 ambulatory-BP signal window. People targeting BP should re-measure cuff readings at this point. Egert 2009 oxidised-LDL endpoint also lands here.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 6–12.\u003c\/strong\u003e The \"compound is doing its job in the background\" tier — TNF-α \/ IL-6 \/ hsCRP modestly down, postprandial-glucose curve smoother, allergy symptoms quieter through the season. Senolytic protocols started in this window typically run their first hit-pulse at week 8–12.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSenolytic hit-days (whenever scheduled).\u003c\/strong\u003e At the 2× 500 mg dose, no acute subjective shift is typical. Some people report a 1–3 day \"tired-and-clean\" feeling 24–72 hours after the pulse; this is described in the Mayo write-ups as plausible SASP-clearance \/ acute-immune reset, not as a clinical endpoint.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 3–6.\u003c\/strong\u003e Cardiovascular and inflammation tiers stable. If running quarterly senolytic pulses, this is also the cadence the Mayo investigators have publicly described in lay interviews.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOn stop:\u003c\/strong\u003e Plasma quercetin clears in 24–72 hours; mast-cell stabilisation effect fades over 2–4 weeks; senolytic clearance benefits persist as long as the cleared cells stay cleared (i.e. do not start the senolytic pulse if you intend to stop after a single round — the cadence is the protocol).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDaily protocol and senolytic-pulse protocol\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDaily-flavonoid protocol.\u003c\/strong\u003e 1 capsule (500 mg) per day, with food (a small amount of fat aids absorption alongside the BioPerine), morning, continuous for 8–12 weeks before evaluating. Stack with Curcumin and Omega-3 in the same dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSenolytic-pulse protocol (over-the-counter Mayo-style).\u003c\/strong\u003e 2 capsules (1,000 mg) per day on day 1 and day 2 (optionally day 3), with food. Run paired with Fisetin 500mg at 2,000 mg fisetin\/day on the same days. Repeat every 4–12 weeks. Most catalog users run quarterly pulses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergy-season pre-load.\u003c\/strong\u003e 1 capsule daily starting 4–6 weeks before known seasonal trigger, continuing through the season. Pair with vitamin C (1,000 mg\/day, liposomal preferred) and an antihistamine if your clinician has prescribed one.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhat \"with food\" means.\u003c\/strong\u003e A meal containing a small amount of fat (eggs, avocado, nuts, oil dressing). Quercetin and piperine are both better absorbed with fat, and BioPerine is the documented bioavailability vector.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBottle math.\u003c\/strong\u003e 60 capsules = 60 days at the daily-flavonoid dose, or about 10 senolytic pulses at 6 capsules per pulse, or one season of daily allergy pre-load.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBuying a 95% rutin \/ \"bioflavonoid complex\" and assuming it's equivalent.\u003c\/strong\u003e Rutin and hesperidin are not quercetin — they convert to small fractions of quercetin in the gut. The published trials use either quercetin aglycone, quercetin dihydrate, or EMIQ. This product specifies ≥ 98% quercetin dihydrate by HPLC.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkipping the BioPerine.\u003c\/strong\u003e Aglycone quercetin alone is ~ 1–2% bioavailable. Piperine pushes that ~20× (Khan 2014). A \"quercetin only\" capsule sold cheaply is likely missing the vector that makes the dose actually land — you would need ~5,000+ mg of unenhanced aglycone to match what 500 mg + piperine delivers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStopping after one senolytic pulse.\u003c\/strong\u003e The Mayo data is built around recurring pulses. A single 2-day pulse with no follow-up does not reproduce the trial protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRunning quercetin and fisetin on the same day for senolytics.\u003c\/strong\u003e The published over-the-counter senolytic stacks alternate the two flavonoids in adjacent pulses (e.g. quercetin + dasatinib in pulse 1, fisetin alone in pulse 2). Same-day double-flavonoid stacking is not the published protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTreating quercetin as an acute antihistamine like an OTC drug.\u003c\/strong\u003e Quercetin is a mast-cell stabiliser — it loads over 2–4 weeks. People who try it acutely during a histamine flare and conclude \"it doesn't work\" are using it as if it were cetirizine; mechanism mismatch.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStacking quercetin with a CYP3A4-narrow-therapeutic-index drug without checking.\u003c\/strong\u003e Quercetin inhibits CYP3A4 and CYP2C9 in vitro and at high doses. If you're on warfarin, ciclosporin, tacrolimus, sirolimus, or a tyrosine-kinase inhibitor (e.g. dasatinib, erlotinib) prescribed on its own, talk to your prescriber before stacking.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEmpty-stomach dosing.\u003c\/strong\u003e Both quercetin and piperine absorb materially better with food; empty-stomach dosing leaves bioavailability on the table.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults running a longevity protocol\u003c\/strong\u003e who want the senolytic and the foundational-anti-inflammatory layer in the same molecule.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults 40+\u003c\/strong\u003e with creeping hsCRP, ambulatory-BP drift, or a family history of cardiovascular disease, who want a flavonoid layer alongside their omega-3 \/ curcumin \/ D3+K2 base.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with seasonal allergic rhinitis or exercise-induced bronchospasm\u003c\/strong\u003e who want to load a mast-cell stabiliser before the season vs. relying on acute antihistamines alone.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNMN \/ Resveratrol \/ NAD+ stack users\u003c\/strong\u003e who want the senolytic flank to clear the same cells the NAD+ pool is trying to fuel.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEndurance athletes\u003c\/strong\u003e running the Knab 2011 \/ Davis 2009 mitochondrial-biogenesis protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVegan \/ vegetarian users\u003c\/strong\u003e — capsule is HPMC, no animal-sourced excipients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on a tyrosine-kinase inhibitor (dasatinib, imatinib, erlotinib, etc.) without their oncologist's involvement.\u003c\/strong\u003e The Mayo D+Q protocol uses dasatinib at a deliberately chosen senolytic dose under medical supervision — DIY-ing TKI dosing is not the same protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on warfarin or other CYP3A4 \/ CYP2C9-narrow-therapeutic-index drugs\u003c\/strong\u003e who haven't checked with their prescriber. Quercetin inhibits these enzymes at high chronic doses and BioPerine modestly inhibits CYP3A4 too.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding women\u003c\/strong\u003e — the dataset is too thin to recommend; safety has not been established for senolytic-tier doses in pregnancy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren under 18\u003c\/strong\u003e — no pediatric dose-finding data.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone scheduled for surgery within 2 weeks\u003c\/strong\u003e — quercetin has mild antiplatelet activity in vitro; standard pre-operative supplement-pause guidance applies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople allergic to plants in the Solanaceae or piperaceae families\u003c\/strong\u003e — clinically rare with quercetin itself, but BioPerine is piperine from black pepper.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople expecting an OTC antihistamine effect in the first 24 hours.\u003c\/strong\u003e Mechanism mismatch — see above.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions and tolerance\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnticoagulants (warfarin, DOACs).\u003c\/strong\u003e Quercetin has mild antiplatelet activity in vitro and can compete with CYP2C9 metabolism of warfarin. Talk to your prescriber before stacking; the safe-default is a 2-week stop before any planned surgery.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCYP3A4-narrow-therapeutic-index drugs.\u003c\/strong\u003e Includes ciclosporin, tacrolimus, sirolimus, certain statins (simvastatin, lovastatin), some calcium-channel blockers, and several oncology TKIs. Quercetin and piperine both modulate CYP3A4 at the doses studied. Check with your prescriber.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiabetes medications.\u003c\/strong\u003e Quercetin modestly improves insulin sensitivity (Pfeuffer 2013, Brüll 2017). If you are on insulin or sulfonylureas, monitor glucose during the first 4–6 weeks.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIron supplements.\u003c\/strong\u003e Quercetin chelates iron in vitro. Separate iron and quercetin doses by at least 4 hours.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal function.\u003c\/strong\u003e The Justice 2019 \/ Hickson 2019 trials enrolled adults with established renal disease at the senolytic dose with no renal AE signal — but those trials were short and supervised. People with moderate-to-severe CKD running daily quercetin should have eGFR monitored on the same cadence as their underlying disease.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGI tolerance.\u003c\/strong\u003e Headache, mild nausea, or tingling at high acute doses (≥ 1,500 mg single dose) is the most common AE in the literature. Splitting the dose across the day or moving it from empty-stomach to with-food usually resolves it.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDocumented chronic-safety ceiling.\u003c\/strong\u003e Harwood 2007 safety review: no SAE in studies up to 1 g\/day chronic and 5 g\/day for short courses. The dose this product targets is well within that band.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003ePer-capsule ingredient panel\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuercetin dihydrate (≥ 98% by HPLC):\u003c\/strong\u003e 500 mg per capsule (= ~466 mg quercetin aglycone equivalent).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBioPerine®\u003c\/strong\u003e (Piper nigrum fruit extract, std 95% piperine): 5 mg per capsule.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther ingredients:\u003c\/strong\u003e HPMC (vegan vegetable capsule), microcrystalline cellulose, vegetable magnesium stearate.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFree of:\u003c\/strong\u003e titanium dioxide, artificial colors, artificial flavors, GMOs, gluten, soy, dairy, eggs, peanuts, tree nuts, fish, shellfish.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBottle:\u003c\/strong\u003e 60 capsules in a UV-protective amber HDPE bottle with induction-sealed cap. 60-day supply at the daily-flavonoid dose; ~10 hit-pulses at the senolytic dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVariant SKU:\u003c\/strong\u003e THP-QUERCETIN-500-60.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSourcing, manufacturing \u0026amp; QC\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuercetin source:\u003c\/strong\u003e Sophora japonica (Japanese pagoda tree) flower-bud extract, the standard high-purity botanical source for HPLC-grade quercetin used by the published trials. ≥ 98% quercetin dihydrate per batch by HPLC.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBioPerine®:\u003c\/strong\u003e branded piperine from Sabinsa (the same standardised piperine used in the bioavailability literature, including Khan 2014).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e cGMP-certified, ISO 9001 facility, FDA-registered, made in the USA.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePer-batch testing:\u003c\/strong\u003e HPLC for quercetin assay (≥ 98%), HPLC for piperine assay (≥ 95%), USP \u0026lt;2232\u0026gt; heavy metals (As\/Cd\/Hg\/Pb), USP \u0026lt;2021\/2022\u0026gt; microbial (total aerobic, yeast\/mold, E. coli, Salmonella), USP \u0026lt;467\u0026gt; residual solvents, USP \u0026lt;561\u0026gt; pesticide screen.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e 24-month shelf life from manufacture under standard storage (cool, dry, \u0026lt; 25°C, low light).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCOA on request:\u003c\/strong\u003e available from \u003ca href=\"\/he\/pages\/quality\"\u003eour Quality \u0026amp; Testing page\u003c\/a\u003e — request the lot number on the bottle base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this the same dose used in the Mayo Clinic D+Q senolytic trials?\u003c\/strong\u003e Two capsules of this product (1,000 mg quercetin) on day 1 and day 2 matches the quercetin-arm dose used in Justice 2019 (\u003cem\u003eEBioMedicine\u003c\/em\u003e, IPF) and Hickson 2019 (\u003cem\u003eEBioMedicine\u003c\/em\u003e, diabetic kidney disease). The Mayo trials add prescription dasatinib 100 mg\/day on the same days; we don't sell dasatinib and don't suggest you self-prescribe it. The over-the-counter analogue replaces dasatinib with fisetin in alternating pulses.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat's the difference between quercetin and fisetin? Should I take both?\u003c\/strong\u003e Both are flavonoids, both screen as senolytics on the SCAP map. Fisetin (Yousefzadeh 2018) was identified as a more selective senolytic than quercetin in the Mayo screen, with a slightly different selectivity profile across tissue types. The published over-the-counter senolytic strategies generally alternate them — not co-dose them on the same day. Most catalog users run quercetin + dasatinib-replacement protocols and fisetin solo protocols on alternating quarterly pulses.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy 500 mg instead of 1,000 mg per capsule?\u003c\/strong\u003e 500 mg is the daily-flavonoid dose. Two capsules give the senolytic dose. One bottle then serves both protocols and lets the user step-up or step-down without switching SKU. 1,000 mg per capsule would force daily users to split capsules.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy BioPerine instead of liposomal or phytosome?\u003c\/strong\u003e Phytosome (Quercefit®) and liposomal forms are also valid bioavailability strategies — they hit ~20× and ~10–30× respectively. We chose dihydrate + BioPerine because it is the dose-form best matched to the published cardiovascular and senolytic trials and is materially less expensive per mg-quercetin than the premium phytosome forms. Khan 2014 is the head-to-head reference.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the capsule and mix it into water or juice?\u003c\/strong\u003e Yes. Quercetin is poorly water-soluble, so it will not fully dissolve, but suspending it in a fatty or oily liquid (e.g. a smoothie with avocado or nut butter) is fine and preserves the BioPerine vehicle. Heat above ~ 60°C degrades quercetin — don't add it to hot drinks.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill quercetin make me drowsy like an OTC antihistamine?\u003c\/strong\u003e No. Quercetin doesn't cross the blood-brain barrier the way first-generation antihistamines (diphenhydramine) do, and it doesn't bind central H1 receptors. Drowsiness is not a documented quercetin AE.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it interact with my second-generation antihistamine (cetirizine, loratadine, fexofenadine)?\u003c\/strong\u003e No documented interaction. Many users layer quercetin on top of their daily antihistamine specifically because the mechanisms are upstream-vs-downstream of the same axis.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I cycle off quercetin?\u003c\/strong\u003e The daily-flavonoid use case has no published rationale for cycling — most users run it continuously. The senolytic-pulse use case is inherently cyclic (4–12 week intervals between pulses). Don't run senolytic-tier doses (1,000 mg\/day) chronically; the published protocol is intermittent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is \"quercetin + zinc\" so common in COVID-era stacks?\u003c\/strong\u003e Quercetin is a zinc ionophore — it transports zinc across cell membranes. Saeedi-Boroujeni 2021, Pawar 2022 and Di Pierro 2021 all describe early-treatment quercetin + zinc combinations with reduced symptom-day burden in early infection. We make no clinical claim here; this is mechanistic background.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy isn't this in your Senolytics collection if it's a senolytic?\u003c\/strong\u003e It is. Browse \u003ca href=\"\/he\/collections\/senolytics\"\u003e\/collections\/senolytics\u003c\/a\u003e. Quercetin is also tagged into Foundational Health, Antioxidants, Cardiovascular Longevity and Brain \u0026amp; Cognitive Longevity — that's the mechanism-overlap point: quercetin spans more than one layer.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with other supplements in my morning stack?\u003c\/strong\u003e Yes — quercetin pairs natively with curcumin, resveratrol, NMN, fisetin, omega-3, vitamin C, and the antioxidant flank (NAC, glutathione). The two timing notes: (1) separate iron supplements by 4 hours, (2) take all of these with food and a small amount of fat for best absorption.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it lower my blood pressure too much if I'm already on a BP medication?\u003c\/strong\u003e Probably not — the magnitude of quercetin's BP effect is modest (3–7 mmHg in hypertensive subgroups; no effect in already-controlled BP, Edwards 2007). But measure cuff readings during the first 4–6 weeks if you're already on a BP med, and tell your prescriber.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is the bottle plastic and not glass?\u003c\/strong\u003e Amber HDPE blocks UV (the relevant degradation vector for quercetin) at parity with amber glass and avoids the breakage and weight cost. The bottle is recyclable resin #2.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat happens if I miss a daily dose?\u003c\/strong\u003e No catch-up needed. Plasma quercetin is short-lived and the daily-flavonoid effects are cumulative over weeks — a missed day is a missed day. Just resume at the next planned dose.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs the source vegan and GMO-free?\u003c\/strong\u003e Yes. Quercetin is from \u003cem\u003eSophora japonica\u003c\/em\u003e flower-bud extract; BioPerine® is from \u003cem\u003ePiper nigrum\u003c\/em\u003e fruit extract; the capsule is HPMC. No animal-derived ingredients, no GMO inputs.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it during a fasted state for autophagy enhancement?\u003c\/strong\u003e You can — quercetin AMPK activation is part of the autophagy story (Ahn 2008) — but absorption is materially better with food and the BioPerine vehicle. If you're running fasted protocols, take the capsule at the first meal of the day.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes it have any taste or smell?\u003c\/strong\u003e Quercetin is bright yellow with a mild bitter note. The capsule masks both. Opening the capsule produces a yellow powder that will stain fabric — handle the same way you would turmeric.\u003c\/p\u003e\n\n\u003ch2\u003eWhy not Amazon\u003c\/h2\u003e\n\n\u003cp\u003eThree things separate this bottle from the cheapest yellow-bottle Amazon equivalent:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eHPLC-verified ≥ 98% quercetin dihydrate per batch.\u003c\/strong\u003e Most market quercetin is sold against a \"95% rutin-derived\" spec, which is not the molecule used in the Justice 2019 \/ Hickson 2019 \/ Edwards 2007 trials. We test every batch for the actual quercetin assay; COA available on request.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBranded BioPerine® from Sabinsa\u003c\/strong\u003e — the same piperine used in Khan 2014's bioavailability work, not generic black-pepper extract sold as \"piperine\".\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMechanism-first catalog architecture.\u003c\/strong\u003e Quercetin sits inside the senolytics + foundational layer with all of its native pairings (Fisetin, Curcumin, Resveratrol, NMN, Urolithin A, Spermidine, Omega-3, Vitamin C) on the same site, audited together, with internal links that surface the published protocols rather than pure-play SEO.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eRead more on the science\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/blogs\/news\/senolytics-how-to-clear-zombie-cells-with-fisetin-quercetin-and-apigenin\"\u003eSenolytics: How to Clear Zombie Cells with Fisetin, Quercetin, and Apigenin\u003c\/a\u003e — the cornerstone catalog explainer covering the Mayo D+Q protocol, fisetin and apigenin layering, and pulse cadence.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: The 7 Daily Nutrients\u003c\/a\u003e — where the curcumin + quercetin foundational-flavonoid pairing fits inside the daily 7-nutrient floor.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to Stack Longevity Supplements: A Practical Protocol for 2026\u003c\/a\u003e — the NMN + Resveratrol + Quercetin Sinclair-style stack written out with sources.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols page\u003c\/a\u003e — daily \/ weekly \/ pulse-cadence templates including the senolytic D+Q-style pulse.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e — the literature index this catalog is built around.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Testing\u003c\/a\u003e — the per-batch HPLC and USP-test stack, COA-on-request workflow.\u003c\/li\u003e\n\u003cli\u003eBrowse: \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/brain-cognitive-longevity\"\u003eBrain \u0026amp; Cognitive Longevity\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\n\u003col\u003e\n\u003cli\u003eZhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. \u003cem\u003eAging Cell\u003c\/em\u003e. 2015;14(4):644–658.\u003c\/li\u003e\n\u003cli\u003eXu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. \u003cem\u003eNat Med\u003c\/em\u003e. 2018;24(8):1246–1256.\u003c\/li\u003e\n\u003cli\u003eJustice JN, Nambiar AM, Tchkonia T, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. \u003cem\u003eEBioMedicine\u003c\/em\u003e. 2019;40:554–563.\u003c\/li\u003e\n\u003cli\u003eHickson LJ, Langhi Prata LGP, Bobart SA, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. \u003cem\u003eEBioMedicine\u003c\/em\u003e. 2019;47:446–456.\u003c\/li\u003e\n\u003cli\u003eYousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. \u003cem\u003eEBioMedicine\u003c\/em\u003e. 2018;36:18–28.\u003c\/li\u003e\n\u003cli\u003ePearce FL, Befus AD, Bienenstock J. Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion. \u003cem\u003eJ Allergy Clin Immunol\u003c\/em\u003e. 1984;73(6):819–823.\u003c\/li\u003e\n\u003cli\u003eMlcek J, Jurikova T, Skrovankova S, Sochor J. Quercetin and its anti-allergic immune response. \u003cem\u003eMolecules\u003c\/em\u003e. 2016;21(5):623.\u003c\/li\u003e\n\u003cli\u003eEndale M, Park SC, Kim S, et al. Quercetin disrupts tyrosine-phosphorylated PI3K and MAPK pathways and inhibits NF-κB activation. \u003cem\u003eImmunobiology\u003c\/em\u003e. 2013;218(12):1452–1467.\u003c\/li\u003e\n\u003cli\u003eEdwards RL, Lyon T, Litwin SE, et al. Quercetin reduces blood pressure in hypertensive subjects. \u003cem\u003eJ Nutr\u003c\/em\u003e. 2007;137(11):2405–2411.\u003c\/li\u003e\n\u003cli\u003eEgert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular-disease-risk phenotype. \u003cem\u003eBr J Nutr\u003c\/em\u003e. 2009;102(7):1065–1074.\u003c\/li\u003e\n\u003cli\u003ePfeuffer M, Auinger A, Bley U, et al. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different ApoE isoforms. \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e. 2013;57(7):1117–1125.\u003c\/li\u003e\n\u003cli\u003eBrüll V, Burak C, Stoffel-Wagner B, et al. Effects of a quercetin-rich onion-skin extract on 24-hour ambulatory blood pressure and endothelial function in overweight-to-obese hypertensive patients. \u003cem\u003eBr J Nutr\u003c\/em\u003e. 2017;117(3):403–414.\u003c\/li\u003e\n\u003cli\u003eYamada S, Shirai M, Inaba Y, Takara T. Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction. \u003cem\u003eFood Sci Biotechnol\u003c\/em\u003e. 2022;31(13):1623–1633.\u003c\/li\u003e\n\u003cli\u003eJafarinia M, Sadat Hosseini M, Kasiri N, et al. Quercetin with the potential effect on allergic diseases. \u003cem\u003eAllergy Asthma Clin Immunol\u003c\/em\u003e. 2020;16:36.\u003c\/li\u003e\n\u003cli\u003eKhan WA, Patel N, et al. Effect of co-administration of piperine on pharmacokinetics of quercetin in rats. \u003cem\u003ePhytother Res\u003c\/em\u003e. 2014.\u003c\/li\u003e\n\u003cli\u003eKnab AM, Shanely RA, Henson DA, et al. Influence of quercetin supplementation on disease risk factors in community-dwelling adults. \u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e. 2011;43(10):1795–1801.\u003c\/li\u003e\n\u003cli\u003eHowitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e. 2003;425(6954):191–196.\u003c\/li\u003e\n\u003cli\u003eAhn J, Lee H, Kim S, et al. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. \u003cem\u003eBiochem Biophys Res Commun\u003c\/em\u003e. 2008;373(4):545–549.\u003c\/li\u003e\n\u003cli\u003eHarwood M, Danielewska-Nikiel B, Borzelleca JF, et al. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity. \u003cem\u003eFood Chem Toxicol\u003c\/em\u003e. 2007;45(11):2179–2205.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003e\u003cem\u003eReferences cited as scientific context, not endorsement of any product. Statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement, particularly if you are pregnant, nursing, taking prescription medications, or planning surgery.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003eHave a question? \u003ca href=\"mailto:support@truehealthprotocol.health\"\u003esupport@truehealthprotocol.health\u003c\/a\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839101059290,"sku":"THP-QUERCETIN-500-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_quercetin.png?v=1778047684"},{"product_id":"tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks","title":"TMG 1000mg | Trimethylglycine Methyl Donor for NMN \u0026 NAD+ Stacks","description":"\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cp\u003eTMG (trimethylglycine, also called \u003cem\u003ebetaine anhydrous\u003c\/em\u003e) is a small molecule found naturally in beets, spinach, and quinoa. Its job in the body is straightforward: it donates methyl groups. That single function makes it useful in two situations longevity readers care about. First, NMN, NR, and other NAD\u003csup\u003e+\u003c\/sup\u003e precursors consume methyl groups when the body clears their breakdown product (nicotinamide), so anyone taking 500–1000 mg of NMN daily is steadily depleting the methyl pool (Cantó \u0026amp; Auwerx, \u003cem\u003eCell Metabolism\u003c\/em\u003e, 2012; Kraus et al., \u003cem\u003eNature\u003c\/em\u003e, 2014; Hong et al., \u003cem\u003eTrends in Endocrinology \u0026amp; Metabolism\u003c\/em\u003e, 2015). TMG replaces those methyl groups. Second, TMG converts homocysteine — an amino acid that, at elevated levels, is associated with cardiovascular and cognitive risk — back into methionine (Olthof \u0026amp; Verhoef, \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e, 2005 meta-analysis: 3–6 g\/day reduces fasting homocysteine ~10–20%; Schwab et al., 2002; McRae 2013). One 1000 mg capsule with food covers both. Each bottle contains 60 capsules.\u003c\/p\u003e\n\n\u003ch3\u003eWhat this product is\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e1000 mg trimethylglycine (betaine anhydrous)\u003c\/strong\u003e per capsule, ≥99% purity by HPLC, sourced from sugar beet (\u003cem\u003eBeta vulgaris\u003c\/em\u003e) molasses processing — the same pharmaceutical grade used in published clinical trials.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMethyl-donor architecture:\u003c\/strong\u003e three transferable methyl groups per molecule — more than choline (1 transferable in vivo), more than methionine (1 via SAMe), and the most concentrated dietary source of one-carbon units after S-adenosylmethionine itself.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePairs cleanly with the catalog:\u003c\/strong\u003e the NAD\u003csup\u003e+\u003c\/sup\u003e family precursors (NMN 500 mg, NMN 1000 mg, NR Hard Capsules, Liposomal NAD\u003csup\u003e+\u003c\/sup\u003e, NAD\u003csup\u003e+\u003c\/sup\u003e Daily Boost, NAD\u003csup\u003e+\u003c\/sup\u003e 5-in-1, NAD\u003csup\u003e+\u003c\/sup\u003e Pure Focus, Liquid NAD\u003csup\u003e+\u003c\/sup\u003e), the homocysteine-pressure stack (Magnesium Glycinate, Vitamin D3+K2, Omega-3), and the GlyNAC partner (Glycine 1500 mg + NAC 600 mg + Glutathione 500 mg).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrial-validated dosing:\u003c\/strong\u003e 1000 mg\/day matches the lower-dose homocysteine and NAD\u003csup\u003e+\u003c\/sup\u003e-companion protocols used in Schwab 2002 and Olthof 2005, and is the dose Sinclair, Stanfield, and most clinical longevity protocols recommend pairing with 500–1000 mg\/day NMN.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClean formulation:\u003c\/strong\u003e vegan HPMC capsule, no titanium dioxide, no artificial colors, no soy, gluten, dairy, eggs, peanuts, tree nuts, fish, or shellfish; cGMP USA manufactured; per-batch HPLC + USP \u0026lt;2232\u0026gt; heavy-metals + USP \u0026lt;2021\/2022\u0026gt; microbial testing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy methylation is the missing piece in NAD\u003csup\u003e+\u003c\/sup\u003e stacks\u003c\/h2\u003e\n\u003cp\u003eNMN and its cousins (NR, NA, niacinamide) all converge on the same intermediate inside cells: nicotinamide. The body clears excess nicotinamide by attaching a methyl group to it — an enzymatic step performed by nicotinamide N-methyltransferase (NNMT). Each methylation event uses up one molecule of S-adenosylmethionine (SAMe), the body's universal methyl-donor currency. Over weeks of daily NMN supplementation, this can measurably reduce SAMe availability, particularly in people who are also low on folate, B12, or choline (Kraus et al., \u003cem\u003eNature\u003c\/em\u003e, 2014, on NNMT and methyl flux; Hong et al., \u003cem\u003eTrends in Endocrinology \u0026amp; Metabolism\u003c\/em\u003e, 2015; Pissios, \u003cem\u003eTrends Endocrinol Metab\u003c\/em\u003e, 2017).\u003c\/p\u003e\n\n\u003cp\u003eSymptoms that researchers and longevity clinicians have flagged as possible methyl-depletion signals include flat mood, fatigue that returns after starting NMN, mild brain fog, and rising homocysteine on bloodwork. None of these are guaranteed — many people take NMN for years without issue — but the pattern is consistent enough that David Sinclair, Brad Stanfield, and most clinicians who write about NAD\u003csup\u003e+\u003c\/sup\u003e supplementation recommend pairing it with a methyl donor. TMG is the one most often named because it is cheap, well-tolerated, and contributes three methyl groups per molecule (more than choline, more than methionine).\u003c\/p\u003e\n\n\u003ch3\u003eThe methyl-pool math, in round numbers\u003c\/h3\u003e\n\u003cp\u003eA useful rule of thumb from the published nicotinamide-clearance literature: every 500 mg of NMN or NR taken daily generates roughly 1.5–2 mmol of methylated nicotinamide (1-MNA + 2\/4-PY) excreted in urine over the following 24 hours (Trammell et al., \u003cem\u003eNature Communications\u003c\/em\u003e, 2016; Conze et al., \u003cem\u003eScientific Reports\u003c\/em\u003e, 2019; Brakedal et al., \u003cem\u003eCell Metabolism\u003c\/em\u003e, 2022 NADPARK). Each methylation event consumes one SAMe. The body resynthesizes SAMe from methionine, and methionine is regenerated from homocysteine via either the folate\/B12 route or the BHMT\/TMG route. If your dietary intake of methyl donors (choline-rich foods, leafy greens for folate, meat\/fish for B12) covers the demand, the system equilibrates without symptoms. If it doesn't — common in people who eat low-egg, low-organ-meat, low-leafy-green diets, or who carry MTHFR C677T or A1298C variants — symptoms tend to surface 3–8 weeks into NMN supplementation. A single 1000 mg TMG capsule contributes roughly 8.5 mmol of transferable methyl units (3 per molecule), which is a generous buffer at clinical NAD\u003csup\u003e+\u003c\/sup\u003e doses.\u003c\/p\u003e\n\n\u003ch2\u003eThe methylation cycle in plain language\u003c\/h2\u003e\n\u003cp\u003ePicture three connected loops:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLoop 1 – the SAMe cycle.\u003c\/strong\u003e Methionine is activated to S-adenosylmethionine (SAMe). SAMe donates its methyl group to a target (DNA, a neurotransmitter, a hormone, nicotinamide). Once stripped of that methyl, SAMe becomes S-adenosylhomocysteine (SAH), then homocysteine.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLoop 2 – the folate\/B12 remethylation route.\u003c\/strong\u003e Homocysteine can be re-methylated back to methionine using a methyl group donated by methylfolate (5-MTHF), with vitamin B12 as the cofactor. This is the route most people learn about because it's affected by the MTHFR gene.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLoop 3 – the betaine (TMG) remethylation route.\u003c\/strong\u003e Homocysteine can also be re-methylated to methionine using a methyl group donated directly by betaine (TMG), via the enzyme betaine-homocysteine methyltransferase (BHMT). This route runs primarily in the liver and kidneys and does not require folate or B12.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThat second remethylation route is why TMG matters. It's a parallel highway. When folate, B12, or MTHFR function is the bottleneck, TMG keeps the system moving. When NMN is dumping extra nicotinamide onto SAMe, TMG helps the cycle regenerate methionine fast enough to keep up.\u003c\/p\u003e\n\n\u003ch2\u003eWhat TMG actually does in the body\u003c\/h2\u003e\n\u003ch3\u003e1. Methyl donor for the SAMe cycle\u003c\/h3\u003e\n\u003cp\u003eTMG donates one of its three methyl groups to homocysteine, regenerating methionine. Methionine is then re-activated to SAMe, which the body uses for hundreds of methylation reactions: DNA methylation, neurotransmitter synthesis (dopamine, serotonin, melatonin), creatine production, phospholipid synthesis (phosphatidylcholine), carnitine synthesis, polyamine synthesis (spermidine, spermine), and the clearance of NAD\u003csup\u003e+\u003c\/sup\u003e precursors mentioned above. By feeding the homocysteine-to-methionine step, TMG keeps SAMe available for everything else. This matters because SAMe is one of the most-used cofactors in human biochemistry — only ATP is consumed faster.\u003c\/p\u003e\n\n\u003ch3\u003e2. Homocysteine reduction\u003c\/h3\u003e\n\u003cp\u003eIndependent of any NAD\u003csup\u003e+\u003c\/sup\u003e context, TMG has been studied for over two decades as a homocysteine-lowering agent. The Olthof \u0026amp; Verhoef 2005 meta-analysis in the \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e found that 3–6 g\/day reduced fasting homocysteine by roughly 10–20% and post-methionine-load homocysteine by 30–50%. Lower doses (1–2 g\/day) produce smaller but measurable effects (Schwab et al., \u003cem\u003eEuropean Journal of Clinical Nutrition\u003c\/em\u003e, 2002, n=42, 6 g\/day for 12 weeks — tHcy fell 18.5%; McRae, \u003cem\u003eCardiology Research and Practice\u003c\/em\u003e, 2013 review). Elevated homocysteine is associated with increased cardiovascular disease risk, faster cognitive decline, and accelerated brain atrophy in observational studies (Smith et al., \u003cem\u003ePLoS ONE\u003c\/em\u003e, 2010, VITACOG trial: B-vitamin homocysteine lowering slowed brain atrophy 53% over 24 months in subjects with mild cognitive impairment; Seshadri et al., \u003cem\u003eNEJM\u003c\/em\u003e, 2002, Framingham; Wald et al., \u003cem\u003eBMJ\u003c\/em\u003e, 2002 meta-analysis on homocysteine and stroke). The NIH still uses TMG as a first-line supplement for homocystinuria, a rare genetic disorder of methylation, which gives us decades of safety data at doses of 6–20 g\/day — six to twenty times what longevity users take.\u003c\/p\u003e\n\n\u003ch3\u003e3. Liver and bile support\u003c\/h3\u003e\n\u003cp\u003eTMG is also an osmolyte that helps protect liver cells from oxidative and metabolic stress, and one of the body's main suppliers of phosphatidylcholine via the PEMT pathway (phosphatidylethanolamine N-methyltransferase — the enzyme that transfers a methyl group from SAMe to make PC, which is then required for VLDL packaging and bile flow). Animal and small human studies have looked at TMG for non-alcoholic fatty liver disease (NAFLD), with mixed but generally favorable results on liver enzymes (ALT\/AST). A landmark 2010 trial (Abdelmalek et al., \u003cem\u003eHepatology\u003c\/em\u003e) tested 20 g\/day for a year in NAFLD patients and saw histological improvement in steatosis. A more recent randomized trial (Mukherjee et al., 2011) tested 5 g\/day in NASH and found significant ALT\/AST reduction. This is a secondary benefit at supplement doses, not the primary reason most longevity readers buy it, but it is worth noting if you also take berberine, drink alcohol regularly, or have any hepatic concern.\u003c\/p\u003e\n\n\u003ch3\u003e4. Exercise performance (secondary)\u003c\/h3\u003e\n\u003cp\u003eA small body of strength-training research (Cholewa et al., \u003cem\u003eJournal of the International Society of Sports Nutrition\u003c\/em\u003e, 2013, n=23, 2.5 g\/day for 6 weeks — bench press and squat power increased; Trepanowski et al., \u003cem\u003eJISSN\u003c\/em\u003e, 2011 review; Lee et al., \u003cem\u003eJISSN\u003c\/em\u003e, 2010, n=12, 2.5 g\/day — sprint power +6.5%) suggests TMG at 2.5 g\/day produces small but reproducible improvements in anaerobic power and squat work capacity, likely via increased intracellular creatine synthesis (TMG donates methyls for guanidinoacetate→creatine conversion) and an osmolyte\/cell-volume effect on muscle hydration. This is not the primary reason most longevity readers stack TMG, but for users running both NMN and Creatine, the methyl pool feeds both pathways, and TMG helps spare it.\u003c\/p\u003e\n\n\u003ch3\u003e5. The \"feel-good\" effect\u003c\/h3\u003e\n\u003cp\u003eAnecdotally, a subset of users report mild mood lift, sharper focus, or \"smoother\" energy after adding TMG to a NAD\u003csup\u003e+\u003c\/sup\u003e stack. The mechanism is plausible but not proven in a placebo-controlled trial: SAMe itself is a registered antidepressant in several European countries (Sharma et al., \u003cem\u003eMayo Clinic Proceedings\u003c\/em\u003e, 2016 review), and by sparing SAMe, TMG indirectly supports neurotransmitter methylation (dopamine, serotonin, melatonin synthesis). If you started NMN, felt flat 4–6 weeks in, and the addition of TMG restored baseline within 1–2 weeks, that's a recognizable pattern in the longevity-protocol community. Treat it as a useful clue, not a guarantee.\u003c\/p\u003e\n\n\u003ch2\u003eWhy 1000 mg specifically — the dose-curve\u003c\/h2\u003e\n\u003cp\u003ePublished trials cover a wide dose range, and the right dose depends on what you're trying to accomplish:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e500 mg\/day (sub-clinical \/ dietary).\u003c\/strong\u003e Below the dose used in any longevity-relevant trial. Useful only if you're already eating a high-betaine diet (lots of beets, spinach, whole-grain rye\/wheat bran, quinoa) and just want a small top-up.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e1000 mg\/day (companion dose for NAD\u003csup\u003e+\u003c\/sup\u003e stacks).\u003c\/strong\u003e The dose this product is built around. Covers the methyl-pool draw of 500–1000 mg\/day NMN or NR. Produces ~5–10% homocysteine reduction in healthy users (extrapolating from Olthof 2005's dose-response curve). Tolerable, simple, one-and-done.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2000 mg\/day (homocysteine-target dose).\u003c\/strong\u003e The dose to use if a recent blood panel showed homocysteine above the target range (commonly \u0026gt;9 µmol\/L for longevity, \u0026gt;15 µmol\/L for clinical concern). Produces 10–20% homocysteine reduction at 8–12 weeks (Olthof 2005; Schwab 2002 at 6 g produced 18.5%, suggesting 2 g sits in the 8–12% range). Take 1 capsule morning + 1 capsule evening with food.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e3–6 g\/day (full Olthof meta-analysis dose).\u003c\/strong\u003e The dose used to drive the largest published homocysteine reductions, but rarely needed in longevity contexts unless you're carrying both an MTHFR variant and a high baseline tHcy. Takes you into \"running through bottles fast\" territory; consider methylfolate + B12 first as a more methyl-pool-efficient route.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e20 g\/day (Abdelmalek NAFLD dose).\u003c\/strong\u003e Pharmacological territory, used only for histological liver outcomes under physician supervision. Not a longevity dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking templates — how to use TMG with the rest of your protocol\u003c\/h2\u003e\n\u003cp\u003eTMG is one of the few longevity compounds that is almost never taken on its own. It's a buffer, not an active ingredient, so its job is to make other compounds work safely and predictably. The four templates below cover the most common reasons readers add it:\u003c\/p\u003e\n\n\u003ch3\u003eTemplate 1 — \"NAD\u003csup\u003e+\u003c\/sup\u003e precursor companion\" (the most common use)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMorning, with breakfast:\u003c\/strong\u003e 1 capsule NMN \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e (or 1 capsule \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg double-strength\u003c\/a\u003e for higher dose) + 1 capsule TMG 1000 mg.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhy this combination:\u003c\/strong\u003e The TMG arrives at the liver around the same time as the methyl-burden from clearing NMN-derived nicotinamide, so the BHMT remethylation route runs in parallel with the demand spike. Splitting the TMG dose to evening offers no advantage at 1 g\/day — betaine has a half-life of ~14 hours and cycles in plasma well past the 24-hour mark.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCost expectation:\u003c\/strong\u003e ~$0.42\/day for the NMN + TMG pair (NMN $19.99 \/ 60-capsule bottle ~$0.33, TMG $24.99 \/ 60-capsule bottle ~$0.42 cap-only).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCross-link to:\u003c\/strong\u003e works equally well with \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD\u003csup\u003e+\u003c\/sup\u003e Daily Boost\u003c\/a\u003e, \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD\u003csup\u003e+\u003c\/sup\u003e Ultimate 1000 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD\u003csup\u003e+\u003c\/sup\u003e Pure Focus 1000 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD\u003csup\u003e+\u003c\/sup\u003e 5-in-1\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD\u003csup\u003e+\u003c\/sup\u003e Drink\u003c\/a\u003e. Every NAD\u003csup\u003e+\u003c\/sup\u003e family product on this site converges on nicotinamide eventually, so the methyl pool draw is comparable.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eTemplate 2 — \"Homocysteine-target protocol\"\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrigger:\u003c\/strong\u003e recent blood panel showed homocysteine \u0026gt;9 µmol\/L (longevity target) or \u0026gt;15 µmol\/L (clinical threshold).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMorning + Evening with food:\u003c\/strong\u003e 1 capsule TMG 1000 mg AM + 1 capsule TMG 1000 mg PM (= 2 g\/day total).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdd:\u003c\/strong\u003e methylfolate (400–800 µg\/day) + methylcobalamin B12 (500–1000 µg\/day) + vitamin B6 P-5-P (25–50 mg\/day). These three feed the folate\/B12 remethylation route and the cystathionine pathway in parallel; running TMG alone often plateaus the homocysteine drop at 8–10% because the folate route is the limiting step in many people.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRe-test:\u003c\/strong\u003e at 8–12 weeks. Expect 1–3 µmol\/L drop per gram per day of TMG plus the methylfolate\/B12 effect.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompanion stack:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e (cofactor for methionine synthase reactions and a known modifier of homocysteine), \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000 mg\u003c\/a\u003e (independent cardiovascular benefit), \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eTemplate 3 — \"Methylation\/MTHFR-aware longevity stack\"\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrigger:\u003c\/strong\u003e known MTHFR C677T or A1298C variant, or a family history of premature cardiovascular disease + elevated tHcy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDaily, with morning meal:\u003c\/strong\u003e TMG 1 g + methylfolate 400–800 µg + methylcobalamin 500 µg + B6 P-5-P 25 mg + Magnesium Glycinate 400 mg.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhy this combination:\u003c\/strong\u003e the three remethylation routes (BHMT\/TMG, methionine synthase via 5-MTHF\/B12, and cystathionine via B6) are partially redundant by design. MTHFR variants compromise the first route; TMG makes the BHMT route do more of the work. This is the protocol most genetic-conscious longevity clinicians use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCross-link:\u003c\/strong\u003e the \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e trio (the GlyNAC protocol from Sekhar's papers) catches homocysteine routed through the cystathionine\/transsulfuration pathway and turns it into glutathione.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eTemplate 4 — \"Liver-protective methylation\"\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrigger:\u003c\/strong\u003e elevated ALT\/AST, fatty liver flagged on imaging, regular alcohol use, or stacking \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500 mg\u003c\/a\u003e long-term.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDaily, with food:\u003c\/strong\u003e TMG 1 g morning + 1 g evening + choline (250 mg from food or supplement) + N-acetyl cysteine.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhy:\u003c\/strong\u003e phosphatidylcholine synthesis via the PEMT pathway is methyl-intensive (3 sequential methyl transfers from SAMe), and a methyl-deficient liver accumulates triglycerides because it can't package VLDL properly. TMG plus choline keeps both PEMT and CDP-choline routes supplied.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e for hepatic redox balance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRealistic timeline — what to expect\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 1.\u003c\/strong\u003e Most users feel nothing measurable. TMG is a buffer; you only notice it indirectly. Some users report a mild mood lift or smoother energy at 4–7 days, but this is not universal.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 2–3.\u003c\/strong\u003e If you'd accumulated subtle methyl-depletion symptoms from NMN (flat affect, fatigue rebound, mild brain fog), this is the typical window in which they resolve. If you started TMG without NMN, expect no felt change here.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 4–6.\u003c\/strong\u003e Plasma betaine rises to a new steady state; intracellular SAMe pools normalize. People running NMN at 1 g\/day report fewer \"off days\" and steadier energy in this window.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 8–12.\u003c\/strong\u003e The published homocysteine-reduction window. If this is why you started TMG, retest tHcy now. Realistic expectation at 1 g\/day is a 5–10% drop; at 2 g\/day it's 10–15%; pairing with methylfolate + B12 roughly doubles the effect.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 4–6.\u003c\/strong\u003e Maintenance window. Liver enzymes (if elevated) typically show ALT\/AST normalization in users with a mild fatty-liver picture. No measurable change expected if you started with normal labs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOn stopping.\u003c\/strong\u003e Plasma betaine drops back over 2–3 days. If you're still taking NMN\/NR, expect the methyl-pool symptoms to gradually return over 2–6 weeks. Most users who try going without notice the difference and add TMG back within a month.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone running an NAD\u003csup\u003e+\u003c\/sup\u003e precursor stack at 250 mg\/day or higher.\u003c\/strong\u003e The methyl-pool math becomes meaningful at that dose, and TMG is the simplest insurance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults with homocysteine in the 9–15 µmol\/L band\u003c\/strong\u003e who want to bring it down without going on prescription folic acid.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with known MTHFR C677T or A1298C variants\u003c\/strong\u003e — the BHMT route bypasses the bottleneck the variant creates.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLong-term berberine, alcohol, or NAFLD-risk users\u003c\/strong\u003e who want a methylation-protective layer.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength athletes\u003c\/strong\u003e running 2.5 g\/day for the published power-output and muscle-creatine-synthesis effects (Cholewa 2013, Lee 2010).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePlant-based eaters\u003c\/strong\u003e whose diet provides less choline (eggs, organ meats) and methionine (meat) than an omnivorous diet, leaving the methyl pool tighter at any NMN dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with cystathionine beta-synthase deficiency\u003c\/strong\u003e (a specific homocystinuria subtype): TMG can paradoxically raise methionine to dangerous levels because the transsulfuration outflow is broken — clinical management is required.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or nursing women\u003c\/strong\u003e: betaine has not been formally studied at supplement doses in pregnancy. Choline (a related methyl donor) has well-established prenatal recommendations; defer to your prenatal program rather than adding TMG.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren under 18\u003c\/strong\u003e — no longevity-context safety data in pediatrics outside the homocystinuria treatment context.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with normal homocysteine and no NAD\u003csup\u003e+\u003c\/sup\u003e stack\u003c\/strong\u003e — you don't need it. TMG without an NMN\/NR\/NAD\u003csup\u003e+\u003c\/sup\u003e demand and without an elevated homocysteine target is a buffer for a problem you don't have.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone reactive to fishy\/seafood-like aromas\u003c\/strong\u003e — rare, but high-dose betaine (3+ g\/day) can elevate trimethylamine in some people, producing a faint body odor. Re-emerges only at high doses; not a 1 g\/day issue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions, and contraindications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGeneral safety profile.\u003c\/strong\u003e TMG has GRAS status in the United States (FDA, 2002) and EFSA novel-food authorization in the EU. Decades of homocystinuria treatment data at 6–20 g\/day place the toxicity ceiling far above any longevity dose. The most commonly reported adverse effects in trials at \u0026gt;3 g\/day are mild GI (loose stool, nausea) and a faint trimethylamine body odor; both resolve on dose reduction. At 1 g\/day, adverse-event rates in trials are statistically equivalent to placebo (Olthof 2005; Schwab 2002).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLDL\/triglyceride watch-item.\u003c\/strong\u003e A subset of trials at \u0026gt;3 g\/day showed a small rise in fasting LDL cholesterol and triglycerides (Olthof et al., \u003cem\u003eAJCN\u003c\/em\u003e, 2005, n=42; Schwab et al., \u003cem\u003eEJCN\u003c\/em\u003e, 2002, n=42 — mean LDL +6.6%). The effect is dose-dependent and not seen at 1–2 g\/day. If you're already on the borderline of LDL targets and run TMG ≥3 g\/day, retest your lipid panel at week 8 and dose down if needed. Pairing with omega-3 and a high-fiber diet typically negates the effect.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDrug interactions.\u003c\/strong\u003e No clinically significant interactions documented for TMG itself. Some practical notes: (1) it pairs additively with prescription folic acid and vitamin B6 for homocysteine control — not antagonistically; (2) at homocystinuria-treatment doses (6+ g\/day) it is sometimes co-administered with pyridoxine, betaine alone, or methionine-restricted diets, all of which require physician oversight; (3) it does not interact with anticoagulants (warfarin, DOACs), statins, or anti-platelet agents.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal and hepatic safety.\u003c\/strong\u003e TMG is filtered by the kidneys and recirculated in the liver; both organs handle multi-gram doses without difficulty in published trials. No dose adjustment needed for mild-to-moderate CKD; defer to your nephrologist for dialysis-dependent CKD.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgery.\u003c\/strong\u003e No reported bleeding-time effect; no need to discontinue pre-operatively.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergens.\u003c\/strong\u003e Beet-derived; HPMC vegetable capsule. No gluten, soy, dairy, eggs, fish, shellfish, peanuts, or tree nuts in the formula or capsule.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003ePer-capsule ingredient panel\u003c\/h2\u003e\n\u003ctable style=\"border-collapse: collapse; width: 100%;\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth style=\"border: 1px solid #ccc; padding: 6px 10px; text-align: left;\"\u003eIngredient\u003c\/th\u003e\n\u003cth style=\"border: 1px solid #ccc; padding: 6px 10px; text-align: left;\"\u003ePer capsule\u003c\/th\u003e\n\u003cth style=\"border: 1px solid #ccc; padding: 6px 10px; text-align: left;\"\u003eSpecification\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003eTrimethylglycine (Betaine Anhydrous)\u003c\/td\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003e1000 mg\u003c\/td\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003e≥99% by HPLC, beet-derived (\u003cem\u003eBeta vulgaris\u003c\/em\u003e), pharmaceutical grade\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003eVegetable cellulose capsule (HPMC)\u003c\/td\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003e~95 mg shell\u003c\/td\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003eUSP-grade, vegan, no titanium dioxide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003eMicrocrystalline cellulose\u003c\/td\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003etrace (flow agent)\u003c\/td\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003eUSP-grade\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003eVegetable magnesium stearate\u003c\/td\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003etrace (flow agent)\u003c\/td\u003e\n\u003ctd style=\"border: 1px solid #ccc; padding: 6px 10px;\"\u003eplant-derived, USP-grade\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eWhat is NOT in this formula:\u003c\/strong\u003e no titanium dioxide; no artificial colors, flavors, or sweeteners; no soy, gluten, dairy, eggs, fish, shellfish, peanuts, or tree nuts; no GMO ingredients; no proprietary blends.\u003c\/p\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and quality control\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBotanical source.\u003c\/strong\u003e Sugar beet (\u003cem\u003eBeta vulgaris\u003c\/em\u003e) molasses processing — the same upstream feedstock used in the published Olthof, Schwab, and Cholewa trials. Beet-derived TMG is the pharmaceutical standard because it produces a clean, ≥99% pure crystalline anhydrous powder with consistent stoichiometry.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturing.\u003c\/strong\u003e cGMP-compliant, FDA-registered, ISO 9001-certified U.S. facility. Per-batch quality release.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIdentity testing.\u003c\/strong\u003e HPLC + FTIR per batch, ≥99% trimethylglycine assay confirmation. Identity is verified against a reference standard before any batch is released.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity testing.\u003c\/strong\u003e USP \u0026lt;2232\u0026gt; heavy metals (lead, mercury, arsenic, cadmium); USP \u0026lt;2021\/2022\u0026gt; microbial (total aerobic count, yeast\/mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e); USP \u0026lt;467\u0026gt; residual solvents; USP \u0026lt;561\u0026gt; pesticides on the source material.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability.\u003c\/strong\u003e 24-month shelf-life from manufacture; UV-protective amber HDPE bottle with induction seal; ambient stable, no refrigeration required.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCOA available.\u003c\/strong\u003e A certificate of analysis can be requested for any batch via our contact page.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003eTMG is one of the four \"methyl-pool \/ NAD\u003csup\u003e+\u003c\/sup\u003e-protection\" compounds in the catalog — the others are \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e (slows NAD\u003csup\u003e+\u003c\/sup\u003e consumption by inhibiting CD38), \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e (the second remethylation cofactor on the cystathionine route), and \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e (the methionine-synthase cofactor). Together they represent the \"make NAD\u003csup\u003e+\u003c\/sup\u003e precursors safe and sustainable\" layer that sits beneath the precursors themselves. If you're new to this layer, the simplest path is TMG + Magnesium with whatever NAD\u003csup\u003e+\u003c\/sup\u003e precursor you've already chosen; Apigenin and Glycine are advanced-tier additions for users running larger NAD\u003csup\u003e+\u003c\/sup\u003e stacks or chasing the GlyNAC protocol specifically.\u003c\/p\u003e\n\n\u003cp\u003eFor category browsing, TMG is grouped under \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD\u003csup\u003e+\u003c\/sup\u003e Family\u003c\/a\u003e (because its primary use case is companion-dose for NAD\u003csup\u003e+\u003c\/sup\u003e precursors), \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e (because methylation is one of the seven daily-nutrient layers that runs underneath every protocol), and \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e (because its homocysteine-lowering effect maps directly to the cardiovascular risk literature). It is also one of the explicitly named compounds in the \u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: The 7 Daily Nutrients\u003c\/a\u003e and \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to Stack Longevity Supplements 2026\u003c\/a\u003e long-form articles.\u003c\/p\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkipping TMG when starting NMN, then adding it after symptoms.\u003c\/strong\u003e The cleaner approach is to start them together. Methyl depletion is easier to prevent than to reverse, and the NMN ramp-up window (week 2–6) is exactly when the demand spike hits hardest.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStopping NMN because you \"felt flat\" without trying TMG first.\u003c\/strong\u003e The flat feeling at 4–6 weeks of NMN is one of the most common reasons people quit, and in many cases it's the methyl-pool draw, not the NMN itself. Add TMG, give it 2–3 weeks, then re-evaluate.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStacking TMG with high-dose niacin (\u0026gt;500 mg\/day) thinking it's the same thing.\u003c\/strong\u003e Niacin is a different molecule with a different mechanism (it's an NAD\u003csup\u003e+\u003c\/sup\u003e precursor itself; flushing nicotinic acid raises HDL, niacinamide does not). TMG doesn't replace niacin and niacin doesn't replace TMG.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRunning TMG at 4+ g\/day when methylfolate would do the same job at lower cost.\u003c\/strong\u003e If your homocysteine is high because of a folate-route bottleneck (most cases), 400 µg methylfolate is more efficient per dollar than scaling TMG. The right protocol is folate + B12 + B6 first, TMG as a layer on top.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTaking TMG only on training days for \"exercise effect.\"\u003c\/strong\u003e The strength-training trials (Cholewa 2013, Lee 2010) used continuous daily dosing for 6–15 days before testing. Pulse-dosing isn't supported by the protocol that produced the effect.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiscontinuing pre-surgery \"to be safe.\"\u003c\/strong\u003e No bleeding-time or anesthesia interaction. There is no reason to stop TMG before surgery.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIgnoring the LDL watch-item at high doses.\u003c\/strong\u003e If you run TMG at 3+ g\/day for homocystinuria-tier reasons, retest lipids at 8 weeks and consider adding omega-3 \/ fiber.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy not Amazon\u003c\/h2\u003e\n\u003cp\u003eThree reasons we built this bottle the way we did:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHPLC-verified ≥99% pharmaceutical-grade identity.\u003c\/strong\u003e Many low-cost private-label TMG products on Amazon test at 92–96% purity with the difference made up of starting-material residues (trimethylamine N-oxide, glycine, methionine) and excipients. The published trials used pharmaceutical-grade. We sourced to that standard.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e1000 mg single-capsule dose.\u003c\/strong\u003e Most marketplace TMG products come in 500 mg capsules, so a 1 g dose means 2 capsules; a 2 g homocysteine-target dose means 4 capsules per day. Our 1000 mg single-cap puts the entry-tier dose in one capsule and the homocysteine dose in two.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMechanism-first catalog architecture.\u003c\/strong\u003e TMG sits inside a longevity catalog where every product cross-links to the others, so the protocol math (NMN methyl-pool draw, MTHFR-aware stacking, homocysteine retest cadence) is on the page rather than in a separate blog you have to find. Amazon optimizes for price-comparison; we optimize for protocol-clarity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003ch3\u003eDo I really need TMG with NMN?\u003c\/h3\u003e\n\u003cp\u003eIf you're taking 250 mg\/day of NMN or less, probably not on day one — the methyl-pool draw is small enough that an omnivorous diet typically covers it. If you're at 500 mg\/day or higher, the methyl-pool math says yes. The cost of being wrong (mild flat mood, fatigue, slow homocysteine creep) is bigger than the cost of being right (one capsule a day at ~$0.42).\u003c\/p\u003e\n\n\u003ch3\u003eCan I take TMG without NMN?\u003c\/h3\u003e\n\u003cp\u003eYes — the homocysteine and liver-support pathways operate independently of any NAD\u003csup\u003e+\u003c\/sup\u003e precursor. People take TMG specifically for an elevated homocysteine reading, for MTHFR-aware methylation support, or for the strength-training power-output effect at 2.5 g\/day.\u003c\/p\u003e\n\n\u003ch3\u003eIs TMG the same as betaine HCl?\u003c\/h3\u003e\n\u003cp\u003eNo, and the distinction matters. Trimethylglycine (betaine anhydrous) is the methyl-donor form used in homocysteine and NAD\u003csup\u003e+\u003c\/sup\u003e-companion trials. Betaine HCl is the same molecule complexed with hydrochloric acid — a digestive aid sold for low-stomach-acid issues. They are not interchangeable for methylation: betaine HCl has the same trimethylglycine content per molecule, but the HCl makes it acidic and clinical trials in methylation use the anhydrous form. This product is anhydrous TMG, not betaine HCl.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does \"anhydrous\" mean?\u003c\/h3\u003e\n\u003cp\u003eIt means the water of crystallization has been removed. Trimethylglycine naturally crystallizes as a hydrate (with one water molecule attached). Anhydrous removes that water, giving you a slightly more concentrated form. This is the standard pharmaceutical grade and what the published clinical trials use. Both forms work; anhydrous is more space-efficient per capsule.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I see homocysteine drop on bloodwork?\u003c\/h3\u003e\n\u003cp\u003eIf you started TMG specifically to lower a high homocysteine reading, re-test at 8–12 weeks. Expect 1–3 µmol\/L per gram per day, with diminishing returns above 2 g\/day in most people. If your starting value was very high (\u0026gt;15 µmol\/L), pair TMG with methylfolate + B12 from day one rather than chasing homocysteine with TMG alone.\u003c\/p\u003e\n\n\u003ch3\u003eShould I take TMG morning or evening?\u003c\/h3\u003e\n\u003cp\u003eMorning, with the same meal you take your NMN\/NR. Single 1 g\/day doses don't benefit from splitting; betaine has a long enough half-life that one daily dose maintains plasma levels through the next morning. If you're running 2 g\/day for a homocysteine target, then split AM\/PM with food.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take TMG with statins \/ blood pressure meds \/ antidepressants?\u003c\/h3\u003e\n\u003cp\u003eYes — TMG has no documented interactions with the major drug classes (statins, ACE inhibitors, ARBs, calcium channel blockers, beta-blockers, SSRIs\/SNRIs, anticoagulants). For SAMe-related antidepressants (registered in some EU countries), TMG is mechanistically synergistic, not antagonistic. As always, run any new supplement past your prescribing physician if you're managing a condition.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take TMG while fasting?\u003c\/h3\u003e\n\u003cp\u003eYou can — TMG itself doesn't break a fast in any meaningful way (no calories, no insulin response). But the standard recommendation is to take it with food because that's the protocol the research used and because it removes any GI discomfort some users report on an empty stomach.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's the right dose if I have an MTHFR variant?\u003c\/h3\u003e\n\u003cp\u003eThe standard MTHFR-aware protocol is TMG 1–2 g\/day + methylfolate 400–800 µg + methylcobalamin 500 µg + B6 P-5-P 25 mg. TMG provides the BHMT-route bypass that MTHFR variants compromise the most heavily. The folate\/B12\/B6 combination is necessary because TMG only handles the BHMT route; the cystathionine and methionine-synthase routes still need their respective cofactors.\u003c\/p\u003e\n\n\u003ch3\u003eIs TMG vegan? Gluten-free? Allergen-free?\u003c\/h3\u003e\n\u003cp\u003eYes to all three. TMG is sourced from sugar beet (plant origin). The capsule is vegetable cellulose (HPMC). No gluten, soy, dairy, eggs, fish, shellfish, peanuts, or tree nuts in the formula or the capsule.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is the bottle a 60-day supply, not 30?\u003c\/h3\u003e\n\u003cp\u003eAt the most common longevity-companion dose (1 capsule\/day), 60 capsules = 60 days. At a homocysteine-target dose (2 capsules\/day), the same bottle = 30 days. We sized the bottle to the more common use case while keeping the per-capsule dose consistent with the higher-tier protocol — so a single SKU covers both.\u003c\/p\u003e\n\n\u003ch3\u003eIs there a fishy\/seafood smell or body odor?\u003c\/h3\u003e\n\u003cp\u003eNot at 1–2 g\/day. A small fraction of people on doses ≥3 g\/day report a faint trimethylamine (\"seafood-y\") aroma; it's the result of gut-bacterial conversion of betaine to TMA in users with a slow flavin-monooxygenase 3 (FMO3) variant. Reducing the dose or splitting it across meals usually resolves it.\u003c\/p\u003e\n\n\u003ch3\u003eDoes TMG raise testosterone or \"boost performance\"?\u003c\/h3\u003e\n\u003cp\u003eNot directly. The strength-training literature (Cholewa 2013, Lee 2010, Trepanowski 2011 review) shows small improvements in anaerobic power output at 2.5 g\/day, likely via creatine-synthesis support and an osmolyte\/cell-volume effect. There is no published mechanism by which TMG raises testosterone. If you're stacking it with creatine, expect a modest synergy; if you're stacking it for hormonal effects, you're stacking the wrong compound.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule and mix it into water or food?\u003c\/h3\u003e\n\u003cp\u003eYes. Trimethylglycine has a faintly sweet, slightly briny taste (it's why it's added to some sports drinks). Stir it into water, smoothies, or yogurt. Heat is fine — TMG is stable up to ~150°C, so cooking-temperature exposure is not a concern.\u003c\/p\u003e\n\n\u003ch3\u003eWhy isn't this product in the Senolytics or Mitochondrial Renewal collections?\u003c\/h3\u003e\n\u003cp\u003eBecause TMG operates on a different layer of the longevity stack — it supports the NAD\u003csup\u003e+\u003c\/sup\u003e and homocysteine layers, not the senescent-cell or mitophagy layers. Catalog organization is mechanism-first; you'll find TMG in \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD\u003csup\u003e+\u003c\/sup\u003e Family\u003c\/a\u003e, \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e, and \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — the three collections that actually map to its mechanism of action.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if I miss a dose?\u003c\/h3\u003e\n\u003cp\u003eTake it when you remember the same day, or skip it and resume the next day. Do not double-up: betaine has a long enough half-life that a missed dose is essentially a non-event, and doubling on an empty stomach can cause mild GI discomfort.\u003c\/p\u003e\n\n\u003ch3\u003eIs the bottle plastic or glass?\u003c\/h3\u003e\n\u003cp\u003eUV-protective amber HDPE plastic with an induction seal. HDPE was chosen for shipping resilience (glass shatters in international transit at meaningfully higher rates) and for the UV-blocking properties of the amber tint, which protects betaine's stability over the 24-month shelf-life.\u003c\/p\u003e\n\n\u003ch2\u003eRead more on the science\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: The 7 Daily Nutrients That Run Underneath Every Longevity Stack\u003c\/a\u003e — the longform article that introduces methylation as one of the seven daily nutrient layers, with the role TMG plays in NAD\u003csup\u003e+\u003c\/sup\u003e-precursor stacks.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to Stack Longevity Supplements: A Practical Protocol for 2026\u003c\/a\u003e — the catalog-wide stacking guide, including the methyl-pool buffer and homocysteine-management layers.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD\u003csup\u003e+\u003c\/sup\u003e? A Beginner's Guide to the Coenzyme Behind Longevity\u003c\/a\u003e — the upstream context for why NAD\u003csup\u003e+\u003c\/sup\u003e precursors create methyl-pool demand in the first place.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/blogs\/news\/nmn-side-effects-what-the-research-actually-shows\"\u003eNMN Side Effects: What the Research Actually Shows\u003c\/a\u003e — covers the methyl-depletion symptom pattern that TMG is designed to prevent.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest Time to Take NMN: Morning, Empty Stomach, or With Food?\u003c\/a\u003e — the timing context for why TMG and NMN are taken together with breakfast.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR: Which NAD\u003csup\u003e+\u003c\/sup\u003e Precursor Actually Works Better?\u003c\/a\u003e — both precursors generate the same methyl-pool draw, so the TMG companion logic applies equally to either.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/pages\/protocols\"\u003eOur Protocols\u003c\/a\u003e — the complete catalog of structured stacks, with TMG positioned in the Foundational, NAD\u003csup\u003e+\u003c\/sup\u003e, and Cardiovascular layers.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e — how we evaluate evidence, with notes on the homocysteine literature and the methylation cycle.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Testing\u003c\/a\u003e — HPLC, heavy-metal, and microbial protocols applied to every batch.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e — sugar-beet feedstock, pharmaceutical-grade specification, and per-batch identity testing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003eOlthof MR, Verhoef P. Effects of betaine intake on plasma homocysteine concentrations and consequences for health. \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e. 2005;81(2):442-450.\u003c\/li\u003e\n\u003cli\u003eSchwab U, Torronen A, Toppinen L, et al. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. \u003cem\u003eEuropean Journal of Clinical Nutrition\u003c\/em\u003e. 2002;56(10):971-977.\u003c\/li\u003e\n\u003cli\u003eMcRae MP. Betaine supplementation decreases plasma homocysteine in healthy adult participants: a meta-analysis. \u003cem\u003eJournal of Chiropractic Medicine\u003c\/em\u003e. 2013;12(1):20-25.\u003c\/li\u003e\n\u003cli\u003eCantó C, Auwerx J. NAD\u003csup\u003e+\u003c\/sup\u003e as a signaling molecule modulating metabolism. \u003cem\u003eCold Spring Harbor Symposia on Quantitative Biology\u003c\/em\u003e. 2011;76:291-298 (and Cantó review series, \u003cem\u003eCell Metabolism\u003c\/em\u003e, 2012-2015).\u003c\/li\u003e\n\u003cli\u003eKraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. \u003cem\u003eNature\u003c\/em\u003e. 2014;508(7495):258-262.\u003c\/li\u003e\n\u003cli\u003eHong S, Moreno-Navarrete JM, Wei X, et al. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. \u003cem\u003eNature Medicine\u003c\/em\u003e. 2015;21(8):887-894.\u003c\/li\u003e\n\u003cli\u003ePissios P. Nicotinamide N-methyltransferase: more than a vitamin B3 clearance enzyme. \u003cem\u003eTrends in Endocrinology \u0026amp; Metabolism\u003c\/em\u003e. 2017;28(5):340-353.\u003c\/li\u003e\n\u003cli\u003eTrammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNature Communications\u003c\/em\u003e. 2016;7:12948.\u003c\/li\u003e\n\u003cli\u003eConze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. \u003cem\u003eScientific Reports\u003c\/em\u003e. 2019;9(1):9772.\u003c\/li\u003e\n\u003cli\u003eBrakedal B, Dolle C, Riemer F, et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2022;34(3):396-407.\u003c\/li\u003e\n\u003cli\u003eSmith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial (VITACOG). \u003cem\u003ePLoS ONE\u003c\/em\u003e. 2010;5(9):e12244.\u003c\/li\u003e\n\u003cli\u003eSeshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. \u003cem\u003eNew England Journal of Medicine\u003c\/em\u003e. 2002;346(7):476-483.\u003c\/li\u003e\n\u003cli\u003eWald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. \u003cem\u003eBMJ\u003c\/em\u003e. 2002;325(7374):1202.\u003c\/li\u003e\n\u003cli\u003eAbdelmalek MF, Sanderson SO, Angulo P, et al. Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. \u003cem\u003eHepatology\u003c\/em\u003e. 2009;50(6):1818-1826.\u003c\/li\u003e\n\u003cli\u003eMukherjee S, Das D, Mukherjee M, et al. Betaine and nonalcoholic steatohepatitis: a randomized controlled trial. \u003cem\u003eIndian Journal of Pharmacology\u003c\/em\u003e. 2011;43(4):485-487.\u003c\/li\u003e\n\u003cli\u003eCholewa JM, Wyszczelska-Rokiel M, Glowacki R, et al. Effects of betaine on body composition, performance, and homocysteine thiolactone. \u003cem\u003eJournal of the International Society of Sports Nutrition\u003c\/em\u003e. 2013;10(1):39.\u003c\/li\u003e\n\u003cli\u003eLee EC, Maresh CM, Kraemer WJ, et al. Ergogenic effects of betaine supplementation on strength and power performance. \u003cem\u003eJournal of the International Society of Sports Nutrition\u003c\/em\u003e. 2010;7:27.\u003c\/li\u003e\n\u003cli\u003eTrepanowski JF, Farney TM, McCarthy CG, et al. The effects of chronic betaine supplementation on exercise performance, skeletal muscle oxygen saturation and associated biochemical parameters in resistance trained men. \u003cem\u003eJournal of Strength and Conditioning Research\u003c\/em\u003e. 2011;25(12):3461-3471.\u003c\/li\u003e\n\u003cli\u003eSharma A, Gerbarg P, Bottiglieri T, et al. S-Adenosylmethionine (SAMe) for neuropsychiatric disorders: a clinician-oriented review of research. \u003cem\u003eMayo Clinic Proceedings\u003c\/em\u003e. 2016;91(4):541-554.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is a dietary supplement. The statements on this page have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed clinician before starting any supplement, particularly if you are pregnant, nursing, taking medication, or managing a medical condition. References are provided for context, not as endorsement of this specific product. Have a question we didn't answer here? Reach out via our \u003ca href=\"\/he\/pages\/contact\"\u003econtact page\u003c\/a\u003e.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839145230554,"sku":"THP-TMG-1000-60","price":24.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_tmg.png?v=1778047687"},{"product_id":"curcumin-1000mg-bioperine-anti-inflammatory-longevity","title":"Curcumin Capsules (AT-014)","description":"\u003cp\u003e\u003cstrong\u003eCurcumin 1000mg with 95% curcuminoids + 5mg BioPerine® — the most-studied anti-inflammatory longevity compound, in the form your body can actually absorb.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3\u003eThe 30-second answer\u003c\/h3\u003e\n\u003cp\u003eCurcumin is the active polyphenol in turmeric (\u003cem\u003eCurcuma longa\u003c\/em\u003e), and it sits at the intersection of two areas modern aging research takes seriously: \u003cstrong\u003einflammaging\u003c\/strong\u003e — the slow, tissue-wide simmer of NF-κB-driven inflammation that accumulates with age (Franceschi \u0026amp; Campisi 2014, \u003cem\u003eJ Gerontol\u003c\/em\u003e) — and the \u003cstrong\u003eendogenous antioxidant system\u003c\/strong\u003e regulated by the Nrf2 transcription factor (glutathione, superoxide dismutase, catalase, heme oxygenase-1). With more than 13,000 peer-reviewed publications on PubMed, including \u003cem\u003eHewlings \u0026amp; Kalman 2017 (Foods)\u003c\/em\u003e, \u003cem\u003eAggarwal \u0026amp; Harikumar 2009 (Int J Biochem Cell Biol)\u003c\/em\u003e, \u003cem\u003eSahebkar 2014 (Phytother Res)\u003c\/em\u003e, \u003cem\u003eDaily 2016 (J Med Food)\u003c\/em\u003e, and \u003cem\u003eSmall 2018 (Am J Geriatric Psychiatry)\u003c\/em\u003e, curcumin is one of the few natural compounds that has been shown — in human trials, not just cell culture — to reduce C-reactive protein (CRP), improve joint pain scores comparably to NSAIDs, raise BDNF, and modulate the same molecular pathways targeted by metformin and rapamycin. The catch every supplement taker eventually runs into is bioavailability: \u003cem\u003eShoba 1998 (Planta Medica)\u003c\/em\u003e showed that ordinary curcumin reaches plasma at near-undetectable levels because it’s poorly water-soluble and rapidly conjugated in the liver. Co-administering 5mg of piperine (the active in BioPerine®) increased systemic bioavailability by \u003cstrong\u003e~2000%\u003c\/strong\u003e in healthy volunteers. This product delivers what the published bioavailability literature actually used: 1000mg of turmeric root extract \u003cstrong\u003estandardized to 95% curcuminoids\u003c\/strong\u003e plus \u003cstrong\u003e5mg BioPerine®\u003c\/strong\u003e at 95% piperine — one capsule, taken with food that contains some fat, once a day.\u003c\/p\u003e\n\n\u003ch3\u003eWhy curcumin keeps appearing in serious longevity research\u003c\/h3\u003e\n\u003cp\u003eAging, at the cellular level, is the slow accumulation of low-grade inflammation. The same NF-κB transcription factor that flares when you sprain an ankle stays mildly switched on for decades, driving joint stiffness, cognitive decline, vascular dysfunction, and insulin resistance — what \u003cem\u003eFranceschi \u0026amp; Campisi 2014 (J Gerontol)\u003c\/em\u003e coined \u003cem\u003einflammaging\u003c\/em\u003e. Long-term human cohort data (Framingham, Rotterdam, ARIC) shows elevated CRP, IL-6, and TNF-α are among the most reliable predictors of all-cause mortality and frailty — outpredicting cholesterol in many analyses. Curcumin is one of the few natural polyphenols that has been shown to \u003cstrong\u003edirectly inhibit NF-κB activation\u003c\/strong\u003e at the IκB-kinase step (\u003cem\u003eSingh \u0026amp; Aggarwal 1995, J Biol Chem\u003c\/em\u003e) \u003cem\u003eand\u003c\/em\u003e simultaneously \u003cstrong\u003eactivate Nrf2\u003c\/strong\u003e (\u003cem\u003eBalogun 2003, Biochem J\u003c\/em\u003e) — the master regulator of the body’s own antioxidant defenses. Most over-the-counter anti-inflammatories suppress symptoms downstream; curcumin works upstream on the signal itself. That dual NF-κB↓ \/ Nrf2↑ profile is also the reason curcumin shows up alongside resveratrol, fisetin, and quercetin in nearly every published longevity-stack review.\u003c\/p\u003e\n\n\u003ch3\u003eThe bioavailability problem — and why BioPerine matters\u003c\/h3\u003e\n\u003cp\u003eCurcumin’s biggest failure mode as a supplement is poor absorption. It has low water solubility (about 11ng\/mL at physiologic pH), rapid intestinal metabolism, and aggressive hepatic glucuronidation\/sulfation. \u003cem\u003eShoba et al. 1998 (Planta Medica)\u003c\/em\u003e dosed healthy volunteers with 2g of curcumin alone and measured serum levels at the limit of detection. The same 2g dose \u003cstrong\u003eplus 20mg piperine\u003c\/strong\u003e raised serum curcumin AUC by \u003cstrong\u003e~2000%\u003c\/strong\u003e. The mechanism: piperine inhibits intestinal and hepatic UDP-glucuronosyltransferase, slowing the rate at which curcumin is conjugated and excreted before it reaches circulation. This is why every reputable curcumin product on the market either uses BioPerine®, a phospholipid carrier (Meriva®), a colloidal nanoparticle (Theracurmin®), or a liposomal vehicle — straight 95% curcuminoid powder without a delivery solution is, pharmacokinetically, mostly wasted.\u003c\/p\u003e\n\n\u003ch3\u003eWhat curcumin actually does — mechanisms in plain English\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNF-κB inhibition.\u003c\/strong\u003e Down-regulates the master inflammation switch that drives chronic disease — specifically by inhibiting IκB kinase (IKK), preventing NF-κB from translocating to the nucleus and switching on TNF-α, IL-1β, IL-6, and COX-2 transcription. Pairs mechanistically with \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (different upstream entry point on the same pathway) and \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (resolvin\/protectin-driven inflammation resolution).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNrf2 activation.\u003c\/strong\u003e Switches on endogenous antioxidant production — glutathione, superoxide dismutase, catalase, heme oxygenase-1 — via Keap1 cysteine modification. Means less dependence on exogenous antioxidants alone. Synergistic with \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e and \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBrain \/ BDNF support.\u003c\/strong\u003e Crosses the blood-brain barrier (one of curcumin’s rare advantages over quercetin and resveratrol). \u003cem\u003eSmall 2018 (Am J Geriatric Psychiatry)\u003c\/em\u003e showed an 18-month Theracurmin trial improved memory-test scores and reduced amyloid\/tau PET signal in non-demented older adults. Best framed as long-game cognitive resilience, not nootropic stimulation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJoint and tendon comfort.\u003c\/strong\u003e \u003cem\u003eDaily 2016 (J Med Food)\u003c\/em\u003e meta-analysis of 8 randomized trials in osteoarthritis: 500–1500 mg\/day of curcuminoids produced clinically meaningful pain-score reduction comparable to ibuprofen 1200–2400 mg\/day, with markedly fewer GI side effects and no anticoagulant burden.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular markers.\u003c\/strong\u003e \u003cem\u003eSahebkar 2014 (Phytother Res)\u003c\/em\u003e meta-analysis: significant CRP reduction (−6.44 mg\/L) in adults with elevated baseline inflammation. Endothelial-function trials (Akazawa 2012, Sugawara 2012) show improvements in flow-mediated dilation comparable to moderate aerobic exercise.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMetabolic \/ AMPK signaling.\u003c\/strong\u003e Activates AMPK and inhibits mTOR — overlapping with the molecular signature of caloric restriction, metformin, and berberine. \u003cem\u003eChuengsamarn 2012 (Diabetes Care)\u003c\/em\u003e: 9-month curcuminoid trial in 240 prediabetic adults reduced progression to type 2 diabetes by 100% vs. placebo (16.4% conversion rate in the placebo arm). Pairs naturally with \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytic adjacent.\u003c\/strong\u003e Curcumin is not a primary senolytic (that’s \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e), but it suppresses the senescence-associated secretory phenotype (SASP) — the inflammatory soup that senescent cells emit before they’re cleared. Curcumin lowers the inflammatory burden of cells you haven’t yet removed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBile and digestive support.\u003c\/strong\u003e Stimulates bile flow (cholagogic). Improves fat digestion. Same mechanism that means people with gallstones should avoid supplemental doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eThe clinical evidence — what published human trials actually showed\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse: collapse; width: 100%;\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTrial\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003eOutcome\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eShoba 1998 (Planta Medica)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e8 healthy volunteers\u003c\/td\u003e\n\u003ctd\u003e2g curcumin ± 20mg piperine, single dose\u003c\/td\u003e\n\u003ctd\u003ePiperine increased curcumin serum AUC by ~2000%; established the BioPerine pairing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eSahebkar 2014 (Phytother Res)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eMeta-analysis, 6 RCTs, 342 adults\u003c\/td\u003e\n\u003ctd\u003e200–1000 mg\/day, 4–12 weeks\u003c\/td\u003e\n\u003ctd\u003eCRP −6.44 mg\/L vs. placebo in adults with elevated inflammation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eDaily 2016 (J Med Food)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eMeta-analysis, 8 RCTs, knee osteoarthritis\u003c\/td\u003e\n\u003ctd\u003e500–1500 mg\/day, 4–12 weeks\u003c\/td\u003e\n\u003ctd\u003eWOMAC pain reduction comparable to NSAIDs; markedly fewer GI events\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eSmall 2018 (Am J Geriatr Psychiatry)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e40 non-demented adults 51–84\u003c\/td\u003e\n\u003ctd\u003e90mg Theracurmin BID, 18 months\u003c\/td\u003e\n\u003ctd\u003eImproved memory and attention; reduced amyloid\/tau PET signal in amygdala\/hypothalamus\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eChuengsamarn 2012 (Diabetes Care)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e240 prediabetic adults\u003c\/td\u003e\n\u003ctd\u003e1500 mg\/day curcuminoids, 9 months\u003c\/td\u003e\n\u003ctd\u003e16.4% → 0% type-2 diabetes progression vs. placebo over 9 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eAkazawa 2012 (Nutr Res)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e32 postmenopausal women\u003c\/td\u003e\n\u003ctd\u003e150mg curcumin\/day, 8 weeks ± aerobic exercise\u003c\/td\u003e\n\u003ctd\u003eFlow-mediated dilation improved comparably to aerobic exercise; additive when stacked\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003ePanahi 2017 (Drug Res)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e117 metabolic syndrome adults\u003c\/td\u003e\n\u003ctd\u003e1000mg curcuminoids + 10mg piperine, 8 weeks\u003c\/td\u003e\n\u003ctd\u003eReduced CRP, IL-6, TNF-α, MDA; improved HDL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eHewlings \u0026amp; Kalman 2017 (Foods)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eComprehensive safety\/efficacy review\u003c\/td\u003e\n\u003ctd\u003eDoses up to 12g\/day in human trials\u003c\/td\u003e\n\u003ctd\u003eNo serious adverse events at supplemental doses; well-tolerated long-term\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eLopresti 2014 (J Affect Disord)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e56 adults with major depression\u003c\/td\u003e\n\u003ctd\u003e500mg BID curcuminoids, 8 weeks\u003c\/td\u003e\n\u003ctd\u003eIDS-SR score improvement vs. placebo, particularly in atypical-depression subgroup\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cem\u003eReferences below are listed in full citation form for verification. Curcumin is one of the most extensively studied natural compounds in modern medicine; the trials above are representative, not exhaustive.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eForm comparison — what the marketing labels actually mean\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse: collapse; width: 100%;\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eCurcuminoid %\u003c\/th\u003e\n\u003cth\u003eBioavailability multiple\u003c\/th\u003e\n\u003cth\u003eCost \/ dose\u003c\/th\u003e\n\u003cth\u003eBest use case\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRaw turmeric powder (kitchen spice)\u003c\/td\u003e\n\u003ctd\u003e~3%\u003c\/td\u003e\n\u003ctd\u003e1× baseline\u003c\/td\u003e\n\u003ctd\u003e$\u003c\/td\u003e\n\u003ctd\u003eCooking; not clinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e80% curcuminoid extract, no carrier\u003c\/td\u003e\n\u003ctd\u003e80%\u003c\/td\u003e\n\u003ctd\u003e~1×\u003c\/td\u003e\n\u003ctd\u003e$\u003c\/td\u003e\n\u003ctd\u003eOutdated; underabsorbed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e95% curcuminoids + BioPerine® (this product)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e95%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e~20×\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$$\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eDaily anti-inflammatory base layer at sustainable cost\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMeriva® \/ phytosome curcumin\u003c\/td\u003e\n\u003ctd\u003e20% (carrier-bound)\u003c\/td\u003e\n\u003ctd\u003e~29× (Belcaro 2010)\u003c\/td\u003e\n\u003ctd\u003e$$$\u003c\/td\u003e\n\u003ctd\u003eOA \/ GI-tolerance issues with piperine\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTheracurmin® \/ colloidal nanoparticle\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003ctd\u003e~27× (Sasaki 2011)\u003c\/td\u003e\n\u003ctd\u003e$$$\u003c\/td\u003e\n\u003ctd\u003eBrain-focused trials (Small 2018 used this form)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiposomal curcumin\u003c\/td\u003e\n\u003ctd\u003evariable\u003c\/td\u003e\n\u003ctd\u003e~10–25×\u003c\/td\u003e\n\u003ctd\u003e$$$\u003c\/td\u003e\n\u003ctd\u003eNiche; comparable to phytosome at premium cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurcuWIN® \/ Longvida®\u003c\/td\u003e\n\u003ctd\u003e~20–46% (carrier-bound)\u003c\/td\u003e\n\u003ctd\u003e~46× \/ ~67×\u003c\/td\u003e\n\u003ctd\u003e$$$$\u003c\/td\u003e\n\u003ctd\u003eSpecialty — high cost for daily use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eFor most people running a permanent daily anti-inflammatory layer, \u003cstrong\u003e95% curcuminoids + BioPerine\u003c\/strong\u003e hits the sweet spot of clinically meaningful absorption at sustainable cost. Specialty formulations (Meriva, Theracurmin, Longvida) are worth the upcharge when you have a specific need: severe inflammation, gut-absorption issues, or a neuro-focused protocol with brain endpoints in mind.\u003c\/p\u003e\n\n\u003ch3\u003eWhere curcumin fits in a longevity stack\u003c\/h3\u003e\n\u003cp\u003eMost longevity protocols cover an NAD+ precursor (\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e), a sirtuin activator (\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e), and senolytics (\u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e). What’s missing in 80% of stacks is the \u003cstrong\u003einflammation layer\u003c\/strong\u003e — and you can have perfect mitochondrial output, restored NAD+, and cleared senescent cells while still aging fast in a constant low-grade NF-κB simmer. Curcumin is the inflammation-layer cornerstone — same NF-κB endpoint as quercetin, different upstream mechanism, additive in published combination trials, and the only one in the catalog with the brain-penetration data.\u003c\/p\u003e\n\n\u003ch3\u003eStacking guide — mechanism-organized\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInflammation layer (the natural pair).\u003c\/strong\u003e Curcumin (NF-κB IKK inhibition) + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (NF-κB downstream + mast-cell stabilization) + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (resolvin\/protectin-driven inflammation resolution). Three different mechanisms converging on the same inflammaging pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNrf2 \/ antioxidant layer.\u003c\/strong\u003e Curcumin + \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e (recycles Vit C\/E\/glutathione) + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e (glutathione precursor) + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e (direct GSH). Curcumin upregulates the system; NAC\/glycine\/ALA feed the substrates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular layer.\u003c\/strong\u003e Curcumin (CRP ↓) + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e (triglycerides, endothelial function) + \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e (LDL, glucose) + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e (mitochondrial energy in cardiac tissue, especially if on a statin).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBrain \/ BDNF layer.\u003c\/strong\u003e Curcumin (BDNF, amyloid, tau) + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 DHA\u003c\/a\u003e (synaptic membrane fluidity) + \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e (BBB-crossing antioxidant) + \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e (HPA-axis \/ cortisol).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytic layer (SASP suppression).\u003c\/strong\u003e Curcumin lowers the inflammatory output of senescent cells you haven’t yet cleared, while \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e trigger their apoptosis. Curcumin runs daily; senolytics run pulsed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK \/ metabolic layer.\u003c\/strong\u003e Curcumin (AMPK↑, mTOR↓) + \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e (AMPK↑ via lysosomal mechanism) + \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCa-AKG\u003c\/a\u003e (metabolite, epigenetic clock) — three different upstream entry points to the AMPK\/mTOR axis that caloric restriction also targets.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJoint \/ connective-tissue layer.\u003c\/strong\u003e Curcumin (NF-κB, prostaglandin signaling) + \u003ca href=\"\/he\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eCollagen peptides\u003c\/a\u003e (cartilage substrate) + \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid + Vit C\u003c\/a\u003e (extracellular matrix support).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational layer.\u003c\/strong\u003e Curcumin sits in the \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e tier alongside \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C\u003c\/a\u003e as a permanent daily, not a pulsed compound.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere this sits in the catalog architecture\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational tier:\u003c\/strong\u003e Curcumin is one of the seven daily essentials in the \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e protocol — the layer that should be in place before exotic compounds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnti-inflammatory cornerstone:\u003c\/strong\u003e The inflammation-layer counterpart to \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e — both NF-κB inhibitors, different upstream mechanisms, additive.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive resilience:\u003c\/strong\u003e Member of the \u003ca href=\"\/he\/collections\/brain-cognitive\"\u003eBrain \u0026amp; Cognitive\u003c\/a\u003e stack, alongside Omega-3 DHA and Astaxanthin, by virtue of its blood-brain-barrier penetration and BDNF data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular:\u003c\/strong\u003e Member of the \u003ca href=\"\/he\/collections\/cardiovascular\"\u003eCardiovascular\u003c\/a\u003e stack via CRP reduction and endothelial-function improvement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJoint \u0026amp; connective tissue:\u003c\/strong\u003e Most-clinically-validated daily for joint comfort short of NSAIDs; pairs with collagen peptides and HA.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhy 1000mg specifically\u003c\/h3\u003e\n\u003cp\u003eThe dose-response curve for curcuminoids in published human trials is fairly well characterized. Below 200mg\/day, even with BioPerine, you’re unlikely to see CRP movement. Between 500 and 1000mg\/day plus piperine, you sit in the band that produced the CRP, joint-comfort, and metabolic outcomes in \u003cem\u003eSahebkar 2014\u003c\/em\u003e, \u003cem\u003eDaily 2016\u003c\/em\u003e, and \u003cem\u003ePanahi 2017\u003c\/em\u003e. Above 1500mg\/day the marginal benefit plateaus and GI tolerance issues climb. \u003cstrong\u003e1000mg of 95% curcuminoids = 950mg active curcuminoids per capsule\u003c\/strong\u003e — right at the modal trial dose, deliverable in a single capsule, with cost-per-day low enough to sustain as a daily for years.\u003c\/p\u003e\n\n\u003ch3\u003eWhat to expect — week by week\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2.\u003c\/strong\u003e Most people notice nothing subjectively. Plasma curcumin steady-state takes about a week to establish.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2–4.\u003c\/strong\u003e Joint stiffness on waking starts to ease. Post-exercise recovery feels modestly faster. Sleep quality may improve modestly via reduced inflammatory tone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4–8.\u003c\/strong\u003e Subjective joint-comfort improvements consolidate; for OA-spectrum users, this is when WOMAC-style pain scores typically drop in trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 8–12.\u003c\/strong\u003e Objective markers move — CRP, IL-6, TNF-α if you’re tracking them. \u003cem\u003eSahebkar 2014\u003c\/em\u003e meta-analysis used 8–12 weeks as the typical window for measurable CRP reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 6–18.\u003c\/strong\u003e The cognitive-resilience and cardiovascular-marker territory, per \u003cem\u003eSmall 2018\u003c\/em\u003e (18 months for memory\/PET endpoints) and \u003cem\u003eAkazawa 2012\u003c\/em\u003e \/ \u003cem\u003eSugawara 2012\u003c\/em\u003e (8 weeks for endothelial function, sustained with continued use).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you stop:\u003c\/strong\u003e Plasma curcumin is cleared within 24–72 hours; the anti-inflammatory benefit unwinds gradually over 4–8 weeks as NF-κB signaling returns to your previous baseline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eDaily protocol\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule (1000mg curcuminoids + 5mg BioPerine) per day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e With a meal that contains some fat — eggs, avocado, olive oil, fish, full-fat yogurt. Curcumin is fat-soluble; the fat improves chylomicron uptake.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food:\u003c\/strong\u003e Yes, always. Reduces the small risk of GI upset and improves absorption.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Continuous daily — curcumin is treated like fish oil and vitamin D in most longevity protocols, not pulse-dosed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (different NF-κB mechanism), \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (resolvin pathway), \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e (immune-modulation overlap).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBottle:\u003c\/strong\u003e 60 vegetable capsules, 60-day supply at one capsule per day.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCommon mistakes to avoid\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking curcumin without piperine, phospholipid, or nanoparticle carrier.\u003c\/strong\u003e Most of the dose is wasted — 1g of plain curcuminoids absorbs roughly the same as 50mg with BioPerine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking curcumin on an empty stomach.\u003c\/strong\u003e Curcumin is fat-soluble; without dietary fat the chylomicron uptake pathway barely engages, and GI tolerance is worse.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting same-day pain relief.\u003c\/strong\u003e Curcumin works on the underlying signal, not the prostaglandin endpoint. NSAIDs work in hours; curcumin works in weeks. Both work; they’re different timescales.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStopping after 2 weeks because “nothing happened.”\u003c\/strong\u003e The \u003cem\u003eSahebkar 2014\u003c\/em\u003e CRP-reduction window is 8–12 weeks; the \u003cem\u003eDaily 2016\u003c\/em\u003e joint-comfort window is 4–12 weeks. Curcumin rewards consistency.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying 80% curcuminoid extract because it’s cheaper.\u003c\/strong\u003e 15–20% less active per milligram. The savings disappear once you account for the dose you actually need.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePairing with anticoagulants without checking.\u003c\/strong\u003e Curcumin has mild antiplatelet activity. If you’re on warfarin, apixaban, rivaroxaban, dabigatran, or daily aspirin, talk to your prescriber before adding it — not because curcumin is dangerous, but because the cumulative bleeding-time effect should be monitored.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eContinuing through gallbladder symptoms.\u003c\/strong\u003e Curcumin stimulates bile flow. People with active gallstones or biliary obstruction can experience symptoms; stop and see a clinician.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone running a longevity or healthspan protocol who wants to add the inflammation layer that most stacks miss.\u003c\/li\u003e\n  \u003cli\u003eAdults over 35 with CRP, IL-6, or TNF-α markers in the upper-normal range — the inflammaging audience.\u003c\/li\u003e\n  \u003cli\u003ePeople with morning joint stiffness, post-exercise inflammation, or osteoarthritis-spectrum symptoms looking for a daily anti-inflammatory that doesn’t carry NSAID GI risk.\u003c\/li\u003e\n  \u003cli\u003eAdults targeting cognitive resilience — particularly with family history of dementia or who want a daily compound with both BDNF and amyloid-clearance signal.\u003c\/li\u003e\n  \u003cli\u003eStatin-users (paired with \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e) and prediabetic \/ metabolic-syndrome adults using curcumin as part of an AMPK \/ inflammation strategy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is not for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnancy or nursing — supplemental doses (above culinary turmeric) are not recommended.\u003c\/li\u003e\n  \u003cli\u003eActive gallstones or biliary tract obstruction — curcumin’s cholagogic effect can provoke symptoms.\u003c\/li\u003e\n  \u003cli\u003eAnyone scheduled for surgery within 2 weeks — stop ahead of elective procedures (mild antiplatelet activity).\u003c\/li\u003e\n  \u003cli\u003eAnyone on warfarin or other anticoagulants without prescriber input.\u003c\/li\u003e\n  \u003cli\u003eChildren under 18 (not the population the trials studied).\u003c\/li\u003e\n  \u003cli\u003eAnyone with a known allergy to turmeric or piperine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSafety and interactions\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants and antiplatelets.\u003c\/strong\u003e Mild additive antiplatelet effect. Talk to your prescriber if you take warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel, or daily aspirin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medications.\u003c\/strong\u003e Curcumin can mildly improve insulin sensitivity (Chuengsamarn 2012). If you’re on insulin or sulfonylureas, monitor glucose more closely in the first month.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIron supplements.\u003c\/strong\u003e Curcumin can chelate iron at high doses. If you have iron-deficiency anemia or take iron, separate by 4+ hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery.\u003c\/strong\u003e Stop 2 weeks before elective procedures.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGI tolerance.\u003c\/strong\u003e Some people experience mild GI upset on an empty stomach — always take with food. Heartburn is a rare reason to switch to a phospholipid form (Meriva).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug-metabolism interactions.\u003c\/strong\u003e Piperine inhibits CYP3A4. If you take a narrow-therapeutic-index drug metabolized by CYP3A4 (some statins, some calcium-channel blockers, certain immunosuppressants), check with your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLong-term safety.\u003c\/strong\u003e Curcumin has been studied at supplemental doses (up to 8g\/day) for 6 months to 2+ years with no serious adverse signal. The 1000mg dose in this product sits well below any reported tolerance threshold.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhat’s in it — per capsule\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTurmeric root extract (\u003cem\u003eCurcuma longa\u003c\/em\u003e) — 1000mg, standardized to 95% curcuminoids = 950mg active curcuminoids\u003c\/strong\u003e (curcumin + demethoxycurcumin + bisdemethoxycurcumin).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBioPerine® (black pepper extract, \u003cem\u003ePiper nigrum\u003c\/em\u003e) — 5mg, standardized to 95% piperine.\u003c\/strong\u003e The branded form used in published bioavailability trials.\u003c\/li\u003e\n  \u003cli\u003eHPMC vegetable capsule (vegan).\u003c\/li\u003e\n  \u003cli\u003eMicrocrystalline cellulose, vegetable magnesium stearate (flow agents at trace levels).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo\u003c\/strong\u003e titanium dioxide, no artificial colors, no GMOs, no soy, no gluten, no dairy.\u003c\/li\u003e\n  \u003cli\u003eUV-protective HDPE bottle, 60 capsules — 2-month supply at one capsule per day.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSourcing, manufacturing, and quality\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eManufactured in a \u003cstrong\u003ecGMP-certified, ISO 9001-registered\u003c\/strong\u003e facility in the United States.\u003c\/li\u003e\n  \u003cli\u003eTurmeric root sourced from \u003cstrong\u003eIndia\u003c\/strong\u003e — the species’ geographic origin and the supply chain with the most established curcuminoid testing infrastructure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC verification\u003c\/strong\u003e of curcuminoid content (must read ≥95% to ship). Per-batch verification of piperine content in BioPerine.\u003c\/li\u003e\n  \u003cli\u003ePer-batch testing for: heavy metals (lead, cadmium, mercury, arsenic) per USP \u0026lt;2232\u0026gt;, pesticide residues per USP \u0026lt;561\u0026gt;, microbial contamination (total plate count, yeast\/mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e) per USP \u0026lt;2021\/2022\u0026gt;, residual solvents per USP \u0026lt;467\u0026gt;, and stability at end-of-shelf-life.\u003c\/li\u003e\n  \u003cli\u003eBioPerine® is the trademarked black pepper extract from Sabinsa Corporation, the formulation used in the majority of published curcumin bioavailability studies, including Shoba 1998.\u003c\/li\u003e\n  \u003cli\u003eCOA (Certificate of Analysis) available on request — \u003ca href=\"\/he\/pages\/contact-business-information\"\u003econtact us\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFrequently asked\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eWhy curcumin instead of just eating turmeric?\u003c\/strong\u003e Raw turmeric powder is roughly 3% curcuminoids by weight. To get a 950mg curcuminoid dose from food, you’d need to eat ~32 grams of turmeric powder per day — about 6 tablespoons — and even then, your body would absorb only a tiny fraction without piperine and fat. The extract concentrates the active compound; BioPerine multiplies what reaches your bloodstream.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat does “95% curcuminoids” actually mean?\u003c\/strong\u003e “Curcuminoids” is the umbrella term for three related compounds — curcumin (~75% of the curcuminoid fraction), demethoxycurcumin (~15%), and bisdemethoxycurcumin (~10%) — all of which contribute to the activity. A 95% standardized extract means 95% of the extract by weight is active curcuminoids. Older or cheaper products are often standardized to 80% or unstandardized; per equivalent capsule, that’s 15–20% less active compound.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy BioPerine and not regular black pepper?\u003c\/strong\u003e BioPerine® is a patented black pepper extract standardized to 95% piperine. It’s the formulation used in the majority of the published curcumin bioavailability studies, including Shoba 1998. Sprinkling pepper on your food gives you maybe 0.1mg of piperine per gram of pepper — not enough to meaningfully shift absorption.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin + BioPerine vs. liposomal \/ phytosome \/ Theracurmin?\u003c\/strong\u003e Specialized formulations like Meriva (phosphatidylcholine), Theracurmin (colloidal nanoparticle), and liposomal curcumin have higher absorption per milligram than curcumin + BioPerine — typically 25–30× for phytosome\/colloidal vs. ~20× for BioPerine. They also cost roughly 3–5× as much per dose. For most people running a daily anti-inflammatory base layer, 1000mg curcuminoids + BioPerine delivers a clinically meaningful dose at a sustainable price. If you have specific reasons (severe inflammation, gut absorption issues, neuro-focused protocol), the premium formulations are worth considering.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Subjective markers (joint comfort, post-exercise recovery, mental clarity) — usually 2–6 weeks of consistent daily use. Objective markers (CRP, oxidative stress panels) — 8–12 weeks per the Sahebkar 2014 meta-analysis. Curcumin is a slow-build compound; the goal is the cumulative anti-inflammatory effect, not a same-day pain reliever.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take curcumin long-term?\u003c\/strong\u003e Yes. Curcumin has been studied in human trials for periods of 6 months to 2+ years at doses up to 8 grams\/day with no serious safety signal. The 1000mg daily dose in this product is well below any reported tolerance threshold. Most longevity protocols treat curcumin as a permanent daily, like fish oil or vitamin D — not a pulse-dosed compound.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin vs. ibuprofen?\u003c\/strong\u003e Multiple randomized trials in osteoarthritis have shown comparable pain-score reduction at curcumin doses of 1000–1500mg\/day vs. typical NSAID doses (Daily 2016 meta-analysis), with markedly fewer GI side effects and no anticoagulant burden. Curcumin works on the underlying inflammation signal; NSAIDs work on prostaglandin synthesis. They’re not equivalent mechanisms, but the clinical outcome on pain scores is similar over 4–12 weeks.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin vs. Boswellia, ginger, or other anti-inflammatory botanicals?\u003c\/strong\u003e Different mechanisms. Boswellia inhibits 5-lipoxygenase (leukotriene pathway). Ginger inhibits COX\/LOX. Curcumin works upstream on NF-κB \/ Nrf2 transcription. Stacking is rational and well-tolerated. If you can run only one as a permanent daily, curcumin has the deepest published trial base.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I cycle off?\u003c\/strong\u003e Not required. There is no published evidence of curcumin tolerance build-up at supplemental doses. Most longevity protocols run curcumin continuously alongside fish oil and vitamin D as the permanent base of the anti-inflammatory layer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy “with food that contains fat”?\u003c\/strong\u003e Curcumin is fat-soluble. Taking it with a fat source increases the fraction that solubilizes into chylomicrons and enters circulation via the lymphatic system — bypassing some of the first-pass hepatic metabolism. This is why curcumin labels recommend taking with a meal, not on an empty stomach.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy pair with Quercetin if it’s the same NF-κB target?\u003c\/strong\u003e Different upstream mechanisms. Curcumin inhibits IκB-kinase (preventing NF-κB activation). Quercetin acts as a flavonoid antioxidant and mast-cell stabilizer that intersects the same downstream pathway from a different angle. Combination trials show additive (not redundant) effects. They’re frequently stacked in published longevity protocols for this reason.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eYellow staining — is that normal?\u003c\/strong\u003e Yes. Curcumin is the natural yellow pigment in turmeric. If a capsule splits open, the powder will stain — this is purity, not a defect. The same pigment turns Indian curries yellow.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill curcumin interact with my medications?\u003c\/strong\u003e The interactions worth flagging to your prescriber are: anticoagulants and antiplatelets (mild additive bleeding-time effect), insulin and sulfonylureas (mild glucose-lowering — monitor in month 1), iron supplements (separate by 4+ hours), and CYP3A4-metabolized drugs (BioPerine inhibits CYP3A4 — relevant for some statins, calcium-channel blockers, and certain immunosuppressants). Curcumin itself is not a strong CYP inhibitor; the piperine in BioPerine is the relevant variable.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs there a CRP threshold below which curcumin doesn’t do anything?\u003c\/strong\u003e The CRP-reduction effect is most pronounced in adults with elevated baseline CRP (above ~3 mg\/L). In adults with already-low CRP (under 1 mg\/L), the absolute reduction is smaller, but the upstream NF-κB \/ Nrf2 effects still operate — you’re running the protocol for the next decade’s baseline, not the current week’s blood draw.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin and depression — is there really an antidepressant signal?\u003c\/strong\u003e Modest but consistent. \u003cem\u003eLopresti 2014 (J Affect Disord)\u003c\/em\u003e showed an effect on Inventory of Depressive Symptomatology scores at 500mg BID over 8 weeks in adults with major depression, particularly in the atypical-depression subgroup. The effect size is real but smaller than that of standard antidepressants — curcumin is best framed as adjunctive (in conversation with a clinician), not a primary treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy is my curcumin dose not bottled with the iron and zinc and other extras some products use?\u003c\/strong\u003e Combination products complicate dose-response and dilute the curcumin per capsule. The published trials used curcumin + piperine alone or curcumin + piperine + a single carrier. We follow that.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs the BioPerine vegan \/ GMO-free?\u003c\/strong\u003e BioPerine® from Sabinsa is non-GMO and vegan. The capsule shell is HPMC (cellulose), so the entire product is vegan.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat’s the difference between “turmeric extract” and “curcumin”?\u003c\/strong\u003e Turmeric extract is the broader plant-derived material; curcumin is the specific active polyphenol. A “turmeric extract standardized to 95% curcuminoids” is concentrated extract where 95% of the weight is the active curcuminoid fraction. A label that just says “turmeric” without a standardization percentage is almost certainly raw turmeric powder — the kitchen spice — and a clinical dose would require ~32 grams a day.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy isn’t curcumin in the senolytics collection?\u003c\/strong\u003e Curcumin suppresses the senescence-associated secretory phenotype (SASP) but doesn’t reliably trigger apoptosis of senescent cells in human-relevant doses. The catalog reserves the “senolytic” tag for compounds with the apoptosis signal — \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e. Curcumin is “senolytic-adjacent” — complementary, not duplicative.\u003c\/p\u003e\n\n\u003ch3\u003eRead more on the science\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/longevity-science\/inflammaging\"\u003eInflammaging — the slow inflammatory simmer behind chronic disease\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/longevity-science\/foundational-7\"\u003eThe Foundational 7 daily nutrients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/longevity-science\/classic-longevity-stack\"\u003eThe classic longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eAll protocols\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSelected references\u003c\/h3\u003e\n\u003cp style=\"font-size: 0.9em;\"\u003eShoba G, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. \u003cem\u003ePlanta Med\u003c\/em\u003e. 1998;64(4):353–356.\u003cbr\u003e\nSingh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin. \u003cem\u003eJ Biol Chem\u003c\/em\u003e. 1995;270(42):24995–25000.\u003cbr\u003e\nBalogun E, et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. \u003cem\u003eBiochem J\u003c\/em\u003e. 2003;371(Pt 3):887–895.\u003cbr\u003e\nAggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent. \u003cem\u003eInt J Biochem Cell Biol\u003c\/em\u003e. 2009;41(1):40–59.\u003cbr\u003e\nAkazawa N, et al. Curcumin ingestion and exercise training improve vascular endothelial function. \u003cem\u003eNutr Res\u003c\/em\u003e. 2012;32(10):795–799.\u003cbr\u003e\nSugawara J, et al. Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women. \u003cem\u003eAm J Hypertens\u003c\/em\u003e. 2012;25(6):651–656.\u003cbr\u003e\nChuengsamarn S, et al. Curcumin extract for prevention of type 2 diabetes. \u003cem\u003eDiabetes Care\u003c\/em\u003e. 2012;35(11):2121–2127.\u003cbr\u003e\nSahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? \u003cem\u003ePhytother Res\u003c\/em\u003e. 2014;28(5):633–642.\u003cbr\u003e\nLopresti AL, et al. Curcumin for the treatment of major depression. \u003cem\u003eJ Affect Disord\u003c\/em\u003e. 2014;167:368–375.\u003cbr\u003e\nFranceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. \u003cem\u003eJ Gerontol A Biol Sci Med Sci\u003c\/em\u003e. 2014;69 Suppl 1:S4–S9.\u003cbr\u003e\nDaily JW, et al. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a meta-analysis of randomized clinical trials. \u003cem\u003eJ Med Food\u003c\/em\u003e. 2016;19(8):717–729.\u003cbr\u003e\nHewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. \u003cem\u003eFoods\u003c\/em\u003e. 2017;6(10):92.\u003cbr\u003e\nPanahi Y, et al. Curcuminoids modify lipid profile in type 2 diabetes mellitus. \u003cem\u003eDrug Res\u003c\/em\u003e. 2017;67(4):244–251.\u003cbr\u003e\nSmall GW, et al. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults. \u003cem\u003eAm J Geriatr Psychiatry\u003c\/em\u003e. 2018;26(3):266–277.\u003cbr\u003e\nBelcaro G, et al. Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. \u003cem\u003eAltern Med Rev\u003c\/em\u003e. 2010;15(4):337–344.\u003cbr\u003e\nSasaki H, et al. Innovative preparation of curcumin for improved oral bioavailability. \u003cem\u003eBiol Pharm Bull\u003c\/em\u003e. 2011;34(5):660–665.\u003cbr\u003e\nAnand P, et al. Bioavailability of curcumin: problems and promises. \u003cem\u003eMol Pharm\u003c\/em\u003e. 2007;4(6):807–818.\u003cbr\u003e\nGupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. \u003cem\u003eAAPS J\u003c\/em\u003e. 2013;15(1):195–218.\u003c\/p\u003e\n\u003cp style=\"font-size: 0.9em;\"\u003e\u003cem\u003eReferences listed in support of mechanism and dose rationale; not as endorsements of off-label medical use. Curcumin and BioPerine are dietary supplements, not pharmaceuticals.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eWhy not just buy this on Amazon?\u003c\/h3\u003e\n\u003cp\u003eYou can. Three things are different here. \u003cstrong\u003e(1) Per-batch HPLC verification\u003c\/strong\u003e of the 95% curcuminoid claim and the 95% piperine claim, with COA available on request — on Amazon you have no idea whether the bottle on the shelf was tested. \u003cstrong\u003e(2) BioPerine® from Sabinsa\u003c\/strong\u003e, the trademarked black pepper extract used in the original Shoba 1998 bioavailability literature — not a no-name piperine commodity. \u003cstrong\u003e(3) The catalog architecture\u003c\/strong\u003e — curcumin is positioned, dosed, and stack-mapped against the rest of a longevity protocol you’re likely running, not sold as a one-off SKU.\u003c\/p\u003e\n\n\u003ch3\u003eHow to take it\u003c\/h3\u003e\n\u003cp\u003e1 capsule once a day, with a meal that contains some fat. Most people take it at breakfast alongside \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e and \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e — they’re all fat-soluble and they share the same dosing rule.\u003c\/p\u003e\n\n\u003ch3\u003eHave a question?\u003c\/h3\u003e\n\u003cp\u003eEmail us at support@truehealthprotocol.health or use the \u003ca href=\"\/he\/pages\/contact-business-information\"\u003econtact page\u003c\/a\u003e. We answer within one business day.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement, especially if you take prescription medication, are pregnant or nursing, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"60 Capsules","offer_id":47839341248730,"sku":"THP-CURCUMIN-1000-60","price":26.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_curcumin.png?v=1778047676"},{"product_id":"pqq-20mg-mitochondrial-biogenesis-activator","title":"PQQ 20mg | Mitochondrial Biogenesis Activator | Pyrroloquinoline Quinone for Cellular Energy \u0026 Brain","description":"\u003ch2\u003eThe mitochondrial biogenesis layer most longevity stacks miss\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e30-second answer:\u003c\/strong\u003e Pyrroloquinoline quinone (PQQ) is the most direct nutritional lever known for \u003cem\u003emitochondrial biogenesis\u003c\/em\u003e — the creation of new mitochondria inside existing cells. Other longevity ingredients support the mitochondria you already have (CoQ10), recycle the broken ones (Urolithin A), or supply the energy currency they run on (NMN, Resveratrol). PQQ is the only widely-studied compound that activates PGC-1α — the master transcription factor that turns on the genes for building new mitochondria — through the same upstream signaling network that exercise and caloric restriction work through. One 20mg capsule daily with a fat-containing meal. Most users notice cognitive effects in 4–8 weeks; the mitochondrial-density change is silent and biological, on the order of 3–6 months.\u003c\/p\u003e\n\n\u003ch2\u003eThe mitochondrial biogenesis problem (and why most stacks ignore it)\u003c\/h2\u003e\n\u003cp\u003eWalk through any serious longevity stack and the mitochondrial coverage will look something like this: NMN or NR to raise NAD\u003csup\u003e+\u003c\/sup\u003e, CoQ10 to support the electron-transport chain, sometimes Urolithin A to clear damaged mitochondria via mitophagy, sometimes Resveratrol or Spermidine to support sirtuins and autophagy. That covers fuel, machinery, cleanup, and renewal signaling. What it doesn't cover is \u003cstrong\u003epopulation\u003c\/strong\u003e — the actual number of working mitochondria inside each cell.\u003c\/p\u003e\n\u003cp\u003eAnd mitochondrial number is one of the most measurable things that declines with age. By the seventh decade of life, mitochondrial density in skeletal muscle is roughly half of what it was at twenty (Conley et al., \u003cem\u003eJournal of Physiology\u003c\/em\u003e, 2000). The same trend appears in cardiac muscle, neurons, hepatocytes, and oocytes. You can have perfectly maintained NAD\u003csup\u003e+\u003c\/sup\u003e levels and pristine CoQ10 status, but if your cells are running on a thinned-out mitochondrial population, they're producing less ATP per unit of tissue, generating more reactive oxygen species per unit of work, and failing earlier under load. This is why people in their seventies fatigue faster than people in their thirties even when their hemoglobin and resting metabolic rate look identical: it isn't fuel delivery, it's how many engines the cells have left.\u003c\/p\u003e\n\u003cp\u003ePQQ is the most direct nutritional lever for this layer. The molecule was discovered in the 1970s as a redox cofactor in bacterial dehydrogenases, but its biological relevance for mammals only became clear in the 1990s when PQQ-deficient diets were shown to cause growth failure, immunosuppression, infertility, and dramatic loss of mitochondrial content in mice — and crucially, that all of these effects could be reversed by restoring PQQ to the diet (Steinberg et al., \u003cem\u003eExperimental Biology and Medicine\u003c\/em\u003e, 1994; Killgore et al., \u003cem\u003eScience\u003c\/em\u003e, 1989). The mechanism turned out to involve PGC-1α (the master regulator of mitochondrial biogenesis), CREB, and a series of downstream genes for mitochondrial DNA replication and oxidative phosphorylation — the same longevity-relevant signaling network that resveratrol, NMN, and caloric restriction work through, but PQQ enters at a different node.\u003c\/p\u003e\n\u003cp\u003eThe first major human supplementation study (Harris et al., \u003cem\u003eThe Journal of Nutritional Biochemistry\u003c\/em\u003e, 2010) showed measurable increases in mitochondrial-related gene expression and reductions in plasma C-reactive protein in healthy adults after eight weeks of PQQ supplementation. A 2013 follow-up showed reductions in oxidative-damage markers (8-isoprostane, methylated lysines) and improvements in mitochondrial-related metabolites (Harris et al., 2013). Subsequent Japanese trials extended the cognitive results — Nakano et al. (2009, 2012) showed improvements in higher cognitive function in middle-aged and older adults, with the effect amplified when PQQ was combined with CoQ10.\u003c\/p\u003e\n\n\u003ch2\u003eHow PQQ actually works inside the cell\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1. PGC-1α activation — mitochondrial biogenesis.\u003c\/strong\u003e PQQ phosphorylates and activates CREB (cAMP response element-binding protein), which in turn activates PGC-1α — the transcription co-activator that turns on the entire genetic program for building new mitochondria, including nuclear respiratory factors NRF1 and NRF2 and mitochondrial transcription factor A (TFAM). This is the same pathway exercise activates. Sometimes called \"exercise in a capsule\" — that's an oversimplification because exercise also drives capillary growth, fiber-type changes, and a hundred other adaptations PQQ does not — but at the molecular level of biogenesis signaling, the description is more accurate than not.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2. Direct redox cofactor activity — durable antioxidant inside the mitochondrial environment.\u003c\/strong\u003e PQQ itself is one of the most catalytically efficient redox cofactors known. It can cycle through approximately 20,000 redox conversions before being consumed, compared with roughly four for ascorbic acid. That makes it an unusually durable antioxidant, particularly inside the lipid-bilayer environment of the inner mitochondrial membrane where most water-soluble antioxidants can't reach effectively. This complements rather than overlaps with CoQ10, which is the inner-membrane antioxidant for the lipid phase but does not catalyze cycle reactions in the same way.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e3. NGF (nerve growth factor) upregulation — neuronal support.\u003c\/strong\u003e PQQ has been shown in cell-culture studies to stimulate NGF mRNA expression and protein release from astrocytes (Yamaguchi et al., \u003cem\u003eBioscience, Biotechnology, and Biochemistry\u003c\/em\u003e, 1993). NGF supports neuronal survival, axonal growth, and synaptic plasticity. This appears to be part of why the most consistent subjective report from PQQ users is improved mental clarity and reduced brain fog rather than the muscular energy effect more typical of CoQ10 — the brain has the highest mitochondrial density and the highest NGF dependence of any organ system.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e4. Synergy with CoQ10.\u003c\/strong\u003e The Nakano et al. (2009) trial in \u003cem\u003eFunctional Foods in Health and Disease\u003c\/em\u003e tested PQQ alone (20mg\/day), CoQ10 alone (300mg\/day), and the combination in adults with cognitive complaints. Both compounds produced individual improvements; the combination produced the largest improvements in attention, working memory, and processing speed. The mechanistic explanation is direct: PQQ drives the creation of new mitochondria, CoQ10 functionally populates them as the obligate cofactor for Complex I, II, and III of the electron transport chain. Building more engines without filling them with the cofactor that makes them run is half a stack; supporting existing engines without making more is the other half. Together is the full picture.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e5. mtDNA protection and biogenesis maintenance.\u003c\/strong\u003e Beyond turning on biogenesis, PQQ has been shown to reduce oxidative damage to mitochondrial DNA itself (Stites et al., \u003cem\u003eJournal of Nutrition\u003c\/em\u003e, 2006; Bauerly et al., \u003cem\u003ePLOS ONE\u003c\/em\u003e, 2011). Mitochondrial DNA is more vulnerable than nuclear DNA because it lacks histones, has fewer repair pathways, and sits in the most oxidative environment in the cell. Protecting mtDNA preserves the genetic blueprint for the new mitochondria PQQ is signaling the cell to build — without that, biogenesis would just produce defective copies.\u003c\/p\u003e\n\n\u003ch2\u003eWhere PQQ fits in your stack — the four-layer mitochondrial protocol\u003c\/h2\u003e\n\u003cp\u003eMitochondrial health is best understood as four distinct layers, each with a different lever:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePopulation (how many you have):\u003c\/strong\u003e PQQ — biogenesis via PGC-1α \/ CREB \/ NRF1 \/ TFAM. Builds new mitochondria.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFunction (how well they run):\u003c\/strong\u003e CoQ10 \/ ubiquinol — Complex I, II, III electron-transport cofactor. Powers existing mitochondria.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCleanup (removing broken ones):\u003c\/strong\u003e Urolithin A — mitophagy via PINK1 \/ Parkin. Recycles defective mitochondria.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFuel (the energy currency they run on):\u003c\/strong\u003e NMN, NR, Liposomal NAD+, Resveratrol — NAD\u003csup\u003e+\u003c\/sup\u003e production, sirtuin activation. Supplies the substrate the mitochondria spend.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost stacks cover one or two of these. The strongest mitochondrial protocols cover all four. PQQ is usually the missing piece because it's the newest of the major longevity ingredients to reach mainstream attention — the molecule was only formally recognized as a vitamin-like compound in 2003 (Kasahara \u0026amp; Kato, \u003cem\u003eNature\u003c\/em\u003e), and the first major human supplementation study didn't appear until 2010. It's also the only one of the four that operates at the gene-expression level rather than the biochemical-substrate level, which is why the time-to-effect is measured in weeks-to-months rather than days.\u003c\/p\u003e\n\u003cp\u003eOne implication of the four-layer model worth naming directly: the layers are not interchangeable. NMN does not cover what PQQ covers. Urolithin A does not cover what PQQ covers. Stacking three NAD\u003csup\u003e+\u003c\/sup\u003e precursors together does not address mitochondrial number. If your stack already includes NMN, CoQ10, and Urolithin A, PQQ is the highest-leverage single addition you can make, because it's the only one that increases the population of working mitochondria the other three are supporting.\u003c\/p\u003e\n\n\u003ch2\u003eWhy PQQ matters for fertility and reproductive health\u003c\/h2\u003e\n\u003cp\u003eOf all the cells in the human body, the oocyte (egg cell) contains by far the most mitochondria — roughly 100,000 of them, compared with about 1,000–2,000 in a typical somatic cell. That density is not accidental. The early embryo runs entirely on mitochondrial ATP from the mother's egg until implantation; the sperm contributes essentially nothing to the embryo's mitochondrial population (and what little it does contribute is actively destroyed by ubiquitin-mediated degradation in the early embryo).\u003c\/p\u003e\n\u003cp\u003eThe downstream implication is that mitochondrial quality and quantity in the oocyte is one of the strongest predictors of fertility outcomes, and the most consistent biological reason that egg quality declines with maternal age. The same logic applies to sperm motility, which is almost entirely mitochondrial-ATP-dependent — the sperm tail is essentially a mitochondrial engine wrapped in a cytoskeletal scaffold; sperm count and morphology speak to genetic health, but motility speaks to mitochondrial bioenergetics.\u003c\/p\u003e\n\u003cp\u003eThis is why CoQ10 (or its reduced form ubiquinol) has been a mainstream recommendation in reproductive endocrinology clinics for over a decade and is now standard adjunctive therapy in many IVF protocols. PQQ extends the same logic at the population level: rather than just supporting the function of existing mitochondria, it actively stimulates the creation of new ones in tissues with high turnover. That's the rationale for stacking PQQ with CoQ10 in a fertility-focused protocol — the same logic that drives the rest of the longevity stack, but with the reproductive system as the primary target tissue.\u003c\/p\u003e\n\u003cp\u003ePQQ has not yet been studied head-to-head as a fertility intervention with the same depth as CoQ10, so this section is a mechanistic argument rather than a clinical-evidence claim. If you are actively trying to conceive, undergoing IVF, or working with a reproductive endocrinologist, the addition of any new supplement to your protocol should be discussed with that specialist before you start. We are providing the mechanism. Your clinician knows your case.\u003c\/p\u003e\n\n\u003ch2\u003eBrain and cognitive support — the most consistent subjective effect\u003c\/h2\u003e\n\u003cp\u003eThe brain is roughly 2% of body weight but consumes around 20% of the body's resting energy — a per-gram metabolic rate higher than any other tissue. That makes it acutely sensitive to mitochondrial population and function. It is also one of the tissues in which PQQ's NGF-upregulating effect is most relevant: NGF supports the survival of cholinergic neurons in the basal forebrain, sympathetic neurons, and nociceptive sensory neurons, all of which are vulnerable to age-related dropout.\u003c\/p\u003e\n\u003cp\u003eThe Nakano et al. (2009 and 2012) trials measured cognitive performance using the Stroop test, attention-shift tasks, and short-term memory assessments in middle-aged and older adults. PQQ at 20mg\/day for 12 weeks produced measurable improvements in attention and processing-speed measures versus placebo. The PQQ + CoQ10 combination amplified the effect. A separate trial in adults with subjective cognitive complaints (Itoh et al., \u003cem\u003eJournal of Clinical Biochemistry and Nutrition\u003c\/em\u003e, 2016) showed reductions in self-reported fatigue and improvements in sleep quality and concentration.\u003c\/p\u003e\n\u003cp\u003eNone of this is a claim of dramatic cognitive enhancement and PQQ is not a stimulant. The signal across these studies is consistent with the mechanism: gradual improvement in mitochondrial-density-dependent functions in tissues that are already working, with the largest effects in people whose baseline cognitive function is below their personal optimum (afternoon brain fog, sleep-disruption-driven fatigue, age-related processing-speed decline). If you are looking for an acute focus aid, you want caffeine, theanine, or a racetam — not PQQ. If you are looking to add the layer that compounds quietly over months and supports the brain's mitochondrial population for years, PQQ is the foundational tool.\u003c\/p\u003e\n\n\u003ch2\u003eCardiovascular and metabolic effects\u003c\/h2\u003e\n\u003cp\u003eThe heart is the second-most mitochondria-dense tissue in the body — cardiomyocytes are roughly 30–35% mitochondria by volume. That density is what allows the heart to contract approximately 100,000 times per day at oxidative-phosphorylation-driven efficiency. It is also why mitochondrial dysfunction shows up clinically as heart failure with preserved ejection fraction, exercise intolerance, and the fatigue patterns associated with chronic cardiovascular disease.\u003c\/p\u003e\n\u003cp\u003eThe Harris 2010 trial showed a measurable reduction in plasma C-reactive protein (CRP) — a systemic inflammation marker associated with cardiovascular risk — after eight weeks of PQQ supplementation. The 2013 Harris follow-up showed reduction in oxidative damage markers including 8-isoprostane (a marker of lipid peroxidation associated with atherosclerosis) and methylated lysines (a marker of mitochondrial protein damage). A 2015 Chinese trial (Zhu et al., \u003cem\u003eCardiovascular Drugs and Therapy\u003c\/em\u003e) studied PQQ in patients with ischemia-reperfusion injury and found cardioprotective effects mediated by activation of PGC-1α and reduction of oxidative damage in cardiac tissue.\u003c\/p\u003e\n\u003cp\u003eNone of this is a claim of cardiovascular treatment. PQQ is not a substitute for any prescribed cardiac therapy, lipid-lowering protocol, or blood-pressure management. It is a long-horizon mitochondrial support tool whose cardiovascular relevance derives from the same general mechanism that drives its skeletal-muscle and brain effects: cardiomyocytes are mitochondria-dense, mitochondria respond to PGC-1α-mediated biogenesis signaling, PQQ activates that pathway, and the downstream effects on inflammation and oxidative stress are measurable.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in this bottle\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePyrroloquinoline quinone disodium salt (PQQ): 20mg\u003c\/strong\u003e — pharmaceutical-grade BioPQQ™-grade material. The disodium salt is the chemical form used in essentially all of the major published clinical trials and the only form with established human oral-bioavailability data. The exact dose used in the Harris 2010 mitochondrial-density study and the Nakano 2009 and 2012 cognitive studies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBioPerine® black pepper extract: 5mg\u003c\/strong\u003e — standardized to 95% piperine. Piperine inhibits the gut and liver enzymes (UGT1A1, CYP3A4) that break down many fat-soluble cofactors, including the ones PQQ is most often stacked with: CoQ10, curcumin, vitamin D, astaxanthin. PQQ itself has reasonable oral bioavailability and does not strictly need piperine; the BioPerine here supports the stack PQQ is intended to operate inside.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVegetable cellulose capsule.\u003c\/strong\u003e No magnesium stearate. No titanium dioxide. No artificial colors. No silicon dioxide. No fillers, dyes, or excipients beyond the active ingredients.\u003c\/li\u003e\n\u003cli\u003e60 capsules per bottle — two-month supply at the standard daily dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDaily protocol (recommended):\u003c\/strong\u003e 1 capsule (20mg) taken in the morning with a fat-containing meal. PQQ is a small molecule with reasonable water solubility, but absorption is improved when taken alongside dietary fat — the same general principle that applies to CoQ10, curcumin, vitamin D, vitamin K, and astaxanthin. Morning rather than evening because the cognitive-clarity and energy-related downstream effects are more useful during the active part of your day; PQQ is not sedating but the mitochondrial-density signaling is most aligned with daytime metabolic demand.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStacking notes:\u003c\/strong\u003e PQQ pairs naturally with CoQ10 — take both with the same fat-containing meal. It also stacks logically with NMN, Urolithin A, Resveratrol, Spermidine, Fisetin, Quercetin, TMG, Apigenin, and the rest of the True Health Protocol mitochondrial and longevity stack. Each works on a different layer (population, function, cleanup, fuel, signaling), so there is no redundancy and no published evidence of negative interaction within this combination set. PQQ is also compatible with most cardiovascular medications and standard multivitamins; the antioxidant and biogenesis effects do not interfere with statins, antihypertensives, or thyroid replacement at the doses studied.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTime to effect:\u003c\/strong\u003e Subjective cognitive effects (mental clarity, reduced afternoon fatigue, sharper attention) are typically reported between weeks 4 and 8. The underlying mitochondrial-density change is much slower — the Harris 2010 study used an 8-week protocol to show changes in mitochondrial-related gene expression and inflammation markers; full effects at the cellular density level likely require 3–6 months of continuous use. The compounds that work via gene expression (PQQ, NMN, Resveratrol, Spermidine) all share this profile: slower onset, longer-duration changes, and best results at consistent daily dosing rather than intermittent or pulsed protocols.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCycling vs. continuous use:\u003c\/strong\u003e Unlike senolytics (Fisetin, Quercetin) which have a published rationale for monthly pulsing, PQQ is most effective as a continuous daily protocol. The biogenesis signaling is sustained, not pulsatile, and the underlying tissue change accumulates with continued exposure. There is no published evidence that PQQ requires breaks, develops tolerance, or downregulates its own pathway over time.\u003c\/p\u003e\n\n\u003ch2\u003eWho should not take this\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding.\u003c\/strong\u003e PQQ has not been studied in human pregnancy. Animal studies in PQQ-deficient diets show severe reproductive and growth effects (which is part of why PQQ is sometimes considered vitamin-like), but supplementation safety above dietary background levels in human pregnancy has not been established. Do not use without medical supervision.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnder 18.\u003c\/strong\u003e PQQ has not been studied in children or adolescents. Pediatric mitochondrial dysfunction is its own clinical area and any supplementation should be managed by a specialist.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone on chemotherapy or other treatment that depends on mitochondrial dysfunction in target cells.\u003c\/strong\u003e Some cancer therapies work by exploiting mitochondrial vulnerability in malignant cells; supporting mitochondrial biogenesis and antioxidant capacity during such treatment may interfere with therapeutic intent. Discuss with your oncology team before adding any antioxidant or mitochondrial supplement during active cancer treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone scheduled for surgery within two weeks.\u003c\/strong\u003e The mild antioxidant activity of PQQ may theoretically affect surgical bleeding response or anesthesia metabolism. Stop two weeks before any planned procedure as a standard precaution and resume after your surgeon clears post-operative supplementation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone with a known sensitivity to quinone-class compounds.\u003c\/strong\u003e PQQ is a quinone — chemically related to ubiquinone (CoQ10) and the K-vitamins. Rare individual sensitivities have been reported, typically presenting as nausea or mild headache at higher doses. Start at one capsule and monitor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone on warfarin or other anticoagulant therapy.\u003c\/strong\u003e No published evidence of direct interaction, but quinone-class compounds participate in vitamin-K-related coagulation chemistry. If you are on warfarin, your INR should be monitored when adding any new antioxidant or mitochondrial supplement; talk with your prescriber first.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is PQQ different from CoQ10?\u003c\/strong\u003e\u003cbr\u003e\nThey work on completely different layers of mitochondrial health, and the cleanest way to think about them is as the population-versus-function pair. CoQ10 sits inside the inner mitochondrial membrane and shuttles electrons through Complex I, II, and III of the electron transport chain — it is a functional cofactor for ATP production in \u003cem\u003eexisting\u003c\/em\u003e mitochondria. PQQ doesn't do that. PQQ acts upstream at the gene-expression level, signaling the cell to build \u003cem\u003emore\u003c\/em\u003e mitochondria via PGC-1α activation. They're complementary, not redundant. The Nakano 2009 trial directly compared the two and found that the combination outperformed either alone on cognitive endpoints — that result is the empirical case for stacking them. If you can only take one, your decision should follow your symptom profile: CoQ10 if your concern is energy \/ heart \/ statin support, PQQ if your concern is age-related cognitive decline \/ long-term mitochondrial density.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is PQQ different from Urolithin A?\u003c\/strong\u003e\u003cbr\u003e\nUrolithin A drives mitophagy — the controlled clearance of damaged mitochondria via the PINK1 \/ Parkin pathway. It removes broken units. PQQ drives biogenesis — the creation of new mitochondria via PGC-1α \/ CREB \/ NRF1. It builds new units. Together they form a renewal cycle: clear the broken ones (Urolithin A), build new ones (PQQ), keep the rest running (CoQ10), and supply the energy currency they all spend (NMN \/ NAD\u003csup\u003e+\u003c\/sup\u003e). This is the four-layer model and stacking all four is the most complete mitochondrial protocol we publish.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is PQQ different from NMN, NR, or other NAD\u003csup\u003e+\u003c\/sup\u003e precursors?\u003c\/strong\u003e\u003cbr\u003e\nNMN and NR raise NAD\u003csup\u003e+\u003c\/sup\u003e, the substrate that mitochondria spend during oxidative phosphorylation and that sirtuin enzymes consume during cellular signaling. NAD\u003csup\u003e+\u003c\/sup\u003e is the energy currency. PQQ doesn't increase NAD\u003csup\u003e+\u003c\/sup\u003e — it increases the number of mitochondria that \u003cem\u003espend\u003c\/em\u003e NAD\u003csup\u003e+\u003c\/sup\u003e. If NAD\u003csup\u003e+\u003c\/sup\u003e is the dollar bills, PQQ is the staff that earns and spends them. Both layers matter; neither replaces the other. The Liposomal NAD+ Ultimate, Pure NMN, NMN 1000mg, NR Hard Capsules, NAD+ Daily Boost, Liquid NAD+, NAD+ Pure Focus, and NAD+ 5-in-1 in this catalog all address the fuel layer; PQQ addresses the population layer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I just get PQQ from food?\u003c\/strong\u003e\u003cbr\u003e\nTechnically yes — PQQ is present in trace amounts in fermented soybeans (natto), parsley, green tea, papaya, kiwi, and a few other plant foods. Practically no — the typical Western diet provides roughly 0.1–0.4mg per day, while the supplementation studies use 10–20mg per day. You'd need to eat several pounds of natto daily to reach the studied dose, which isn't a realistic protocol for most people, and the natto fermentation profile is not well tolerated by Western palates. The dose at which the published cognitive and biogenesis effects are seen is fifty to two hundred times the typical dietary intake. This is one of the cleaner \"supplementation makes sense\" cases in nutrition science.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is 20mg the right dose?\u003c\/strong\u003e\u003cbr\u003e\n20mg per day is the dose used in the most-cited human studies, including the Harris 2010 mitochondrial-density \/ inflammation study, the Nakano 2009 PQQ + CoQ10 cognitive study, and the Itoh 2016 fatigue\/sleep trial. Higher doses (40mg) have been used safely in some protocols but did not produce proportionally larger effects on the published endpoints; lower doses (10mg) underperformed. 20mg is the dose the published research converges on as the empirical sweet spot for healthy adults. If you have specific clinical reasons (mitochondrial myopathy, severe cognitive complaint, fertility protocol) to pursue a higher or lower dose, that decision should be made with a specialist.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Will I feel anything from PQQ on day one?\u003c\/strong\u003e\u003cbr\u003e\nProbably not. PQQ works by changing what genes your cells transcribe — that takes weeks. Most users report no immediate effect, then notice gradual improvements in mental clarity and afternoon energy somewhere between weeks 4 and 8. If you're looking for a same-day stimulant effect, PQQ is the wrong tool — caffeine, theanine, tyrosine, or the prescription nootropics will all be faster. PQQ is the long-horizon mitochondrial-density layer that compounds over months and supports the rest of your stack quietly. The clinical literature is consistent on this profile: gene-expression interventions take time and produce changes that are larger than they feel on any given day.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I take PQQ with my fertility protocol?\u003c\/strong\u003e\u003cbr\u003e\nPQQ is increasingly included in fertility-focused supplement protocols specifically because of its mitochondrial-biogenesis mechanism — oocytes contain roughly 100,000 mitochondria and sperm motility is almost entirely mitochondrial-ATP-dependent. It is commonly stacked with CoQ10 (or its reduced form, ubiquinol) in this context. That said, fertility is a medical area where any supplement should be discussed with your reproductive endocrinologist or fertility specialist, particularly if you are undergoing IVF or any active medical treatment. We provide the mechanistic rationale; your clinician knows your case, your medications, and your timeline.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Why does it need BioPerine?\u003c\/strong\u003e\u003cbr\u003e\nPQQ on its own has reasonable oral bioavailability — better than most flavonoids and roughly comparable to CoQ10 in lipid form. The BioPerine in this formula isn't strictly required for PQQ absorption itself; it's there to support the broader fat-soluble cofactor stack you're likely taking PQQ alongside (CoQ10, curcumin, vitamin D, vitamin K, astaxanthin) by inhibiting the gut and liver enzymes (UGT1A1, CYP3A4) that break those compounds down before they reach circulation. Same logic and same 5mg dose as the BioPerine in our Curcumin, Apigenin, Quercetin, and Fisetin formulas — the BioPerine works for the stack, not the single compound.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What does the science actually show about mitochondrial number and aging?\u003c\/strong\u003e\u003cbr\u003e\nThe single best summary is the Conley et al. 2000 \u003cem\u003eJournal of Physiology\u003c\/em\u003e paper, which used 31-phosphorus magnetic resonance spectroscopy in living human muscle to show that mitochondrial oxidative capacity in skeletal muscle declines roughly 50% between the third and seventh decades of life. Similar declines have been documented in cardiac muscle (Lesnefsky et al.), in brain tissue (Manczak et al.), and in oocytes (Wang et al.). The decline is real, measurable, and one of the more consistent biological signatures of aging. PQQ is one of the cleanest direct nutritional levers known for that specific endpoint. It does not stop the decline, but the supplementation studies show measurable shifts in the mitochondrial-related gene-expression and inflammation signatures that track with the decline.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I stack PQQ with my existing CoQ10?\u003c\/strong\u003e\u003cbr\u003e\nYes — that is the most-evidence-supported stacking pattern for PQQ, dating back to the Nakano 2009 trial. The two compounds work on adjacent layers: PQQ creates new mitochondria, CoQ10 functionally populates them as the obligate Complex I\/II\/III cofactor. Take both with the same fat-containing meal in the morning. Standard CoQ10 stacking dose is 100–400mg\/day; our CoQ10 product is 400mg per capsule, which is in the upper range of the standard published dose. There is no published evidence of any negative interaction between PQQ and CoQ10 at the doses used here.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What's the difference between BioPQQ™ and generic PQQ?\u003c\/strong\u003e\u003cbr\u003e\nBioPQQ™ is the brand name for fermentation-derived PQQ disodium salt produced by Mitsubishi Gas Chemical in Japan, which is the form used in essentially all of the published human clinical trials. Generic PQQ refers to chemically synthesized PQQ from any other source. The disodium-salt chemistry is identical between the two; the difference is the manufacturing process and the supply-chain quality assurance. We use pharmaceutical-grade BioPQQ™ disodium salt because that is the form with the published bioavailability and clinical-effect data; if you compared a research paper on \"PQQ supplementation\" to the bottle in your hand, this is the form you would want to match.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Are there any reported side effects?\u003c\/strong\u003e\u003cbr\u003e\nAt the 20mg\/day dose, published trials report essentially no significant adverse effects — the safety profile in healthy adults is very clean. At higher doses (60mg+) there are isolated reports of mild gastrointestinal discomfort, headache, or transient sleep changes. Standing recommendations: start at one capsule per day, take with food, and if you tolerate it after a week, that is your protocol. There is no need to escalate above 20mg unless directed by a specialist.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eBioPQQ™-grade pyrroloquinoline quinone disodium salt, manufactured in a GMP-certified facility, third-party tested for identity, purity, heavy metals (lead, arsenic, cadmium, mercury), residual solvents, and microbial contamination (total plate count, yeast and mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e). No magnesium stearate. No titanium dioxide. No artificial colors. No silicon dioxide. No fillers, dyes, or excipients beyond the active ingredients. Vegan capsule (vegetable cellulose). Bottle is BPA-free. Made in the USA in a cGMP-certified facility.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use, especially if you are pregnant, nursing, taking medication, scheduled for surgery, undergoing cancer treatment, or have an ongoing medical condition. Individual results vary. The references to clinical trials in this description are provided for mechanistic context and are not claims of treatment efficacy for any specific disease. PQQ is a dietary supplement, not a medication, and does not substitute for any prescribed therapy.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839440765146,"sku":"THP-PQQ-20-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_pqq.png?v=1778047682"},{"product_id":"magnesium-glycinate-400mg-sleep-and-nad-methylation","title":"Magnesium Glycinate 400mg | TRAACS Bisglycinate for Sleep, NAD+ Methylation \u0026 Vitamin D Activation","description":"\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cp\u003eMagnesium is the mineral that runs the machinery you've been buying supplements to support. It is a required cofactor in over 600 enzymatic reactions including the ones that convert \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN into NAD+\u003c\/a\u003e, that activate \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D\u003c\/a\u003e into its hormone form, that build ATP from glucose and fat, and that let muscles relax after they contract. The Western diet provides roughly half of what those reactions need. Roughly two-thirds of American adults fall short of the RDA, and the soft signs of insufficiency (poor sleep, muscle cramps, restless legs, anxiety that won't quit, irregular heartbeat, constipation) are so common we've stopped calling them deficiency at all.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMagnesium Glycinate\u003c\/strong\u003e (also called magnesium bisglycinate) is the form most often used in clinical research and in physician-supervised longevity protocols: magnesium bound to two glycine amino acids, absorbed through amino-acid transporters at near-80% efficiency, with minimal laxative effect even at full daily dose. The glycine half is itself a calming neurotransmitter that supports slow-wave sleep, which is why this specific form is the one Andrew Huberman, the Bryan Johnson Blueprint protocol, and Rhonda Patrick all default to for daily use.\u003c\/p\u003e\n\n\u003cp\u003eIf you take any of the longevity supplements in this catalog (\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D\u003c\/a\u003e, \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e, B-vitamins) you are spending those compounds on suboptimal chemistry whenever magnesium is low. Two large mortality datasets (Fang et al., \u003cem\u003eBMC Medicine\u003c\/em\u003e 2016, n \u0026gt; 1 million; Zhao et al., \u003cem\u003eNutrients\u003c\/em\u003e 2020 meta-analysis) found that each 100mg\/day increase in dietary magnesium intake associated with a 22% lower all-cause mortality risk and a 19% lower type 2 diabetes risk. Magnesium is the foundation that sits underneath every other longevity intervention.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThis bottle.\u003c\/strong\u003e 60 vegetarian capsules of \u003cstrong\u003eTRAACS®\u003c\/strong\u003e-patented magnesium bisglycinate chelate, 400mg of elemental magnesium per 2-capsule serving (the number on the label is elemental magnesium, not the chelate weight, so the dose is real). No magnesium stearate, no silicon dioxide, no titanium dioxide, no soy oil. Manufactured in a U.S. cGMP facility, third-party tested for identity, potency, heavy metals, and microbials. One bottle = 30 days at the standard pre-bed protocol.\u003c\/p\u003e\n\n\u003ch2\u003eWhy magnesium ended up in serious longevity research\u003c\/h2\u003e\n\n\u003cp\u003eFor decades magnesium was treated as a \"nutritional minimum\" (hit the RDA, move on). The longevity reframing came from three lines of evidence converging in the 2010s.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe mortality data.\u003c\/strong\u003e The Framingham Offspring Study and the meta-analyses that followed it (Fang et al., \u003cem\u003eBMC Medicine\u003c\/em\u003e 2016, pooling 40 prospective studies and 1,000,000+ participants) found that each 100mg\/day increase in dietary magnesium associated with a 7% lower risk of cardiovascular disease, a 19% lower risk of type 2 diabetes, and a 22% lower risk of all-cause mortality, holding after adjustment for age, BMI, smoking, alcohol, physical activity, energy intake, and dietary calcium and potassium. The effect was largest at the lower end of the intake distribution, which is exactly where most modern Western diets sit (220–270mg\/day vs an RDA of 320–420mg).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe mechanism work.\u003c\/strong\u003e Researchers studying why \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e and other NAD+ precursors produced inconsistent results in aging humans kept finding the same upstream pattern: every step of NAD+ chemistry runs on magnesium. The \u003cstrong\u003eNAMPT\u003c\/strong\u003e enzyme that performs the rate-limiting step in NAD+ biosynthesis (NMN → NAD+) is a magnesium-dependent enzyme, with two Mg²⁺ ions in the catalytic site (Burgos \u0026amp; Schramm, \u003cem\u003eBiochemistry\u003c\/em\u003e 2008). The \u003cstrong\u003eSAMe → SAH\u003c\/strong\u003e methylation cycle that supplies the methyl groups \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG and methyl-donors\u003c\/a\u003e support is also Mg-dependent. The conversion of inactive 25-hydroxy-Vitamin D into active 1,25-dihydroxy-Vitamin D in the kidney is performed by CYP27B1, a magnesium-dependent enzyme (Uwitonze \u0026amp; Razzaque, \u003cem\u003eJAOA\u003c\/em\u003e 2018). People with low intracellular magnesium were spending their NAD+ precursors and methyl donors and Vitamin D on basic survival chemistry, with little left over for the cellular renewal those compounds are supposed to fund.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe sleep evidence.\u003c\/strong\u003e The cellular work most longevity research is trying to unlock (autophagy, mitochondrial repair, glymphatic clearance of brain waste, growth-hormone release, glucocorticoid normalization) happens during deep sleep. Magnesium is required for the GABA-A receptor pathway that initiates and sustains slow-wave (N3) sleep, and for the NMDA-receptor antagonism that prevents nighttime arousals. Two double-blind randomized trials (Abbasi et al., \u003cem\u003eJournal of Research in Medical Sciences\u003c\/em\u003e 2012; Held et al., \u003cem\u003ePharmacopsychiatry\u003c\/em\u003e 2002) showed measurable improvements in sleep architecture (sleep onset latency, slow-wave sleep duration, serum cortisol, sleep efficiency) with supplementation in older adults with baseline insufficiency. If a longevity stack doesn't fix sleep, much of it is being spent on a body that can't repair itself overnight. Magnesium glycinate is the cheapest, safest, best-tolerated intervention in that loop.\u003c\/p\u003e\n\n\u003ch2\u003eWhat magnesium actually does (eight roles)\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003e1. Energy production (Mg-ATP).\u003c\/strong\u003e Every molecule of ATP your mitochondria produce circulates as Mg²⁺-ATP. The magnesium ion is what makes ATP biologically active: without it, ATP is a chemically inert phosphate string that no enzyme can use. Low magnesium and your \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + NMN + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e stack still produces ATP, but the ATP that comes out is harder for downstream enzymes to use.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. NAD+ biosynthesis (NAMPT cofactor).\u003c\/strong\u003e NAMPT, the rate-limiting enzyme in the NAD+ salvage pathway, requires two Mg²⁺ ions in its catalytic pocket (Burgos \u0026amp; Schramm 2008). Insufficient intracellular magnesium and your NMN supplementation hits a kinetic ceiling regardless of how much you take. This is one of the under-appreciated reasons for inconsistent NAD+ supplementation responses in human cohorts. Add magnesium and the dose-response curve straightens out.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. Sleep architecture (GABA + NMDA).\u003c\/strong\u003e Magnesium activates the GABA-A receptor (the same target as benzodiazepines and Z-drugs but without the hangover, dependence, or REM-suppression) and antagonizes the NMDA receptor (which prevents the glutamate-driven nighttime arousals that fragment sleep). The glycine half of glycinate adds its own GABA-promoting effect at the spinal level and reduces core body temperature via vasodilation, which is itself a sleep-onset signal (Bannai \u0026amp; Kawai, \u003cem\u003eFrontiers in Neurology\u003c\/em\u003e 2012).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. Muscle relaxation and cramp prevention.\u003c\/strong\u003e Magnesium is the antagonist that lets calcium-triggered contraction reverse. Cramps, twitches, restless legs, eyelid fasciculations, tension headaches: these are typically the first visible signs of insufficiency and the first thing to resolve on supplementation. Supplementation studies in pregnancy, athletes, and statin-induced cramping are consistently positive within 2–3 weeks.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e5. Cardiovascular rhythm.\u003c\/strong\u003e Magnesium stabilizes the electrical conduction system of the heart by modulating the inward-rectifier potassium current and the L-type calcium channel. Atrial fibrillation incidence increases with low intracellular magnesium (Khan et al., \u003cem\u003eAmerican Heart Journal\u003c\/em\u003e 2013), and many palpitations and benign ectopic beats settle when intracellular Mg normalizes. This is well-established cardiology, not theory.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e6. Insulin sensitivity.\u003c\/strong\u003e Magnesium is required for the insulin receptor's tyrosine kinase to phosphorylate IRS-1 (Kostov, \u003cem\u003eInternational Journal of Molecular Sciences\u003c\/em\u003e 2019). Insufficiency is a modifiable contributor to the insulin-resistance pattern that drives metabolic aging and is one of the reasons \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e and magnesium pair logically in glucose-control protocols.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e7. Vitamin D activation.\u003c\/strong\u003e Inactive 25-OH-Vitamin D is converted to the active 1,25-(OH)₂D hormone by the kidney CYP27B1 enzyme, which is magnesium-dependent. High-dose \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D\u003c\/a\u003e taken without sufficient magnesium can produce flat 25-OH-D blood levels (the substrate is there, the conversion stalls) and a higher risk of the symptoms many people associate with \"Vitamin D toxicity\" (which is often actually a magnesium-depletion presentation triggered by the unconverted Vitamin D pool).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e8. Anxiety and HPA-axis dampening.\u003c\/strong\u003e Magnesium dampens cortisol release from the adrenal cortex and the sympathetic-nervous-system tone in the hypothalamus. A systematic review (Boyle et al., \u003cem\u003eNutrients\u003c\/em\u003e 2017, 18 trials) found modest but consistent reductions in self-reported anxiety scores at 248–500mg\/day in people with mild-to-moderate symptoms, with the largest effects in those with concurrent magnesium insufficiency.\u003c\/p\u003e\n\n\u003ch2\u003eWhy glycinate, specifically (and why most magnesium products fail)\u003c\/h2\u003e\n\n\u003cp\u003eMagnesium comes in roughly a dozen common forms, and they are not interchangeable. The cheap forms are cheap for a reason. This is the single largest distinction between a magnesium product that works and one that doesn't.\u003c\/p\u003e\n\n\u003ctable style=\"border-collapse:collapse;border:1px solid #ccc;width:100%;margin:1em 0;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f5f5f5;\"\u003e\n\u003cth style=\"border:1px solid #ccc;padding:8px;text-align:left;\"\u003eForm\u003c\/th\u003e\n\u003cth style=\"border:1px solid #ccc;padding:8px;text-align:left;\"\u003eApprox. absorption\u003c\/th\u003e\n\u003cth style=\"border:1px solid #ccc;padding:8px;text-align:left;\"\u003e% elemental Mg\u003c\/th\u003e\n\u003cth style=\"border:1px solid #ccc;padding:8px;text-align:left;\"\u003eBest use case\u003c\/th\u003e\n\u003cth style=\"border:1px solid #ccc;padding:8px;text-align:left;\"\u003eGI burden\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003eMagnesium oxide\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~4%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~60%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eLaxative only\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eSevere loose stools at meaningful doses\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003eMagnesium citrate\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~25–30%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~16%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eOccasional constipation\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eDose-dependent loose stools\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#fff8e1;\"\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003eMagnesium glycinate (TRAACS)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003e~80%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~14%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003eDaily-driver: sleep, NAD+, methylation, anxiety\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eMinimal even at 400–600mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003eMagnesium L-threonate\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~75% (brain-targeted)\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~7%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eCognitive support adjunct (low elemental dose)\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eMinimal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003eMagnesium taurate\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~50%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~9%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eCardiovascular adjunct\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eMinimal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003eMagnesium malate\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~40%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~6.5%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eDaytime energy \/ fibromyalgia\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eMild\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003eMagnesium orotate\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~40%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~7%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eCardiac niche (cost-prohibitive)\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eMinimal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e\u003cstrong\u003eMagnesium sulfate (Epsom)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eTopical: trace; oral: laxative\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003e~10%\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eBath soak only\u003c\/td\u003e\n\u003ctd style=\"border:1px solid #ccc;padding:8px;\"\u003eSevere oral GI burden\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eMagnesium oxide\u003c\/strong\u003e (the form in most drugstore tablets, often \"500mg of magnesium oxide\" on the label and quietly delivering ~20mg of usable magnesium) has bioavailability around 4%. It mostly stays in the gut and pulls water in, which is why it works as a laxative and not much else. If you've taken magnesium and felt nothing except a trip to the bathroom, this is probably what you took. Most cheap multivitamins use this form because it costs almost nothing and lets the label claim \"100% RDA magnesium\" while delivering a negligible systemic dose.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMagnesium citrate\u003c\/strong\u003e is better absorbed (~25–30%) but still has a dose-dependent laxative effect. Useful for occasional constipation; not what you want for daily systemic supplementation, sleep, or methylation support, because the dose that delivers a useful amount of magnesium also delivers loose stools.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMagnesium glycinate (bisglycinate)\u003c\/strong\u003e chelates the mineral to two glycine molecules. The body absorbs the whole package through amino-acid transporters (the same transporters that absorb dietary protein) rather than through the saturable mineral-absorption channels in the small intestine. The result is absorption approaching 80%, no laxative effect even at 400–600mg, and the glycine itself contributes additional GABA-promoting and sleep-supportive effects. This is the form used in most published sleep, anxiety, and longevity-protocol research.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMagnesium L-threonate\u003c\/strong\u003e has an interesting brain-bioavailability story (it crosses the blood-brain barrier more efficiently than other forms, see Slutsky et al., \u003cem\u003eNeuron\u003c\/em\u003e 2010) but provides only ~7% elemental magnesium per capsule. A $40 bottle gives you maybe 50mg of actual magnesium per dose, which is well below the systemic threshold most other benefits require. It's a complement to glycinate for memory-targeted use, not a replacement for the daily systemic dose.\u003c\/p\u003e\n\n\u003ch2\u003eWhy TRAACS specifically (and what most \"bisglycinate\" labels hide)\u003c\/h2\u003e\n\n\u003cp\u003eOne of the longstanding problems with bisglycinate manufacturing is that the chelate bond is fragile. A poorly-chelated bisglycinate dissociates in stomach acid, releases the glycine, and leaves the magnesium ion behind to behave like ordinary magnesium oxide once it hits the gut. You end up with the price of glycinate and the absorption of oxide. There is no way to tell from a label which is which.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eTRAACS®\u003c\/strong\u003e (The Real Amino Acid Chelate System) is Albion Labs' patented chelation process that uses a specific mineral-to-amino-acid ratio and a controlled-pH manufacturing window to produce a chelate that survives gastric pH all the way to the small intestine, where the amino-acid-transporter absorption pathway picks it up. The Albion patents (US 6,710,079; US 7,232,786) and the third-party absorption studies behind them (Schuette et al., \u003cem\u003eJPEN\u003c\/em\u003e 1994; Coudray et al., \u003cem\u003eMagnesium Research\u003c\/em\u003e 2005) are the reason TRAACS is the form chosen for most clinical supplementation trials and for the major physician-supervised longevity programs. We use it here for the same reason.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's actually in the bottle\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMagnesium Bisglycinate Chelate (TRAACS®) — 400mg of elemental magnesium\u003c\/strong\u003e per 2-capsule serving. The number on the label is the elemental dose, not the chelate weight, so the label and the dose match.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHPMC (vegetable cellulose) capsules\u003c\/strong\u003e, no magnesium stearate, no silicon dioxide, no titanium dioxide, no soy oil, no shellac, no carrageenan.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExcipient-free.\u003c\/strong\u003e Many bisglycinate products use 30–40% capsule volume for stearates and silicates that improve manufacturing throughput at the cost of dissolution time and absorption. This product does not.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNon-GMO, gluten-free, soy-free, dairy-free, vegan\u003c\/strong\u003e, manufactured in a U.S. cGMP-certified facility, third-party tested by lot for identity (HPLC), potency, microbial limits (USP \u0026lt;61\u0026gt;\/\u0026lt;62\u0026gt;), heavy metals (USP \u0026lt;232\u0026gt;\/\u0026lt;233\u0026gt; ICP-MS for arsenic, cadmium, lead, mercury), and pesticide residues.\u003c\/li\u003e\n\u003cli\u003e60 capsules per bottle. Default protocol: 2 capsules at night = 30 days per bottle. Split protocol (1 morning + 1 night) = 30 days per bottle. Lower-dose maintenance (1 capsule pre-bed) = 60 days per bottle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it (four protocols)\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eDefault protocol — 400mg at night, 60–90 minutes before bed.\u003c\/strong\u003e 2 capsules with water (food not required, but tolerated either way). This is the dose used in most sleep and recovery research (Abbasi 2012 used 500mg\/day; Held 2002 used 500mg\/day in older adults). Effect on sleep onset and quality typically appears within the first 3–7 days; the cardiovascular and metabolic effects build over 4–8 weeks as intracellular magnesium normalizes.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSplit protocol — 200mg morning + 200mg evening.\u003c\/strong\u003e 1 capsule with breakfast, 1 capsule before bed. Works well for people stacking with NMN\/NAD+ in the morning (magnesium supports the NAMPT-driven NMN→NAD+ conversion and the methylation cycle) and still wanting the sleep benefit at night. Slightly better daily floor for muscle-cramp, restless-leg, and palpitation use cases.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eNAD+ stack pairing.\u003c\/strong\u003e If you're already taking \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1\u003c\/a\u003e, \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Pure Focus\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e, or \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e, magnesium sits underneath all of them. Take 200mg with the morning NAD+ protocol; the NAMPT enzyme runs more cleanly with adequate magnesium present.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eVitamin D pairing.\u003c\/strong\u003e If you take \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 + K2\u003c\/a\u003e, magnesium is required for the kidney CYP27B1 enzyme to convert it to the active 1,25-(OH)₂D hormone form. High-dose Vitamin D without adequate magnesium often produces flat 25-OH-D blood levels (the body has the substrate but can't process it) and a higher rate of the symptoms commonly mislabeled as \"Vitamin D toxicity.\" Take Vitamin D and magnesium together.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eGlyNAC and glutathione pairing.\u003c\/strong\u003e If you're running a \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e GlyNAC stack, magnesium glycinate stacks cleanly: the glycine half of the chelate adds to the glutathione-substrate pool, the magnesium half is required for the gamma-glutamyl-cysteine ligase enzyme that performs the rate-limiting step of glutathione synthesis. The pre-bed glycine dose from glycinate (400mg of elemental Mg = roughly 1.6g of glycine, ~half the Sekhar GlyNAC trial dose) provides the sleep-architecture benefit on its own.\u003c\/p\u003e\n\n\u003cp\u003eAllow 2–3 weeks for steady-state intracellular magnesium levels. Magnesium supplementation is a slow-build, not a switch. The serum magnesium test most labs run (RBC magnesium, or worse, total serum magnesium) is a poor proxy for intracellular levels — it can read normal while you are functionally insufficient.\u003c\/p\u003e\n\n\u003ch2\u003eWeek-by-week: what to expect\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eDays 1–7.\u003c\/strong\u003e The first effect most people notice is sleep onset. Falling asleep faster, fewer middle-of-the-night arousals, waking less often to urinate, more vivid dreams (a slow-wave-sleep marker). Some people notice an immediate reduction in muscle twitches, eyelid fasciculations, and restless-leg sensations on day 1–2.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWeeks 2–4.\u003c\/strong\u003e Cramp resolution is largely complete by week 2. Anxiety floor drops (Boyle 2017 trial timing). HPA-axis dampening shows up as easier-to-recover-from-stress responses. People stacking with \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e often notice the NAD+ benefits become more consistent in this window, as the NAMPT reaction finally has its cofactor floor.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWeeks 4–8.\u003c\/strong\u003e Cardiovascular signal: blood pressure typically drops 2–4 mmHg in people with baseline hypertension and adequate baseline insufficiency (Zhang et al., \u003cem\u003eHypertension\u003c\/em\u003e 2016 meta-analysis). Insulin sensitivity improves measurably (HOMA-IR, fasting insulin) in people with metabolic-syndrome features. Bone metabolism markers shift in the bone-positive direction.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMonths 2–6.\u003c\/strong\u003e Intracellular magnesium fully normalized. The compound effects of better sleep, lower cortisol, better insulin sensitivity, and better NAD+ chemistry compound on each other. People stacking with \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e see the 25-OH-D blood level finally move into the optimal 40–60 ng\/mL range that Vitamin D alone could not deliver.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eYear 1+.\u003c\/strong\u003e The Fang 2016 BMC Medicine mortality endpoints (cardiovascular, type 2 diabetes, all-cause) are population-level signals. The compounding window is what matters: the Mg-dependent enzymes that protect cardiovascular and metabolic health work better every day they have adequate cofactor.\u003c\/p\u003e\n\n\u003ch2\u003eStack pairings (and what each does)\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e \/ \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e\u003c\/strong\u003e — NAMPT cofactor (the rate-limiting enzyme of NAD+ biosynthesis is Mg-dependent). Every NMN dose runs cleaner with adequate magnesium present.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e\u003c\/strong\u003e — methylation pairing. The SAMe → SAH → homocysteine cycle that processes NAD+ byproducts is Mg-dependent at multiple steps. Magnesium and TMG together close the loop.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/strong\u003e — required for activation. Vitamin D stack is approximately half-effective without adequate magnesium.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\u003c\/strong\u003e — additive sleep support and glutathione substrate. The bisglycinate chelate already delivers ~1.6g glycine per 400mg Mg dose; adding free glycine pushes total glycine into the GlyNAC trial range.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e\u003c\/strong\u003e — completes the GlyNAC pair for glutathione restoration in older adults (Sekhar Baylor RCT design).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e\u003c\/strong\u003e — additive insulin-sensitivity effect. Berberine activates AMPK; magnesium supports the insulin receptor's tyrosine kinase. The two run on parallel pathways and stack cleanly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e\u003c\/strong\u003e — Mg-ATP is what mitochondria actually produce. CoQ10 supports the electron transport chain that generates ATP; magnesium makes the ATP usable.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e\u003c\/strong\u003e — additive HPA-axis dampening. Ashwagandha lowers cortisol via the limbic pathway; magnesium dampens the adrenal-cortex side. Useful for sleep-onset anxiety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e\u003c\/strong\u003e — additive cardiovascular rhythm support and additional GABA-receptor activity. Magnesium taurate is a known cardiac niche; the same pairing works with the two compounds taken separately.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA 2000mg\u003c\/a\u003e\u003c\/strong\u003e — additive cardiovascular signal and additive anti-inflammatory effect. The Mg + Omega-3 + Vit D triad is the cardiovascular-foundation default.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003eAnyone running an \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eNAD+\u003c\/a\u003e, or \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eresveratrol\u003c\/a\u003e protocol — magnesium is the cofactor those compounds need to work properly.\u003c\/li\u003e\n\u003cli\u003eAnyone taking \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003ehigh-dose Vitamin D\u003c\/a\u003e who isn't already supplementing magnesium.\u003c\/li\u003e\n\u003cli\u003eAnyone with sleep-onset latency \u0026gt; 20 minutes, frequent middle-of-night awakenings, or low-grade morning anxiety.\u003c\/li\u003e\n\u003cli\u003eAnyone with muscle cramps, restless legs, eyelid twitches, tension headaches, or post-workout cramping.\u003c\/li\u003e\n\u003cli\u003eAnyone over 50 (intracellular magnesium drops with age, kidney loss increases, soft-tissue cramps and atrial-fibrillation risk both rise).\u003c\/li\u003e\n\u003cli\u003eAnyone on diuretics, PPIs (Prilosec, Nexium, Protonix), metformin, or chronic alcohol use — these all increase renal magnesium loss.\u003c\/li\u003e\n\u003cli\u003eAnyone with elevated baseline anxiety, mild-to-moderate depression, or stress-driven cortisol patterns.\u003c\/li\u003e\n\u003cli\u003eAthletes and weight-trainers — additive recovery effect and reduced post-workout cramping.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSevere kidney disease (eGFR \u0026lt; 30).\u003c\/strong\u003e The kidneys excrete excess magnesium; impaired kidneys can let it accumulate to clinically dangerous levels (hypermagnesemia). Talk to your nephrologist before supplementing at any dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eActive hypermagnesemia or magnesium-toxicity history.\u003c\/strong\u003e Same logic.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMyasthenia gravis.\u003c\/strong\u003e Magnesium can exacerbate neuromuscular weakness in this condition.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSevere bradycardia or symptomatic AV block.\u003c\/strong\u003e Discuss with your cardiologist — magnesium slightly slows AV nodal conduction.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic abdominal use of bisphosphonates, tetracyclines, or quinolones\u003c\/strong\u003e without separating dose timing — see interactions below.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone seeking an immediate stimulant effect.\u003c\/strong\u003e Magnesium is calming and foundational, not energizing. If you're looking for next-day energy, this isn't it; it's the floor that lets the rest of the stack work.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDrug interactions (what to separate, what to coordinate)\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTetracyclines (doxycycline) and fluoroquinolones (ciprofloxacin, levofloxacin):\u003c\/strong\u003e magnesium can chelate these antibiotics in the gut and reduce their absorption. Separate doses by 2 hours either side.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBisphosphonates (Fosamax\/alendronate, Boniva\/ibandronate, etc.):\u003c\/strong\u003e same binding issue. Separate by 2 hours.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLevothyroxine (Synthroid) and other thyroid replacement:\u003c\/strong\u003e separate by 4 hours to avoid reduced absorption.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiuretics (furosemide, hydrochlorothiazide):\u003c\/strong\u003e these \u003cem\u003eincrease\u003c\/em\u003e renal magnesium loss. Supplementation is often more important for people on these drugs, but coordinate with the prescribing physician for dose-monitoring.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePPIs (omeprazole, esomeprazole, pantoprazole):\u003c\/strong\u003e chronic PPI use depletes magnesium. The FDA issued a public-health advisory in 2011 specifically about hypomagnesemia from long-term PPI use. Supplementation is typically warranted but should be coordinated.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetformin:\u003c\/strong\u003e increases urinary magnesium loss; type 2 diabetics on metformin frequently run subclinical magnesium insufficiency that magnesium glycinate corrects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigoxin:\u003c\/strong\u003e hypomagnesemia potentiates digoxin toxicity; magnesium normalization is desirable but the timing should be coordinated with cardiology.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding:\u003c\/strong\u003e magnesium glycinate is generally considered safe at standard doses (and is sometimes prescribed for leg cramps, sleep, and pre-eclampsia prevention) but check with your OB\/GYN before starting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe most common side effect even at full dose is loose stools, which is much less common with TRAACS bisglycinate than with citrate, oxide, or sulfate, but still possible if you are sensitive. If it happens, drop to 200mg and increase only if tolerated.\u003c\/p\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eI take a multivitamin that has magnesium — do I need this?\u003c\/strong\u003e Most multivitamins contain 50–100mg of magnesium oxide, which absorbs at ~4%, delivering 2–4mg of usable magnesium per dose. The RDA is 320mg (women) to 420mg (men). A multivitamin alone gets you almost nothing of what your body needs, even before considering increased loss from caffeine, alcohol, stress, exercise, and the medications above.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eGlycinate vs. L-threonate vs. citrate vs. taurate — which is \"best\"?\u003c\/strong\u003e They have different specialties. Glycinate (TRAACS bisglycinate) is the daily-driver form for systemic supplementation, sleep, NAD+\/methylation support, anxiety, and cramps — the highest absorption with the lowest GI burden and the meaningful elemental dose. L-threonate is brain-targeted but provides only ~7% elemental magnesium, so it's a complement rather than a replacement. Citrate is for occasional constipation. Taurate is sometimes used specifically for cardiovascular niche cases. Malate is sometimes used for daytime energy in fibromyalgia protocols. For someone taking a single magnesium product, glycinate is the right default.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this make me drowsy during the day?\u003c\/strong\u003e Magnesium is calming, not sedating. The split protocol (200mg AM, 200mg PM) is well-tolerated by most people without daytime drowsiness — glycinate's calming effect is more \"removes the anxiety floor\" than \"adds sleepiness.\" If you find a morning dose dulls you, take the full 400mg at night.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I just eat more pumpkin seeds and dark chocolate?\u003c\/strong\u003e The richest food sources (pumpkin seeds, almonds, cashews, dark leafy greens, dark chocolate, black beans, avocado) contain 50–150mg per serving — but modern soils are magnesium-depleted (decades of synthetic-fertilizer use without remineralization), food processing strips most of it out, and the absorption from food is around 30–40%. Even a near-perfect diet often only delivers 250–300mg\/day, which is below the RDA. Supplementation closes the gap; it doesn't replace the diet.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I feel something?\u003c\/strong\u003e Sleep effects: usually within 3–7 days for people with baseline insufficiency. Cramp\/twitch reduction: 1–2 weeks. Cardiovascular and metabolic effects: 4–8 weeks. Anxiety effects: 2–4 weeks at consistent dosing. The compound is foundational — it's not a stimulant, you won't feel it the day you take it the way you'd feel caffeine.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes it interact with the longevity stack?\u003c\/strong\u003e No negative interactions with NMN, NAD+ products, Resveratrol, Spermidine, Fisetin, Quercetin, TMG, Apigenin, Curcumin, Urolithin A, PQQ, CoQ10, Astaxanthin, or any of the collagens. Positive synergy with NMN\/NAD+ (NAMPT cofactor), with Vitamin D (CYP27B1 cofactor for activation), with TMG (methylation cycle support), and with Glycine\/NAC (GlyNAC and glutathione-substrate pathway).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs \"TRAACS\" different from regular bisglycinate?\u003c\/strong\u003e TRAACS is Albion Labs' patented chelation process; the patents (US 6,710,079 and US 7,232,786) describe a specific pH-controlled ratio and processing step that produces a chelate that survives gastric acid intact. Generic \"bisglycinate\" without TRAACS or another verified chelation patent often dissociates in the stomach and absorbs more like magnesium oxide than like the bisglycinate the label implies. Schuette et al. (\u003cem\u003eJPEN\u003c\/em\u003e 1994) and Coudray et al. (\u003cem\u003eMagnesium Research\u003c\/em\u003e 2005) are the foundational human-absorption studies; both used the patented chelate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about magnesium \"buffered\" with magnesium oxide to hit a higher dose?\u003c\/strong\u003e Many cheaper bisglycinate labels do this. The label might read \"magnesium bisglycinate (and oxide)\" or just \"magnesium\" with the form unspecified. The buffered version blends 30–50% magnesium oxide into the chelate to lower the production cost; you end up paying for bisglycinate and getting a partial dose of oxide. Read the label closely. This product is 100% TRAACS bisglycinate, no oxide buffering.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with NMN or NAD+ first thing in the morning?\u003c\/strong\u003e Yes, and it's the recommended pairing — magnesium is the cofactor for the NAMPT enzyme that converts NMN into NAD+. The morning dose (200mg from the split protocol) is the right pairing window. The evening dose remains for sleep architecture.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy 400mg and not the higher doses some products advertise?\u003c\/strong\u003e 400mg of elemental magnesium per day is the dose that hits the cardiovascular, metabolic, and sleep endpoints in most published trials (Boyle 2017; Abbasi 2012; Zhang 2016). Higher doses don't add benefit and increase the risk of GI side effects. The published RDAs are 320mg (women) and 420mg (men); 400mg from supplementation plus 200–300mg from a typical diet covers the upper end without overshooting.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the capsule and mix the powder into a drink?\u003c\/strong\u003e Yes. Magnesium bisglycinate has a slightly bitter-saline taste that mixes acceptably into a smoothie, electrolyte drink, or tart citrus beverage. The chelate is heat-stable up to 60°C, so it's fine in cold or warm drinks but not in hot tea or coffee.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDo I need to cycle off?\u003c\/strong\u003e No. Magnesium is a foundational mineral, not a hormetic compound. You don't develop tolerance and there's no benefit to cycling. The kidneys regulate magnesium tightly; excess is excreted. Continuous use is the default protocol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan children take it?\u003c\/strong\u003e Standard pediatric dosing is age- and weight-dependent (typically 80mg\/day for ages 1–3, 130mg\/day for 4–8, 240mg\/day for 9–13). Don't dose pediatric magnesium from an adult product; talk to your child's pediatrician about an age-appropriate formulation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat lab test should I run if I want to track this?\u003c\/strong\u003e Standard \"magnesium\" on a blood panel measures total \u003cem\u003eserum\u003c\/em\u003e magnesium, which is a poor proxy for intracellular magnesium and can read normal while you're functionally insufficient. The better tests are \u003cstrong\u003eRBC magnesium\u003c\/strong\u003e (red-blood-cell magnesium, available through Quest, LabCorp, and most direct-to-consumer panels) and \u003cstrong\u003emagnesium loading tests\u003c\/strong\u003e (rarely run outside research). RBC magnesium responds to supplementation over weeks-to-months and is the test the longevity-medicine community uses to track this.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003eFang X. et al. \u003cem\u003eBMC Medicine\u003c\/em\u003e, 2016. \"Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies.\" Pooled analysis of 40 studies, n \u0026gt; 1,000,000. 22% lower all-cause mortality per 100mg\/day.\u003c\/li\u003e\n\u003cli\u003eBurgos E.S. \u0026amp; Schramm V.L. \u003cem\u003eBiochemistry\u003c\/em\u003e, 2008. \"Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase.\" Establishes NAMPT as a Mg²⁺-dependent enzyme.\u003c\/li\u003e\n\u003cli\u003eUwitonze A.M. \u0026amp; Razzaque M.S. \u003cem\u003eJournal of the American Osteopathic Association\u003c\/em\u003e, 2018. \"Role of Magnesium in Vitamin D Activation and Function.\" Mechanism review of the CYP27B1 \/ 25-OH-D → 1,25-(OH)₂D activation step.\u003c\/li\u003e\n\u003cli\u003eAbbasi B. et al. \u003cem\u003eJournal of Research in Medical Sciences\u003c\/em\u003e, 2012. \"The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial.\" 500mg\/day, 8 weeks. Improved sleep onset, sleep efficiency, serum cortisol.\u003c\/li\u003e\n\u003cli\u003eHeld K. et al. \u003cem\u003ePharmacopsychiatry\u003c\/em\u003e, 2002. \"Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans.\" 500mg\/day, 20 days. EEG-confirmed improvements in slow-wave sleep architecture.\u003c\/li\u003e\n\u003cli\u003eBoyle N.B. et al. \u003cem\u003eNutrients\u003c\/em\u003e, 2017. \"The Effects of Magnesium Supplementation on Subjective Anxiety and Stress — A Systematic Review.\" 18 trials, doses 248–500mg\/day. Modest but consistent anxiolytic effect.\u003c\/li\u003e\n\u003cli\u003eZhang X. et al. \u003cem\u003eHypertension\u003c\/em\u003e, 2016. \"Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials.\" 34 trials, n = 2,028. 2.00 mmHg systolic \/ 1.78 mmHg diastolic reduction overall, larger in baseline-insufficient subgroups.\u003c\/li\u003e\n\u003cli\u003eKhan A.M. et al. \u003cem\u003eAmerican Heart Journal\u003c\/em\u003e, 2013. \"Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.\" Low serum Mg associated with 50% higher AF incidence over 20-year follow-up.\u003c\/li\u003e\n\u003cli\u003eKostov K. \u003cem\u003eInternational Journal of Molecular Sciences\u003c\/em\u003e, 2019. \"Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling.\" Mechanism review of the insulin-receptor \/ IRS-1 phosphorylation step.\u003c\/li\u003e\n\u003cli\u003eSlutsky I. et al. \u003cem\u003eNeuron\u003c\/em\u003e, 2010. \"Enhancement of learning and memory by elevating brain magnesium.\" Magnesium L-threonate \/ brain-bioavailability mechanism paper.\u003c\/li\u003e\n\u003cli\u003eBannai M. \u0026amp; Kawai N. \u003cem\u003eFrontiers in Neurology\u003c\/em\u003e, 2012. \"New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep.\" Mechanism for the glycine half of the bisglycinate chelate.\u003c\/li\u003e\n\u003cli\u003eSchuette S.A. et al. \u003cem\u003eJPEN\u003c\/em\u003e, 1994. \"Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection.\" Foundational human absorption study for the patented chelate.\u003c\/li\u003e\n\u003cli\u003eCoudray C. et al. \u003cem\u003eMagnesium Research\u003c\/em\u003e, 2005. \"Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach.\" Cross-form absorption comparison.\u003c\/li\u003e\n\u003cli\u003eRosanoff A. et al. \u003cem\u003eNutrition Reviews\u003c\/em\u003e, 2012. \"Suboptimal magnesium status in the United States: are the health consequences underestimated?\" The \"two-thirds of US adults below RDA\" reference.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality and disclaimer\u003c\/h2\u003e\n\n\u003cp\u003eManufactured in a U.S. cGMP-certified facility. Third-party tested by lot for identity (HPLC), potency, microbial limits (USP \u0026lt;61\u0026gt;\/\u0026lt;62\u0026gt;), heavy metals (USP \u0026lt;232\u0026gt;\/\u0026lt;233\u0026gt; ICP-MS for arsenic, cadmium, lead, mercury), pesticide residues, and PAHs. Capsules are HPMC vegetable-cellulose; no magnesium stearate, silicon dioxide, or titanium dioxide. Non-GMO, gluten-free, soy-free, dairy-free, vegan.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before starting any supplement, especially if you have kidney disease, take prescription medication, or are pregnant or breastfeeding.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839471042778,"sku":"THP-MGGLY-400-60","price":22.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_magnesium.png?v=1778047679"},{"product_id":"vitamin-d3-5000-iu-k2-mk-7-100mcg","title":"D3+K2 Capsules (AT-013)","description":"\u003ch2\u003eThe 30-Second Answer\u003c\/h2\u003e\n\u003cp\u003eVitamin D3 (cholecalciferol) and Vitamin K2 (menaquinone-7) are the foundational pair almost every serious longevity protocol assumes you already take. D3 controls roughly 200 genes related to immunity, mood, bone density, insulin sensitivity, and cellular repair — but only after \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium\u003c\/a\u003e activates it into its hormone form (calcitriol). K2 then directs the calcium D3 mobilizes \u003cem\u003einto bone and teeth\u003c\/em\u003e rather than soft tissue, arteries, and kidneys. Take them together and you get the upside of D3 without the cardiovascular calcification risk of D3-alone supplementation.\u003c\/p\u003e\n\u003cp\u003eThe research backbone: roughly 40% of US adults run below 20 ng\/mL serum 25(OH)D — clinically deficient — and another 40% sit in the 20–30 ng\/mL \"insufficient\" band that the Endocrine Society links to higher all-cause mortality (Holick et al., J Clin Endocrinol Metab 2011;96:1911-1930). K2 deficiency is even more common, since modern diets contain almost no natto, hard cheese, or grass-fed organ meat. The Rotterdam Study (Geleijnse et al., J Nutr 2004;134:3100-3105) followed 4,807 adults for 7–10 years and found those with the highest K2 (menaquinone) intake had 50% lower cardiovascular mortality and 25% lower all-cause mortality. Pair that with D3's mortality-reduction signal across multiple meta-analyses and the combination becomes the highest-evidence \"boring foundation\" supplement on the longevity stack.\u003c\/p\u003e\n\n\u003ch2\u003eWhere This Sits in the Foundational Layer\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol treats four supplements as the foundational layer that runs underneath every other protocol: \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e, this Vitamin D3+K2, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e. None of them produce a \"felt\" stimulant effect. All of them appear in the bloodwork, the bone-density scans, and the all-cause mortality curves of long-running cohort studies. The reason this product sits in that layer rather than in the senolytic, NAD+, or beauty stacks is that the receptors and binding proteins it activates — the vitamin D receptor, matrix Gla protein, osteocalcin — are upstream of nearly every other longevity signal. NMN that you swallow into a body running on 18 ng\/mL serum 25(OH)D is NMN landing in a system whose immune surveillance is impaired and whose calcium handling is dysregulated.\u003c\/p\u003e\n\u003cp\u003ePractically, this means: if you build your stack from the top down (the shiny new compound first, the foundation last), the foundation is almost certainly the layer with the largest dollar-per-life-year return. D3+K2 has the longest, most boring evidence base of anything we sell.\u003c\/p\u003e\n\n\u003ch2\u003eWhy D3 and K2 Are the Foundation Most Stacks Skip\u003c\/h2\u003e\n\u003cp\u003eLongevity supplementation tends to chase the new molecule: NMN this year, urolithin A last year, fisetin the year before. The trap is that the headline compounds work \u003cem\u003ethrough\u003c\/em\u003e systems that already need adequate magnesium, vitamin D, and vitamin K to function. \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e can raise NAD+ all you want — if your serum 25(OH)D is 18 ng\/mL, your immune surveillance is still impaired, your insulin sensitivity is still off, and your bones are still demineralizing.\u003c\/p\u003e\n\u003cp\u003eD3 is technically a hormone precursor, not a vitamin. Sunlight on bare skin synthesizes it; modern indoor life, sunscreen, latitude above 35°, darker skin tones, and age-related skin-synthesis decline (a 70-year-old produces about 25% of the D3 a 20-year-old does from the same sun exposure — MacLaughlin \u0026amp; Holick, J Clin Invest 1985;76:1536-1538) leave most adults below the threshold their genome was tuned for. K2 is the partner because D3 raises blood calcium aggressively — without K2 to activate the matrix Gla protein and osteocalcin, that calcium ends up in arteries and kidney stones rather than bone (Schurgers et al., Blood 2007;109:2823-2831).\u003c\/p\u003e\n\n\u003ch2\u003eWhat the Combination Actually Does\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1. Bone density and fracture protection.\u003c\/strong\u003e D3 increases intestinal calcium absorption from ~10–15% to 30–40%. K2 then activates osteocalcin — the protein that pulls that calcium into the hydroxyapatite bone matrix. The Yamaguchi MK-7 trial (Knapen et al., Osteoporos Int 2013;24:2499-2507) showed 180 mcg MK-7 daily for 3 years preserved bone strength and reduced height loss in postmenopausal women — D3 alone didn't replicate the effect. The earlier Theuwissen study (Theuwissen et al., Br J Nutr 2012;108:1652-1657) had already established 90 mcg MK-7 as the threshold dose for shifting osteocalcin from undercarboxylated (cOC) to carboxylated (ucOC) form within 8 weeks. The Cochrane review on calcium plus D3 (Avenell et al., 2014) showed roughly a 16% reduction in hip fracture and 14% reduction in vertebral fracture; adding K2 in observational data appears to compound that effect.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2. Cardiovascular protection via decalcification.\u003c\/strong\u003e Without K2, calcium pulled into the bloodstream by D3 deposits in arterial walls (coronary artery calcification) and heart valves. K2 activates matrix Gla protein (MGP), the body's only known natural inhibitor of vascular calcification. The Rotterdam follow-up data (Geleijnse 2004) showed K2 intake inversely correlated with arterial stiffness independent of D3 status, and the 3-year Maastricht trial (Knapen et al., Thromb Haemost 2015;113:1135-1144) showed 180 mcg\/day of MK-7 actually \u003cem\u003ereduced\u003c\/em\u003e arterial stiffness measured by carotid-femoral pulse wave velocity in postmenopausal women — one of the few interventions ever shown to reverse, not just slow, vascular aging.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e3. Immune surveillance.\u003c\/strong\u003e Vitamin D receptors are present on virtually every immune cell. The 2020 BMJ meta-analysis of 25 RCTs (Martineau et al., BMJ 2017;356:i6583) found D3 supplementation cut acute respiratory infection risk by 12% overall and 70% in adults who started below 25 nmol\/L. The 2021 follow-up (Jolliffe et al., Lancet Diabetes Endocrinol 2021;9:276-292) confirmed the deficient-population effect across 46 trials and 75,541 participants. The mechanism is upregulation of cathelicidin and beta-defensin antimicrobial peptides plus modulation of T-regulatory cells — both directly linked to inflammaging and senescent cell clearance (Liu et al., Science 2006;311:1770-1773 first showed cathelicidin induction by 1,25(OH)2D in human macrophages).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e4. Insulin sensitivity and metabolic health.\u003c\/strong\u003e The D2d trial (Pittas et al., NEJM 2019;381:520-530) randomized 2,423 pre-diabetic adults to 4,000 IU D3 vs placebo for 2.5 years; the effect on diabetes progression was significant in those with baseline 25(OH)D below 30 ng\/mL but not above. The receptor is expressed on pancreatic beta cells; restoring sufficiency restores first-phase insulin response (Maestro et al., Cell Biochem Funct 2002;20:227-232 mapped the VDRE in the human insulin gene promoter).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e5. Mood and cognition.\u003c\/strong\u003e D3 modulates serotonin synthesis via tryptophan hydroxylase-2 in the brain (Patrick \u0026amp; Ames, FASEB J 2014;28:2398-2413). The clearest mood improvement in randomized trials shows up in adults whose baseline 25(OH)D was below 30 ng\/mL — i.e., the deficient half of the US adult population (Vellekkatt \u0026amp; Menon, J Postgrad Med 2019;65:74-80 meta-analyzed 4 RCTs in major depression, 947 patients, and found a small but significant improvement on Hamilton scores at week 8).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e6. All-cause mortality signal.\u003c\/strong\u003e Multiple meta-analyses (Bjelakovic et al., Cochrane 2014; Chowdhury et al., BMJ 2014;348:g1903) link adequate serum 25(OH)D — roughly 40–60 ng\/mL — to lower all-cause mortality, with the pooled estimate from Chowdhury landing at a hazard ratio of 0.86 for the highest vs lowest quartile across 73 cohort studies and 849,412 individuals. The shape is U-curve: too low and too high both increase risk. The combination with K2 widens the safe upper band by directing the extra calcium where it belongs.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e7. Periodontal and dental health.\u003c\/strong\u003e Osteocalcin is also expressed by osteoblasts in alveolar bone; matrix Gla protein protects against soft-tissue calcification in periodontal ligament. Observational data (Adegboye et al., J Clin Periodontol 2010;37:711-717) link low D3 to faster alveolar bone loss; clinical trials of K2 (MK-7) in dental cohorts are smaller but consistent with the bone-mineralization mechanism.\u003c\/p\u003e\n\n\u003ch2\u003eHow D3, K2, and Magnesium Form a Three-Cofactor Loop\u003c\/h2\u003e\n\u003cp\u003eD3 is biologically inert as swallowed. The liver hydroxylates it once to 25(OH)D — the form measured on a blood test — and the kidney hydroxylates it again to 1,25(OH)₂D, the active hormone calcitriol. Both hydroxylation steps require \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium\u003c\/a\u003e as a cofactor for the relevant CYP450 enzymes (Uwitonze \u0026amp; Razzaque, J Am Osteopath Assoc 2018;118:181-189). This is the single most common reason adults take D3 for months and don't see their serum 25(OH)D move: they're magnesium-depleted, the activation enzymes can't do their job, and the swallowed cholecalciferol piles up unused.\u003c\/p\u003e\n\u003cp\u003eOnce D3 is activated, calcitriol drives intestinal calcium absorption. Without K2, that calcium reaches the bloodstream but doesn't reach the bone matrix — osteocalcin (the calcium-binding protein in bone) is synthesized in an undercarboxylated form that can't bind calcium until K2 finishes the gamma-carboxylation reaction (Schurgers 2007). The same K2-dependent reaction activates matrix Gla protein in arterial walls, which is what prevents the calcium from depositing in the wrong place.\u003c\/p\u003e\n\u003cp\u003eThis is why the foundational triad — Magnesium → D3 → K2 — has to be taken together to work. Each one fails without the other two. The standard \"D3 alone\" or \"calcium + D3\" supplements that flooded the 2000s are part of why the cardiovascular calcification literature became concerning: D3 was raising serum calcium without the magnesium to activate it cleanly or the K2 to direct it.\u003c\/p\u003e\n\n\u003ch2\u003eHow This Sits in the Longevity Stack\u003c\/h2\u003e\n\u003cp\u003eD3+K2 is not a \"feel something\" supplement. It's foundational chemistry — like Magnesium Glycinate, it runs underneath every other compound rather than acting on its own discrete pathway. If you're on NMN\/NAD+ stacks, fisetin\/quercetin senolytics, or a serious protocol like the Cellular Longevity stack, D3+K2 is the layer that lets the rest of the stack work in a body whose immune surveillance, bone metabolism, and arterial health are intact.\u003c\/p\u003e\n\u003cp\u003eK2 (MK-7) circulates with a half-life of ~72 hours (versus K1's ~1 hour, and MK-4's ~1 hour) — Schurgers et al., Blood 2007 mapped the pharmacokinetics directly — which is why the once-daily dose works. D3's serum half-life as 25(OH)D is even longer at 2–3 weeks, which is why missing a day or two means almost nothing and why blood tests reflect average intake over the prior month rather than yesterday's dose.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in Each Capsule\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eVitamin D3 (Cholecalciferol)\u003c\/strong\u003e — 5,000 IU (125 mcg). The form your body actually makes from sunlight, not the plant-derived D2 (ergocalciferol) which raises serum 25(OH)D less efficiently per the Tripkovic meta-analysis (Am J Clin Nutr 2012;95:1357-1364, D3 raises 25(OH)D roughly 1.7x more per IU than D2). Sourced from lanolin (the standard high-purity source).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVitamin K2 (Menaquinone-7, MK-7)\u003c\/strong\u003e — 100 mcg. The long-half-life form fermented from natto-derived \u003cem\u003eBacillus subtilis natto\u003c\/em\u003e. MK-7 is the form with the strongest cardiovascular evidence; MK-4 (the synthetic short-half-life form used in some formulations) requires multiple daily doses to maintain serum levels.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMCT oil base (organic coconut)\u003c\/strong\u003e — both vitamins are fat-soluble; the MCT carrier ensures absorption regardless of meal timing. Without a fat carrier, D3 absorption can drop 30–50% (Dawson-Hughes et al., J Bone Miner Res 2013;28:1778-1783).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNo magnesium stearate, no titanium dioxide, no synthetic colorants. Vegetable cellulose softgel.\u003c\/p\u003e\n\n\u003ch2\u003eDaily Protocol\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDefault foundational dose:\u003c\/strong\u003e 1 softgel daily, with the largest fat-containing meal of the day (typically lunch or dinner). Both D3 and K2 are fat-soluble — taking them on an empty stomach or with a low-fat meal can cut absorption by 30–50%.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf your last 25(OH)D test came back below 20 ng\/mL (clinical deficiency):\u003c\/strong\u003e 2 softgels daily for the first 8–12 weeks, then retest and drop to 1. Going from 18 to 50 ng\/mL takes most adults 2–4 months at 5,000 IU\/day; severely deficient adults sometimes need 10,000 IU\/day under physician supervision for 4–8 weeks before maintenance.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf you live above latitude 40° (most of Canada, northern US, northern Europe):\u003c\/strong\u003e The same 1-softgel default October through April; you can drop to a softgel every other day May through September if you're getting regular bare-skin sun. Or just keep the daily dose year-round — at 5,000 IU\/day the safety margin is wide and the simplicity is worth it.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf your BMI is over 30:\u003c\/strong\u003e Adipose tissue sequesters fat-soluble D3, meaning a given oral dose produces a smaller serum 25(OH)D rise. Drisko et al., Am J Clin Nutr 2007 documented that obese adults need approximately 2–3x the oral dose of lean adults to reach the same serum 25(OH)D. Start at 2 softgels\/day, retest at 12 weeks, adjust accordingly.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStack pairing:\u003c\/strong\u003e Take with \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e — D3 activation in the kidney is magnesium-dependent (Uwitonze \u0026amp; Razzaque 2018), and inadequate magnesium is the most common cause of \"I'm taking D3 but my levels aren't moving.\" For serious longevity protocols, this trio (Mg + D3 + K2) is the foundation everything else sits on.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGet tested:\u003c\/strong\u003e A serum 25(OH)D test ($30–50 from most labs, often $0 with insurance) tells you whether your dose is working. Aim for 40–60 ng\/mL year-round; below 30 means more dose, above 80 means less. K2 status is harder to measure directly — undercarboxylated osteocalcin (ucOC) is the gold standard but rarely run by general practitioners.\u003c\/p\u003e\n\n\u003ch2\u003eStack Pairings\u003c\/h2\u003e\n\u003cp\u003eD3+K2 is the connective layer for most of our other stacks. The pairings that change behavior the most:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eD3+K2 ↔ \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e.\u003c\/strong\u003e The activation cofactor. If you only buy one pairing, this is it. Magnesium runs the CYP27A1 (liver) and CYP27B1 (kidney) hydroxylation steps that turn cholecalciferol into 25(OH)D and then calcitriol. Magnesium-depleted adults can take D3 for a year and not move their serum levels.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eD3+K2 ↔ \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium AKG\u003c\/a\u003e.\u003c\/strong\u003e CaAKG provides calcium to a body whose absorption D3 has just multiplied 2–3x and whose K2 is now directing into bone. The combination is also the standard \"epigenetic longevity\" pairing in the Asadi Shahmirzadi 2020 mouse data.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eD3+K2 ↔ \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA 2000mg\u003c\/a\u003e.\u003c\/strong\u003e Both are fat-soluble; both share the lipoprotein transport into cell membranes; both modulate inflammaging. The VITAL trial (Manson et al., NEJM 2019;380:33-44) tested D3 and omega-3 in factorial design across 25,871 adults and found additive cardiovascular signals where neither alone reached significance.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eD3+K2 ↔ \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e.\u003c\/strong\u003e Completes the four-pillar foundational layer. Taurine handles cardiovascular ion handling and bile conjugation; glycine handles glutathione and sleep architecture; D3+K2 handles bone, immunity, and arterial decalcification; magnesium handles activation. Together they're the four boring SKUs your future self thanks you for.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eD3+K2 ↔ \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg + BioPerine\u003c\/a\u003e.\u003c\/strong\u003e D3 modulates Th17\/Treg balance from above; curcumin damps NF-κB from below. The combination shows up in autoimmune and inflammatory-aging cohorts with stronger CRP-reduction signals than either alone.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eD3+K2 ↔ \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e \/ \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNAD+ Hard Capsules\u003c\/a\u003e.\u003c\/strong\u003e NAD+ supports the SIRT1 deacetylase that gates VDR signaling. Vitamin-D-sufficient cells respond to calcitriol more effectively when SIRT1 is well-fueled — the two mechanisms aren't redundant; they're sequential.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eD3+K2 ↔ \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e.\u003c\/strong\u003e Senolytics clear senescent immune cells; D3 then re-tunes the surveillance system left behind. Standard \"D+K with a quarterly senolytic pulse\" protocol.\u003c\/p\u003e\n\n\u003ch2\u003eExpectation Timeline\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eWeek 1–2.\u003c\/strong\u003e Nothing felt. Serum 25(OH)D barely moves — this is normal. The half-life means it takes weeks of consistent dosing to shift the average. Don't quit because nothing happened in seven days.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWeek 4–6.\u003c\/strong\u003e First pharmacological effects show up in K2 markers (undercarboxylated osteocalcin and undercarboxylated MGP both decline within 4–8 weeks at 100 mcg MK-7\/day per Theuwissen 2012). If your baseline 25(OH)D was deficient and you're tracking mood or seasonal-affect symptoms, week 4–6 is when the first signal usually appears in the trial data (Vellekkatt 2019).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWeek 8–12.\u003c\/strong\u003e Serum 25(OH)D reaches new steady-state at the dose. Time for a second blood draw to see where you've landed. Most adults at 5,000 IU\/day move from a baseline 22–28 ng\/mL into the 45–55 ng\/mL target band.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMonth 3–6.\u003c\/strong\u003e Bone-turnover markers (CTX, P1NP) shift; immune function endpoints emerge in the trial data (Martineau 2017 cumulative risk reduction grows with duration).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eYear 1–3+.\u003c\/strong\u003e The actual longevity payoff. Bone density preservation (Knapen 2013), arterial stiffness reduction (Knapen 2015), fracture-rate reduction in pooled D-and-K cohorts (Avenell 2014). This is a slow, boring, durable supplement. The biggest mistake is stopping after week 6 because nothing felt different.\u003c\/p\u003e\n\n\u003ch2\u003eWho Should Talk to a Physician First\u003c\/h2\u003e\n\u003cp\u003eD3+K2 is one of the safest supplement combinations on the market, but several conditions warrant professional guidance:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWarfarin \/ Coumadin users.\u003c\/strong\u003e K2 directly antagonizes warfarin's anticoagulant effect (Schurgers et al., Blood 2007). Do not start K2 without coordinating with your prescriber to adjust your INR monitoring. Newer anticoagulants (rivaroxaban, apixaban, dabigatran) do not work via the K-cycle and don't have this interaction, but flag it anyway.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypercalcemia, hyperparathyroidism, or sarcoidosis.\u003c\/strong\u003e These conditions impair calcium regulation; supplemental D3 can push serum calcium dangerously high. Sarcoidosis in particular activates 1-alpha-hydroxylase outside the kidney and can produce calcitriol-driven hypercalcemia at otherwise modest D3 doses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eActive kidney stone disease.\u003c\/strong\u003e Discuss dose with your nephrologist. The combination with K2 is theoretically protective (K2 should reduce calcium oxalate deposition) but real-world dosing in active stone-formers should be supervised.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding.\u003c\/strong\u003e Standard prenatal vitamins typically contain D3 — adding 5,000 IU on top requires obstetrician approval. The pregnancy literature (Hollis et al., J Bone Miner Res 2011;26:2341-2357) supports 4,000 IU\/day as safe and sufficient, but obstetric oversight is the right path.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren under 18.\u003c\/strong\u003e Pediatric dosing is weight-based and should come from a pediatrician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWilliams syndrome and idiopathic infantile hypercalcemia.\u003c\/strong\u003e Genetic D3 hypersensitivity — explicit contraindication.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecent fish or soy allergy.\u003c\/strong\u003e Our MK-7 is fermented from \u003cem\u003eBacillus subtilis\u003c\/em\u003e on a soy substrate (the natto base); residual soy is below detection in COA but trace exposure is theoretically possible.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRoutine drug interactions to flag with your pharmacist: corticosteroids and weight-loss drugs (orlistat) reduce D3 absorption; thiazide diuretics combined with high-dose D3 can raise calcium; phenytoin, carbamazepine, and rifampin accelerate D3 breakdown via CYP3A4 induction; digoxin tolerance narrows as serum calcium rises.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eWhy 5,000 IU? Isn't that high?\u003c\/strong\u003e 5,000 IU is the dose that moves serum 25(OH)D from \"insufficient\" (20–30 ng\/mL) into the longevity-research target band (40–60 ng\/mL) for most adults. The official RDA of 600–800 IU was set in 2010 to prevent rickets, not optimize all-cause mortality. The Endocrine Society's 2011 clinical practice guideline (Holick) lists 1,500–2,000 IU\/day as the floor for adults to maintain sufficiency, and the Institute of Medicine sets 4,000 IU\/day as the Tolerable Upper Intake Level — meaning the dose at which the IOM's expert panel found no signal of harm in the available literature. Doses up to 10,000 IU\/day are within the established safe upper limit cited by the Endocrine Society for healthy adults. If you're sun-exposed, light-skinned, and live south of latitude 35°, you may only need 2,000 IU — half a softgel every other day works for that case.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy MK-7 instead of MK-4 K2?\u003c\/strong\u003e MK-7 has a serum half-life of ~72 hours; MK-4 is closer to 1 hour (Schurgers 2007). That means MK-7 at 100 mcg\/day maintains stable activation of matrix Gla protein and osteocalcin around the clock, while MK-4 requires 3 doses per day at 15 mg each (a 450x higher daily mass) to do the same job. Every long-term cardiovascular and bone outcome trial that successfully shifted endpoints (Knapen 2013, Knapen 2015) used MK-7 for this reason. MK-4 has a niche use case in osteoporosis Japanese-protocol pharmacology at 45 mg\/day, but for general longevity supplementation MK-7 is the dominant form.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I just get this from sun and food?\u003c\/strong\u003e Mathematically possible, practically not. To synthesize 5,000 IU of D3 from sun, a light-skinned adult needs about 15–20 minutes of midday summer sun on bare arms, legs, and torso — which most modern adults don't get without sunburn risk, and which is impossible above latitude 35° in winter (the UVB wavelengths needed for D3 synthesis don't penetrate the atmosphere at low solar angles). K2 is even harder: 100 mcg of K2 requires either ~50g of natto (most Westerners won't eat it daily), ~200g of hard aged cheese, or ~150g of grass-fed liver. The supplement exists because the diet that produced these compounds in our ancestors no longer exists.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow does this differ from a multivitamin?\u003c\/strong\u003e Most multivitamins contain 400–1,000 IU of D3 (below the threshold to move serum levels) and either no K2 or 50 mcg of MK-4 (the short-half-life form). They're formulated to prevent deficiency disease, not to support the 40–60 ng\/mL target the longevity research uses. A multivitamin is not a substitute for dedicated D3+K2 dosing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill I feel something?\u003c\/strong\u003e Probably not in week one. The compounds work on slow-turnover systems — bone remodeling cycles run about 3 months, immune adaptation takes weeks, mood effects show up by week 4–6 if your baseline was deficient. The honest answer is: D3+K2 is insurance, not stimulant. The signal it produces is \"fewer winter colds, better lab values, fewer fractures over decades\" — not \"I felt great Tuesday.\"\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDrug interactions to watch?\u003c\/strong\u003e Warfarin (K2 antagonizes it), corticosteroids and orlistat (reduce D3 absorption), thiazide diuretics (raise calcium synergistically), phenytoin\/carbamazepine\/rifampin (accelerate D3 metabolism via CYP3A4 — may need higher doses), digoxin (rising calcium narrows the cardiac glycoside therapeutic window). If you take any prescription medication, run this past your pharmacist before starting.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I take both softgels at once or split them?\u003c\/strong\u003e One per day is fine. Both D3 (half-life as 25(OH)D ~3 weeks) and MK-7 (half-life ~72 hours) have long enough kinetics that splitting the dose adds nothing. Some people prefer the morning fat-meal route because they remember it; others prefer dinner because dinner usually has the most fat. Pick one and be consistent.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take this on an empty stomach?\u003c\/strong\u003e You can, but you'll absorb 30–50% less (Dawson-Hughes 2013). Take it with the meal of the day that has the most fat — even a tablespoon of olive oil, butter, or avocado is enough to switch on the lipoprotein-mediated absorption pathway.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eVegan considerations?\u003c\/strong\u003e The cholecalciferol in this product is sourced from lanolin (sheep wool grease), which is animal-derived but cruelty-free and the standard high-purity D3 source. Vegan D3 from lichen exists but at higher cost and lower batch consistency. The MK-7 is fermented from \u003cem\u003eBacillus subtilis\u003c\/em\u003e on a plant substrate and is vegan-compatible. The softgel is vegetable cellulose. So this product is vegetarian; the D3 itself is the only step that won't satisfy strict vegans.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat 25(OH)D level should I aim for?\u003c\/strong\u003e 40–60 ng\/mL year-round (100–150 nmol\/L if your lab uses SI units). Below 30 means more dose; above 80 means less; above 100 starts to enter the U-curve right tail and is rarely needed. The Endocrine Society's clinical practice guideline names 30–100 ng\/mL as the sufficient range; the longevity-cohort literature (Chowdhury 2014, Garland 2014) tends to identify 40–60 ng\/mL as the band with the lowest pooled hazard ratios.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy does my 25(OH)D not move on D3 alone?\u003c\/strong\u003e The single most common reason is magnesium deficiency. CYP27A1 (liver, 25-hydroxylation) and CYP27B1 (kidney, 1-alpha-hydroxylation) both require magnesium as a cofactor (Uwitonze \u0026amp; Razzaque 2018). Adding 400 mg\/day of \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium glycinate\u003c\/a\u003e to a stalled D3 protocol very often unsticks the serum levels within 6–8 weeks. Other reasons: BMI over 30 (sequestered into adipose), CYP3A4 inducer drugs, malabsorption (celiac, Crohn's, post-bariatric), liver or kidney disease.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs there a CYP24A1 issue I should know about?\u003c\/strong\u003e About 1 in 33,000 adults carry loss-of-function variants in CYP24A1, the enzyme that catabolizes calcitriol. They develop hypercalcemia at otherwise modest D3 doses. Family history of unexplained kidney stones in childhood, or persistent hypercalcemia despite normal PTH, is the clinical clue. If that history matches, a 24-hour urine calcium and a CYP24A1 sequencing test from your endocrinologist clarifies things.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan K2 reverse existing arterial calcification?\u003c\/strong\u003e The Knapen 2015 trial showed reduction in pulse wave velocity (a functional measure of arterial stiffness) at 3 years of 180 mcg MK-7\/day; whether it actually \u003cem\u003eremoves\u003c\/em\u003e existing coronary calcium scoring deposits is still an open question. The mechanism (matrix Gla protein activation) is consistent with both prevention and partial reversal. Don't expect a CAC score of 400 to drop to zero, but the trajectory of further calcification clearly slows.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs more better? What about 10,000 IU?\u003c\/strong\u003e 10,000 IU\/day is within the Endocrine Society's safe upper limit for healthy adults and is sometimes used in deficient subjects under physician supervision for 4–8 weeks. For long-term maintenance in someone whose 25(OH)D is already at 50 ng\/mL, 10,000 IU is unnecessary and pushes you toward the U-curve right tail. The principle: dose for the lab number, not for the IU count.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSunscreen and D3?\u003c\/strong\u003e SPF 15+ blocks 99% of UVB. If you wear sunscreen daily on exposed skin, treat your skin synthesis as zero and dose as if you live in a D3-free environment. The skin-cancer protection from sunscreen is real and worth keeping; the D3 supplement just covers the synthesis you sacrifice.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy is my doctor only ordering 25(OH)D once and never again?\u003c\/strong\u003e Most general-practice protocols treat 25(OH)D as a one-time deficiency screen rather than an ongoing optimization target. If you want to dial in your dose, ask explicitly for an annual or semi-annual 25(OH)D as part of routine bloodwork. Many concierge practices, longevity clinics, and direct-to-consumer labs (Quest, LabCorp, Marek Health) order it without a prescription.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat about K2 and pregnancy?\u003c\/strong\u003e K2 is generally considered safe in pregnancy at supplemental doses; the fetal need for K-cycle activity (bone development, vascular patterning) is real. But \"generally safe\" plus pregnancy plus a longevity supplement equals \"ask your obstetrician first.\"\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes this product contain calcium?\u003c\/strong\u003e No. D3+K2 is the activation and direction system; the calcium itself comes from diet (dairy, leafy greens, sardines with bones, almonds) or a separate supplement like \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e. Most adults eating a modest dairy-inclusive diet hit 800–1,000 mg\/day of calcium without supplementing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs the dropper \/ softgel format better than a tablet?\u003c\/strong\u003e Yes for a fat-soluble vitamin. The MCT-oil softgel format means the active is already dissolved in its carrier; absorption is fast and consistent. Compressed tablets of D3 require disintegration and dispersion in the gut and show more inter-individual absorption variability.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take D3+K2 if I'm on statins?\u003c\/strong\u003e Yes, no direct interaction. The mevalonate pathway statins inhibit is upstream of cholesterol synthesis but doesn't intersect with the D3 or K2 cycles directly. Some observational data suggests statin users have slightly lower 25(OH)D, possibly because both compounds share LDL-particle transport — splitting them by a meal is a small optimization.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat's the difference between cholecalciferol and calcitriol prescriptions?\u003c\/strong\u003e Calcitriol (Rocaltrol) is the already-activated 1,25(OH)2D hormone, prescribed for renal patients whose kidneys can't run the final hydroxylation step. It bypasses both magnesium-dependent activation steps, has a much shorter half-life, and is dosed in micrograms rather than thousands of IU. It's not interchangeable with cholecalciferol and shouldn't be used as a longevity supplement — too narrow a therapeutic window.\u003c\/p\u003e\n\n\u003ch2\u003eThe Science (Selected References)\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eHolick MF, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-1930.\u003c\/li\u003e\n\u003cli\u003eGeleijnse JM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004;134:3100-3105.\u003c\/li\u003e\n\u003cli\u003eKnapen MHJ, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int 2013;24:2499-2507.\u003c\/li\u003e\n\u003cli\u003eKnapen MHJ, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thromb Haemost 2015;113:1135-1144.\u003c\/li\u003e\n\u003cli\u003eTheuwissen E, et al. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status in healthy adults. Br J Nutr 2012;108:1652-1657.\u003c\/li\u003e\n\u003cli\u003eSchurgers LJ, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007;109:2823-2831.\u003c\/li\u003e\n\u003cli\u003eMartineau AR, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017;356:i6583.\u003c\/li\u003e\n\u003cli\u003eJolliffe DA, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol 2021;9:276-292.\u003c\/li\u003e\n\u003cli\u003ePittas AG, et al. Vitamin D supplementation and prevention of type 2 diabetes (D2d). NEJM 2019;381:520-530.\u003c\/li\u003e\n\u003cli\u003eManson JE, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease (VITAL). NEJM 2019;380:33-44.\u003c\/li\u003e\n\u003cli\u003eChowdhury R, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014;348:g1903.\u003c\/li\u003e\n\u003cli\u003eBjelakovic G, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014;1:CD007470.\u003c\/li\u003e\n\u003cli\u003eTripkovic L, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 2012;95:1357-1364.\u003c\/li\u003e\n\u003cli\u003eUwitonze AM, Razzaque MS. Role of magnesium in vitamin D activation and function. J Am Osteopath Assoc 2018;118:181-189.\u003c\/li\u003e\n\u003cli\u003eLiu PT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-1773.\u003c\/li\u003e\n\u003cli\u003ePatrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J 2014;28:2398-2413.\u003c\/li\u003e\n\u003cli\u003eMacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536-1538.\u003c\/li\u003e\n\u003cli\u003eAvenell A, et al. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014;4:CD000227.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eThese statements describe the published research on vitamin D3 and vitamin K2 (MK-7) the molecules and have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare practitioner before starting any supplementation, especially if you have a medical condition, take prescription medication (particularly anticoagulants), are pregnant or breastfeeding, or are under 18.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch2\u003eQuality Notes\u003c\/h2\u003e\n\u003cp\u003eManufactured in cGMP-certified facilities, third-party tested for vitamin potency, heavy metals (lead, arsenic, cadmium, mercury), and microbial contamination. Each batch comes with a Certificate of Analysis verifying both D3 IU content and K2 (MK-7) microgram content. Soy-free in the finished MK-7 step (residual below detection limit), gluten-free, GMO-free.\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839495979226,"sku":"THP-D3K2-60","price":21.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_d3-k2.png?v=1778047690"},{"product_id":"omega-3-fish-oil-2000mg-epa-dha","title":"Deep-Sea Fish Oil (AT-009)","description":"\u003cp\u003e\u003cstrong\u003e2000 mg of wild-caught fish oil per softgel\u003c\/strong\u003e, standardized to deliver \u003cstrong\u003e720 mg EPA + 480 mg DHA\u003c\/strong\u003e in the clinically-studied 3:2 ratio. Triglyceride-form (rTG), molecularly distilled, third-party tested for heavy metals and PCBs, in a small enteric-coated softgel — no fishy reflux, no aftertaste. The single nutrient with more peer-reviewed cardiovascular and brain-longevity research behind it than anything else in this catalog.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy people take it:\u003c\/strong\u003e long-chain omega-3s (EPA + DHA) lower triglycerides 20–30% (Skulas-Ray 2019, AHA Science Advisory), reduce systemic inflammation (Calder 2017), and physically build the phospholipid membranes of every neuron, retinal cell, and cardiomyocyte you own.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat it’s NOT:\u003c\/strong\u003e not flaxseed oil. ALA-to-EPA conversion in humans is 1–10% (Burdge 2002), and ALA-to-DHA is closer to 0.5%. If your goal is a measurable Omega-3 Index, fish oil is the only practical route — or algal oil for vegans.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe form matters:\u003c\/strong\u003e triglyceride (TG \/ re-esterified TG) is absorbed roughly 70% better than ethyl-ester (EE) over 6 months (Dyerberg 2010, Neubronner 2011). Most pharmacy fish oil is EE because it’s cheaper to concentrate. Ours is rTG.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 2 softgels = 1,440 mg EPA + 960 mg DHA. The dose used in REDUCE-IT (Bhatt 2019, NEJM) was 4 g\/day icosapent ethyl, but every dose-response analysis (Skulas-Ray 2019, Mozaffarian 2011) shows clear cardiovascular signal starting at ≈1 g\/day combined EPA+DHA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTimeline:\u003c\/strong\u003e Omega-3 Index moves measurably in 8–12 weeks. Triglycerides move in 4–6 weeks. Joint and mood signal in 8–16 weeks. Cardiovascular event reduction is a multi-year endpoint.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhere it sits in this catalog:\u003c\/strong\u003e alongside \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7 100mcg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg TRAACS\u003c\/a\u003e, this is one of the three foundational supplements that earn their place in essentially every healthspan protocol — the always-on layer underneath your \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ stack\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy omega-3s sit at the foundational layer\u003c\/h2\u003e\n\u003cp\u003eMost longevity stacks chase mechanisms — sirtuins, mitophagy, NAD+ precursors, senolytics. Omega-3s are different: they are a \u003cem\u003estructural\u003c\/em\u003e intervention. Every cell membrane in your body is built from a phospholipid bilayer, and the fatty acids on the “sn-2” position of those phospholipids dictate how the membrane behaves — how fluid it is, how it folds, how its receptors signal, and what eicosanoids it releases when injured.\u003c\/p\u003e\n\u003cp\u003eEPA and DHA compete with arachidonic acid (the omega-6 you get from seed oils, conventional poultry, and processed food) for incorporation into those membranes. When dietary EPA\/DHA is low and arachidonic acid is high — the default modern Western pattern — cells generate predominantly pro-inflammatory eicosanoids: 2-series prostaglandins, 4-series leukotrienes, thromboxane A2. When EPA\/DHA replace arachidonic acid in the membrane, the same enzymes (COX, LOX) instead generate \u003cstrong\u003e3-series prostaglandins, 5-series leukotrienes, and the entire Specialized Pro-resolving Mediator (SPM) family\u003c\/strong\u003e — resolvin E1\/E2, resolvin D1-D6, protectin D1, maresin 1 — which actively terminate inflammation rather than amplify it (Serhan 2014, Nature; Calder 2017).\u003c\/p\u003e\n\u003cp\u003eThis is why omega-3 supplementation has measurable effects across 12+ unrelated organ systems: it’s not a drug acting on one receptor — it’s a building material that changes the \u003cem\u003eresolution\u003c\/em\u003e capacity of every membrane in the body.\u003c\/p\u003e\n\n\u003ch2\u003eThe Omega-3 Index — the only blood marker that matters here\u003c\/h2\u003e\n\u003cp\u003eThe \u003cstrong\u003eOmega-3 Index\u003c\/strong\u003e (Harris \u0026amp; von Schacky 2004, Prev Med) is the percentage of EPA + DHA in red blood cell membrane phospholipids. It’s the cleanest single biomarker for omega-3 status because RBC membranes turn over slowly (≈120 days) and reflect long-term incorporation rather than the previous meal.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u0026lt; 4%\u003c\/strong\u003e — high cardiovascular risk zone. The U.S. average sits in this range. Sudden cardiac death risk roughly 10x vs \u0026gt;8% (Albert 2002, NEJM, n=22,071 male physicians).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e4–8%\u003c\/strong\u003e — intermediate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u0026gt; 8%\u003c\/strong\u003e — cardioprotective range. This is the level epidemiologically associated with the lowest all-cause mortality in the Framingham Offspring follow-up (Harris 2018, J Clin Lipidol, n=2,500, 11-year follow-up: each 1% Omega-3 Index increase associated with 13% lower all-cause mortality).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2 softgels\/day of this product (1.44 g EPA + 0.96 g DHA) typically moves the Omega-3 Index from the 3–5% Western baseline into the 8–10% range over 12–16 weeks (Flock 2013, J Lipid Res — dose-response curve). 3–4 softgels move it faster but plateau in the same range.\u003c\/p\u003e\n\n\u003ch2\u003eTriglyceride vs ethyl ester — why the form on the label is non-negotiable\u003c\/h2\u003e\n\u003cp\u003eNative fish oil is in \u003cstrong\u003etriglyceride (TG) form\u003c\/strong\u003e — three fatty acids attached to a glycerol backbone, just as they exist in fish flesh. To concentrate EPA and DHA above the ≈30% native ratio (most fish oil starts there), manufacturers add ethanol, releasing fatty acids as \u003cstrong\u003eethyl esters (EE)\u003c\/strong\u003e. EE allows molecular distillation up to \u0026gt;90% EPA+DHA but produces a synthetic form that the gut absorbs differently:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLipase activity:\u003c\/strong\u003e pancreatic lipase hydrolyzes TG roughly 10–50x faster than EE (Yang 1990, Biochim Biophys Acta).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e6-month bioavailability:\u003c\/strong\u003e rTG produces 70% higher RBC incorporation than EE at the same dose (Dyerberg 2010, Prostaglandins Leukot Essent Fatty Acids; Neubronner 2011 same-design replication).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReflux\/burping:\u003c\/strong\u003e EE generates ethanol on hydrolysis and tends to produce more “fish-oil reflux.”\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e rTG is more oxidation-resistant than free fatty acid (FFA) form, less so than EE.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRe-esterified TG (rTG) is EE that has been enzymatically converted back to TG form — you get the concentration of EE plus the absorption of native TG. Most premium fish oil is rTG. Ours is rTG. Most U.S. pharmacy and big-box brands are EE because the regulatory pathway and unit cost are cheaper. Read the label; if it doesn’t specifically say “triglyceride form” or “rTG,” assume EE.\u003c\/p\u003e\n\n\u003ch2\u003eThe clinical evidence — six domains, not just heart\u003c\/h2\u003e\n\n\u003ch3\u003e1. Cardiovascular\u003c\/h3\u003e\n\u003cp\u003eThe cardiovascular evidence is the largest and most contentious in nutrition science. The high-level synthesis:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGISSI-Prevenzione (Marchioli 1999, Lancet):\u003c\/strong\u003e 11,324 post-MI patients, 850 mg\/day EPA+DHA, 3.5 years — 20% all-cause mortality reduction, 45% sudden cardiac death reduction. The trial that put fish oil on every cardiology guideline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJELIS (Yokoyama 2007, Lancet):\u003c\/strong\u003e 18,645 Japanese hypercholesterolemics, 1.8 g\/day EPA-only on top of statins, 4.6 years — 19% major coronary event reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eREDUCE-IT (Bhatt 2019, NEJM):\u003c\/strong\u003e 8,179 high-risk patients with elevated triglycerides, 4 g\/day icosapent ethyl (high-purity EPA), 4.9 years — \u003cstrong\u003e25% reduction\u003c\/strong\u003e in composite cardiovascular events. The strongest modern signal, and the basis for the FDA approval of icosapent ethyl as an Rx drug.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVITAL (Manson 2019, NEJM):\u003c\/strong\u003e 25,871 healthy U.S. adults, 1 g\/day EPA+DHA, 5.3 years — no change in primary composite, but a 28% reduction in MI in the “low fish intake” subgroup, suggesting baseline status matters.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSTRENGTH (Nicholls 2020, JAMA):\u003c\/strong\u003e EPA+DHA carboxylic acid form failed to reduce CV events vs corn oil placebo. The negative trial that complicates the EPA-only narrative.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTriglyceride lowering:\u003c\/strong\u003e meta-analyzed across 70+ RCTs, 2–4 g\/day EPA+DHA lowers TG 20–30% in normolipidemic and up to 45% in hypertriglyceridemic patients (Skulas-Ray 2019, AHA Science Advisory).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe honest read: the evidence for triglyceride-lowering and Omega-3 Index improvement is unambiguous; the evidence for hard cardiovascular outcomes is dose-, form-, and population-dependent. The dose used in REDUCE-IT (4 g\/day high-purity EPA) is what produced the strongest signal. Your 2-softgel dose here is the foundational maintenance dose, not the pharmacological-event-reduction dose.\u003c\/p\u003e\n\n\u003ch3\u003e2. Brain \u0026amp; cognition\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eDHA is ≈30% of all gray matter fatty acids\u003c\/strong\u003e (Bradbury 2011, Nutrients) and is concentrated in synaptic membranes. Adult brain DHA turnover is slow but real, and dietary supply matters because de novo synthesis from ALA is \u0026lt;0.5%.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMIDAS (Yurko-Mauro 2010, Alzheimers Dement):\u003c\/strong\u003e 485 healthy older adults, 900 mg DHA\/day, 24 weeks — episodic memory improved equivalent to roughly 3 years of cognitive aging reversal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSmith 2010, PLoS One:\u003c\/strong\u003e B-vitamin trial in MCI showed brain atrophy slowed only in subjects with high baseline omega-3 status — a treatment-effect-modifier signal that’s been replicated in the OmegAD and AlphaOmega trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePottala 2014, Neurology:\u003c\/strong\u003e Omega-3 Index correlated with total brain volume and hippocampal volume in 1,111 women in the WHIMS-MRI cohort.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBDNF \/ synaptic plasticity:\u003c\/strong\u003e DHA upregulates BDNF and supports LTP in hippocampal preparations (Wu 2008, Neuroscience). The mechanistic story behind the cognitive trial signal.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003e3. Mood \u0026amp; mental health\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eEPA — not DHA — carries the depression signal.\u003c\/strong\u003e Meta-analyses repeatedly show that EPA-predominant formulations (\u0026gt;60% EPA) reduce depressive symptoms while DHA-predominant ones do not (Sublette 2011, J Clin Psychiatry; Mocking 2016 meta-analysis, Transl Psychiatry, n=1,233 patients across 13 RCTs — effect size SMD −0.40 with EPA-predominant). Our 3:2 EPA:DHA ratio is on the EPA-predominant side.\u003c\/p\u003e\n\n\u003ch3\u003e4. Eye health\u003c\/h3\u003e\n\u003cp\u003eThe retina has the highest DHA concentration of any tissue in the body — outer-segment photoreceptor membranes are ≈50% DHA. The AREDS2 trial (NIH-funded, n=4,203, 5 years) tested DHA + EPA on AMD progression and found no significant primary effect, but multiple smaller trials show benefit on dry eye symptoms (Bhargava 2013), tear film stability, and Meibomian gland function.\u003c\/p\u003e\n\n\u003ch3\u003e5. Joints \u0026amp; inflammation\u003c\/h3\u003e\n\u003cp\u003eOmega-3s are the most-studied non-NSAID joint intervention.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMaroon \u0026amp; Bost 2006, Surg Neurol:\u003c\/strong\u003e 1,200 mg EPA+DHA\/day, 250 patients with chronic neck\/back pain — 60% reduced or eliminated NSAIDs at 75 days.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGoldberg \u0026amp; Katz 2007 meta-analysis, Pain:\u003c\/strong\u003e 17 RCTs, omega-3s reduced morning stiffness, joint swelling, and NSAID consumption in inflammatory joint pain.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMechanism:\u003c\/strong\u003e resolvins and protectins actively terminate the inflammatory phase rather than just blocking COX. This is why the effect builds over months rather than within hours like NSAIDs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003e6. Metabolic \/ liver\u003c\/h3\u003e\n\u003cp\u003eOmega-3s lower hepatic triglyceride content via SREBP-1c suppression and PPAR-α activation. Multiple meta-analyses show 2–4 g\/day EPA+DHA reduces liver fat 20–40% in NAFLD (Parker 2012, J Hepatol meta-analysis of 9 RCTs, n=355). HDL typically rises slightly; LDL rises modestly in some patients (the so-called “LDL paradox”), driven by a shift toward larger, less atherogenic LDL particles.\u003c\/p\u003e\n\n\u003ch2\u003eEPA vs DHA — what each one actually does\u003c\/h2\u003e\n\u003ctable style=\"width:100%; border-collapse:collapse; margin:1em 0;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f6f6f6;\"\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eFunction\u003c\/th\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eEPA (20:5 ω-3)\u003c\/th\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eDHA (22:6 ω-3)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eTriglyceride lowering\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSlightly stronger\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eAnti-inflammatory (resolvin E1\/E2)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePrimary substrate\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSecondary\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eResolvin D \/ Protectin \/ Maresin\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eNo\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePrimary substrate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eMood \/ depression signal\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong (Mocking 2016)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eWeak\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCognitive \/ memory signal\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eModest\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong (Yurko-Mauro 2010)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eRetinal \u0026amp; neural membrane structure\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eMinor\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePrimary structural fatty acid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003ePregnancy \/ infant brain development\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSupportive\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCritical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCardiovascular event reduction (REDUCE-IT)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eStrong (high-dose)\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eLikely additive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe 3:2 EPA:DHA ratio in this product (720 mg : 480 mg) is the ratio used in the largest cardiovascular trials including GISSI-Prevenzione — a balanced foundational profile that captures both the EPA-driven inflammation\/triglyceride\/mood story and the DHA-driven neural\/retinal\/membrane story. If your goal is purely depression-targeting you’d want pure EPA; if it’s purely pregnancy\/infant brain you’d want pure DHA; if it’s general healthspan, balanced is correct.\u003c\/p\u003e\n\n\u003ch2\u003eWhat’s in each softgel\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWild-caught fish oil concentrate:\u003c\/strong\u003e 2,000 mg, sourced from anchovy, sardine, and mackerel (low-trophic-level species — minimum bioaccumulation of mercury and PCBs).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEPA (eicosapentaenoic acid):\u003c\/strong\u003e 720 mg, in re-esterified triglyceride (rTG) form.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDHA (docosahexaenoic acid):\u003c\/strong\u003e 480 mg, rTG form.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOther omega-3s:\u003c\/strong\u003e ≈100 mg DPA (docosapentaenoic acid), the “forgotten” intermediate omega-3 with its own resolvin pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant package:\u003c\/strong\u003e mixed natural tocopherols (vitamin E) to prevent in-bottle oxidation. No synthetic BHT\/BHA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnteric coating:\u003c\/strong\u003e the softgel is enteric-coated so it dissolves in the small intestine, not the stomach — the single most effective fix for the “fishy reflux” problem.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat’s NOT in it:\u003c\/strong\u003e no titanium dioxide, no artificial colors, no soybean oil filler (a common label trick in budget fish oil), no proprietary blends.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and oxidation\u003c\/h2\u003e\n\u003cp\u003eFish oil is a peroxidation-vulnerable product. The clinical-grade signals to look for:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMolecular distillation\u003c\/strong\u003e — multi-stage vacuum process that removes mercury, PCBs, dioxins, and PFAS to below the most stringent international standards (CRN, GOED Voluntary Monograph, IFOS 5-star).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeroxide value (PV) \u0026lt; 5 meq\/kg\u003c\/strong\u003e and \u003cstrong\u003ep-Anisidine value (p-AV) \u0026lt; 20\u003c\/strong\u003e — both measures of oxidation. Industry-grade rancidity is – at minimum — PV \u0026gt; 5 or p-AV \u0026gt; 20. Multiple supermarket brands fail this on independent testing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTOTOX (total oxidation) \u0026lt; 26\u003c\/strong\u003e — the combined freshness metric.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e Hg, Pb, As, Cd all under USP \u0026lt;232\u0026gt; limits, third-party verified per batch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMarine-traceable sourcing:\u003c\/strong\u003e small forage fish (anchovy, sardine, mackerel) — not large predators (tuna, swordfish, shark) where mercury and PCBs concentrate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNitrogen-flushed fill\u003c\/strong\u003e and \u003cstrong\u003eUV-protected amber bottle\u003c\/strong\u003e — both reduce in-bottle oxidation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured, FDA-registered facility\u003c\/strong\u003e — per-batch certificate of analysis available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard dose:\u003c\/strong\u003e 2 softgels daily with the largest meal of the day. Fat-meal absorption \u0026gt; light\/empty-stomach absorption (Lawson 1988, Biochem Biophys Res Commun — the original observation; Davidson 2012 NEJM letter on the same effect with prescription EPA).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose protocol:\u003c\/strong\u003e 3–4 softgels daily for elevated triglycerides, active inflammatory pain, or aggressive Omega-3 Index targeting. Monitor with a finger-prick Omega-3 Index test at week 12 (DHL OmegaQuant or equivalent).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e any consistent timing works; with-food matters more than morning vs evening. The 24-hour pharmacokinetic curve is flat at steady state.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you take a blood thinner\u003c\/strong\u003e (warfarin, apixaban, rivaroxaban, clopidogrel): omega-3 prolongs bleeding time modestly at high doses (\u0026gt;3 g\/day). The clinical evidence for actual bleeding events at maintenance doses is weak (Wachira 2014 meta-analysis, Mayo Clin Proc; ACC\/AHA 2019 guidelines explicitly do not recommend stopping fish oil pre-procedure for \u0026lt;3 g\/day). Talk to your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e some surgeons request a 7–14 day stop pre-op out of caution. Follow your surgical team’s protocol.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e cool, dark, dry. Refrigeration extends shelf life beyond the printed expiration. If a softgel ever tastes overtly fishy or rancid, throw out the bottle — it’s oxidized.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat it pairs with — the foundational layer\u003c\/h2\u003e\n\u003ctable style=\"width:100%; border-collapse:collapse; margin:1em 0;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f6f6f6;\"\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003ePair\u003c\/th\u003e\n\u003cth style=\"padding:8px; border:1px solid #ddd; text-align:left;\"\u003eWhy\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eThe two highest-deficiency-prevalence interventions in the modern Western diet. Both fat-soluble — same meal, same softgel slot. The cardiovascular and bone evidence stacks rather than overlaps.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg TRAACS\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCardiovascular triad complete: omega-3 lowers TG and inflammation, Vitamin D supports calcium handling, magnesium handles arterial smooth-muscle tone and NAMPT cofactor duty. Fang 2016 mortality meta + GISSI overlap.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/astaxanthin-12mg-haematococcus-pluvialis\"\u003eAstaxanthin 12mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eThe single best in-membrane antioxidant for protecting omega-3 phospholipids from peroxidation. Astaxanthin spans the lipid bilayer (one polar end, one nonpolar end) and physically shields PUFA double bonds. The classical “DHA + astaxanthin” pair.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/coq10-fertility-cellular-energy-support\"\u003eCoQ10 400mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eCardiovascular pair. CoQ10 is mitochondrial-membrane-resident; omega-3s rebuild the membrane it sits in. Lipid-soluble — co-dose with same fat meal.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/curcumin-1000mg-95-curcuminoids-with-bioperine\"\u003eCurcumin 1000mg + BioPerine\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eAnti-inflammatory pair via two non-overlapping mechanisms — omega-3s shift eicosanoid output from pro-inflammatory to pro-resolving; curcumin inhibits NF-κB \/ COX-2 directly. Strongest joint-pain evidence in combination.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/glutathione-500mg-reduced-gsh-enteric-coated\"\u003eGlutathione 500mg (enteric)\u003c\/a\u003e \u0026amp; \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eLipid peroxidation defense. PUFAs are the fuel for membrane peroxidation; glutathione (and the NAC GlyNAC pair) is the primary regeneration system. Without GSH support, high-dose fish oil + low-antioxidant intake is suboptimal.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e \/ \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eNAD+ stack pairs with omega-3 mechanistically: NAD+ supports mitochondrial ATP throughput, omega-3 supplies the membrane phospholipids those mitochondria sit in. Without omega-3 substrate, mitochondrial membranes drift toward stiff, arachidonic-acid-rich profiles even with abundant NAD+.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti Collagen Complex\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eJoint pair. Collagen is the structural protein; omega-3 is the inflammation modulator. The two address different sides of the same pathology — cartilage matrix supply + synovial inflammation resolution.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eUniversal antioxidant pair. ALA recycles vitamin C, vitamin E, and glutathione — all three of which protect omega-3 PUFAs from peroxidation. The complete antioxidant umbrella for any high-PUFA intake.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides 5000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/biotin-10000-mcg-maximum-strength\"\u003eBiotin 10,000mcg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px; border:1px solid #ddd;\"\u003eSkin\/hair\/nails triad. DHA is structural in skin barrier ceramide synthesis; collagen and biotin are the matrix and growth-phase complements. The dermatology stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhat to expect — realistic timeline\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e usually no felt change. Some people notice softer stools (mild lipid laxation) or a one-week period of mild fish-oil reflux that resolves once the enteric coating is acclimated. Triglycerides start to decline but you wouldn’t lab-detect it yet.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–6:\u003c\/strong\u003e measurable triglyceride drop (lab a fasting lipid panel at week 6 if you want a number). Some users notice less morning joint stiffness. Mood signal — if any — starts here in the EPA-responsive subgroup.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e Omega-3 Index moves measurably (re-test at week 12 with a finger-prick kit). Joint, skin barrier, and dry-eye signals consolidate. Cognitive signal — if any — starts here.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the membrane composition is now fully turned over. This is the steady-state phase — omega-3 is doing what it does for you, whatever that turns out to be in your particular biology.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e the cardiovascular and cognitive endpoints in the long-term cohorts (Framingham Offspring, AlphaOmega, MIDAS open-label extension) are measured in years, not weeks. Maintenance is the strategy, not pulse-dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect:\u003c\/strong\u003e not a stimulant, not a quick fix, not a weight-loss agent (modest at best), not a substitute for omega-6 reduction (vegetable oils still matter), not a substitute for blood pressure or lipid medication if your numbers are deep into clinical-treatment range.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone whose dietary fish intake is \u0026lt;2 servings\/week of fatty fish — which is most adults outside coastal Asia and the Mediterranean.\u003c\/li\u003e\n  \u003cli\u003eAnyone running an \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ stack\u003c\/a\u003e, sirtuin stack, or longevity protocol — omega-3 is the foundational substrate underneath those interventions.\u003c\/li\u003e\n  \u003cli\u003eAdults 40+ thinking about cardiovascular and cognitive trajectory.\u003c\/li\u003e\n  \u003cli\u003ePostmenopausal women: omega-3 status correlates with hippocampal and total brain volume in WHIMS-MRI; the period of most-rapid bone and brain aging.\u003c\/li\u003e\n  \u003cli\u003eAthletes and high-training-load individuals managing chronic low-grade inflammation.\u003c\/li\u003e\n  \u003cli\u003ePeople with elevated triglycerides (\u0026gt;150 mg\/dL) for whom dietary change alone hasn’t moved the number.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a family history of premature cardiovascular disease — the highest-leverage intervention category in the entire VITAL\/REDUCE-IT\/JELIS literature.\u003c\/li\u003e\n  \u003cli\u003ePeople with chronic joint pain or low-grade inflammation looking to reduce NSAID load.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFish allergy:\u003c\/strong\u003e this is a fish-derived product. A vegan algal-DHA product is the alternative.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive anticoagulation\u003c\/strong\u003e at high doses: 1–2 g\/day combined EPA+DHA appears safe in the meta-analyzed evidence even on warfarin\/DOAC; doses \u0026gt;3 g\/day in this context warrant prescriber discussion.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery (\u0026lt; 7–14 days):\u003c\/strong\u003e follow your surgical team’s instructions. Most current cardiology guidance does not require a stop, but practice varies by surgeon.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy:\u003c\/strong\u003e DHA is critical for fetal brain development — but pregnancy supplementation should be guided by your OB, ideally with a low-mercury algal DHA product or a doctor-supervised fish oil protocol. This product is not labeled for pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAtrial fibrillation history:\u003c\/strong\u003e very-high-dose icosapent ethyl in REDUCE-IT modestly increased AF events. Standard 1–2 g\/day combined EPA+DHA carries no comparable signal in maintenance trials, but if you have known AF, raise it with your cardiologist before going to 3–4 g\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChronic GI fat malabsorption\u003c\/strong\u003e (severe pancreatic insufficiency, advanced IBD with steatorrhea): rTG fish oil still requires lipase. Speak with your GI team about phospholipid-form omega-3 (krill, herring roe) which is partially absorbed without lipase.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eIs this triglyceride form (TG\/rTG) or ethyl ester (EE)?\u003c\/strong\u003e\u003cbr\u003e\nRe-esterified triglyceride (rTG). The form with the best long-term bioavailability data (Dyerberg 2010, Neubronner 2011) and the form most premium fish oil brands use. If you’ve compared labels and seen the EE\/TG distinction, this is on the rTG side.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is the dose 1,200 mg EPA+DHA at 2 softgels rather than 4 g like REDUCE-IT?\u003c\/strong\u003e\u003cbr\u003e\nREDUCE-IT used 4 g\/day icosapent ethyl (high-purity EPA) in patients with elevated triglycerides on statins as a pharmacologic intervention. The 1,200 mg combined EPA+DHA dose (or 2,400 mg at 4 softgels) is the maintenance dose used in the foundational Omega-3 Index literature and in GISSI-Prevenzione. If your goal is post-MI cardioprotection or aggressive triglyceride lowering, 4 softgels\/day = 2,880 mg combined EPA+DHA is closer to the trial-equivalent dose. For general healthspan, 2 softgels.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to flaxseed oil or chia?\u003c\/strong\u003e\u003cbr\u003e\nFlax\/chia provide ALA, the short-chain plant omega-3. ALA-to-EPA conversion in humans is 1–10%; ALA-to-DHA is 0.5% or less (Burdge 2002, Br J Nutr). If your goal is moving the Omega-3 Index, flax does it inefficiently. Algal oil (DHA-only or DHA+EPA) is the legitimate vegan alternative.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to krill oil?\u003c\/strong\u003e\u003cbr\u003e\nKrill provides phospholipid-form omega-3 plus astaxanthin, both at lower per-capsule EPA+DHA than fish oil. Phospholipid form has a small absorption advantage in some studies (Schuchardt 2011); the per-mg cost is higher; the krill stocks are managed but ecologically debated. For matched EPA+DHA delivery, fish oil is more cost-efficient. The classical “fish oil + standalone \u003ca href=\"\/he\/products\/astaxanthin-12mg-haematococcus-pluvialis\"\u003eastaxanthin\u003c\/a\u003e” pair gives you both in measured doses.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this raise my LDL?\u003c\/strong\u003e\u003cbr\u003e\nIn some individuals, particularly with high baseline triglycerides, omega-3 raises LDL-C modestly. This is largely a particle-size shift (fewer small dense LDL, more large buoyant LDL) which is metabolically favorable, not a true atherogenic burden increase. ApoB and LDL-P are the better markers. Re-test ApoB at week 12 if this question matters to you.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about “burping fish”?\u003c\/strong\u003e\u003cbr\u003e\nThree causes: oxidized oil (the bottle is rancid — throw it out), gastric-dissolution softgels (no enteric coating), and large dose on empty stomach. Enteric coating on this product addresses #2; with-food dosing addresses #3; cool-dark storage addresses #1.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow much mercury \/ heavy metal is in fish oil?\u003c\/strong\u003e\u003cbr\u003e\nIn a properly molecularly-distilled product, all heavy metals are below detection limits per USP \u0026lt;232\u0026gt;. Mercury bioaccumulates in fish flesh, not fish oil — the distillation process strips it almost entirely. Anchovy\/sardine\/mackerel are low-trophic-level forage fish that don’t accumulate much to begin with; molecular distillation removes the residual.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I take this with or without food?\u003c\/strong\u003e\u003cbr\u003e\nWith food — particularly with a meal containing some fat — absorption is meaningfully better than empty-stomach (Lawson 1988; Davidson 2012 NEJM letter). Same fat meal as your \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, your \u003ca href=\"\/he\/products\/coq10-fertility-cellular-energy-support\"\u003eCoQ10\u003c\/a\u003e, and your \u003ca href=\"\/he\/products\/astaxanthin-12mg-haematococcus-pluvialis\"\u003eastaxanthin\u003c\/a\u003e if you take them.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with my statin?\u003c\/strong\u003e\u003cbr\u003e\nYes. The cardiovascular evidence for omega-3 is largely on top of statin therapy (JELIS, REDUCE-IT). No pharmacokinetic interaction. Many cardiologists actively co-prescribe.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes fish oil thin the blood — should I stop before surgery?\u003c\/strong\u003e\u003cbr\u003e\nModest effect on bleeding time at high doses; weak evidence for actual bleeding events at maintenance doses. ACC\/AHA 2019 guidelines explicitly do not require pre-procedure cessation at standard doses. Your surgical team may have local policy — follow theirs.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy DPA on the label?\u003c\/strong\u003e\u003cbr\u003e\nDocosapentaenoic acid (22:5 ω-3) is the “forgotten” intermediate omega-3 between EPA and DHA. It’s a precursor to its own resolvin family (Rv-DPA series) and has independent triglyceride and platelet effects (Byelashov 2015). It’s naturally present in marine oils (the ≈100 mg here is native, not added) and is generally not concentrated out of premium products.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow do I know if it’s working?\u003c\/strong\u003e\u003cbr\u003e\nThree options: (1) lab a fasting lipid panel at week 6 and look for triglyceride decline; (2) order a finger-prick Omega-3 Index test at week 12; (3) track subjective endpoints — morning joint stiffness, dry eye, mood, sleep — against a baseline diary. Option 2 is the only truly objective single-data-point readout because the Omega-3 Index reflects the membrane-level intervention you’re actually buying.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eVegan \/ vegetarian alternative?\u003c\/strong\u003e\u003cbr\u003e\nAlgal oil (Schizochytrium-derived DHA, sometimes with EPA) is the legitimate plant-based EPA\/DHA source. Same molecules, different organism, lower aftertaste. We don’t currently stock an algal product but it’s on the catalog roadmap.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this if I have an iodine sensitivity?\u003c\/strong\u003e\u003cbr\u003e\nFish oil contains negligible iodine — iodine concentrates in fish flesh and thyroid, not the oil fraction. Generally compatible with low-iodine diets.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat’s the difference between this and prescription fish oil (Vascepa, Lovaza)?\u003c\/strong\u003e\u003cbr\u003e\nVascepa is icosapent ethyl — pure EPA in ethyl ester form, FDA-approved as a drug. Lovaza is mixed EPA\/DHA in ethyl ester form, FDA-approved. Both are EE not rTG; both are dosed at 2–4 g\/day; both are insurance-billable for triglyceride lowering or for the REDUCE-IT indication. This is not a drug, and the FDA disclaimer below applies. The active fatty acid molecules are the same.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy enteric coating?\u003c\/strong\u003e\u003cbr\u003e\nA standard softgel dissolves in the stomach. If the contents oxidize there or the user is sensitive to fish-oil reflux, “fish burps” happen. An enteric-coated softgel passes intact through the stomach and dissolves in the duodenum, where the oil meets bile acids and lipase under physiological conditions. The reflux\/burp problem largely disappears.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the True Health Protocol catalog\u003c\/h2\u003e\n\u003cp\u003eOmega-3 Fish Oil 2000mg is one of the four foundational always-on supplements in the catalog — alongside \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-with-k2-mk7-100mcg\"\u003eVitamin D3 + K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate TRAACS\u003c\/a\u003e, and the \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e+\u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-precursor\"\u003eGlycine\u003c\/a\u003e GlyNAC pair. These are the supplements that do not chase a specific pathway but instead supply the structural and cofactor inputs that every other intervention assumes. Without them, an aggressive NMN\/sirtuin\/senolytic stack is being deployed onto a substrate-deficient cellular environment.\u003c\/p\u003e\n\u003cp\u003eThe supplementary anti-inflammatory and joint pairings — \u003ca href=\"\/he\/products\/curcumin-1000mg-95-curcuminoids-with-bioperine\"\u003eCurcumin + BioPerine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti Collagen Complex\u003c\/a\u003e, \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides\u003c\/a\u003e — sit on top of the omega-3 substrate. The cardiovascular pairings (\u003ca href=\"\/he\/products\/coq10-fertility-cellular-energy-support\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/taurine-1000mg-foundational-cardiovascular-mitochondrial\"\u003eTaurine\u003c\/a\u003e) similarly assume omega-3 as the membrane-quality baseline.\u003c\/p\u003e\n\u003cp\u003eThe NAD+ family (\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-500mg-pure-nmn-30-day-supply\"\u003eNMN 500\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-1000mg-anti-aging-formula\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e) and the senolytic\/sirtuin family (\u003ca href=\"\/he\/products\/fisetin-500mg-mayo-ranked-senolytic-flavonoid\"\u003eFisetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-bioperine-cd38-inhibitor\"\u003eApigenin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/resveratrol-600mg-trans-resveratrol-sirt1-activator\"\u003eResveratrol\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e) layer above this. None of those pathways function correctly with stiff arachidonic-acid-dominated membranes.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003eMarchioli R et al. \u003cem\u003eGISSI-Prevenzione\u003c\/em\u003e. Lancet 1999;354(9177):447-455. (Post-MI all-cause mortality reduction.)\u003c\/li\u003e\n  \u003cli\u003eYokoyama M et al. \u003cem\u003eJELIS\u003c\/em\u003e. Lancet 2007;369(9567):1090-1098. (EPA on statins, Japanese hyperlipidemic cohort.)\u003c\/li\u003e\n  \u003cli\u003eBhatt DL et al. \u003cem\u003eREDUCE-IT\u003c\/em\u003e. N Engl J Med 2019;380:11-22. (4 g\/day icosapent ethyl, 25% CV event reduction.)\u003c\/li\u003e\n  \u003cli\u003eManson JE et al. \u003cem\u003eVITAL\u003c\/em\u003e. N Engl J Med 2019;380:23-32. (1 g\/day EPA+DHA in healthy U.S. adults, subgroup signal in low-fish-intake stratum.)\u003c\/li\u003e\n  \u003cli\u003eNicholls SJ et al. \u003cem\u003eSTRENGTH\u003c\/em\u003e. JAMA 2020;324(22):2268-2280. (EPA+DHA carboxylic acid, negative primary trial — the complicating result.)\u003c\/li\u003e\n  \u003cli\u003eAlbert CM et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346(15):1113-1118.\u003c\/li\u003e\n  \u003cli\u003eSkulas-Ray AC et al. AHA Science Advisory: omega-3 fatty acids for the management of hypertriglyceridemia. Circulation 2019;140:e673-e691.\u003c\/li\u003e\n  \u003cli\u003eHarris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004;39(1):212-220.\u003c\/li\u003e\n  \u003cli\u003eHarris WS et al. Omega-3 blood levels and total and cause-specific mortality — the Framingham Offspring Cohort. J Clin Lipidol 2018;12(3):718-727.\u003c\/li\u003e\n  \u003cli\u003eDyerberg J et al. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids 2010;83(3):137-141. (rTG vs EE absorption.)\u003c\/li\u003e\n  \u003cli\u003eNeubronner J et al. Enhanced increase of Omega-3 Index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur J Clin Nutr 2011;65(2):247-254.\u003c\/li\u003e\n  \u003cli\u003eYurko-Mauro K et al. \u003cem\u003eMIDAS\u003c\/em\u003e: Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010;6(6):456-464.\u003c\/li\u003e\n  \u003cli\u003ePottala JV et al. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes — WHIMS-MRI study. Neurology 2014;82(5):435-442.\u003c\/li\u003e\n  \u003cli\u003eSmith AD et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment. PLoS One 2010;5(9):e12244. (Omega-3 baseline as treatment-effect modifier.)\u003c\/li\u003e\n  \u003cli\u003eMocking RJT et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry 2016;6:e756.\u003c\/li\u003e\n  \u003cli\u003eMaroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to non-steroidal anti-inflammatory drugs for discogenic pain. Surg Neurol 2006;65(4):326-331.\u003c\/li\u003e\n  \u003cli\u003eCalder PC. Omega-3 fatty acids and inflammatory processes. Biochem Soc Trans 2017;45(5):1105-1115.\u003c\/li\u003e\n  \u003cli\u003eSerhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014;510:92-101.\u003c\/li\u003e\n  \u003cli\u003eBurdge GC. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Br J Nutr 2002;88(4):411-420.\u003c\/li\u003e\n  \u003cli\u003eParker HM et al. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012;56(4):944-951.\u003c\/li\u003e\n  \u003cli\u003eWachira JK et al. Fish oils, omega-3 fatty acids, and bleeding: a systematic review and meta-analysis. Mayo Clin Proc 2014.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eReading on this catalog’s blog\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/the-foundational-four-supplements-of-healthspan\"\u003eThe Foundational Four: omega-3, vitamin D, magnesium, and the GlyNAC pair\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/the-omega-3-index-and-why-it-matters\"\u003eThe Omega-3 Index — the only blood marker that actually measures fish oil status\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/triglyceride-vs-ethyl-ester-fish-oil\"\u003eTriglyceride vs ethyl ester: why the form on the label is non-negotiable\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/cardiovascular-supplement-stack\"\u003eThe cardiovascular pairing stack — omega-3, CoQ10, magnesium, taurine, vitamin K2\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/membrane-fluidity-and-aging\"\u003eMembrane fluidity and aging: why every NAD+ stack assumes omega-3 substrate\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Speak with a qualified healthcare professional before adding fish oil to your protocol if you take blood thinners, are scheduled for surgery, or have a known atrial fibrillation history. The information here is educational and reflects published research as of 2025.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839533596890,"sku":"THP-OMEGA3-2000-60","price":24.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_omega-3.png?v=1778047681"},{"product_id":"alpha-lipoic-acid-600mg-universal-antioxidant","title":"Alpha-Lipoic Acid 600mg | Universal Antioxidant + Mitochondrial Cofactor for Glucose \u0026 Longevity","description":"\u003cp\u003e\u003cstrong\u003e600 mg of Alpha-Lipoic Acid per capsule\u003c\/strong\u003e — the universal antioxidant that works in both water and fat compartments, recycles other antioxidants the body has already used, chelates heavy metals, and sits as a direct cofactor inside two of the mitochondrial enzyme complexes that convert food into ATP. Approved as a prescription drug for diabetic peripheral neuropathy in Germany since 1966 (Thioctacid®); sold as a dietary supplement in the US. The 600 mg dose is the dose used across all four landmark German RCTs — ALADIN, ALADIN III, SYDNEY 2, and NATHAN 1. Standardized purity, vegan capsule, no titanium dioxide, no magnesium stearate.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUniversal antioxidant\u003c\/strong\u003e — uniquely both water-soluble \u003cem\u003eand\u003c\/em\u003e fat-soluble (the dihydrolipoate ↔ lipoate redox couple is amphipathic), so it works inside the cell membrane \u003cem\u003eand\u003c\/em\u003e in the cytoplasm, mitochondria, and bloodstream. Almost every other antioxidant is restricted to one compartment (Packer 1995, \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRecycles other antioxidants\u003c\/strong\u003e — regenerates the spent (oxidized) forms of Vitamin C, Vitamin E (α-tocopherol), reduced glutathione, and CoQ10 back to their active forms. The whole antioxidant network runs longer per dose with ALA in the picture (Bast \u0026amp; Haenen 1988; Kagan 1992).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial cofactor\u003c\/strong\u003e — ALA is the prosthetic group on lipoyllysine residues of pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH), and the branched-chain α-keto-acid complex. The cell literally cannot burn glucose, glutamine, or BCAAs for ATP without it (Bustamante 1998).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGlucose \u0026amp; nerve support\u003c\/strong\u003e — the most-studied compound for diabetic peripheral neuropathy in Europe. Four large RCTs (ALADIN, ALADIN III, SYDNEY 2, NATHAN 1) pooled in Ziegler 2004 and Mijnhout 2012 meta-analyses showed a clinically meaningful reduction in Total Symptom Score (TSS) at the 600 mg\/day oral dose this product matches.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK activator + insulin sensitizer\u003c\/strong\u003e — Konrad 2001 and Jacob 1999 showed measurable increase in glucose uptake and GLUT4 translocation in skeletal muscle in lean and Type-2 diabetic adults at 600 mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNrf2 pathway\u003c\/strong\u003e — ALA is one of the most reliable Nrf2\/ARE pathway inducers in the supplement world (Suh 2004), upregulating endogenous glutathione synthesis, NQO1, and Phase II detoxification enzymes — the same axis hit by sulforaphane and curcumin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest paired with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e for metabolic-health stacks (different mechanism — same target organ); \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e for mitochondrial stacks; \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e + \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eVitamin C\u003c\/a\u003e for the antioxidant network; \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e for the NAD+ axis (PDH\/KGDH need both NAD+ \u003cem\u003eand\u003c\/em\u003e lipoate to function).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy a metabolic supplement ended up in serious longevity research\u003c\/h2\u003e\n\u003cp\u003eAlpha-lipoic acid was discovered in 1937 in \u003cem\u003eLactobacillus casei\u003c\/em\u003e and isolated in pure form by Lester Reed at the University of Texas in 1951. For its first half-century it was studied almost exclusively as a metabolic cofactor — the small disulfide molecule covalently bound to the E2 subunits of the α-keto-acid dehydrogenase complexes. Without it, the cell cannot oxidatively decarboxylate pyruvate to acetyl-CoA (PDH), cannot run the Krebs cycle past α-ketoglutarate (KGDH), and cannot break down leucine, isoleucine, or valine.\u003c\/p\u003e\n\n\u003cp\u003eThe shift into longevity research started in the late 1980s when Lester Packer's lab at UC Berkeley discovered that \u003cem\u003efree\u003c\/em\u003e ALA (not the protein-bound form) and its reduced form dihydrolipoate (DHLA) are extraordinary redox-active compounds with three properties almost no other antioxidant has: (1) they cross the blood-brain barrier, (2) they're equally active in aqueous and lipid compartments, and (3) they reduce the oxidized forms of every other major antioxidant in the cell — vitamin C, vitamin E, glutathione, CoQ10. Packer christened ALA the “universal antioxidant” in his 1995 \u003cem\u003eFree Radical Biology \u0026amp; Medicine\u003c\/em\u003e review, and the field has used that term ever since.\u003c\/p\u003e\n\n\u003cp\u003eThe metabolic-medicine track and the longevity track converged in the 1990s when Hager and Maczurek and others started looking at age-related declines in mitochondrial PDH\/KGDH activity in brain tissue. Aged neurons have less lipoate on their dehydrogenase complexes; supplementing free ALA partially rescues activity in mouse models (Hagen 1999). The same lab showed ALA-fed older rats walk on a rotarod like young rats, reverse age-related declines in carnitine acetyl-transferase, and have lower 8-OHdG (oxidative DNA damage marker) in liver mitochondria.\u003c\/p\u003e\n\n\u003cp\u003eIn humans the longevity case is less direct than the metabolic case — there is no NATHAN 1 for healthspan — but the supporting biomarker work is substantial. ALA has consistently lowered fasting glucose, insulin, HbA1c, triglycerides, total cholesterol, hs-CRP, IL-6, MDA, F2-isoprostanes, and 8-OHdG across dozens of human RCTs in metabolic syndrome, NAFLD, PCOS, MS, and Alzheimer's pilot populations. Every one of those is a mid-life longevity biomarker. ALA's main function in modern protocols is as a foundational layer that hits glucose, lipids, mitochondrial substrate flux, antioxidant recycling, and heavy-metal chelation simultaneously — four mechanisms most other compounds don't combine.\u003c\/p\u003e\n\n\u003ch2\u003eThe four mechanisms in plain language\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1. The mitochondrial cofactor job (the original reason it exists).\u003c\/strong\u003e ALA is the prosthetic group covalently attached to lysine residues on the E2 subunit of three enzyme complexes: pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH), and the branched-chain α-keto-acid dehydrogenase (BCKDH). The lipoyllysine arm physically swings between three active sites, transferring acetyl\/acyl groups and transferring electrons to FAD. PDH gates pyruvate → acetyl-CoA, the bottleneck step where carbohydrates enter the Krebs cycle. KGDH gates α-ketoglutarate → succinyl-CoA, the rate-limiting step of the Krebs cycle itself. BCKDH gates leucine\/isoleucine\/valine catabolism. Without lipoate, none of these complexes function. With age, lipoate content of these complexes drops; supplementing the free precursor partly compensates (Bustamante 1998; Hagen 1999).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. The antioxidant-recycling job (Packer's discovery).\u003c\/strong\u003e ALA gets reduced to DHLA inside cells, then DHLA reduces oxidized vitamin C (dehydroascorbate → ascorbate), oxidized vitamin E radicals (via vitamin C), oxidized glutathione (GSSG → GSH), and CoQ10 (ubiquinone → ubiquinol). One ALA molecule can keep the network running through many oxidant exposures because it sits at the top of the recycling cascade. This is the structural reason ALA pairs particularly well with \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eglutathione\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003evitamin C\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e rather than competing with them.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. The Nrf2 pathway job (added in the 2000s).\u003c\/strong\u003e ALA modifies cysteine residues on Keap1, releases Nrf2 to translocate to the nucleus, and turns on the Antioxidant Response Element (ARE) — driving expression of glutathione synthesis enzymes (GCLC\/GCLM), NQO1, heme oxygenase-1 (HO-1), and the Phase II detoxification battery. Suh 2004 showed ALA restores GSH synthesis in old rats by ~50%. This is the same pathway sulforaphane, curcumin, and the SIRT1 activators converge on. Hitting it from multiple angles is why senolytic and longevity stacks layer ALA with \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003ecurcumin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. The insulin-sensitization \/ AMPK job (the metabolic case).\u003c\/strong\u003e Lee 2005 and Konrad 2001 showed ALA activates AMPK in muscle, increases GLUT4 translocation to the membrane, and increases insulin-mediated glucose uptake. The acute effect of a single 600 mg oral dose is measurable on a euglycemic clamp (Jacob 1999). Repeated dosing for 4 weeks in T2D patients lowered fasting glucose ~20% and triglycerides ~25% in Akbari 2018 meta. ALA and \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e hit AMPK by different mechanisms (ALA via mitochondrial AMP\/ATP shift, berberine via direct AMPK kinase activation), which is why they stack rather than compete.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eBonus mechanism: heavy-metal chelation.\u003c\/strong\u003e ALA's two thiol groups in the reduced (DHLA) form bind mercury, copper, iron, lead, cadmium, and arsenic. Lin 1989 and Patrick 2002 reviewed the chelation work. ALA is the only antioxidant that chelates and recycles Vitamin C\/E\/glutathione simultaneously — a useful property for adults with chronic background metal exposure (older fillings, well water, occupational).\u003c\/p\u003e\n\n\u003ch2\u003eThe trial bench — what 600 mg\/day actually does in humans\u003c\/h2\u003e\n\u003cp\u003eALA has one of the longest, deepest, and best-replicated trial records in supplemental medicine, anchored by four large multi-center German RCTs in diabetic peripheral neuropathy at the 600 mg dose this product matches.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eALADIN (Ziegler 1995, \u003cem\u003eDiabetologia\u003c\/em\u003e):\u003c\/strong\u003e 328 T2D patients with symptomatic distal symmetric polyneuropathy. 1200, 600, or 100 mg\/day IV vs placebo, 3 weeks. 600 mg dose — significant reduction in Total Symptom Score (TSS) and Hamburg Pain Adjective List score; no benefit at 100 mg. The first proof of dose-response.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eALADIN II (Reljanovic 1999):\u003c\/strong\u003e 65 T1D + T2D, 600 or 1200 mg\/day IV for 5 days, then 600\/1200 mg\/day oral for 2 years. Significant improvement in nerve conduction velocity in sural and tibial nerves at both doses. 1200 not better than 600.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eALADIN III (Ziegler 1999):\u003c\/strong\u003e 509 T2D, 600 mg\/day IV for 3 weeks then 1800 mg\/day oral for 6 months. The IV phase reduced TSS; the oral 1800 mg phase failed to maintain that on TSS but improved the Neuropathy Impairment Score for the lower limbs (NIS-LL).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDEKAN (Ziegler 1997):\u003c\/strong\u003e 73 T2D with cardiac autonomic neuropathy. 800 mg\/day oral 4 months. Significant improvement in heart-rate variability vs placebo. The first cardiac-autonomic ALA trial.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eORPIL (Ruhnau 1999):\u003c\/strong\u003e 24 T2D, 1800 mg\/day oral 3 weeks. Significant TSS reduction at 19 days. Established that oral could replicate the IV symptom benefit, opening the door to chronic oral dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSYDNEY (Ametov 2003):\u003c\/strong\u003e 120 diabetics, 600 mg\/day IV 14 infusions over 3 weeks. TSS dropped 5.7 points vs 1.8 placebo — one of the largest absolute symptom reductions on record.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSYDNEY 2 (Ziegler 2006):\u003c\/strong\u003e The dose-finding oral RCT — 181 patients, 600 vs 1200 vs 1800 mg\/day for 5 weeks. \u003cem\u003eAll three doses\u003c\/em\u003e beat placebo on TSS; 1200 and 1800 had more nausea. \u003cstrong\u003e600 mg\/day oral was the optimal risk\/benefit dose\u003c\/strong\u003e — this is the dose this product matches.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNATHAN 1 (Ziegler 2011, \u003cem\u003eDiabetes Care\u003c\/em\u003e):\u003c\/strong\u003e The landmark 4-year trial — 460 T1D + T2D with mild-to-moderate DPN, 600 mg\/day oral. Primary composite endpoint trended favorable (NIS-LL + 7 neurophysiologic tests, p=0.105) and reached significance on NIS, NIS-LL, muscle weakness, and clinical neurologic examination. The longest ALA RCT ever performed; it confirmed durability of effect and a safety profile equivalent to placebo over 4 years of daily use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMijnhout 2012 meta-analysis (\u003cem\u003eInt J Endocrinol\u003c\/em\u003e):\u003c\/strong\u003e Pooled 5 RCTs at 600 mg\/day. Significant 2.26-point TSS reduction (95%CI -2.83 to -1.69) and significant improvement on NIS-LL.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eOutside neuropathy, the human evidence base is broad:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsulin sensitivity \/ Type-2 diabetes:\u003c\/strong\u003e Akbari 2018 meta-analysis pooled 24 RCTs — significant reductions in fasting glucose, fasting insulin, HOMA-IR, and HbA1c. Effect sizes are modest (~10-15%) but statistically robust and additive on top of standard care.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLipid profile:\u003c\/strong\u003e Mohammadi 2017 and Akbari 2018 meta-analyses showed significant reductions in total cholesterol, LDL, and triglycerides; modest HDL increase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeight \/ waist circumference:\u003c\/strong\u003e Kucukgoncu 2017 meta-analysis — ALA reduced body weight by 1.27 kg vs placebo across 12 RCTs. Modest but consistent effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAFLD:\u003c\/strong\u003e de Sousa 2019 review of 6 RCTs — ALA reduced ALT, AST, GGT and hepatic steatosis on ultrasound; mechanism likely a combination of insulin sensitization + Nrf2 + lipid lowering.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePCOS:\u003c\/strong\u003e Genazzani 2010 and Masharani 2010 — ALA improved menstrual regularity, lowered insulin\/HOMA-IR, and improved ovulatory function in lean PCOS women, as a metformin alternative or adjunct.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMultiple sclerosis:\u003c\/strong\u003e Khalili 2014 — 1200 mg\/day for 12 weeks significantly increased serum total antioxidant capacity in 52 relapsing-remitting MS patients. A pilot Spain-Mayer 2017 of 1200 mg\/day for 2 years showed a 68% reduction in brain volume loss vs placebo.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlzheimer's pilot:\u003c\/strong\u003e Hager 2007 — 9-month open-label of 600 mg\/day in mild AD slowed cognitive decline (ADAS-cog stable vs natural-history rate of progression). Maczurek 2008 review summarizes the AD case.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive aging:\u003c\/strong\u003e Gosselin 2019 systematic review of ALA in cognitive function trials — positive signal in MCI\/mild AD, less clear in healthy older adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMigraine:\u003c\/strong\u003e Magis 2007 — 600 mg\/day for 3 months reduced migraine frequency and severity vs placebo.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHypertension:\u003c\/strong\u003e Mohammadi 2017 meta — modest 2-3 mmHg systolic reduction across pooled trials.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy 600 mg, why once daily, and why R\/S vs R\u003c\/h2\u003e\n\u003cp\u003eThe 600 mg\/day oral dose used in this product is the single most-replicated dose in the human ALA literature. SYDNEY 2 demonstrated that 1200 and 1800 mg\/day weren't more effective than 600 for symptom score, and they had more GI side effects (mostly nausea). NATHAN 1 confirmed 600 mg\/day is safe and effective for 4 years of daily use. Ziegler 2014 (\u003cem\u003eAntioxidants \u0026amp; Redox Signaling\u003c\/em\u003e) summarized: \u003cem\u003e“The therapeutic dose of oral ALA in diabetic neuropathy is 600 mg\/day. Higher doses do not produce additional benefit and are associated with more adverse events.”\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003eALA exists in two enantiomers — the natural \u003cstrong\u003eR-isomer\u003c\/strong\u003e (R-ALA) and the synthetic \u003cstrong\u003eS-isomer\u003c\/strong\u003e. Most consumer products (and all of the German DPN trials including NATHAN 1) used \u003cstrong\u003eracemic R\/S-ALA\u003c\/strong\u003e — a 50\/50 mix. R-ALA is the form your mitochondria make and use; S-ALA is metabolically inert as a cofactor but is still redox-active and contributes to the antioxidant pool. Some \"stabilized R-ALA\" products claim better absorption per mg, but the trial database that established efficacy was built on racemic ALA. We use racemic R\/S-ALA at 600 mg precisely because that's the molecule and dose the trials validated. (If you specifically want R-ALA, it's available; you'd typically take 200-300 mg of R-ALA to roughly equate to 600 mg of racemic.)\u003c\/p\u003e\n\n\u003cp\u003eThe half-life of oral ALA is short — ~30 minutes plasma, with the antioxidant effect on the GSH\/Nrf2 axis lasting 6-12 hours. Once-daily dosing is what the trials used; some clinicians split into 300 mg twice daily on an empty stomach for steadier exposure. Both schedules are evidence-supported.\u003c\/p\u003e\n\n\u003ch2\u003eWhere ALA fits vs. the other compounds in this catalog\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol stacks tend to layer ALA at the foundational antioxidant layer, alongside the GlyNAC pair, vitamin C, and CoQ10. Here's how ALA differs from the closest neighbors:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e:\u003c\/strong\u003e Glutathione\/NAC give the cell the substrate and precursor for the body's master antioxidant. ALA \u003cem\u003erecycles\u003c\/em\u003e oxidized glutathione back to active form and turns on the Nrf2 axis that drives glutathione \u003cem\u003esynthesis\u003c\/em\u003e. The three are designed to layer — substrate (NAC), product (GSH), and recycler\/upregulator (ALA).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e:\u003c\/strong\u003e CoQ10 and PQQ live inside the mitochondrial inner membrane — CoQ10 as the mobile electron carrier of complex I→III, PQQ as a redox cofactor and biogenesis activator. ALA sits in the matrix on PDH\/KGDH and recycles ubiquinone ↔ ubiquinol. The three together cover the substrate-flux + electron-transport + redox-recycling axes of mitochondrial energy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e:\u003c\/strong\u003e Both lower fasting glucose and improve insulin sensitivity by AMPK activation, but by different upstream mechanisms (ALA via mitochondrial AMP\/ATP ratio; berberine by direct AMPK kinase activation and gut-microbiome shifts). Stacking is additive (Bertuglia 2008 in animals, several human pilot studies). Berberine has the broader metabolic profile (lipids+glucose+gut); ALA has the broader antioxidant + neuropathy profile.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e:\u003c\/strong\u003e Both activate Nrf2 and inhibit NF-κB. Curcumin is more potent on inflammation; ALA is more potent on glucose. Stacking covers both axes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e:\u003c\/strong\u003e Both are membrane-active antioxidants but astaxanthin lives in the lipid bilayer fixed at right-angles to the membrane; ALA spans aqueous + lipid. They're complementary, not redundant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. NAD+ axis (\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e):\u003c\/strong\u003e PDH and KGDH need \u003cem\u003eboth\u003c\/em\u003e lipoate and NAD+ to function. NAD+ precursors raise the pool of the electron acceptor; ALA provides the cofactor that loads that pool. They're substrate-and-cofactor partners, not competitors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e:\u003c\/strong\u003e Urolithin A activates mitophagy — clears damaged mitochondria. ALA helps the surviving mitochondria run cleaner. Sequential, not redundant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e:\u003c\/strong\u003e CaAKG provides α-ketoglutarate as a Krebs-cycle intermediate. KGDH then uses lipoate (from ALA) to convert it to succinyl-CoA. They literally work on the same enzyme.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in this product\u003c\/h2\u003e\n\u003cp\u003eEach capsule delivers \u003cstrong\u003e600 mg of pharmaceutical-grade racemic R\/S Alpha-Lipoic Acid\u003c\/strong\u003e — the exact molecule and dose used in the SYDNEY 2 and NATHAN 1 trials. We chose racemic over R-only stabilized forms because the entire human evidence base was built on the racemic mixture; switching to R-only changes the dose-response curve and we have no equivalent four-year trial on R-only at this dose.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e60 vegetarian capsules\u003c\/strong\u003e per bottle — 60-day supply at the standard 600 mg\/day or 30-day supply at split 300 mg twice-daily.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHPMC vegan capsule shell\u003c\/strong\u003e — no gelatin, no animal sourcing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo titanium dioxide\u003c\/strong\u003e (banned in EU food in 2022, still common in US supplements). No magnesium stearate, no silicon dioxide, no PEG, no dyes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExcipient-minimal formulation\u003c\/strong\u003e — only the active and rice flour as a flow agent. We don't include any “stabilizers” that mask oxidized ALA in old-batch product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUV-protective amber HDPE bottle\u003c\/strong\u003e with a foil induction seal — ALA is photosensitive and oxidatively self-degrading; clear bottles and over-large headspace are common ways product loses potency on the shelf.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured in a US FDA-registered facility.\u003c\/strong\u003e Per-batch Certificate of Analysis covers ALA assay (HPLC), residual solvents (EU Pharmacopoeia method), heavy metals (USP \u0026lt;232\u0026gt; \/ ICP-MS), microbial limits (USP \u0026lt;2021\u0026gt;), and absence of pesticides.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmed by HPLC.\u003c\/strong\u003e Many ALA products are sold by total-disulfide assay rather than chromatographic identity; we run HPLC against a reference standard so the labeled mg matches the actual mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergen-free formulation\u003c\/strong\u003e — no gluten, soy, dairy, peanut, tree-nut, egg, fish, or shellfish.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard protocol:\u003c\/strong\u003e 1 capsule (600 mg) once daily on an empty stomach — either 30 min before breakfast or 2-3 hr after dinner. Empty stomach matters: food (especially dairy and high-mineral meals) reduces ALA absorption ~30-40% (Gleiter 1996). The German DPN trials specified empty-stomach dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTwice-daily option:\u003c\/strong\u003e Some clinicians split into 300 mg morning + 300 mg afternoon, both empty-stomach. Same total exposure with steadier plasma levels. Either schedule is supported.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake with the rest of the antioxidant-network stack at the same time:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eglutathione\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003evitamin C\u003c\/a\u003e, \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e. Network compounds work better dosed together.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDon't take it within 2 hours of \u003ca href=\"\/he\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003emulti-collagen\u003c\/a\u003e, iron, or thyroid medication (levothyroxine).\u003c\/strong\u003e ALA chelates metals; that's a mechanism feature, but it can blunt absorption of those products. Separate by ~2-3 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsulin \/ sulfonylurea users:\u003c\/strong\u003e ALA can additively lower glucose. Talk to your prescriber and start with closer glucose self-monitoring during the first 2-4 weeks of use. The 600 mg dose is typically not problematic alone but stacks with insulin\/sulfonylureas on a same-target.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e Take when you remember if it's still on an empty stomach; otherwise skip and resume the next day. Don't double-dose — ALA's symptom benefits build over weeks; missing a single day is not consequential.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e Not required. NATHAN 1 ran 4 years of continuous daily use without dose-related toxicity. Long-term use is the use case the trials validated.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat it pairs with — the longevity\/metabolic stack\u003c\/h2\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePair with\u003c\/th\u003e\n\u003cth\u003eWhy\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eDifferent upstream activator of the same AMPK target. Lipid + glucose + gut additive. Take berberine with meals; ALA empty-stomach — the schedules don't conflict.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eThe GlyNAC + ALA network: substrate + product + recycler. Sechi 2009 GlyNAC + ALA showed measurable GSH:GSSG ratio improvement in older adults.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eCloses the GlyNAC loop — glycine is the third amino acid in glutathione. Kumar 2023 GlyNAC trial showed body-composition + glucose benefit in older adults at 24 weeks.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eALA recycles oxidized vitamin C back to ascorbate. Liposomal form delivers steady plasma vs ascorbic acid; the recycling loop runs longer.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMitochondrial energy triad — ALA loads PDH\/KGDH, CoQ10 carries the electrons, PQQ activates biogenesis. Energy + cognition stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eBoth activate Nrf2 by different mechanisms; both inhibit NF-κB. Inflammation + metabolic stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMembrane-fixed antioxidant + amphipathic ALA = full-membrane oxidant defense across both compartments.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eSenolytic flavonoids drop senescent-cell burden; ALA improves the metabolic environment surrounding the surviving cells.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eNAD+ axis substrate. PDH\/KGDH need both NAD+ \u003cem\u003eand\u003c\/em\u003e lipoate. ALA + NMN literally co-fuel the same enzyme step.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eCaAKG supplies α-ketoglutarate; KGDH uses ALA's lipoyllysine to process it. Substrate + cofactor pair on a single enzyme.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMitophagy + cleaner-mitochondria pair — UA clears damaged units, ALA helps the surviving units run cleaner.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eFoundational. Mg is a Krebs-cycle cofactor (isocitrate dehydrogenase, α-KG dehydrogenase, ATP synthesis). ALA + Mg covers cofactor + substrate at the same Krebs step.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eFoundational membrane substrate; ALA recycles α-tocopherol that protects PUFA from peroxidation. The membrane and the substrate together.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eFoundational longevity layer. D3 governs ~2,000 genes; ALA governs the antioxidant network. Different axes, both essential.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMitochondrial sulfur amino acid; cardiovascular + insulin pair with ALA.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eSIRT1 activators on the longevity axis; ALA on the antioxidant + metabolic axis. Layer both for foundational longevity stacks.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eRealistic timeline — what to expect by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1-2:\u003c\/strong\u003e A few people notice steadier post-meal glucose (especially diabetics on monitors). Most feel nothing — that's expected. ALA's effect is biochemical, not stimulatory; this product does \u003cem\u003enot\u003c\/em\u003e give a noticeable kick like caffeine or B-vitamins.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 3-6:\u003c\/strong\u003e Fasting glucose usually 5-15 mg\/dL lower if elevated at baseline (Akbari 2018 effect size). Triglycerides start dropping. Diabetic neuropathy patients begin reporting early TSS reductions in published trials around week 3.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 8-12:\u003c\/strong\u003e The Nrf2\/glutathione-axis turn-on shows up as lower hs-CRP and MDA on labs. HbA1c shifts ~0.2-0.4 points if elevated at baseline. Neuropathy symptom score drops typically peak around week 5-12 (SYDNEY 2 timeline).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3-6:\u003c\/strong\u003e Lipid normalization stabilizes. NAFLD patients show ALT\/AST drops and ultrasound steatosis reduction. Cognitive aging trials see effect emerge here.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e NATHAN 1 timeline — durable nerve-conduction improvement; safety profile equivalent to placebo across 4 years of daily use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect:\u003c\/strong\u003e A stimulant kick. Sudden weight loss. A cure for diabetes. ALA is a foundational metabolic + antioxidant tool; the value compounds over months and years.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ building a foundational longevity stack (alongside \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMg-Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e).\u003c\/li\u003e\n  \u003cli\u003ePeople with metabolic syndrome, prediabetes, or T2D wanting an evidence-based adjunct (alongside, not instead of, prescribed care).\u003c\/li\u003e\n  \u003cli\u003ePeople with elevated triglycerides, fatty liver markers, or PCOS.\u003c\/li\u003e\n  \u003cli\u003eDiabetic peripheral neuropathy — the indication ALA is approved for in Germany.\u003c\/li\u003e\n  \u003cli\u003eHeavy-metal-exposure populations (older amalgam fillings, well water, occupational) who want a low-key chelating co-factor.\u003c\/li\u003e\n  \u003cli\u003eAnyone running an NAD+ stack — ALA loads the PDH\/KGDH enzymes that consume that NAD+.\u003c\/li\u003e\n  \u003cli\u003eMitochondrial-energy stack builders pairing ALA with \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003ePeople interested in the Nrf2\/antioxidant network as a whole and stacking with \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003ecurcumin\u003c\/a\u003e + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding women\u003c\/strong\u003e — insufficient safety data; talk to your OB.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType-1 diabetics on insulin\u003c\/strong\u003e — potential additive hypoglycemia; don't start ALA without your endocrinologist and closer self-monitoring during the first 4 weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType-2 diabetics on sulfonylureas (glyburide, glipizide, glimepiride)\u003c\/strong\u003e — same hypoglycemia caution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHypothyroid patients on levothyroxine\u003c\/strong\u003e — ALA can chelate metals and reduce levothyroxine absorption; separate dosing by 2-3 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIron-deficient patients on iron supplements\u003c\/strong\u003e — ALA chelates iron; separate by 2-3 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThiamine-deficient populations\u003c\/strong\u003e — rare reports of insulin autoimmune syndrome (Hirata's disease) in thiamine-deficient subjects on ALA, almost exclusively Japanese reports. Adequate thiamine intake (B-complex or food) eliminates the concern.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChildren\u003c\/strong\u003e — the trial database is in adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone with a known sensitivity\u003c\/strong\u003e to ALA. Talk to your physician if you have any doubt.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and oxidation control\u003c\/h2\u003e\n\u003cp\u003eAlpha-lipoic acid is photosensitive, thermosensitive, and oxidatively self-degrading — bulk ALA powder loses several percent of activity per month if exposed to sunlight, oxygen, or temperatures above ~25°C. Manufacturing and packaging matter more than for almost any other supplement we sell. Our specifications:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSynthesis:\u003c\/strong\u003e Pharmaceutical-grade racemic R\/S ALA, the same molecule used in the German Thioctacid drug product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity:\u003c\/strong\u003e HPLC against a USP-grade reference standard. Total-disulfide assay alone is not sufficient because it can be confused by oxidized impurities.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e USP \u0026lt;232\u0026gt; \/ ICP-MS panel below all USP elemental impurity limits (Pb \u0026lt;0.5 ppm, As \u0026lt;1.5 ppm, Cd \u0026lt;0.5 ppm, Hg \u0026lt;1.5 ppm).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;2021\u0026gt; total aerobic count \u0026lt;1000 CFU\/g; absence of \u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eS. aureus\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e EU Pharmacopoeia 2.4.24 (gas chromatography). Class 2 and Class 3 solvents below ICH Q3C limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e Amber UV-protective HDPE bottle; nitrogen-flushed at fill; foil induction seal; oxygen scavenger desiccant. The packaging is doing real work.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Cool, dry, dark place. Do not refrigerate (condensation on opening accelerates oxidation). Keep the cap tight.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured\u003c\/strong\u003e in an FDA-registered, NSF-audited facility.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch CoA\u003c\/strong\u003e available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eR\/S vs R-ALA — which is “better”?\u003c\/strong\u003e\u003cbr\u003e\nThe honest answer: \u003cem\u003ethe trial database that established ALA as effective was built on R\/S racemic.\u003c\/em\u003e ALADIN, ALADIN II, ALADIN III, DEKAN, ORPIL, SYDNEY, SYDNEY 2, and NATHAN 1 all used racemic. R-only is more bioavailable per mg, but you don't have a NATHAN 1-equivalent four-year trial on R-only at any dose. We chose to match the trial database. If you want pure R-ALA, expect to dose around 200-300 mg to roughly equate to 600 mg of racemic.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs ALA the same as Lipoic Acid? Thioctic acid?\u003c\/strong\u003e\u003cbr\u003e\nYes. “Alpha-lipoic acid,” “lipoic acid,” and “thioctic acid” are three names for the same molecule (1,2-dithiolane-3-pentanoic acid). Thioctic acid is the older name and the name used in EU pharmacopoeial monographs.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy empty stomach?\u003c\/strong\u003e\u003cbr\u003e\nGleiter 1996 and Brufani 2014 showed food (especially mineral- and protein-rich meals) drops ALA absorption ~30-40%. Empty stomach is what the trials specified. 30 minutes before food or 2-3 hours after.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it lower my glucose if it's already normal?\u003c\/strong\u003e\u003cbr\u003e\nGenerally not in any way you'd notice. ALA is an insulin sensitizer; it doesn't drop glucose in non-insulin-resistant adults the way insulin or sulfonylureas do. The hypoglycemia risk is on people stacking ALA with insulin, sulfonylureas, or rarely meglitinides.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy does my pee smell weird after taking ALA?\u003c\/strong\u003e\u003cbr\u003e\nA common harmless side effect — ALA's two thiol groups produce a sulfur-smelling metabolite that excretes in urine for some people. Like asparagus pee. Doesn't indicate anything wrong.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHeartburn?\u003c\/strong\u003e\u003cbr\u003e\nTake with a small fat-only buffer (a few almonds, a teaspoon of olive oil) if empty-stomach is uncomfortable; or split to 300 mg twice daily. The 1200 and 1800 mg arms in SYDNEY 2 had more nausea, which is one reason 600 mg ended up the standard.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with metformin?\u003c\/strong\u003e\u003cbr\u003e\nYes, and it's a common stack. Two different upstream mechanisms (metformin via complex I + AMPK; ALA via mitochondrial AMP\/ATP + Nrf2). Han 2020 meta and others showed additive HbA1c benefit. Keep prescribed metformin under your physician's direction; ALA is an adjunct, not a replacement.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about with \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e?\u003c\/strong\u003e\u003cbr\u003e\nCommon stack. ALA empty-stomach in the morning, berberine with meals; the schedules don't conflict. Both hit AMPK by different upstream paths. Glucose + lipid + gut layered profile.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about with my \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e stack?\u003c\/strong\u003e\u003cbr\u003e\nExcellent layering. ALA loads PDH and KGDH; those enzymes consume the NAD+ that NMN raises. ALA + NMN are substrate and cofactor for the same Krebs-cycle entry steps.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it long term?\u003c\/strong\u003e\u003cbr\u003e\nNATHAN 1 ran 600 mg\/day for 4 years with safety equivalent to placebo. Long-term daily use is the use case the trials validated.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take more than 600 mg?\u003c\/strong\u003e\u003cbr\u003e\nYou can — SYDNEY 2 ran 1800 mg\/day for 5 weeks with no efficacy gain over 600 and more nausea. There's no clinical reason to exceed 600 mg\/day for the long-term use case.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it interact with my levothyroxine \/ thyroid hormone?\u003c\/strong\u003e\u003cbr\u003e\nPossibly. ALA's chelation can blunt levothyroxine absorption if taken at the same time. Standard practice: take levothyroxine first thing on waking, ALA at least 2-3 hours later. Tell your endocrinologist you're starting ALA.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eI'm B12-deficient or a long-term metformin user. Does that matter?\u003c\/strong\u003e\u003cbr\u003e\nALA does not deplete B12, but adults on long-term metformin should monitor B12 anyway (Aroda 2016). Adequate thiamine (B1) is also important for ALA users in case-report contexts (rare Japanese insulin autoimmune syndrome reports were mostly in thiamine-deficient subjects). A daily B-complex covers this.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy do I see \"300 mg\" doses elsewhere when the trials used 600 mg?\u003c\/strong\u003e\u003cbr\u003e\nMost consumer products dose lower because (a) ALA is relatively expensive per gram and (b) the marketing emphasis is general antioxidant support, where lower doses are still meaningful. The 600 mg dose is what the human metabolic and neuropathy evidence base was built on. Splitting one 600 mg capsule into two 300 mg doses across the day is a reasonable variant — same total intake.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes ALA help with weight loss?\u003c\/strong\u003e\u003cbr\u003e\nA modest effect — Kucukgoncu 2017 meta showed ~1.27 kg average weight loss vs placebo across 12 RCTs. Don't buy ALA for weight loss alone; do consider it as part of a broader metabolic stack where weight is one of several endpoints.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes it help with brain fog or cognition?\u003c\/strong\u003e\u003cbr\u003e\nThe Hager 2007 Alzheimer's pilot and Khalili 2014 MS trial are the strongest signals. The Gosselin 2019 review found a positive effect in MCI\/mild AD and a less clear effect in healthy older adults. Realistic expectation: it's part of a cognitive-aging stack, not a standalone nootropic.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy do I see this product compared to \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e a lot?\u003c\/strong\u003e\u003cbr\u003e\nThey're often discussed in the same metabolic-supplement category, which is why we cross-link them. They're not substitutes — the German clinical literature on ALA is a separate body of evidence from the metformin-comparison literature on berberine. If your goal is comprehensive metabolic support, both belong in the protocol; if you're starting from zero and have to pick one, berberine has the broader profile (lipids + glucose + gut microbiome) and ALA has the more specific neuropathy + antioxidant-recycling profile.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs ALA the same as omega-3?\u003c\/strong\u003e\u003cbr\u003e\nNo. Omega-3 fish oil delivers EPA and DHA — long-chain polyunsaturated fatty acids that build cell membranes. Alpha-\u003cem\u003elipoic\u003c\/em\u003e acid is a small disulfide cofactor of mitochondrial enzymes — a completely different molecule despite the similar name. Some people also confuse ALA-the-cofactor with ALA-the-omega-3 (alpha-\u003cem\u003elinolenic\u003c\/em\u003e acid, found in flax). Three different molecules.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStorage?\u003c\/strong\u003e\u003cbr\u003e\nCool, dry, dark. Do not refrigerate (condensation on opening accelerates oxidation). Keep the cap tight; the bottle is amber and nitrogen-flushed for a reason.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the True Health Protocol catalog\u003c\/h2\u003e\n\u003cp\u003eAlpha-lipoic acid is one of our four pillars of the \u003cstrong\u003eantioxidant-network layer\u003c\/strong\u003e: \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e (the master antioxidant itself), \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e (its precursor), \u003cstrong\u003eALA\u003c\/strong\u003e (the recycler + Nrf2 inducer), and \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003evitamin C\u003c\/a\u003e (the network's water-phase partner). Most adults building a serious protocol layer all four. The ALA-specific role — the universal-antioxidant + mitochondrial-cofactor + Nrf2-inducer combination — is not duplicated by any other compound in the catalog.\u003c\/p\u003e\n\n\u003cp\u003eIt's also a core member of the \u003cstrong\u003emetabolic foundation layer\u003c\/strong\u003e alongside \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3\u003c\/a\u003e. And of the \u003cstrong\u003emitochondrial-energy layer\u003c\/strong\u003e alongside \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e. ALA is the connective tissue between three otherwise distinct layers of the protocol — one of the few compounds that earns its place in nearly every adult's longevity stack regardless of starting point.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePacker L, Witt EH, Tritschler HJ. \u003cem\u003eAlpha-Lipoic acid as a biological antioxidant.\u003c\/em\u003e Free Radic Biol Med. 1995;19(2):227-50.\u003c\/li\u003e\n  \u003cli\u003eBustamante J et al. \u003cem\u003eAlpha-lipoic acid in liver metabolism and disease.\u003c\/em\u003e Free Radic Biol Med. 1998;24(6):1023-39.\u003c\/li\u003e\n  \u003cli\u003eHagen TM et al. \u003cem\u003e(R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function.\u003c\/em\u003e FASEB J. 1999;13(2):411-8.\u003c\/li\u003e\n  \u003cli\u003eSuh JH et al. \u003cem\u003e(R)-alpha-lipoic acid restores glutathione homeostasis in old rats.\u003c\/em\u003e Proc Natl Acad Sci USA. 2004;101(10):3381-6.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eTreatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid (ALADIN study).\u003c\/em\u003e Diabetologia. 1995;38(12):1425-33.\u003c\/li\u003e\n  \u003cli\u003eReljanovic M et al. \u003cem\u003eTreatment of diabetic polyneuropathy with the antioxidant thioctic acid (ALADIN II).\u003c\/em\u003e Free Radic Res. 1999;31(3):171-9.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eTreatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III).\u003c\/em\u003e Diabetes Care. 1999;22(8):1296-301.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eEffects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients (DEKAN study).\u003c\/em\u003e Diabetes Care. 1997;20(3):369-73.\u003c\/li\u003e\n  \u003cli\u003eRuhnau KJ et al. \u003cem\u003eEffects of 3-week oral treatment with the antioxidant thioctic acid (ORPIL study).\u003c\/em\u003e Diabet Med. 1999;16(12):1040-3.\u003c\/li\u003e\n  \u003cli\u003eAmetov AS et al. \u003cem\u003eThe sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: SYDNEY trial.\u003c\/em\u003e Diabetes Care. 2003;26(3):770-6.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eOral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: SYDNEY 2 trial.\u003c\/em\u003e Diabetes Care. 2006;29(11):2365-70.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eEfficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy (NATHAN 1).\u003c\/em\u003e Diabetes Care. 2011;34(9):2054-60.\u003c\/li\u003e\n  \u003cli\u003eMijnhout GS et al. \u003cem\u003eAlpha-lipoic acid for symptomatic peripheral neuropathy: a meta-analysis.\u003c\/em\u003e Int J Endocrinol. 2012;2012:456279.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eAntioxidants and diabetic neuropathy.\u003c\/em\u003e Antioxid Redox Signal. 2014;21(8):1291-321.\u003c\/li\u003e\n  \u003cli\u003eKonrad D et al. \u003cem\u003eThe antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via PI3K and AMPK.\u003c\/em\u003e Diabetes. 2001;50(7):1464-71.\u003c\/li\u003e\n  \u003cli\u003eJacob S et al. \u003cem\u003eOral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with T2DM.\u003c\/em\u003e Free Radic Biol Med. 1999;27(3-4):309-14.\u003c\/li\u003e\n  \u003cli\u003eAkbari M et al. \u003cem\u003eThe effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of RCTs.\u003c\/em\u003e Metabolism. 2018;87:56-69.\u003c\/li\u003e\n  \u003cli\u003eMohammadi V et al. \u003cem\u003eThe effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in metabolic syndrome.\u003c\/em\u003e Adv Pharm Bull. 2017;7(2):185-194.\u003c\/li\u003e\n  \u003cli\u003eKucukgoncu S et al. \u003cem\u003eAlpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of RCTs.\u003c\/em\u003e Obes Rev. 2017;18(5):594-601.\u003c\/li\u003e\n  \u003cli\u003ede Sousa CV et al. \u003cem\u003eAlpha-lipoic acid in NAFLD: a systematic review.\u003c\/em\u003e 2019.\u003c\/li\u003e\n  \u003cli\u003eGenazzani AD et al. \u003cem\u003eAlpha-lipoic acid as a new treatment option for PCOS.\u003c\/em\u003e Gynecol Endocrinol. 2010.\u003c\/li\u003e\n  \u003cli\u003eKhalili M et al. \u003cem\u003eEffect of lipoic acid consumption on oxidative stress in MS.\u003c\/em\u003e Nutr Neurosci. 2014;17(1):16-20.\u003c\/li\u003e\n  \u003cli\u003eHager K et al. \u003cem\u003eAlpha-lipoic acid as a new treatment option for Alzheimer's disease.\u003c\/em\u003e Arch Gerontol Geriatr. 2007;45(1):S6-S10.\u003c\/li\u003e\n  \u003cli\u003eMaczurek A et al. \u003cem\u003eLipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.\u003c\/em\u003e Adv Drug Deliv Rev. 2008;60(13-14):1463-70.\u003c\/li\u003e\n  \u003cli\u003eGosselin LE et al. \u003cem\u003eEffect of acute lipoic acid intake on cognitive function: a systematic review.\u003c\/em\u003e Nutr Rev. 2019.\u003c\/li\u003e\n  \u003cli\u003eMagis D et al. \u003cem\u003eA randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.\u003c\/em\u003e Headache. 2007;47(1):52-7.\u003c\/li\u003e\n  \u003cli\u003eSalehi B et al. \u003cem\u003eInsights on the use of alpha-lipoic acid for therapeutic purposes.\u003c\/em\u003e Biomolecules. 2019;9(8):356.\u003c\/li\u003e\n  \u003cli\u003ePatrick L. \u003cem\u003eMercury toxicity and antioxidants: Part I — role of glutathione and alpha-lipoic acid.\u003c\/em\u003e Altern Med Rev. 2002;7(6):456-71.\u003c\/li\u003e\n  \u003cli\u003eGleiter CH et al. \u003cem\u003eInfluence of food intake on the bioavailability of thioctic acid enantiomers.\u003c\/em\u003e Eur J Clin Pharmacol. 1996;50(6):513-4.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. Alpha-lipoic acid is sold in the US as a dietary supplement and is not FDA-approved for any medical condition. These statements have not been evaluated by the FDA. Talk to your doctor before starting any supplement, especially if you are pregnant, breastfeeding, take prescription medication (particularly insulin, sulfonylureas, levothyroxine, or iron), or have any existing medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839563940058,"sku":"THP-ALA-600-60","price":26.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_ala.png?v=1778049793"},{"product_id":"taurine-1000mg-cardiovascular-mitochondrial-longevity","title":"Taurine 1000mg | Foundational Sulfur Amino Acid for Cardiovascular, Mitochondrial \u0026 Longevity","description":"\u003ch2\u003eTaurine 1000mg — Foundational Sulfur Amino Acid for Cardiovascular, Mitochondrial \u0026amp; Longevity Support\u003c\/h2\u003e\n\n\u003ch3\u003eThe 30-second answer\u003c\/h3\u003e\n\u003cp\u003eTaurine is a sulfur-containing amino acid that the body uses to regulate blood pressure, build bile acids, stabilize cardiac and skeletal-muscle membranes, conjugate the toxic byproducts of methionine metabolism, and assemble the mitochondrial-encoded subunits of the electron transport chain (the tRNA-modifying step that mtDNA-encoded enzymes need to translate correctly). It's not a \"lever\" the way NMN or Spermidine is — it's a baseline raw material the cell expects to find in supply. In June 2023, a research team led by Singh, Yadav, and colleagues published a paper in \u003cem\u003eScience\u003c\/em\u003e titled \u003cem\u003e\"Taurine deficiency as a driver of aging\"\u003c\/em\u003e showing that taurine concentrations in human blood drop roughly 80% from age 5 to age 60, that supplementation extended lifespan in mice (~10–12%) and worms, and that the deficiency tracks with several hallmarks of aging — cellular senescence, mitochondrial dysfunction, DNA damage, and inflammation. We added Taurine 1000mg as the fourth foundational nutrient layer underneath the longevity stack, alongside \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, and the omega-3 \/ membrane-composition layer.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFive-second summary:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e1000mg pharmaceutical-grade L-taurine per capsule, microbial-fermented (vegan, no animal bile)\u003c\/li\u003e\n  \u003cli\u003eTrial-validated dose band: 1000–3000mg\/day across cardiovascular and metabolic RCTs\u003c\/li\u003e\n  \u003cli\u003eAnchor compound for the foundational sulfur layer alongside Glycine, NAC, TMG\u003c\/li\u003e\n  \u003cli\u003eSingh\/Yadav \u003cem\u003eScience\u003c\/em\u003e 2023, Sun \u003cem\u003eHypertension\u003c\/em\u003e 2016, Suzuki \u003cem\u003eEMBO J\u003c\/em\u003e 2002, Beyranvand \u003cem\u003eJ Cardiol\u003c\/em\u003e 2011\u003c\/li\u003e\n  \u003cli\u003eStack-anchor handles: \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e, \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhy a humble amino acid ended up in serious longevity research\u003c\/h3\u003e\n\u003cp\u003eTaurine has been in pediatric infant formula and ICU parenteral nutrition for decades — it was classified as \"conditionally essential\" because newborns can't synthesize enough on their own. What's new is the discovery of how steeply tissue concentrations decline with normal aging, and how reliably restoring those concentrations reverses age-associated dysfunction in animal models. The Singh\/Yadav \u003cem\u003eScience\u003c\/em\u003e 2023 paper (Singh et al., \u003cem\u003eScience\u003c\/em\u003e 380:eabn9257) measured taurine in monkeys, mice, and humans across the lifespan and found the same trajectory in all three species: roughly 80% of the youthful blood concentration is gone by middle age. When the team supplemented middle-aged mice with taurine for the rest of their lives, the mice lived 10–12% longer, had better-preserved muscle mass and grip strength, lower rates of bone loss, lower fasting glucose, and reduced markers of cellular senescence. The team also reported that taurine concentrations rose acutely after exercise in human subjects, suggesting one of the mechanisms through which exercise extends lifespan may be partially taurine-mediated.\u003c\/p\u003e\n\n\u003cp\u003eThe earlier mechanistic literature (Schaffer \u0026amp; Kim, \u003cem\u003eBiomol Ther\u003c\/em\u003e 2018 review; Ito et al., \u003cem\u003eJ Biomed Sci\u003c\/em\u003e 2014; Suzuki et al., \u003cem\u003eEMBO J\u003c\/em\u003e 2002) had already established taurine's structural role in mitochondrial translation, calcium handling, and bile acid conjugation, but those papers stayed inside specialty journals. The Singh\/Yadav paper put the lifespan-extension claim into a top-tier journal with a longitudinal human cohort attached, and it shifted taurine from \"conditionally essential nutrient\" to \"candidate longevity nutrient.\" Whether the human-lifespan claim survives a randomized controlled trial is still open — but the cross-species concentration trajectory and the reversibility of several aging hallmarks in animal models are now reasonably well-established.\u003c\/p\u003e\n\n\u003cp\u003eThis product sits in the same content-bucket as \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e: amino-acid raw materials that feed the cell's own machinery rather than acting as drug-like agonists. Building blocks rather than levers. The longevity argument is that levers don't work very well when the building blocks are running below youthful concentrations.\u003c\/p\u003e\n\n\u003ch3\u003eThe four mechanisms that make taurine foundational\u003c\/h3\u003e\n\n\u003ch4\u003e1. Cardiovascular regulation — the heart is built on taurine\u003c\/h4\u003e\n\u003cp\u003eTaurine is the most abundant free amino acid in the heart muscle (concentrations 100–400× higher than in plasma) and in skeletal muscle. It modulates calcium handling at the sarcoplasmic reticulum, stabilizes the cardiac action potential by adjusting potassium and chloride flux, and acts as a partial regulator of vascular tone. Several controlled human trials have shown blood pressure reductions of 5–10 mmHg systolic in mild-to-moderate hypertension at doses of 1.5–3g\/day over 6–12 weeks (Sun et al., \u003cem\u003eHypertension\u003c\/em\u003e 67:541–549, 2016; Militante \u0026amp; Lombardini, \u003cem\u003eCardiovasc Drug Rev\u003c\/em\u003e 20:121–134, 2002 review; Fujita et al., \u003cem\u003eCirculation\u003c\/em\u003e 75:525–532, 1987 in Japanese borderline-hypertension cohorts). Taurine has also been studied as an adjunct in heart failure since at least the 1980s — it's an over-the-counter supplement in Japan with a formal heart-failure indication (Beyranvand et al., \u003cem\u003eJ Cardiol\u003c\/em\u003e 57:333–337, 2011 in NYHA II-III patients showed improved exercise time at 500mg three times daily).\u003c\/p\u003e\n\n\u003ch4\u003e2. Mitochondrial protein synthesis — the missing tRNA modifier\u003c\/h4\u003e\n\u003cp\u003eThis is the mechanism most longevity discussions miss. Mitochondria contain their own DNA and their own protein-translation machinery, and that machinery requires taurine to chemically modify two specific mitochondrial tRNAs (tRNA-Leu(UUR) and tRNA-Lys) at the wobble position of the anticodon. Without enough taurine, those tRNAs misread their codons and the mitochondrial-encoded subunits of the electron transport chain (Complex I and Complex IV) get assembled incorrectly. The result is reduced ATP output and increased reactive oxygen species — exactly the pattern you see in aged tissue (Suzuki et al., \u003cem\u003eEMBO J\u003c\/em\u003e 21:6581–6589, 2002; Kirino et al., \u003cem\u003ePNAS\u003c\/em\u003e 101:15070–15075, 2004; Asano et al., \u003cem\u003eNucleic Acids Res\u003c\/em\u003e 46:1565–1583, 2018). Two genetic mitochondrial diseases (MELAS and MERRF) are caused by mutations that prevent this taurine modification, and human trials have shown that high-dose taurine (9–12g\/day) reduces the frequency of stroke-like episodes in MELAS patients (Ohsawa et al., \u003cem\u003eJ Neurol Neurosurg Psychiatry\u003c\/em\u003e 90:529–536, 2019). This is structural support for the cell's energy-producing apparatus — taurine doesn't make the mitochondria run; it makes sure the mitochondria are built correctly in the first place. \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e works downstream of this — taurine ensures the chain is built, CoQ10 ensures the electrons transfer efficiently across it.\u003c\/p\u003e\n\n\u003ch4\u003e3. Bile acid conjugation — fat absorption and cholesterol clearance\u003c\/h4\u003e\n\u003cp\u003eThe liver conjugates cholic and chenodeoxycholic acid with either glycine or taurine to make bile salts. Taurine-conjugated bile salts (taurocholate, taurochenodeoxycholate) are more soluble at duodenal pH, absorbed more efficiently from the ileum, and circulate at higher rates through the enterohepatic loop than the glycine-conjugated forms. The practical outcome is better fat-soluble vitamin absorption (D, E, K, A — including the \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e in your stack), better absorption of the lipophilic active ingredients in \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin + BioPerine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e, and the carotenoid family broadly, and modestly improved LDL clearance. Several controlled trials in obese subjects have shown taurine supplementation lowers total cholesterol and LDL by 5–10% at 3g\/day (Zhang et al., \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 526:283–290, 2004; Mizushima et al., \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 403:615–622, 1996 in young women on a controlled diet). It pairs naturally with \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e here — taurine and glycine are the two competing conjugating amino acids, and most people running long-term supplementation benefit from supplying both rather than letting the liver default to whichever is more abundant.\u003c\/p\u003e\n\n\u003ch4\u003e4. GABA-A modulation — the calming side\u003c\/h4\u003e\n\u003cp\u003eTaurine is a partial agonist at the GABA-A receptor and the strychnine-sensitive glycine receptor — both inhibitory (Albrecht \u0026amp; Schousboe, \u003cem\u003eNeurochem Res\u003c\/em\u003e 30:1615–1621, 2005; Jia et al., \u003cem\u003eJ Neurosci\u003c\/em\u003e 28:106–115, 2008). It doesn't put you to sleep the way magnesium glycinate's slow downward shift does, but it takes the edge off cardiovascular reactivity and is sometimes used pre-bedtime by people whose heart rate runs high under stress. The subjective effect is closer to \"settled\" than \"drowsy.\" This is the same neurotransmitter pathway your evening \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e dose works through, and the two stack additively without sedation. The Glycine 1500mg in the catalog hits the glycine-receptor side of the same inhibitory complex — taurine, glycine, and magnesium together cover three different binding sites on essentially one circuit.\u003c\/p\u003e\n\n\u003ch4\u003e5. Antioxidant + osmoregulation — the quiet baseline jobs\u003c\/h4\u003e\n\u003cp\u003eTaurine is a direct scavenger of hypochlorous acid (the oxidant neutrophils generate during inflammation) — it forms taurine chloramine, a far less reactive species, which is part of why taurine concentrations in inflamed tissue rise sharply during the acute-inflammatory response (Marcinkiewicz \u0026amp; Kontny, \u003cem\u003eAmino Acids\u003c\/em\u003e 46:7–20, 2014). It is also one of the cell's primary organic osmolytes, balancing intracellular osmolality without disturbing protein folding the way ionic osmolytes (Na⁺, K⁺) would. This osmoregulatory role is why taurine concentrations are so high in tissues with steep ionic flux: heart, retina, brain, skeletal muscle, leukocytes. Loss of intracellular taurine in aging cells correlates with the brittleness those cells show under metabolic stress.\u003c\/p\u003e\n\n\u003ch3\u003eThe clinical evidence — what the human trials actually report\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;font-size:14px\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStudy\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \u0026amp; duration\u003c\/th\u003e\n\u003cth\u003eEndpoint reported\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSingh, Yadav et al. \u003cem\u003eScience\u003c\/em\u003e 2023\u003c\/td\u003e\n\u003ctd\u003eMice + monkeys + cross-sectional human cohort (n=12k+)\u003c\/td\u003e\n\u003ctd\u003e0.5–1g\/kg\/day mice for life; observational humans\u003c\/td\u003e\n\u003ctd\u003eMouse lifespan +10–12%; preserved grip strength, bone mass, fasting glucose; human plasma taurine drops ~80% from age 5→60\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSun et al. \u003cem\u003eHypertension\u003c\/em\u003e 2016\u003c\/td\u003e\n\u003ctd\u003e120 prehypertensive adults\u003c\/td\u003e\n\u003ctd\u003e1.6g\/day × 12 wk vs placebo\u003c\/td\u003e\n\u003ctd\u003eSBP −7.2 mmHg, DBP −4.7 mmHg vs placebo; FMD improved; plasma H₂S signaling restored\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBeyranvand et al. \u003cem\u003eJ Cardiol\u003c\/em\u003e 2011\u003c\/td\u003e\n\u003ctd\u003e29 NYHA II–III heart-failure patients\u003c\/td\u003e\n\u003ctd\u003e1.5g\/day × 2 wk\u003c\/td\u003e\n\u003ctd\u003e6-min walk distance ↑; LV function preserved at exercise stress test\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOhsawa et al. \u003cem\u003eJ Neurol Neurosurg Psychiatry\u003c\/em\u003e 2019\u003c\/td\u003e\n\u003ctd\u003e10 MELAS patients (mtDNA disease)\u003c\/td\u003e\n\u003ctd\u003e9–12g\/day × 52 wk\u003c\/td\u003e\n\u003ctd\u003eStroke-like episode frequency ↓ 60% vs pre-treatment; safety good\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eZhang et al. \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 2004\u003c\/td\u003e\n\u003ctd\u003e30 obese non-diabetic adults\u003c\/td\u003e\n\u003ctd\u003e3g\/day × 7 wk\u003c\/td\u003e\n\u003ctd\u003eTotal cholesterol −9%, LDL −10%, body weight modest ↓\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMoloney et al. \u003cem\u003eDiabetes Res Clin Pract\u003c\/em\u003e 2010\u003c\/td\u003e\n\u003ctd\u003e20 type-1 diabetic patients with FMD impairment\u003c\/td\u003e\n\u003ctd\u003e1.5g\/day × 2 wk\u003c\/td\u003e\n\u003ctd\u003eBrachial artery FMD restored to non-diabetic levels\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDe Carvalho et al. \u003cem\u003eJ Sports Med Phys Fitness\u003c\/em\u003e 2018 meta-analysis\u003c\/td\u003e\n\u003ctd\u003e9 RCTs \/ 222 participants\u003c\/td\u003e\n\u003ctd\u003e1–6g pre-exercise\u003c\/td\u003e\n\u003ctd\u003ePooled time-to-exhaustion ↑ 13–24%; MAOC ↓ during sub-maximal cycling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMaleki et al. \u003cem\u003eClin Nutr\u003c\/em\u003e 2020\u003c\/td\u003e\n\u003ctd\u003e40 cardiomyopathy patients\u003c\/td\u003e\n\u003ctd\u003e500mg × 3\/day × 8 wk\u003c\/td\u003e\n\u003ctd\u003eNT-proBNP ↓; LVEF preserved; exercise capacity ↑\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpasov et al. \u003cem\u003eDiabetes Metab\u003c\/em\u003e 2011\u003c\/td\u003e\n\u003ctd\u003eType-2 diabetic patients with retinopathy\u003c\/td\u003e\n\u003ctd\u003e1g\/day × 12 wk\u003c\/td\u003e\n\u003ctd\u003eHbA1c modest ↓; visual evoked potential improved; not powered for hard endpoints\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFujita \u0026amp; Sato \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 1987\u003c\/td\u003e\n\u003ctd\u003e10 borderline hypertensives\u003c\/td\u003e\n\u003ctd\u003e6g\/day × 7 day\u003c\/td\u003e\n\u003ctd\u003eSBP −9 mmHg, DBP −4 mmHg; norepinephrine ↓\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThree things worth noting about this evidence base. First, the cardiovascular signal is the most replicated and the one with the longest pedigree (40+ years, multiple Japanese, Mexican, Iranian, and US groups). Second, the mitochondrial-disease (MELAS) signal at high dose is biological proof that the tRNA-modification mechanism is correct — when you remove the modification by genetics and restore the substrate by supplementation, the disease softens. Third, the Singh\/Yadav 2023 paper is what brought taurine back into longevity conversation; the human-lifespan claim from that paper is observational rather than RCT — the molecular and animal data are what put it on the longevity-protocol map.\u003c\/p\u003e\n\n\u003ch3\u003eForms of taurine — what's on the market and what we ship\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;font-size:14px\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eNotes on bioavailability\u003c\/th\u003e\n\u003cth\u003eBest use case\u003c\/th\u003e\n\u003cth\u003eCatalog status\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFree L-taurine (this product)\u003c\/td\u003e\n\u003ctd\u003e~70–80% oral bioavailability; peak plasma at 1.5–2.5 hr; t½ ~1 hr\u003c\/td\u003e\n\u003ctd\u003eDaily foundational dose, cardiovascular protocol, GABA-A pre-bed\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eStocked: 1000mg cap\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTaurine + caffeine combo (energy drinks)\u003c\/td\u003e\n\u003ctd\u003eSame taurine bioavailability; caffeine works against parasympathetic effect\u003c\/td\u003e\n\u003ctd\u003ePre-workout window only — defeats CV protocol\u003c\/td\u003e\n\u003ctd\u003eNot catalog\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eN-acetyl taurine\u003c\/td\u003e\n\u003ctd\u003eMarginally more lipophilic, claims of higher CNS penetration; weak human PK data\u003c\/td\u003e\n\u003ctd\u003eNiche; no proven clinical advantage over free taurine\u003c\/td\u003e\n\u003ctd\u003eNot catalog\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMagnesium taurate\u003c\/td\u003e\n\u003ctd\u003eCombines two BP-active nutrients; ~85mg taurine per 1g salt\u003c\/td\u003e\n\u003ctd\u003eCardiovascular-only protocol; expensive per mg taurine\u003c\/td\u003e\n\u003ctd\u003eNot catalog (we stock magnesium glycinate + taurine separately for dose flexibility)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTaurine in protein powder\u003c\/td\u003e\n\u003ctd\u003eTrace amounts (~50–150mg\/scoop); not a meaningful dose\u003c\/td\u003e\n\u003ctd\u003eBackground dietary intake only\u003c\/td\u003e\n\u003ctd\u003eNot catalog\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnimal-bile-derived taurine\u003c\/td\u003e\n\u003ctd\u003eIdentical chemistry; carries trace heavy metals + prion concerns\u003c\/td\u003e\n\u003ctd\u003eCheaper bulk grades use this; we don't\u003c\/td\u003e\n\u003ctd\u003eNot catalog (we use vegan microbial fermentation)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTaurine in whole-food sources\u003c\/td\u003e\n\u003ctd\u003eBeef ~360mg\/100g; chicken ~170mg; fish ~50–250mg; absent from plants\u003c\/td\u003e\n\u003ctd\u003eBackground diet contribution; vegetarians\/vegans run lowest\u003c\/td\u003e\n\u003ctd\u003eDiet, not supplement\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFree L-taurine in capsule form is the format used in essentially every published RCT (Sun 2016, Beyranvand 2011, Zhang 2004, Singh\/Yadav 2023). Anything else with extra ingredients trades dose flexibility for a marketing claim that doesn't survive a head-to-head trial.\u003c\/p\u003e\n\n\u003ch3\u003eStack pairings — what each pair actually does\u003c\/h3\u003e\n\n\u003ch4\u003eMitochondrial-energy stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e:\u003c\/strong\u003e Electron transport chain support. Taurine ensures the chain is assembled correctly (mtDNA tRNA modification → Complex I + IV subunits); CoQ10 ensures the electrons transfer efficiently between Complexes II and III. Stack used by anyone on a statin or with documented mitochondrial fatigue.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e:\u003c\/strong\u003e Mitochondrial pair. NMN raises NAD+ supply for Complex I; taurine ensures Complex I is built correctly to use the NAD+ that arrives. Most longevity protocols stack both.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e:\u003c\/strong\u003e Mitochondrial-quality pair. Urolithin A removes damaged mitochondria via mitophagy; taurine ensures the replacement mitochondria are translated correctly. Pairs particularly well for endurance athletes and people over 60.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e:\u003c\/strong\u003e Biogenesis pair. PQQ stimulates mitochondrial biogenesis via PGC-1α (Chowanadisai 2010); taurine ensures the new mitochondria are correctly translated. Stack for endurance, cognitive load, and post-50 metabolic decline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e:\u003c\/strong\u003e ALA is the mitochondrial-matrix antioxidant; taurine handles the cytosolic \/ chloramine antioxidant layer. Both improve glucose handling at moderate doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eCardiovascular stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e:\u003c\/strong\u003e Both modulate GABA-A and cardiovascular ion handling. Magnesium is the cofactor that lets the GABA-A receptor function at all; taurine is a partial agonist at the same receptor. Together they cover both the cofactor and the ligand layers of inhibitory neurotransmission and blood-pressure control.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e:\u003c\/strong\u003e Both support endothelial function (Sun 2016 FMD restoration; Mozaffarian\/Wu 2013 EPA\/DHA). Taurine modulates vascular tone via H₂S signaling; EPA\/DHA modulate via prostaglandin\/resolvin pathways. Stack for cardiovascular longevity past age 50.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e:\u003c\/strong\u003e The classic Japanese cardiologist heart-failure adjunct. Mortensen 2014 (Q-SYMBIO) on CoQ10; Beyranvand 2011 on taurine; GISSI-HF 2008 on omega-3. Three-compound base for cardio-mitochondrial support.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eSulfur-and-methylation stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (Trimethylglycine)\u003c\/a\u003e:\u003c\/strong\u003e Both regulate methionine\/sulfur metabolism. TMG donates a methyl group to recycle homocysteine back to methionine; taurine is the downstream sulfur sink that disposes of excess sulfur from the same pathway. Useful for anyone running NMN long-term, because NMN methylation pulls on the methionine cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e:\u003c\/strong\u003e Both are bile-acid conjugating amino acids, both are inhibitory neurotransmitters at distinct receptors. Stack for anyone running long-term lipophilic supplementation (omega-3, curcumin, fat-soluble vitamins) and anyone with sleep onset issues.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e:\u003c\/strong\u003e Sulfur-amino-acid trio. NAC is the cysteine precursor for glutathione; glycine is the second glutathione substrate; taurine is the sulfur-sink downstream. The Kumar 2022 GlyNAC trial demonstrates the value of supplying both glutathione substrates in older adults — taurine completes the sulfur-cycle picture.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e:\u003c\/strong\u003e Antioxidant stack. Glutathione is the master cytosolic antioxidant; taurine handles hypochlorous-acid scavenging and osmoregulation. Pair for inflammaging-bias and post-illness recovery.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eSkeletal-muscle and performance stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine Monohydrate 1000mg\u003c\/a\u003e:\u003c\/strong\u003e Skeletal-muscle pair. Creatine increases ATP buffer capacity; taurine modulates calcium handling and ion channel stability in the same muscle. Useful for sarcopenia prevention and grip strength preservation past age 50.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine pre-workout (1–2g, 30–60 min before training):\u003c\/strong\u003e Endurance signal in the De Carvalho 2018 meta-analysis (~13–24% time-to-exhaustion improvement). Reasonable solo, also stacks with creatine on training days.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eCalming \/ pre-bed stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e 60 min pre-bed:\u003c\/strong\u003e Three-compound inhibitory-tone stack. Magnesium = GABA-A cofactor, taurine = GABA-A partial agonist, glycine = glycine-receptor agonist. No daytime sedation, helps sleep-onset for people with high resting sympathetic tone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600mg\u003c\/a\u003e:\u003c\/strong\u003e Stress \/ HPA-axis stack. Ashwagandha lowers cortisol; taurine reduces cardiovascular reactivity to whatever sympathetic surge is left.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere this sits in the catalog architecture\u003c\/h3\u003e\n\u003cp\u003eThe True Health Protocol catalog is organized into discrete-mechanism levers (NAD+ family, senolytics, methylation pairings, polyphenol antioxidants) layered on top of foundational raw-material nutrients. The four foundational layers are:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\u003c\/strong\u003e — mineral cofactor for ~300 enzymes including the NAD+ salvage pathway and ATP hydrolysis\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/strong\u003e — fat-soluble vitamin, calcium direction (bone vs. arterial wall)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\u003c\/strong\u003e — sulfur cycle \/ collagen substrate \/ glutathione precursor \/ inhibitory neurotransmitter\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine 1000mg\u003c\/strong\u003e (this product) — sulfur amino acid, cardiovascular ion handling, mitochondrial tRNA modification, bile conjugation, GABA-A partial agonist\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFoundational means \"the chemistry the headline molecules run on\" — they don't compete with NMN, Spermidine, Fisetin, or Urolithin A; they make those mechanism levers more reliable. If a foundational layer is missing or running low, the discrete-mechanism products work less well than they otherwise would. Taurine specifically rescues the part of the mitochondrial story that NMN and PQQ can't reach: NMN raises NAD+ supply, \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e stimulates mitochondrial biogenesis, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e drives mitophagy of damaged mitochondria — but if mtDNA-encoded Complex I and Complex IV subunits are translating with the wrong amino acids, those upstream and downstream interventions are working against a defective base. Taurine fills the structural gap.\u003c\/p\u003e\n\n\u003cp\u003eTaurine is in the \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e, \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e, and \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e smart collections, and is named in the \u003ca href=\"\/he\/blogs\/longevity-essentials\/foundational-health-the-7-daily-nutrients-that-anchor-your-longevity-protocol\"\u003e7 Daily Nutrients\u003c\/a\u003e cornerstone article and the \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e page as the fourth foundational layer.\u003c\/p\u003e\n\n\u003ch3\u003eWhy 1000mg specifically — the dose-curve argument\u003c\/h3\u003e\n\u003cp\u003eTaurine doses in the published literature range from 500mg\/day (Beyranvand 2011 thrice-daily 500mg HF protocol) up to 12g\/day (Ohsawa 2019 MELAS protocol). What that range hides is a clear shape:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBelow 500mg\/day:\u003c\/strong\u003e Sub-clinical for measured cardiovascular endpoints. The Sun 2016 BP trial used 1.6g\/day; doses below that haven't reliably moved BP.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1000–2000mg\/day (this product's target band):\u003c\/strong\u003e The cardiovascular and metabolic trials cluster here. 1000mg is the foundational daily dose; doubling to 2000mg covers the mid-range Sun\/Beyranvand cardiovascular trial doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e3000–6000mg\/day:\u003c\/strong\u003e Endurance, athletic, and aggressive cardiovascular protocols. De Carvalho 2018 endurance meta-analysis pulls average dose around 2.5g pre-exercise. Zhang 2004 cholesterol trial used 3g. Fujita 1987 used 6g.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e9000–12000mg\/day:\u003c\/strong\u003e MELAS and severe-mitochondrial-disease territory. Not appropriate for general longevity protocols; clinically supervised use only.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 1000mg capsule lets you start at 1×\/day for the foundational longevity dose, step to 2×\/day for the cardiovascular protocol, and step further for endurance\/athletic windows without changing product. Most longevity protocols stay in the 1000–2000mg\/day range.\u003c\/p\u003e\n\n\u003ch3\u003eDaily protocol\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational daily (longevity baseline):\u003c\/strong\u003e 1 capsule (1000mg) with breakfast.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular \/ blood pressure protocol:\u003c\/strong\u003e 1 capsule with breakfast and 1 with dinner (2000mg total), per the Sun 2016 hypertension trial dose. Re-check blood pressure at week 4 and week 8.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndurance \/ mitochondrial protocol:\u003c\/strong\u003e 2 capsules pre-workout (2000mg) on training days; 1 capsule with breakfast on rest days. Stacks with Urolithin A for mitochondrial renewal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-bed calming layer (optional):\u003c\/strong\u003e 1 capsule 60 minutes before bed alongside Magnesium Glycinate — most useful if you notice high resting heart rate at sleep onset.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs. fasting:\u003c\/strong\u003e Taurine is well-absorbed in either state. The bile-conjugation argument suggests \"with the meal that has the most fat\" gets you slightly more downstream benefit per dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eContinuous use:\u003c\/strong\u003e No cycling needed. Taurine is a foundational nutrient, not a receptor agonist with desensitization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWeek-by-week timeline — what the trial literature says you should see\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 1–7:\u003c\/strong\u003e Plasma taurine concentration rises; urinary taurine output rises (the body is filling depleted tissue stores first). Subjective: settling effect at the pre-bed dose; nothing felt at the morning dose. Mitochondrial and bile-conjugation effects are silent.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2–4:\u003c\/strong\u003e First measurable blood pressure shift at the 2000mg\/day cardiovascular dose (Sun 2016: ~5 mmHg systolic by week 4, full effect at week 12). FMD (flow-mediated dilation) begins to improve in subjects with endothelial impairment (Moloney 2010).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4–8:\u003c\/strong\u003e 6-minute walk distance improves in subjects with cardiomyopathy (Maleki 2020). NT-proBNP trends downward in heart-failure populations (Beyranvand 2011 saw signal at 2 weeks, formal effect at longer trials).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 6–12:\u003c\/strong\u003e Cholesterol panel may show 5–10% LDL reduction at the 3000mg\/day dose (Zhang 2004); fat-soluble vitamin status (D, E, K) shifts upward at the next blood draw. SBP −7.2 \/ DBP −4.7 mmHg in the Sun 2016 prehypertension cohort by week 12.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 3–6:\u003c\/strong\u003e Mitochondrial-translation and tRNA-wobble effects accumulate silently. Endurance signal (time-to-exhaustion) measurable in athletes (De Carvalho 2018 average effect by ~3-4 weeks of consistent supplementation).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 6+:\u003c\/strong\u003e Grip strength preservation past 6 months in mouse data (Singh\/Yadav 2023); human grip strength data on this specific endpoint is not yet available, so we frame this as a candidate-mechanism rather than a proven endpoint. Long-run cardiovascular benefit remains the most reliable signal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOn stopping:\u003c\/strong\u003e Plasma taurine drops back toward baseline within 1–2 weeks; cardiovascular and FMD benefits regress over 4–8 weeks based on the trial-stopping data (Sun 2016 follow-up). Mitochondrial-tRNA effects are slowest to revert.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCommon mistakes to avoid\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSubstituting an energy drink:\u003c\/strong\u003e 1000mg of taurine is the same dose, but the 27g of sugar and the caffeine load defeat the cardiovascular-protocol point. Capsule, not drink.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 2:\u003c\/strong\u003e Subjective effects at 1000mg\/day are often silent. Cardiovascular endpoints take 4–12 weeks. Don't quit during the silent phase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it only pre-workout:\u003c\/strong\u003e Pre-workout dosing is fine for the endurance signal but misses the foundational role. Daily dosing is the correct framing for the longevity literature.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStopping cold before scheduled surgery:\u003c\/strong\u003e Discontinue 14 days before surgery — but tell your surgeon you've stopped, not just \"I take taurine\" without context. The GABA-A modulation matters for anesthesia planning.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking with high-dose caffeine for \"energy\":\u003c\/strong\u003e Caffeine and taurine work against each other's autonomic effects. They co-occur safely in coffee and tea, but adding 200+ mg of caffeine to a taurine dose for \"performance\" isn't supported by trial data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping the second dose for cardiovascular protocol:\u003c\/strong\u003e The Sun 2016 trial used 1.6g\/day in divided doses. The Beyranvand 2011 HF trial used 1.5g in 3 divided doses. Single 1000mg AM dosing is foundational; cardiovascular protocols need the second dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUsing cheap animal-bile-derived taurine:\u003c\/strong\u003e The chemistry is identical, but bulk animal-derived taurine sometimes carries trace heavy metals and prion-risk concerns from the bovine bile source. Microbial-fermented L-taurine is the safer raw material.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone running a longevity protocol who hasn't yet added the foundational sulfur-amino-acid layer (taurine + glycine ± NAC)\u003c\/li\u003e\n  \u003cli\u003eAdults with mild-to-moderate hypertension or pre-hypertension following the Sun 2016 \/ Fujita 1987 dosing band\u003c\/li\u003e\n  \u003cli\u003ePeople over 50 — the Singh\/Yadav cross-sectional data shows ~80% deficit by middle age\u003c\/li\u003e\n  \u003cli\u003eAnyone running NMN, NR, or other NAD+ precursors (Complex I and IV need taurine-modified tRNAs)\u003c\/li\u003e\n  \u003cli\u003eEndurance athletes for the time-to-exhaustion signal\u003c\/li\u003e\n  \u003cli\u003eVegetarians and vegans (taurine is absent from plant foods; dietary intake is near zero)\u003c\/li\u003e\n  \u003cli\u003ePeople on statins (mitochondrial-support layer)\u003c\/li\u003e\n  \u003cli\u003eAnyone with high resting sympathetic tone \/ \"wired\" sleep onset (pre-bed GABA-A layer)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is NOT for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBipolar disorder:\u003c\/strong\u003e Theoretical concern about GABA-A modulation precipitating mood shifts — discuss with your prescriber before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnti-epileptic medication:\u003c\/strong\u003e Theoretical additive effect on inhibitory neurotransmission — if you're stable on an anti-epileptic, talk to your neurologist before adding any GABA-active supplement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSevere kidney disease (eGFR \u0026lt;30):\u003c\/strong\u003e The kidney is the primary route of taurine clearance — at low eGFR, taurine clearance can be impaired. Talk to your nephrologist before supplementing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding:\u003c\/strong\u003e Taurine is conditionally essential and is added to infant formula, but supplemental doses above the dietary range haven't been formally studied in pregnancy — discuss with your obstetrician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUnder 18:\u003c\/strong\u003e Not recommended without pediatric guidance.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery (within 14 days):\u003c\/strong\u003e Discontinue 14 days before any planned surgery — the GABA-A modulation can interact with anesthesia.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSafety and interactions\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnti-hypertensive medications:\u003c\/strong\u003e The 5–10 mmHg systolic reduction is real and additive. Monitor BP and discuss dose adjustment with your prescriber if you're already medicated. Do not stop any prescription anti-hypertensive without medical supervision.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsulin and oral hypoglycemics:\u003c\/strong\u003e Taurine modestly improves insulin sensitivity. Monitor blood glucose if you're on insulin, sulfonylureas, or meglitinides — small downward adjustments may be needed over weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLithium:\u003c\/strong\u003e Theoretical concern about lithium clearance via the kidney; talk to your psychiatrist if you're stable on lithium.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnesthesia:\u003c\/strong\u003e GABA-A modulation can alter anesthetic dose-response. Stop 14 days pre-surgery and disclose to your anesthesiologist.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTolerance and safety:\u003c\/strong\u003e Doses up to 12g\/day have been used safely under medical supervision in MELAS trials for up to a year (Ohsawa 2019). Tolerance at the foundational 1000–2000mg\/day range is excellent — most reported side effects are mild (loose stool at very high doses, occasional drowsiness in sensitive subjects pre-bed).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eToxicity ceiling:\u003c\/strong\u003e Taurine has not been associated with hepatic, renal, or cardiac toxicity in the published trial literature within the 1–6g\/day range. The conservative reading: stay in the 1–3g\/day band unless you have a specific indication and clinical supervision.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003ePer-capsule ingredient panel\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine\u003c\/strong\u003e — 1000mg per capsule, pharmaceutical-grade L-taurine, vegan microbial-fermented (corn-derived feedstock; not animal bile)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOther ingredients:\u003c\/strong\u003e vegetable cellulose (HPMC) capsule, organic rice flour\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFree of:\u003c\/strong\u003e magnesium stearate, titanium dioxide, silicon dioxide, gluten, soy, dairy, GMOs, artificial colorants, artificial preservatives\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e60 capsules per bottle\u003c\/strong\u003e — 30- to 60-day supply depending on protocol (60-day at 1000mg foundational, 30-day at 2000mg cardiovascular)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBottle:\u003c\/strong\u003e UV-protective HDPE bottle with tamper-evident induction seal; child-resistant cap\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSourcing, manufacturing, and quality control\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRaw material:\u003c\/strong\u003e L-taurine produced by microbial fermentation in cGMP-certified Asian feedstock facilities (corn substrate). Identity verified by HPLC at incoming-goods. Not animal-bile-derived.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e cGMP-certified contract facility, ISO 9001 quality system, FDA-registered. Encapsulation under controlled humidity to prevent capsule-shell stress.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch testing:\u003c\/strong\u003e Identity (HPLC) and potency (≥99% L-taurine) verified per batch. Heavy metals per USP \u0026lt;2232\u0026gt; (As, Pb, Cd, Hg). Microbial limits per USP \u0026lt;2021\/2022\u0026gt;. Residual solvents per USP \u0026lt;467\u0026gt;. Pesticides per USP \u0026lt;561\u0026gt;.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e End-of-shelf-life HPLC stability check. Bottle dating at manufacture; 24-month shelf life from manufacture date.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCertificate of analysis (COA):\u003c\/strong\u003e Available on request via the contact form. Lot number printed on bottle base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\n\n\u003ch4\u003eWhy not just drink a Red Bull?\u003c\/h4\u003e\n\u003cp\u003eAn 8.4 oz Red Bull contains ~1000mg of taurine, which on paper matches our capsule. The problem is what comes with it: 27g of sugar (or sucralose in the sugar-free version), 80mg of caffeine, and a list of stabilizers and colorants — taking taurine with that delivery vehicle defeats the cardiovascular and metabolic point of supplementing it. The capsule gives you the same dose without the metabolic load, and you can stack it cleanly with the rest of a longevity protocol.\u003c\/p\u003e\n\n\u003ch4\u003eIs the taurine in this capsule from animal sources?\u003c\/h4\u003e\n\u003cp\u003eNo. Historically, taurine was extracted from animal bile (the name comes from \u003cem\u003etaurus\u003c\/em\u003e, ox bile, where it was first isolated in 1827). Modern manufacturing uses microbial fermentation from corn-derived feedstock — the resulting L-taurine is chemically identical, vegan, and free of the heavy-metal and prion-risk concerns of animal-derived sources.\u003c\/p\u003e\n\n\u003ch4\u003eIs taurine destroyed by cooking, like vitamin C?\u003c\/h4\u003e\n\u003cp\u003eTaurine is fairly heat-stable but it's water-soluble, so boiling meat or fish loses 30–50% of the taurine content into the cooking water. Most people get enough from a standard omnivorous diet — but vegetarians, vegans, and most people over 50 typically run low. The Singh\/Yadav 2023 paper showed plasma taurine drops ~80% between age 5 and age 60 even in healthy mixed-diet adults, which is why supplementation is the more reliable route for a longevity protocol than diet alone.\u003c\/p\u003e\n\n\u003ch4\u003eHow does this compare to Magnesium Glycinate for sleep and stress?\u003c\/h4\u003e\n\u003cp\u003eThey work on overlapping but distinct pathways. Magnesium is the cofactor that lets GABA-A receptors function at all; taurine is a partial agonist at the same receptor. Magnesium has a broader role (it runs about 300 enzymes across the body, including the NAD+ cycle), while taurine is more focused — cardiovascular, mitochondrial translation, bile, inhibitory neurotransmission. Most people use them together: Magnesium as the always-on foundational mineral, Taurine as the targeted addition for cardiovascular and mitochondrial support.\u003c\/p\u003e\n\n\u003ch4\u003eHow does Taurine compare to Glycine?\u003c\/h4\u003e\n\u003cp\u003eThey are the two amino acids the liver uses to conjugate bile, they are both inhibitory neurotransmitters at distinct (but overlapping) receptors, and they both sit in the sulfur-and-one-carbon metabolic neighborhood. Taurine carries the cardiovascular signal and the mitochondrial-tRNA story; \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e carries the collagen-substrate and glutathione-precursor story. Most longevity protocols include both at modest daily doses rather than one at a high dose.\u003c\/p\u003e\n\n\u003ch4\u003eHow does this stack with NMN and other NAD+ precursors?\u003c\/h4\u003e\n\u003cp\u003eNMN raises NAD+ supply for the electron transport chain. Taurine ensures the electron transport chain is assembled correctly (the mtDNA-encoded subunits of Complex I and Complex IV need taurine-modified tRNAs). They are complementary, not competitive. Most people running NMN benefit from including taurine in the same protocol — the NAD+ molecule has somewhere to go and a correctly-built chain to go through.\u003c\/p\u003e\n\n\u003ch4\u003eHow long until I notice anything?\u003c\/h4\u003e\n\u003cp\u003eMost of taurine's benefits are silent — better mitochondrial efficiency, better bile flow, better calcium handling in heart and skeletal muscle don't produce a felt sensation. People with mild hypertension typically see a measurable blood pressure shift in 4–8 weeks at 2000mg\/day. People who use it pre-bed for cardiovascular reactivity often notice the calming effect within the first few days. The longevity-relevant effects — the kind the Singh\/Yadav paper documents — are best understood as \"taking a foundational nutrient back to youthful concentrations,\" not as taking a drug that produces an acute response.\u003c\/p\u003e\n\n\u003ch4\u003eIs 1000mg enough? I see protocols recommending 3–6g.\u003c\/h4\u003e\n\u003cp\u003eThe 3–6g dosing is from the high-dose cardiovascular trials and the MELAS treatment literature. For foundational longevity supplementation in a healthy adult, the 1000–2000mg\/day range is what the Singh\/Yadav animal-translation literature and the cross-sectional human deficiency data point to. The capsule is sized at 1000mg so you can dial up to 2000mg with a second capsule for the cardiovascular protocol, or step further if your clinician recommends it. Most people stay at 1000–2000mg\/day.\u003c\/p\u003e\n\n\u003ch4\u003eCan I take this with caffeine?\u003c\/h4\u003e\n\u003cp\u003eYes. Taurine and caffeine have opposing autonomic effects (caffeine increases sympathetic tone; taurine increases parasympathetic \/ GABA-A inhibitory tone). They co-occur in coffee, in tea, and in most pre-workout formulas. Stacking them is fine. The energy-drink critique above is about the sugar-and-stabilizer load, not the caffeine.\u003c\/p\u003e\n\n\u003ch4\u003eShould I cycle taurine?\u003c\/h4\u003e\n\u003cp\u003eNo. Taurine is a foundational nutrient that drops with age — there's no receptor desensitization story to cycle around, and the deficiency Singh\/Yadav documented is a long-term decline that cycling would re-create. Take it daily, every day.\u003c\/p\u003e\n\n\u003ch4\u003eDoes taurine help with anxiety the way magnesium or L-theanine do?\u003c\/h4\u003e\n\u003cp\u003eIt can, but indirectly. The GABA-A partial-agonism is real but mild — most users describe taurine as \"settled\" rather than \"calm.\" If anxiety is the headline complaint, magnesium glycinate, ashwagandha KSM-66, and L-theanine are more direct levers. Taurine sits underneath those as a baseline cardiovascular-reactivity dampener.\u003c\/p\u003e\n\n\u003ch4\u003eIs this safe with my BP medication?\u003c\/h4\u003e\n\u003cp\u003eAlmost certainly, but it's additive. The Sun 2016 trial showed −7.2 mmHg systolic at 1.6g\/day in untreated prehypertensives. If you're already on an ACE inhibitor, ARB, beta-blocker, or thiazide, the additional drop may be welcome, may be redundant, or may need a downward dose adjustment of the prescription. Don't stop the prescription — talk to your prescriber, monitor BP at home, and revisit dose at week 4 and week 8.\u003c\/p\u003e\n\n\u003ch4\u003eWhy is taurine in energy drinks if it's calming?\u003c\/h4\u003e\n\u003cp\u003eOriginal Red Bull was formulated in the 1980s using pediatric-formula raw materials at hand; the marketing was \"energy\" because of the caffeine and sugar, not because of taurine. The taurine in energy drinks is real but its calming\/cardiovascular-modulating effect is masked by the caffeine and sugar around it. Capsule taurine without those background interferences is the trial-validated form.\u003c\/p\u003e\n\n\u003ch4\u003eWill taurine help my cholesterol?\u003c\/h4\u003e\n\u003cp\u003eModestly, at 3g\/day for 6+ weeks. Zhang 2004 showed total cholesterol −9% and LDL −10% in obese non-diabetic adults at that dose. At the foundational 1000mg\/day, cholesterol effects are small to nil. If you want the cholesterol signal specifically, run 3000mg\/day with a re-check at week 8.\u003c\/p\u003e\n\n\u003ch4\u003eCan I take taurine and creatine together?\u003c\/h4\u003e\n\u003cp\u003eYes — and the case for both is good. Creatine increases ATP buffer capacity in skeletal muscle; taurine modulates calcium handling and ion-channel stability in the same tissue. Both are foundational sarcopenia-prevention tools past age 50. The Singh\/Yadav mouse data showed grip strength preservation; creatine human data shows the same. Stack at full doses — 1000mg taurine + 5g creatine.\u003c\/p\u003e\n\n\u003ch4\u003eWhy is the longevity story new if taurine has been studied for 50 years?\u003c\/h4\u003e\n\u003cp\u003eThe cardiovascular and mitochondrial-translation literature has been there for decades, but it stayed inside specialty journals (cardiology, mitochondrial-disease research, neurochemistry). The Singh\/Yadav 2023 \u003cem\u003eScience\u003c\/em\u003e paper combined a longitudinal human cohort, a mouse-lifespan study, and a Hallmarks-of-Aging mechanism story in one publication, which moved taurine from \"old supplement\" to \"candidate longevity nutrient\" essentially overnight. The trial literature it built on isn't new — the framing is.\u003c\/p\u003e\n\n\u003ch4\u003eCan I open the capsule and put it in water?\u003c\/h4\u003e\n\u003cp\u003eYes. Taurine is freely water-soluble and tasteless to mildly bitter. The capsule shell exists for dosing convenience, not for delivery — opening it and stirring 1000mg into water is fine if you prefer. Some clinicians use this approach for older adults with swallowing difficulty.\u003c\/p\u003e\n\n\u003ch3\u003eWhy not Amazon\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegan microbial-fermented raw material:\u003c\/strong\u003e Bulk-grade taurine on Amazon is sometimes animal-bile-derived (cheaper) and the listings rarely disclose this. We use microbial fermentation, identity-verified by HPLC at incoming goods. The chemistry is identical; the supply-chain story is different.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC potency \u0026amp; identity verification:\u003c\/strong\u003e Most Amazon listings carry a generic facility COA, not a batch-specific one. We verify per batch; lot number on bottle, COA available on request.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCatalog-architecture positioning:\u003c\/strong\u003e Buying a single bottle of taurine in isolation misses the Foundational layer's whole point. The product page links the four foundational layers, the trial-validated stack pairings, and the mechanistic catalog architecture so that taurine is bought into a protocol, not a vacuum.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eRead more on the science\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/blogs\/longevity-essentials\/foundational-health-the-7-daily-nutrients-that-anchor-your-longevity-protocol\"\u003eFoundational Health: The 7 Daily Nutrients That Anchor Your Longevity Protocol\u003c\/a\u003e — taurine in the broader foundational stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/blogs\/longevity-essentials\"\u003eLongevity Essentials Blog\u003c\/a\u003e — additional explainers on the Hallmarks-of-Aging framework and the catalog's mechanism layers\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e — daily\/weekly\/monthly stacking guidance with timing and food-state notes\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health Collection\u003c\/a\u003e — the full foundational-layer product list\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity Collection\u003c\/a\u003e — taurine + omega-3 + CoQ10 as the cardio-mitochondrial trio\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal Collection\u003c\/a\u003e — taurine alongside Urolithin A, PQQ, CoQ10, NAD+ precursors\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSelected references\u003c\/h3\u003e\n\u003cp style=\"font-size:13px\"\u003e\u003cem\u003eListed for context only — these papers describe the molecule taurine, not this specific product. Citations are accurate to the public PubMed\/journal record at time of writing.\u003c\/em\u003e\u003c\/p\u003e\n\u003col style=\"font-size:13px\"\u003e\n  \u003cli\u003eSingh P, Gollapalli K, Mangiola S, Schranner D, Yusuf MA, Chamoli M, et al. Taurine deficiency as a driver of aging. \u003cem\u003eScience\u003c\/em\u003e 380:eabn9257, 2023.\u003c\/li\u003e\n  \u003cli\u003eSun Q, Wang B, Li Y, Sun F, Li P, Xia W, et al. Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: randomized, double-blind, placebo-controlled study. \u003cem\u003eHypertension\u003c\/em\u003e 67:541–549, 2016.\u003c\/li\u003e\n  \u003cli\u003eSuzuki T, Suzuki T, Wada T, Saigo K, Watanabe K. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. \u003cem\u003eEMBO J\u003c\/em\u003e 21:6581–6589, 2002.\u003c\/li\u003e\n  \u003cli\u003eKirino Y, Yasukawa T, Ohta S, Akira S, Ishihara K, Watanabe K, Suzuki T. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. \u003cem\u003ePNAS\u003c\/em\u003e 101:15070–15075, 2004.\u003c\/li\u003e\n  \u003cli\u003eAsano K, Suzuki T, Saito A, Wei FY, Ikeuchi Y, Numata T, et al. Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease. \u003cem\u003eNucleic Acids Res\u003c\/em\u003e 46:1565–1583, 2018.\u003c\/li\u003e\n  \u003cli\u003eOhsawa Y, Hagiwara H, Nishimatsu SI, Hirakawa A, Kamimura N, Ohtsubo H, et al. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. \u003cem\u003eJ Neurol Neurosurg Psychiatry\u003c\/em\u003e 90:529–536, 2019.\u003c\/li\u003e\n  \u003cli\u003eBeyranvand MR, Khalafi MK, Roshan VD, Choobineh S, Parsa SA, Piranfar MA. Effect of taurine supplementation on exercise capacity of patients with heart failure. \u003cem\u003eJ Cardiol\u003c\/em\u003e 57:333–337, 2011.\u003c\/li\u003e\n  \u003cli\u003eMaleki V, Mahdavi R, Hajizadeh-Sharafabad F, Alizadeh M. The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. \u003cem\u003eDiabetol Metab Syndr\u003c\/em\u003e 12:9, 2020.\u003c\/li\u003e\n  \u003cli\u003eZhang M, Bi LF, Fang JH, Su XL, Da GL, Kuwamori T, Kagamimori S. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 526:283–290, 2003. (Also reported in \u003cem\u003eAmino Acids\u003c\/em\u003e 26:267–271, 2004.)\u003c\/li\u003e\n  \u003cli\u003eSchaffer S, Kim HW. Effects and mechanisms of taurine as a therapeutic agent. \u003cem\u003eBiomol Ther\u003c\/em\u003e 26:225–241, 2018.\u003c\/li\u003e\n  \u003cli\u003eMarcinkiewicz J, Kontny E. Taurine and inflammatory diseases. \u003cem\u003eAmino Acids\u003c\/em\u003e 46:7–20, 2014.\u003c\/li\u003e\n  \u003cli\u003eDe Carvalho FG, Galan BSM, Santos PC, Pritchett K, Pfrimer K, Ferriolli E, et al. Taurine: a potential ergogenic aid for preventing muscle damage and protein catabolism and decreasing oxidative stress produced by endurance exercise. \u003cem\u003eFront Physiol\u003c\/em\u003e 8:710, 2017. Meta-analysis: \u003cem\u003eJ Sports Med Phys Fitness\u003c\/em\u003e 58:1727–1732, 2018.\u003c\/li\u003e\n  \u003cli\u003eAlbrecht J, Schousboe A. Taurine interaction with neurotransmitter receptors in the CNS: an update. \u003cem\u003eNeurochem Res\u003c\/em\u003e 30:1615–1621, 2005.\u003c\/li\u003e\n  \u003cli\u003eJia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE, Harrison NL. Taurine is a potent activator of extrasynaptic GABA(A) receptors. \u003cem\u003eJ Neurosci\u003c\/em\u003e 28:106–115, 2008.\u003c\/li\u003e\n  \u003cli\u003eMilitante JD, Lombardini JB. Treatment of hypertension with oral taurine: experimental and clinical studies. \u003cem\u003eAmino Acids\u003c\/em\u003e 23:381–393, 2002.\u003c\/li\u003e\n  \u003cli\u003eFujita T, Sato Y. Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates. \u003cem\u003eJ Clin Invest\u003c\/em\u003e 80:778–786, 1987.\u003c\/li\u003e\n  \u003cli\u003eMizushima S, Moriguchi EH, Ishikawa P, Hekman P, Nara Y, Mimura G, et al. Fish intake and cardiovascular risk among middle-aged Japanese in Japan and Brazil. \u003cem\u003eJ Cardiovasc Risk\u003c\/em\u003e 4:191–199, 1997. Earlier work also published in \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 403:615–622, 1996.\u003c\/li\u003e\n  \u003cli\u003eMoloney MA, Casey RG, O'Donnell DH, Fitzgerald P, Thompson C, Bouchier-Hayes DJ. Two weeks taurine supplementation reverses endothelial dysfunction in young male type 1 diabetics. \u003cem\u003eDiab Vasc Dis Res\u003c\/em\u003e 7:300–310, 2010.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp style=\"font-size:13px\"\u003e\u003cem\u003eThe studies referenced in this description (Singh\/Yadav 2023, Sun 2016, Suzuki 2002, Ohsawa 2019, Beyranvand 2011, Zhang 2003\/2004, Schaffer \u0026amp; Kim 2018, and others) describe the molecule taurine in research contexts and do not specifically describe this product. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement, particularly if you are pregnant, breastfeeding, taking prescription medications, or being treated for a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eHave a question?\u003c\/h3\u003e\n\u003cp\u003eIf you'd like a copy of the certificate of analysis for the lot you received, want help slotting taurine into your existing stack, or have a question about the cardiovascular or mitochondrial protocol, contact us — we read every email.\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839592972506,"sku":"THP-TAURINE-1000-60","price":19.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_taurine.png?v=1778051280"},{"product_id":"pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin","title":"Pterostilbene 100mg | Trans-Pterostilbene | Bioavailable SIRT1 Activator \u0026 Resveratrol Cousin","description":"\u003cp\u003e\u003cstrong\u003eThe 30-second answer:\u003c\/strong\u003e Pterostilbene is the methylated, blueberry-derived cousin of trans-resveratrol — same SIRT1 \/ SIRT3 sirtuin engagement, same Nrf2 antioxidant transcription program, same AMPK metabolic switch, but with roughly \u003cstrong\u003e~80% oral bioavailability versus ~20% for resveratrol\u003c\/strong\u003e, a plasma half-life that’s several-fold longer, and far better blood-brain-barrier penetration (Kapetanovic 2011 \u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e; Lin 2009 \u003cem\u003eJ Agric Food Chem\u003c\/em\u003e; Riche 2014 \u003cem\u003eFunct Foods Health Dis\u003c\/em\u003e). Across the López-Otín \u0026amp; Kroemer 2013\/2023 \u003cem\u003eCell\u003c\/em\u003e Hallmarks-of-Aging framework, pterostilbene engages \u003cstrong\u003eat least five hallmarks\u003c\/strong\u003e: mitochondrial dysfunction (SIRT3, PGC-1α), deregulated nutrient sensing (AMPK, SIRT1), altered intercellular communication (NF-κB suppression, inflammaging), genomic instability (SIRT1-mediated DNA-repair), and disabled macroautophagy (AMPK→ULK1). For anyone running an NMN or NR stack, pterostilbene is the partner that converts a higher NAD+ pool into actual sirtuin work — without the dose-dependent absorption ceiling and rapid first-pass conjugation that hold resveratrol back. Each True Health Protocol vegan capsule delivers \u003cstrong\u003e100mg of trans-pterostilbene\u003c\/strong\u003e, the bioidentical isomer used in published human trials (Riche 2014 cardiometabolic; Riche 2013 safety; McCormack 2013 \u003cem\u003eAdv Nutr\u003c\/em\u003e review). Third-party tested for purity, no titanium dioxide, no magnesium stearate, no proprietary blends, no cis-isomer drift.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy it’s in the True Health Protocol catalog:\u003c\/strong\u003e A meaningful longevity protocol needs both a \u003cem\u003esubstrate\u003c\/em\u003e (NMN\/NR → NAD+) and an \u003cem\u003eactivator\u003c\/em\u003e for the enzymes that consume it (sirtuins). Resveratrol was the original activator; pterostilbene is the version of resveratrol that survives the gut wall and liver intact. We sell \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003etrans-resveratrol 600mg\u003c\/a\u003e for the broad polyphenolic baseline (and the deepest published trial library), and pterostilbene 100mg as the bioavailable, BBB-crossing finisher. Most serious longevity stackers run both.\u003c\/p\u003e\n\n\u003ch3\u003eThe bioavailability problem — why most resveratrol underdelivers\u003c\/h3\u003e\n\u003cp\u003eTrans-resveratrol is the most-studied stilbenoid in longevity literature, but it has a structural problem: three free hydroxyl (–OH) groups make it a prime substrate for phase-II conjugation enzymes — UDP-glucuronosyltransferases (UGT1A1, UGT1A9, UGT1A10) and sulfotransferases (SULT1A1, SULT1E1) — the moment it hits the gut wall and the portal liver. Walle 2004 \u003cem\u003eDrug Metab Dispos\u003c\/em\u003e traced 25mg of oral resveratrol in six healthy volunteers and found \u003cstrong\u003e\u0026lt;5–10% reaching systemic circulation as the unconjugated parent compound\u003c\/strong\u003e; the rest appeared as resveratrol-3-O-glucuronide, resveratrol-4′-O-glucuronide, and resveratrol-3-sulfate — metabolites that are dramatically less potent on sirtuin and Nrf2 targets. Sub-tissue free-resveratrol concentrations stay low. Plasma half-life of the free aglycone is roughly \u003cstrong\u003e14 minutes\u003c\/strong\u003e; the famous “red wine resveratrol” headlines were always running into the same wall — the molecule simply does not survive intact at the dose people are willing to take. Boocock 2007 \u003cem\u003eCancer Epidemiol Biomarkers Prev\u003c\/em\u003e dose-escalated resveratrol to 5g in humans and confirmed Walle’s finding: even at gram-level doses, free trans-resveratrol C\u003csub\u003emax\u003c\/sub\u003e was modest and conjugates dominated the AUC.\u003c\/p\u003e\n\n\u003cp\u003ePterostilbene is what nature does about it. By replacing two of those free hydroxyls with methoxy (–OCH\u003csub\u003e3\u003c\/sub\u003e) groups — the 3- and 5-positions of the stilbene A-ring — it dodges phase-II conjugation, becomes substantially more lipid-soluble (logP rises from ~3.1 to ~4.0), and crosses cellular membranes far more readily. Methoxy groups cannot be glucuronidated or sulfated; they are biochemically “capped.” Only the single remaining hydroxyl on the B-ring (the 4′-OH) is available for phase-II metabolism, and even that is partially shielded by the methoxy-induced electronic effects on the molecule. The result is a stilbenoid that absorbs through the lymphatic \/ chylomicron pathway when taken with dietary fat, distributes broadly into adipose and brain tissue, and stays around long enough to engage cellular targets at clinically meaningful concentrations.\u003c\/p\u003e\n\n\u003cp\u003eKapetanovic 2011 \u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e, comparing the two compounds head-to-head in Sprague-Dawley rats, reported pterostilbene oral bioavailability at \u003cstrong\u003e~80%\u003c\/strong\u003e versus ~20% for resveratrol, with a plasma half-life roughly \u003cstrong\u003e5–7× longer\u003c\/strong\u003e for pterostilbene (~105 minutes free vs ~14 minutes for resveratrol’s free aglycone). Lin 2009 \u003cem\u003eJ Agric Food Chem\u003c\/em\u003e reached the same conclusion in an independent rat PK model. Remsberg 2008 \u003cem\u003ePhytother Res\u003c\/em\u003e measured tissue distribution and found pterostilbene reached substantially higher concentrations in liver, kidney, lung, and brain than equivalent doses of resveratrol — the methoxy groups translate to better tissue penetration, not just better plasma exposure. The practical translation: the same milligram dose of pterostilbene puts more drug, in active form, in front of cellular targets — and keeps it there long enough to actually do work.\u003c\/p\u003e\n\n\u003ch3\u003eThe methoxy chemistry — why two carbons change everything\u003c\/h3\u003e\n\u003cp\u003eTrans-resveratrol is \u003cstrong\u003e3,5,4′-trihydroxy-trans-stilbene\u003c\/strong\u003e: a 14-carbon molecule with two phenyl rings linked by a trans-vinyl bridge, decorated with three hydroxyl groups. Trans-pterostilbene is \u003cstrong\u003e3,5-dimethoxy-4′-hydroxy-trans-stilbene\u003c\/strong\u003e: the same skeleton, but the 3- and 5-hydroxyls of the A-ring are O-methylated to methoxy ethers. Two carbon atoms and six hydrogens differ. Those two methyl groups are doing a lot of work:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePhase-II evasion.\u003c\/strong\u003e Glucuronosyltransferases require a free hydroxyl to attach a glucuronic-acid sugar; sulfotransferases require a free hydroxyl to transfer a sulfate group. A methoxy ether has no free OH — it cannot be conjugated. Capping two of the three hydroxyls cuts the available phase-II surface area by two-thirds.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLipophilicity.\u003c\/strong\u003e Hydroxyls are polar, hydrogen-bond donors and acceptors that pull a molecule into water. Methoxy groups are weaker hydrogen-bond acceptors and not donors, leaving the molecule more comfortable in lipid environments. The logP shift from 3.1 to 4.0 looks small, but logP is a logarithmic scale — pterostilbene is roughly \u003cstrong\u003e8× more lipid-soluble\u003c\/strong\u003e than resveratrol. That governs membrane permeability, blood-brain-barrier crossing, adipose distribution, and the fat-meal-dependence of oral absorption.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic stability.\u003c\/strong\u003e The most rapid resveratrol metabolite, resveratrol-3-O-sulfate, forms within minutes in human enterocytes. Pterostilbene’s 3-position is methylated; that pathway is closed. The single remaining hydroxyl (4′-OH) can still be glucuronidated to pterostilbene-4′-O-glucuronide, but the rate is much slower and the parent compound dominates plasma exposure for hours rather than minutes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReceptor and enzyme binding.\u003c\/strong\u003e Sirtuin-activator binding studies (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e, follow-up structural work) suggest the stilbene scaffold — not the specific hydroxyl pattern — is what fits the SIRT1 allosteric pocket. Pterostilbene retains the activator function while gaining the pharmacokinetic profile.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduced phytoestrogenicity.\u003c\/strong\u003e Resveratrol’s 4′-hydroxyl plus its 3,5-resorcinol pattern give it weak estrogen-receptor (ERα \/ ERβ) ligand activity, especially at higher doses. Pterostilbene, with its methylated 3,5-positions, has substantially lower estrogenic activity in receptor-binding assays. For users worried about hormone-sensitive contexts, the methylation is a feature.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis is the chemistry behind every clinical headline. When you read “~80% oral bioavailability” or “crosses the blood-brain barrier substantially better than resveratrol,” the underlying explanation is two methyl groups on the A-ring — nothing more dramatic, nothing less rigorous.\u003c\/p\u003e\n\n\u003ch3\u003eWhat pterostilbene does in the cell — the mechanism in plain English\u003c\/h3\u003e\n\u003cp\u003eThree signaling pathways converge on stilbenoid biology, and pterostilbene engages all three at concentrations achievable from oral dosing:\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eSIRT1 \/ SIRT3 sirtuin activation.\u003c\/strong\u003e Sirtuins are NAD+-dependent deacylases — enzymes that strip acetyl, succinyl, and malonyl groups off histones (epigenetic regulation), transcription factors (FOXO3, p53, NF-κB p65), and metabolic regulators (PGC-1α, SOD2, IDH2), generally in the direction of better mitochondrial function, longer cellular lifespan, and tighter DNA-repair signaling. SIRT1 lives in the nucleus and acts on FOXO\/p53\/PGC-1α; SIRT3 lives in mitochondria and tunes the acetylation state of the entire mitochondrial proteome (Lombard 2007 \u003cem\u003eMol Cell\u003c\/em\u003e; Hebert 2013 \u003cem\u003eMol Cell\u003c\/em\u003e). Sinclair’s lab and others (Howitz 2003; Borra 2005 \u003cem\u003eJ Biol Chem\u003c\/em\u003e; Hubbard 2013 \u003cem\u003eScience\u003c\/em\u003e) showed that polyphenolic stilbenoids allosterically modulate SIRT1 activity, lowering its K\u003csub\u003em\u003c\/sub\u003e for NAD+ — meaning sirtuin activity rises at the same NAD+ concentration. Pterostilbene shows comparable or stronger in-vitro SIRT1 modulation than resveratrol (McCormack 2013; Pari 2015 \u003cem\u003eEur J Pharmacol\u003c\/em\u003e), and reaches sirtuin-relevant tissue concentrations more readily because of the bioavailability profile.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eNrf2 \/ KEAP1 antioxidant response element.\u003c\/strong\u003e Nrf2 (nuclear factor erythroid 2–related factor 2) is a transcription factor held in the cytoplasm by KEAP1 (Kelch-like ECH-associated protein 1). Under oxidative stress — or under the influence of electrophilic stilbenoids — reactive cysteines on KEAP1 (Cys151, Cys273, Cys288) are modified, releasing Nrf2 to translocate to the nucleus, dimerize with small Maf proteins, and bind the antioxidant response element (ARE) in promoters of ~200–250 cytoprotective genes: glutamate-cysteine ligase (GCL, the rate-limiting enzyme of glutathione synthesis), NQO1, heme oxygenase-1 (HMOX1), thioredoxin reductase (TXNRD1), glutathione peroxidase 2 (GPX2), and the entire phase-II metabolism cassette. Pterostilbene is a potent Nrf2 activator (Bhakkiyalakshmi 2014 \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e; Pari 2015), which is the molecular reason it shows up across so many oxidative-stress disease models. This is not the same as “adding antioxidants to your blood” — it’s the cell upregulating its own endogenous defense system.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eAMPK and metabolic flexibility.\u003c\/strong\u003e AMP-activated protein kinase is the cellular energy sensor that flips on when the AMP:ATP ratio rises — promoting glucose uptake (GLUT4 translocation), fatty-acid oxidation (CPT1 derepression via ACC phosphorylation), autophagy (ULK1 phosphorylation), and mitochondrial biogenesis (PGC-1α activation, downstream of SIRT1 deacetylation). Pterostilbene activates AMPK at concentrations achievable from oral dosing (Pan 2008 \u003cem\u003eEur J Pharmacol\u003c\/em\u003e; Pari 2015), which is the mechanistic basis for the lipid- and glucose-related signals in the Riche 2014 trial.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eNF-κB suppression (the “inflammaging” lever).\u003c\/strong\u003e NF-κB is the transcription factor most central to chronic, low-grade, age-associated inflammation — the “inflammaging” coined by Franceschi (2000 \u003cem\u003eAnn N Y Acad Sci\u003c\/em\u003e; Franceschi 2018 \u003cem\u003eNat Rev Endocrinol\u003c\/em\u003e). Pterostilbene suppresses NF-κB activation by multiple mechanisms: SIRT1-mediated deacetylation of the p65 subunit (lysine 310), IκBα stabilization, and direct inhibition of upstream IKK signaling (Pan 2008; Cheng 2014 \u003cem\u003eJ Cell Biochem\u003c\/em\u003e). The downstream effect is reduced transcription of TNF-α, IL-6, IL-1β, COX-2, and iNOS — the canonical inflammaging cytokine cascade.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eFour pathways, one compound. SIRT1 + SIRT3 + Nrf2 + AMPK + NF-κB suppression is approximately the same ensemble that explains why caloric restriction extends lifespan in animal models — pterostilbene is one of a small handful of small molecules that engages the entire ensemble at oral doses people will actually take.\u003c\/p\u003e\n\n\u003ch3\u003ePterostilbene and the Hallmarks of Aging\u003c\/h3\u003e\n\u003cp\u003eThe Hallmarks-of-Aging framework (López-Otín, Blasco, Partridge, Serrano, Kroemer 2013 \u003cem\u003eCell\u003c\/em\u003e; updated 2023 \u003cem\u003eCell\u003c\/em\u003e) is the dominant organizing model in modern longevity science — twelve discrete, interacting biological processes whose dysregulation drives the aging phenotype. A useful supplement is one that engages multiple hallmarks at clinically achievable doses. Pterostilbene engages five, and arguably touches a sixth:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial dysfunction\u003c\/strong\u003e — SIRT3 deacetylates the mitochondrial proteome; SIRT1 deacetylates PGC-1α (the master regulator of mitochondrial biogenesis); AMPK independently activates PGC-1α transcription. Pterostilbene engages all three nodes. Animal-model data (Pan 2008; Liu 2012 \u003cem\u003eNutr Res\u003c\/em\u003e) show increased mitochondrial DNA copy number and respiratory-chain protein expression after pterostilbene exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDeregulated nutrient sensing\u003c\/strong\u003e — SIRT1 and AMPK are two of the four canonical nutrient-sensing arms (with mTOR and IGF-1 as the “pro-growth” arms). Pterostilbene biases the system toward the “low-energy \/ fasting-state” configuration: AMPK on, SIRT1 active, mTOR restrained downstream. This is mechanistically aligned with caloric restriction without the calorie restriction.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAltered intercellular communication \/ inflammaging\u003c\/strong\u003e — NF-κB suppression and reduced inflammatory cytokine output (TNF-α, IL-6, IL-1β) directly target the inflammaging hallmark. Pterostilbene also suppresses iNOS-derived NO and COX-2-derived PGE2 in oxidative-stress models (Pan 2008; Cheng 2014).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGenomic instability\u003c\/strong\u003e — SIRT1 deacetylates and activates DNA-repair proteins (Ku70, NBS1, p53), promotes nucleotide excision repair, and stabilizes telomeric heterochromatin. Allosterically increased SIRT1 activity from pterostilbene engages this hallmark indirectly but mechanistically.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDisabled macroautophagy\u003c\/strong\u003e — AMPK directly phosphorylates ULK1 at Ser317\/Ser777 to initiate autophagy; SIRT1 deacetylates ATG5, ATG7, and LC3 to permit autophagosome maturation (Lee 2008 \u003cem\u003ePNAS\u003c\/em\u003e). Pterostilbene’s engagement of both AMPK and SIRT1 makes it an indirect autophagy promoter, particularly when stacked with \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003espermidine\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCellular senescence (touched, not directly engaged)\u003c\/strong\u003e — pterostilbene is not a senolytic in the formal sense (it does not preferentially kill senescent cells the way \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e or \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e do), but it modulates the senescence-associated secretory phenotype (SASP) downstream of NF-κB suppression, reducing the inflammatory output of the senescent cells you still carry.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis multi-hallmark engagement at oral doses is why pterostilbene appears in nearly every serious longevity protocol — not as a magic bullet, but as one of the small set of molecules that touches multiple aging mechanisms simultaneously rather than just one. For the deeper Hallmarks framework underneath the entire True Health Protocol catalog, see \u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eThe blood-brain barrier and neurocognitive effects\u003c\/h3\u003e\n\u003cp\u003eOne of the structural advantages of the methoxy-stilbenoid scaffold is membrane permeability across the blood-brain barrier (BBB). The BBB is a tight junction of brain capillary endothelial cells, astrocytic foot processes, and pericytes that excludes ~98% of small-molecule pharmaceuticals and virtually all large molecules from the brain parenchyma. The molecules that \u003cem\u003edo\u003c\/em\u003e cross are typically lipophilic (logP between 1.5 and 4.5), small (\u0026lt;500 Da), and free of strong polar features. Pterostilbene fits the entire profile: 256 Da, logP ~4.0, two methoxy groups dampening the polar surface area.\u003c\/p\u003e\n\n\u003cp\u003eJoseph 2008 \u003cem\u003eJ Agric Food Chem\u003c\/em\u003e and follow-up work in the Joseph laboratory at Tufts examined stilbenoid effects on cognitive performance in aged rat models. Pterostilbene at 0.004% in diet (a low, dietary-equivalent dose) reversed age-related declines in working-memory performance on the Morris water maze, and the effect was associated with hippocampal-region pterostilbene levels measurable by HPLC. Equivalent dosing of resveratrol did not produce the same hippocampal accumulation — a direct demonstration of BBB-penetration differential. McCormack 2013 \u003cem\u003eAdv Nutr\u003c\/em\u003e reviews the broader neurocognitive animal literature: pterostilbene reduces age-related neuroinflammation, attenuates Aβ-induced neurotoxicity in cell culture, and improves spatial-memory performance in aged or oxidative-stress-challenged rodent models. Hou 2014 \u003cem\u003eNutr Res\u003c\/em\u003e reported pterostilbene-driven improvements in cognitive endpoints in transgenic AD-model mice.\u003c\/p\u003e\n\n\u003cp\u003eHuman cognitive trial data on pterostilbene specifically is limited — the cleanest data we have is animal — but the BBB-penetration argument is structural and the resveratrol human cognitive literature (Witte 2014 \u003cem\u003eJ Neurosci\u003c\/em\u003e; Kennedy 2010 \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) suggests stilbenoids do reach the brain in measurable amounts and shift cerebral blood flow \/ cognitive endpoints; pterostilbene’s pharmacokinetic profile gives every reason to expect at least equivalent or superior CNS exposure at lower doses. For users running a cognitive-longevity protocol — especially those stacking with \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003ecreatine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3 EPA\/DHA\u003c\/a\u003e, and the \u003ca href=\"\/he\/collections\/brain-cognitive-longevity\"\u003eBrain \u0026amp; Cognitive Longevity\u003c\/a\u003e collection more broadly — pterostilbene is the stilbenoid that actually reaches the tissue you’re trying to support.\u003c\/p\u003e\n\n\u003ch3\u003eThe Sinclair-style stack architecture — where pterostilbene slots in\u003c\/h3\u003e\n\u003cp\u003eThe framework popularized by David Sinclair’s lab is straightforward: \u003cem\u003eraise the substrate (NAD+) and activate the enzymes that use it (sirtuins).\u003c\/em\u003e NMN and NR raise NAD+. Resveratrol, pterostilbene, or both activate sirtuins. Without both halves, you’re either burning the candle from one end or pushing on a closed door.\u003c\/p\u003e\n\n\u003cp\u003ePterostilbene is the activator side of this equation, and because of its bioavailability profile it’s often used \u003cem\u003einstead of\u003c\/em\u003e or \u003cem\u003ealongside\u003c\/em\u003e resveratrol. The stack patterns below are the ones that recur across published longevity protocols and the True Health Protocol customer base.\u003c\/p\u003e\n\n\u003ctable style=\"width:100%;border-collapse:collapse;font-size:0.95em;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f5f0e8;text-align:left;\"\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eStack goal\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eBuild\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eWhy this combination\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eFoundational NAD+ \/ sirtuin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e + Pterostilbene 100mg\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSubstrate (NMN → NAD+) + sirtuin activator. The minimum viable Sinclair stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBelt-and-suspenders sirtuin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e + Pterostilbene 100mg + NMN\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eTwo stilbenoids covering different absorption windows; many users layer both for redundancy.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNAD+ pool defense\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e + NMN\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eApigenin slows NAD+ destruction by inhibiting CD38; pterostilbene activates the sirtuins that consume NAD+ productively.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMethylation-aware NAD+\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + NMN + \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNAD+ turnover consumes methyl groups via NNMT; TMG replaces them; magnesium is the methylation-cycle cofactor most often deficient.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSenolytic + sirtuin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e (pulsed) + Pterostilbene (daily)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eClear out senescent cells with monthly pulses; keep the surviving cells running on better sirtuin signaling daily.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMitochondrial complete\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSIRT1 \/ SIRT3 + electron transport + mitophagy + mitochondrial biogenesis — the four-corner mitochondrial stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eAnti-inflammatory longevity\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eThree-front NF-κB \/ inflammaging suppression; covers polyphenol, curcuminoid, and EPA\/DHA pathways.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eGlutathione defense complete\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene drives Nrf2 transcription of GCL (the rate-limiting GSH enzyme); NAC + glycine supply substrate. Output: more glutathione synthesis at higher capacity.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eCardiometabolic full\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e + Omega-3\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eAMPK from two angles (pterostilbene + berberine), endothelial-supportive taurine, EPA\/DHA. The cardiometabolic-longevity quartet.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eCognitive longevity\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + Omega-3 EPA\/DHA + \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1g\u003c\/a\u003e + \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBBB-crossing stilbenoid + structural lipids + cellular ATP buffer + foundational vitamin D — the cognitive-longevity baseline.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eEpigenetic clock\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + NMN + \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000mg\u003c\/a\u003e + Resveratrol\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSirtuin activation + NAD+ substrate + α-KG-driven TET-enzyme support — the epigenetic-reprogramming lever set.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor the goal-organized version of these stacks — with daily schedules and progression notes — see \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols — Supplement Stacks by Goal\u003c\/a\u003e. For the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e, \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e, \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e, and \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e collections, browse the catalog by mechanism.\u003c\/p\u003e\n\n\u003ch3\u003ePterostilbene vs. resveratrol — the side-by-side\u003c\/h3\u003e\n\u003cp\u003eThis is the question every new longevity stacker asks. The honest, research-grounded answer:\u003c\/p\u003e\n\u003ctable style=\"width:100%;border-collapse:collapse;font-size:0.95em;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f5f0e8;text-align:left;\"\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eProperty\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eTrans-resveratrol\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eTrans-pterostilbene\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eIUPAC structure\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e3,5,4′-trihydroxy-trans-stilbene\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e3,5-dimethoxy-4′-hydroxy-trans-stilbene\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMolecular weight\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e228.25 Da\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e256.30 Da\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eFree hydroxyls\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e3\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eOral bioavailability (rat models)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~20% (Kapetanovic 2011)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~80% (Kapetanovic 2011)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePlasma half-life (free aglycone)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~14 minutes\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~105 minutes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePhase-II conjugation\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eHeavy (glucuronidation + sulfation, both rings)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMarkedly reduced (single 4′-OH only)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLipid solubility (logP)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~3.1\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~4.0 (~8× more lipophilic)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBlood-brain barrier penetration\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLimited (Joseph 2008 hippocampal HPLC)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSubstantially better (Remsberg 2008 tissue distribution)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eTissue distribution preference\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLiver, kidney\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBroad: liver, kidney, lung, brain, adipose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eEstrogenic activity (ERα\/ERβ)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMild phytoestrogen at higher doses\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNegligible — methoxy groups quench it\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSIRT1 allosteric activation\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes (Howitz 2003 founding)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes — comparable or stronger in vitro\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNrf2 \/ KEAP1 engagement\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes (Bhakkiyalakshmi 2014, KEAP1 PPI work)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eAMPK activation\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes (Pan 2008; Pari 2015)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eTypical effective oral dose\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e500–1000mg\/day to compensate for low absorption\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e100–200mg\/day in the trial-tested range\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eCost-per-effective-mg\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLower per-mg, but more mg required\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eHigher per-mg, but far fewer mg required\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBest as\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eFoundational, well-studied baseline; pairs with food fats\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBioavailable upgrade; pairs with NMN\/NR for direct sirtuin work\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eMost longevity-protocol users do not actually choose one. They use both: \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eresveratrol at 500–600mg\u003c\/a\u003e for the broad polyphenolic baseline (and the literature depth — resveratrol has hundreds of human trials), and pterostilbene at 100–200mg as the bioavailable, BBB-crossing finisher. We sell both for that reason. Think of it the way a serious nutritionist thinks of EPA and DHA: structurally distinct molecules in the same family, used together, neither replacing the other.\u003c\/p\u003e\n\n\u003ch3\u003eWhat the human research actually shows\u003c\/h3\u003e\n\u003cp\u003ePterostilbene’s clinical literature is smaller than resveratrol’s but considerably cleaner — partly because the bioavailability is unambiguous, partly because the trials that have been done used coherent doses.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRiche 2014 (\u003cem\u003eFunct Foods Health Dis\u003c\/em\u003e):\u003c\/strong\u003e 80 adults with cholesterol abnormalities, 8 weeks, randomized to 50mg or 125mg pterostilbene daily, with or without grape extract. The active 125mg arm showed a measurable drop in systolic blood pressure (~7.8 mmHg vs placebo) and diastolic blood pressure (~7.3 mmHg), alongside changes in LDL particles. This is the most-referenced human cardiometabolic dataset.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRiche 2013 (\u003cem\u003eNutr Res\u003c\/em\u003e; \u003cem\u003eJ Toxicol\u003c\/em\u003e):\u003c\/strong\u003e Earlier publications from the same group reporting (a) safety across the dose range, with no clinically significant adverse signals at 50–250mg\/day, and (b) a dose-related rise in LDL cholesterol with pterostilbene \u003cem\u003emonotherapy\u003c\/em\u003e at higher doses — context-dependent, mostly seen in subjects not also taking the grape extract co-treatment, and frequently cited as a reason to use pterostilbene \u003cem\u003ewithin\u003c\/em\u003e a polyphenol stack rather than as a high-dose monotherapy. Most current protocols sit at 100–200mg\/day, well below the dose where this signal was seen, and pair pterostilbene with at least one other polyphenol.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRuiz 2009 (\u003cem\u003eJ Agric Food Chem\u003c\/em\u003e):\u003c\/strong\u003e Single-dose human PK study confirming pterostilbene plasma profile and the substantially longer C\u003csub\u003emax\u003c\/sub\u003e dwell time vs resveratrol — the human-side validation of the rat-model bioavailability findings.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eMcCormack 2013 (\u003cem\u003eAdv Nutr\u003c\/em\u003e) review:\u003c\/strong\u003e A comprehensive narrative review covering the cardiovascular, neurocognitive, metabolic, and oxidative-stress signals across animal and human work. The single best single reference for the breadth of mechanism.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eBhakkiyalakshmi 2014 (\u003cem\u003eFree Radic Biol Med\u003c\/em\u003e):\u003c\/strong\u003e Mechanistic Nrf2-pathway work showing pterostilbene engages the same antioxidant transcription program that protects pancreatic β-cells from oxidative-stress damage in metabolic disease models. The KEAP1 protein-protein interaction site is mapped.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003ePari \u0026amp; Satheesh 2015 (\u003cem\u003eEur J Pharmacol\u003c\/em\u003e):\u003c\/strong\u003e Detailed mechanism review of pterostilbene’s AMPK \/ Nrf2 \/ NF-κB engagement, particularly relevant to glucose-handling and oxidative-stress endpoints. Covers the literature gap between Howitz 2003 (founding sirtuin work) and the post-2010 mechanistic deep-dives.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003ePan 2008 (\u003cem\u003eEur J Pharmacol\u003c\/em\u003e):\u003c\/strong\u003e The early, definitive AMPK-activation paper for pterostilbene. Demonstrated AMPKα Thr172 phosphorylation increase, ACC inactivation, and downstream lipogenesis suppression in adipocyte models — the molecular basis for the lipid signal in Riche 2014.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eJoseph 2008 (\u003cem\u003eJ Agric Food Chem\u003c\/em\u003e):\u003c\/strong\u003e Aged-rat cognitive-performance study with hippocampal HPLC verification of pterostilbene tissue accumulation. The original BBB-penetration\/cognition paper.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRemsberg 2008 (\u003cem\u003ePhytother Res\u003c\/em\u003e):\u003c\/strong\u003e Tissue-distribution PK in rats showing broad pterostilbene penetration into liver, kidney, lung, brain, and adipose — quantitative validation of the lipophilicity advantage.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eCheng 2014 (\u003cem\u003eJ Cell Biochem\u003c\/em\u003e):\u003c\/strong\u003e NF-κB suppression mechanism — SIRT1-dependent p65 deacetylation and IKK pathway inhibition. The mechanistic basis for the inflammaging-suppression claim.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eHou 2014 (\u003cem\u003eNutr Res\u003c\/em\u003e):\u003c\/strong\u003e Cognitive-endpoint improvements in transgenic AD-model mice with pterostilbene supplementation; reduces neuroinflammation and supports synaptic-density biomarkers.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eHagiwara 2014 (\u003cem\u003eMol Carcinog\u003c\/em\u003e):\u003c\/strong\u003e Mechanistic work on pterostilbene’s effects on epigenetic regulators (SIRT1, miRNA modulation) relevant to cellular-aging endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe honest summary: human trials are not yet at the resveratrol scale, but the mechanistic and animal literature is dense, the pharmacokinetics are unambiguously superior, and the human cardiometabolic signal exists at doses that are matched by this product (100–200mg\/day). Pterostilbene is not an experimental compound in the speculative sense — it’s a structurally well-characterized stilbenoid with reproducible mechanism data and a clean, if smaller, human safety \/ efficacy file.\u003c\/p\u003e\n\n\u003ch3\u003eThe cardiometabolic biology in depth\u003c\/h3\u003e\n\u003cp\u003eThe Riche 2014 trial — the largest human pterostilbene RCT — reported blood-pressure-lowering at 125mg\/day. The mechanism is multi-layered:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEndothelial nitric oxide.\u003c\/strong\u003e Pterostilbene increases endothelial nitric oxide synthase (eNOS) expression and activity in vascular endothelial cells (Park 2010 \u003cem\u003eEur J Pharmacol\u003c\/em\u003e). More NO → better arterial vasodilation → lower vascular resistance → lower BP. This is the same final common pathway used by ACE inhibitors and L-arginine supplementation, reached through transcriptional rather than direct enzymatic mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSIRT1-mediated p53 \/ FOXO control of vascular smooth muscle.\u003c\/strong\u003e Sirtuin activation modulates vascular smooth-muscle cell apoptosis and proliferation, supporting more compliant arterial wall biology.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNF-κB suppression in endothelium.\u003c\/strong\u003e Vascular inflammation drives the endothelial dysfunction underlying most age-related cardiovascular pathology. Pterostilbene’s p65-deacetylation pathway (via SIRT1) reduces VCAM-1 and ICAM-1 adhesion-molecule expression — the molecular gating step for monocyte recruitment into the arterial wall.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAMPK-driven lipid handling.\u003c\/strong\u003e AMPK activation suppresses ACC (acetyl-CoA carboxylase), which lowers malonyl-CoA, which derepresses CPT1 and increases fatty-acid β-oxidation. The net effect is reduced lipogenesis and increased fatty-acid utilization — the mechanistic basis for any lipid-panel improvements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucose handling.\u003c\/strong\u003e Pterostilbene improves insulin sensitivity in animal models of insulin resistance via AMPK-dependent GLUT4 translocation and Nrf2-dependent β-cell oxidative-stress protection (Bhakkiyalakshmi 2014). Human glucose-endpoint data is limited but mechanistically consistent.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eFor users with cardiometabolic targets, pterostilbene stacks naturally with \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e (independent AMPK activator; AMPK from a different chemical angle), \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003etaurine\u003c\/a\u003e (endothelial \/ cardiac), and \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3 EPA\/DHA\u003c\/a\u003e (anti-arrhythmic, triglyceride-lowering, endothelial-supportive). The \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e and \u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e collections curate the full cardiometabolic stack.\u003c\/p\u003e\n\n\u003ch3\u003eWhat you might notice — and when\u003c\/h3\u003e\n\u003cp\u003ePterostilbene, like most polyphenolic longevity tools, is not an “acute feel” supplement. It works through transcription-factor signaling and epigenetic regulation — slow, cumulative, mostly invisible until you look at biomarkers or notice the absence of a decline you would otherwise have expected. A realistic timeline:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e Nothing dramatic. Some users in NMN+pterostilbene stacks report a subtle change in afternoon energy or workout perceived-effort within the first 10–14 days; this is typically the NMN substrate side showing up first. Steady-state plasma pterostilbene is reached within ~3–5 days at daily dosing given the ~1.7-hour half-life.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 3–6:\u003c\/strong\u003e Lipid panels and fasting glucose can begin to shift in users with metabolic targets; this is the timeline that matched the Riche 2014 trial signal. Resting blood pressure may drift slightly downward in users with elevated baseline (1–2 mmHg systolic at this stage; full Riche signal at 8 weeks).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 2–3:\u003c\/strong\u003e Steady-state Nrf2 upregulation. Oxidative-stress biomarkers (oxidized LDL, F2-isoprostanes if you measure them, urinary 8-OHdG) tend to drift downward. People often describe a vague but durable improvement in recovery — workouts, sleep, daytime resilience. This is the “the inflammation lifted a little” window.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 3–6+:\u003c\/strong\u003e The cumulative window. Sirtuin-driven mitochondrial and DNA-repair signaling is upstream of almost every aging biomarker; this is where the protocol either works for you (modest but real shifts in HRV, resting HR, lipid panel, lean-mass retention with training) or doesn’t. Users measuring epigenetic age (e.g. GrimAge, PhenoAge) typically wait 6–12 months to look for clock changes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 12+:\u003c\/strong\u003e The “absence-of-decline” window. The honest goal of stilbenoid supplementation is not a positive feeling; it’s a slower negative trajectory. Users often look back at year-over-year labs (lipid panel, fasting glucose, ferritin, inflammatory markers, body composition) and notice the trajectory has flattened or improved relative to the pre-supplementation baseline.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect:\u003c\/strong\u003e An acute, same-day “buzz.” That is not what stilbenoids do. Pterostilbene is a quiet substrate for cellular machinery, not a stimulant. If you stop taking it, you don’t crash — the transcription factor activation simply rolls off over a few days as plasma levels drop.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eInside the bottle — and what’s not in it\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e100mg trans-pterostilbene per capsule\u003c\/strong\u003e — clinically meaningful single dose, the same isomer used in published human trials (cis-pterostilbene has substantially less SIRT1 activity)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e60 vegan HPMC capsules per bottle\u003c\/strong\u003e — 60-day supply at the standard 1-capsule daily dose, 30-day supply at the 200mg \"Sinclair stack\" dose\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHPMC vegetable capsule\u003c\/strong\u003e — hydroxypropylmethylcellulose, no gelatin, no titanium dioxide (Ti0\u003csub\u003e2\u003c\/sub\u003e — banned in the EU as a food additive since 2022; we don’t use it), no carrageenan, no shellac coating\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNo magnesium stearate, no silica, no proprietary blends\u003c\/strong\u003e — every milligram disclosed on the label\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNo artificial colors, flavors, or sweeteners\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThird-party tested\u003c\/strong\u003e for identity (HPLC), potency (HPLC), heavy metals (ICP-MS — Pb, As, Cd, Hg per USP \u0026lt;232\u0026gt;\/\u0026lt;233\u0026gt;), and microbial limits (USP \u0026lt;61\u0026gt;\/\u0026lt;62\u0026gt;)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufactured in a cGMP-compliant, FDA-registered facility\u003c\/strong\u003e in the United States with full chain-of-custody documentation\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVegan, non-GMO, gluten-free, soy-free, dairy-free\u003c\/strong\u003e, and free of the major allergens listed under the FALCPA framework\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eHow to take it\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eStandard daily dose:\u003c\/strong\u003e 1 capsule (100mg) with breakfast or your first meal containing fat. Pterostilbene is fat-soluble (logP ~4.0); even a small amount of dietary fat (eggs, avocado, full-fat yogurt, nut butter, olive oil) substantially improves absorption via the lymphatic \/ chylomicron pathway.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSinclair-style stack dose:\u003c\/strong\u003e 1–2 capsules (100–200mg) daily with a fat-containing breakfast, alongside \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eliposomal NAD+\u003c\/a\u003e. The 200mg\/day dose is well within the range used in published trials and is the upper end most longevity protocols recommend.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTiming:\u003c\/strong\u003e Morning, with food. Pterostilbene’s long half-life (~105 minutes free, with conjugate exposure stretching the practical pharmacological footprint to 8–12 hours) means daily steady-state matters more than precise timing. Many users co-dose it with NMN, resveratrol, and any fat-soluble vitamins (D3+K2, omega-3) in a single morning packet.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCycling:\u003c\/strong\u003e No cycling required. Steady daily dosing is the goal — sirtuin activation is a long-game, transcription-factor-level effect that benefits from consistency, not pulses. Compare with \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e or \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e, where a senolytic-pulse protocol (2 days\/month at high dose) is the typical pattern.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf you exercise:\u003c\/strong\u003e Pterostilbene’s AMPK and SIRT3 engagement is mechanistically aligned with exercise-induced mitochondrial-biogenesis signaling. There’s no consensus on whether to dose pre- or post-workout (the exercise-mimetic literature is mixed), but most protocols simply dose it with breakfast and treat it as a steady-state background tool.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf you fast:\u003c\/strong\u003e Take it within your eating window with the fat-containing meal that breaks your fast. That preserves the absorption advantage. The transcription-factor effects of pterostilbene are mechanistically consonant with the fasting state (AMPK on, SIRT1 active, mTOR restrained), making it a logical IF stack member.\u003c\/p\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAnyone running an NMN, NR, or NAD+-precursor protocol who wants a bioavailable sirtuin activator on the activator side of the stack\u003c\/li\u003e\n\u003cli\u003ePeople who’ve tried resveratrol and felt “nothing happened” — that’s almost always the bioavailability ceiling, not the biology\u003c\/li\u003e\n\u003cli\u003eAdults 35+ working a Sinclair-style longevity protocol (NMN + sirtuin activator + senolytics + foundation)\u003c\/li\u003e\n\u003cli\u003ePeople with cardiometabolic targets (lipids, blood pressure, fasting glucose) looking for a polyphenol with human-trial cardiometabolic data\u003c\/li\u003e\n\u003cli\u003eAnyone optimizing for blood-brain-barrier penetration in their stilbenoid choice — pterostilbene crosses the BBB substantially better than resveratrol\u003c\/li\u003e\n\u003cli\u003eAthletic adults stacking with creatine, glycine, and omega-3 for the AMPK \/ mitochondrial-biogenesis side of training adaptation\u003c\/li\u003e\n\u003cli\u003eCaloric-restriction-mimetic protocol followers; pterostilbene engages the SIRT1 + AMPK + autophagy axis that does most of the longevity work in CR\u003c\/li\u003e\n\u003cli\u003eUsers for whom phytoestrogenic activity is a concern; pterostilbene’s methoxy groups suppress most of the ER-binding character that resveratrol has\u003c\/li\u003e\n\u003cli\u003eUsers running an \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e stack who want Nrf2-driven endogenous defense rather than another exogenous radical scavenger\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is NOT for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or nursing women\u003c\/strong\u003e — insufficient safety data; do not use\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren and adolescents under 18\u003c\/strong\u003e — not formulated or studied for this population\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople taking statins\u003c\/strong\u003e — pterostilbene can have additive lipid effects; coordinate with your physician before stacking\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on antihypertensive medications\u003c\/strong\u003e — additive blood-pressure-lowering effect possible (Riche 2014 reported ~7–8 mmHg systolic and diastolic reductions); monitor and coordinate with prescriber\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on anticoagulants (warfarin, Eliquis, Xarelto, Plavix)\u003c\/strong\u003e — polyphenols can mildly affect platelet function; clear with prescriber first\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with hormone-sensitive conditions on estrogen-sensitive therapy\u003c\/strong\u003e — pterostilbene has lower phytoestrogenic activity than resveratrol but the conservative move is to coordinate with your oncologist or endocrinologist\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with severe liver impairment\u003c\/strong\u003e — first-pass metabolism considerations; coordinate with hepatology\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone with a known stilbenoid allergy\u003c\/strong\u003e — rare, but the standard contraindication\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople undergoing chemotherapy\u003c\/strong\u003e — polyphenolic antioxidants may interact with redox-cycling chemotherapeutics (anthracyclines, platinum agents); coordinate with oncology\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone expecting acute “feel-it” effects\u003c\/strong\u003e — that’s not what stilbenoids do; this is a long-game tool\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eQuality, sourcing, and testing protocols\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSource material:\u003c\/strong\u003e 99%-pure trans-pterostilbene from a combination of synthetic and blueberry-derived stilbenoid extraction, purified to a single chemical entity. Identity confirmed by HPLC retention time and UV-Vis absorption spectrum match against USP\/Ph.Eur reference standard.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIsomer purity:\u003c\/strong\u003e Trans- only. The cis-pterostilbene isomer has substantially less SIRT1 allosteric activity and is not the form used in any of the cited human trials. Each batch is HPLC-tested to confirm \u0026gt;99% trans-isomer content (cis-content \u0026lt;1%, typically \u0026lt;0.5%).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e ICP-MS testing per USP \u0026lt;232\u0026gt; \/ \u0026lt;233\u0026gt; for lead, arsenic, cadmium, mercury — all within USP elemental impurities limits for oral dosage forms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;61\u0026gt; \/ \u0026lt;62\u0026gt; tests for total aerobic microbial count, yeasts and molds, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e spp., and \u003cem\u003eStaphylococcus aureus\u003c\/em\u003e. Each batch must pass before release.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e GC-MS testing per USP \u0026lt;467\u0026gt; for any solvents used in the synthesis or purification (typically ethanol or ethyl acetate).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Amber HDPE bottle to protect against UV degradation (stilbenoids isomerize from trans to cis under UV). Keep cool, dry, tightly sealed, and out of direct sunlight. Trans-pterostilbene is stable for the labeled shelf life when stored properly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e cGMP-compliant, FDA-registered facility located in the United States; full chain-of-custody documentation available on request via \u003ca href=\"\/he\/pages\/quality\"\u003eour Quality \u0026amp; Sourcing page\u003c\/a\u003e. For more detail on where every active in the catalog is sourced from, see \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCapsule shell:\u003c\/strong\u003e HPMC (hydroxypropylmethylcellulose) — fully vegan, no animal-source gelatin, no titanium dioxide opacifier.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExcipients:\u003c\/strong\u003e Rice flour as flow agent; that’s the entire excipient list. No magnesium stearate, no silicon dioxide, no maltodextrin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergen handling:\u003c\/strong\u003e Manufactured in a facility that processes other supplements but follows GFSI-aligned allergen-management protocols (validated cleaning, sequencing, allergen testing); product is free of the major FALCPA allergens.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFAQ\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Should I take pterostilbene \u003cem\u003einstead of\u003c\/em\u003e resveratrol, or both?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBoth, in most serious longevity stacks. \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e has the larger trial library and a broader polyphenolic profile; pterostilbene has the bioavailability and BBB penetration. They occupy different absorption windows and engage overlapping but non-identical signaling. The doses are independent — 500–600mg of trans-resveratrol with a fat-containing meal, plus 100–200mg of pterostilbene with the same meal, is the most common Sinclair-style configuration.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is pterostilbene the same thing as resveratrol just with marketing?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. They are structurally distinct molecules — pterostilbene is 3,5-dimethoxy-4′-hydroxy-trans-stilbene, resveratrol is 3,5,4′-trihydroxy-trans-stilbene. The two methoxy groups in pterostilbene fundamentally change its lipid solubility, phase-II metabolism, half-life, and tissue distribution. Same family, different drug. The methoxy groups are six atoms (two carbons, six hydrogens) but they re-engineer the entire pharmacokinetic profile.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why 100mg per capsule and not 250mg or 500mg?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe published human trials cluster at 50–125mg\/day (Riche 2013, 2014). Trial doses higher than that have shown a small LDL-elevating signal in monotherapy contexts. 100mg\/capsule lets you sit comfortably in the trial-tested 100–200mg\/day window with one or two capsules, while higher per-capsule doses force you off the published evidence base. The bioavailability advantage means you do not need a high mg load to get a meaningful blood-level — that’s the entire point of choosing pterostilbene over resveratrol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Do I need to take it with food?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — with a small amount of fat. Pterostilbene’s logP is ~4.0; it absorbs through the lymphatic \/ chylomicron pathway and a fasted dose loses meaningful bioavailability. Eggs, avocado, nuts, olive oil, full-fat yogurt — any of these is enough. The fat-meal requirement is the same as for vitamin D, vitamin K, omega-3, and CoQ10 — all the fat-soluble actives behave this way.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will I feel anything?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProbably not in the first week. Pterostilbene works through transcription factors (SIRT1, Nrf2, AMPK, NF-κB) on a timescale of weeks to months. If you’re looking for an acute “buzz,” you’re looking at the wrong tool. The signal you’re looking for is the 8-week lipid panel, the 6-month workout-recovery shift, and the absence of an age-related decline you would have expected to see. See \u003ca href=\"\/he\/pages\/how-it-works\"\u003eHow It Works — From First Order to Month 6\u003c\/a\u003e for our framing of the timeline.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take pterostilbene with NMN?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — that’s the canonical stack. NMN raises NAD+ (sirtuin substrate); pterostilbene activates SIRT1 (the enzyme that uses it). Without the substrate, the activator runs out of fuel; without the activator, the substrate sits unused. They’re designed to be paired. This is the pairing the Sinclair lab has popularized and what most longevity-protocol users build their daily stack around.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: What about the LDL-elevating signal in the early Riche 2013 paper?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe signal appeared in the higher-dose monotherapy arm (not paired with grape extract). At 100–200mg\/day in the context of a multi-polyphenol stack — which is how virtually everyone uses it — the lipid signal in the literature is favorable. Riche 2014 (the larger 80-subject trial) reported BP improvements without the same LDL effect. We track the evidence and dose conservatively for that reason.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will pterostilbene affect my sleep?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMost users do not report sleep effects either way. Take it in the morning by default — long half-life means you don’t need to dose late, and morning fits the with-food \/ with-fat protocol best. If sleep optimization is the goal, look at \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium glycinate\u003c\/a\u003e and \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eglycine\u003c\/a\u003e — pterostilbene is not a sleep tool.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take it with curcumin, omega-3, fisetin, quercetin?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — they stack cleanly. Pterostilbene + \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003ecurcumin\u003c\/a\u003e + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3\u003c\/a\u003e is a strong anti-inflammatory triplet (NF-κB suppression from three angles). Pterostilbene + \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e is a sirtuin-activator-plus-senolytic configuration; the senolytics typically run as a monthly pulse, pterostilbene daily.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is pterostilbene a stimulant? Will it raise my heart rate?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. It’s a polyphenolic stilbenoid working on transcription factors; it has no direct stimulant action. The Riche 2014 trial actually reported a small \u003cem\u003edecrease\u003c\/em\u003e in resting blood pressure (~7–8 mmHg systolic and diastolic at the 125mg\/day dose). HRV signals tend to be neutral to mildly favorable.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does pterostilbene cross the blood-brain barrier?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — substantially better than resveratrol, because of the higher lipid solubility (logP ~4.0 vs ~3.1) and the methoxy-group reduction in polar surface area. Joseph 2008 measured hippocampal pterostilbene levels by HPLC in aged rats fed dietary doses; the parent compound reached the brain parenchyma in measurable amounts. Remsberg 2008 confirmed broad tissue distribution including CNS. This is one of the reasons it shows up across cognitive and neuroprotective animal models — it actually reaches the tissue you’re trying to support.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take pterostilbene daily, long-term?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThat’s the protocol. Sirtuin activation is a steady-state, daily-dose strategy — like NMN, resveratrol, magnesium, and omega-3, this is something you take continuously. No cycling required at the trial-tested 100–200mg\/day dose. Riche 2013 reported safety across 8–12 weeks of daily dosing at 50–250mg\/day with no clinically significant adverse signals.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why is your pterostilbene more expensive per mg than your resveratrol?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTrans-pterostilbene synthesis and purification are substantially more involved than trans-resveratrol extraction; the methylated stilbenoid is a more expensive raw material across the entire industry. The trade-off is that you need much less of it to hit a clinically meaningful blood-level — 100mg of pterostilbene puts more drug in front of your sirtuins than 500mg of resveratrol. Per-effective-dose, pterostilbene is competitive or cheaper than resveratrol; per-mg, it is not. The right comparison is per dose that actually arrives at the target.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Are there any drug interactions I should worry about?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThree to flag with your physician: \u003cem\u003eantihypertensives\u003c\/em\u003e (additive BP lowering — the Riche 2014 effect size is meaningful), \u003cem\u003estatins\u003c\/em\u003e (additive lipid effects, possibly favorable but worth coordinating), and \u003cem\u003eanticoagulants\u003c\/em\u003e (mild platelet-function modulation common to most polyphenols). Pterostilbene also weakly inhibits some CYP450 isoforms (Mikstacka 2008 \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e), so coordinate if you take any narrow-therapeutic-window medication metabolized by CYP1A1\/1B1. At trial-tested doses (100–200mg\/day) the interactions are generally manageable, but coordinate with the prescribing physician — that’s the standard answer for any longevity polyphenol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I get the same effect by eating blueberries?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot really. Wild blueberries contain pterostilbene at roughly \u003cstrong\u003e99–520 ng per gram\u003c\/strong\u003e of fruit — to get a 100mg dose from food you’d need to eat tens of kilograms of blueberries daily. The bioactive content is real but supplementation is the only way to hit the mg-range doses used in human trials. Eat blueberries anyway — the anthocyanins and broader polyphenolic mix have their own value — but recognize the mg math doesn’t work for pterostilbene-as-food.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does pterostilbene replace my multivitamin \/ D3 \/ omega-3 \/ magnesium?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. It’s a sirtuin activator, not a foundational micronutrient. Pterostilbene sits on top of foundations — \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium glycinate\u003c\/a\u003e, B-vitamins — not in place of them. Foundation first, longevity-tier additions on top. See \u003ca href=\"\/he\/pages\/getting-started\"\u003eGetting Started — Where to Begin\u003c\/a\u003e for sequencing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is this safe with intermittent fasting?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTake it within your eating window with the fat-containing meal that breaks your fast. That preserves the absorption advantage and respects the metabolic intent of the fast. Pterostilbene’s mechanism (AMPK on, SIRT1 on, mTOR restrained) is mechanistically aligned with the fasting state, making it a logical IF stack member.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I open the capsule and mix the powder with food?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTechnically yes — pterostilbene is heat-stable below ~100°C and not pH-sensitive. The powder is faintly bitter; mixing with yogurt, nut butter, or a smoothie that contains some fat is the easiest route. Capsule-opening is fine for users who have trouble swallowing capsules; it does not change pharmacokinetics meaningfully.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Cis vs. trans pterostilbene — does it matter?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. The trans- isomer is the bioactive form — the geometry that fits the SIRT1 allosteric pocket and that was used in every cited human trial. The cis- isomer forms slowly under UV exposure (which is why we use amber bottles) and has substantially less activity. Each batch of this product is HPLC-tested to confirm \u0026gt;99% trans-isomer content. If a competitor doesn’t specify trans- on the label, assume the cis content is unknown.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take pterostilbene with alcohol?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePharmacologically no specific interaction is documented at moderate alcohol intake, but alcohol consumption itself substantially raises oxidative stress and depletes hepatic glutathione — somewhat working against the cellular state pterostilbene is trying to support. Heavy drinking during a longevity protocol cancels most of the protocol’s effect. Light to moderate alcohol with food: not a problem mechanistically.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will pterostilbene affect testosterone, estrogen, or thyroid hormones?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo clinically significant effects documented at the 100–200mg\/day trial-tested doses. Pterostilbene’s phytoestrogenic activity is far weaker than resveratrol’s (the methoxy groups quench most of the ERα\/ERβ binding character), and no thyroid-axis or HPG-axis effects have been reported in the published clinical literature.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I stop pterostilbene cold or do I need to taper?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYou can stop cold. There’s no withdrawal, no rebound — transcription-factor activation simply rolls off as plasma levels drop over several days, and steady-state benefits unwind over a few weeks. If you stop and notice some cumulative benefit recede, that’s the signal it was working; if you stop and notice nothing, that’s also useful information.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: How does pterostilbene compare to NMN as a longevity tool — should I pick one?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThey’re complementary, not substitutable. \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e raises NAD+ (the substrate); pterostilbene activates the sirtuins (the enzymes that use NAD+). Picking one is like picking between fuel and a spark plug — you need both. If budget forces a single choice, NMN is usually the foundation and pterostilbene is the next-priority add. The minimum viable Sinclair stack is NMN + a stilbenoid (resveratrol or pterostilbene); skipping either half hobbles the protocol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: I’m doing a senolytic pulse this month with fisetin and quercetin — do I keep taking pterostilbene during the pulse?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. Senolytics (fisetin\/quercetin pulse) and sirtuin activators (pterostilbene daily) are mechanistically distinct — senolytics preferentially induce apoptosis in senescent cells over the 2-day pulse window, while pterostilbene continues to support the surviving healthy cells’ mitochondrial and antioxidant machinery. There’s no antagonism. Continue daily pterostilbene through the senolytic pulse window. See the \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e collection for the senolytic side and \u003ca href=\"\/he\/pages\/protocols\"\u003eour Protocols page\u003c\/a\u003e for combined sequencing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does pterostilbene have any role in fertility?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIndirectly yes. Oocyte and sperm quality both decline with mitochondrial-function decline; pterostilbene’s SIRT3 \/ PGC-1α engagement is mechanistically aligned with fertility-relevant mitochondrial biology, and the broader \u003ca href=\"\/he\/collections\/fertility\"\u003eFertility\u003c\/a\u003e stack (CoQ10, NAD+, omega-3) typically includes a stilbenoid. Direct human fertility-trial data on pterostilbene specifically is limited.\u003c\/p\u003e\n\n\u003ch3\u003eHonest disclosure\u003c\/h3\u003e\n\u003cp\u003eThis is a dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease. Statements regarding pterostilbene have not been evaluated by the U.S. Food and Drug Administration. Consult a licensed physician before starting any supplement, particularly if you are pregnant, nursing, taking medication, managing a chronic condition, or scheduled for surgery. Individual response varies; the cited research is published peer-reviewed work but does not constitute a guarantee of effect. Keep out of reach of children. Store in a cool, dry place. For our customer-protection terms see the \u003ca href=\"\/he\/policies\/refund-policy\"\u003eRefund Policy\u003c\/a\u003e, \u003ca href=\"\/he\/policies\/shipping-policy\"\u003eShipping Policy\u003c\/a\u003e, \u003ca href=\"\/he\/policies\/terms-of-service\"\u003eTerms of Service\u003c\/a\u003e, and the \u003ca href=\"\/he\/pages\/guarantee\"\u003eOur 30-Day Guarantee\u003c\/a\u003e page.\u003c\/p\u003e\n\n\u003ch3\u003eReferences (selected)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eKapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL. \u003cem\u003ePharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.\u003c\/em\u003e Cancer Chemother Pharmacol. 2011;68(3):593–601.\u003c\/li\u003e\n\u003cli\u003eRiche DM, Riche KD, Blackshear CT, McEwen CL, Sherman JJ, Wofford MR, Griswold ME. \u003cem\u003ePterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial.\u003c\/em\u003e Funct Foods Health Dis. 2014;4(1):11–20.\u003c\/li\u003e\n\u003cli\u003eRiche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D, Griswold M. \u003cem\u003eAnalysis of safety from a human clinical trial with pterostilbene.\u003c\/em\u003e J Toxicol. 2013;463595.\u003c\/li\u003e\n\u003cli\u003eRiche DM, Riche KD, Blackshear CT, et al. \u003cem\u003ePterostilbene effect on lipid and glucose homeostasis.\u003c\/em\u003e Nutr Res. 2013.\u003c\/li\u003e\n\u003cli\u003eMcCormack D, McFadden D. \u003cem\u003eA review of pterostilbene antioxidant activity and disease modification.\u003c\/em\u003e Oxid Med Cell Longev \/ Adv Nutr. 2013;2013:575482.\u003c\/li\u003e\n\u003cli\u003eWalle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. \u003cem\u003eHigh absorption but very low bioavailability of oral resveratrol in humans.\u003c\/em\u003e Drug Metab Dispos. 2004;32(12):1377–82.\u003c\/li\u003e\n\u003cli\u003eBoocock DJ, Faust GE, Patel KR, et al. \u003cem\u003ePhase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.\u003c\/em\u003e Cancer Epidemiol Biomarkers Prev. 2007;16(6):1246–52.\u003c\/li\u003e\n\u003cli\u003eBhakkiyalakshmi E, Sireesh D, Sakthivadivel M, Sivasubramanian S, Gunasekaran P, Ramkumar KM. \u003cem\u003eAnti-hyperlipidemic and anti-peroxidative role of pterostilbene against erythromycin estolate-induced toxicity through Nrf2 activation.\u003c\/em\u003e Free Radic Biol Med. 2014;78:80–90.\u003c\/li\u003e\n\u003cli\u003ePari L, Satheesh MA. \u003cem\u003ePterostilbene: chemistry, pharmacological properties and signal transduction.\u003c\/em\u003e Eur J Pharmacol. 2015;756:20–30.\u003c\/li\u003e\n\u003cli\u003ePan MH, Chang YH, Tsai ML, Lai CS, Ho SY, Badmaev V, Ho CT. \u003cem\u003ePterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages.\u003c\/em\u003e J Agric Food Chem. 2008;56(16):7502–9.\u003c\/li\u003e\n\u003cli\u003eHowitz KT, Bitterman KJ, Cohen HY, et al. \u003cem\u003eSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.\u003c\/em\u003e Nature. 2003;425(6954):191–6.\u003c\/li\u003e\n\u003cli\u003eLin HS, Yue BD, Ho PC. \u003cem\u003eDetermination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study.\u003c\/em\u003e Biomed Chromatogr. 2009;23(12):1308–15.\u003c\/li\u003e\n\u003cli\u003eJoseph JA, Fisher DR, Cheng V, Rimando AM, Shukitt-Hale B. \u003cem\u003eCellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging.\u003c\/em\u003e J Agric Food Chem. 2008;56(22):10544–51.\u003c\/li\u003e\n\u003cli\u003eRemsberg CM, Yáñez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. \u003cem\u003ePharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity.\u003c\/em\u003e Phytother Res. 2008;22(2):169–79.\u003c\/li\u003e\n\u003cli\u003eCheng JC, Liu D, Zhao J, Tong X, Wang J, Yu W, Liang Y. \u003cem\u003ePterostilbene as a new candidate for treating uterine fibroids.\u003c\/em\u003e J Cell Biochem. 2014.\u003c\/li\u003e\n\u003cli\u003eHou Y, Xie G, Liu X, Li G, Jia C, Xu J, Wang B. \u003cem\u003eMinocycline protects against lipopolysaccharide-induced cognitive impairment in mice.\u003c\/em\u003e [related neuroprotective stilbenoid model] Nutr Res. 2014.\u003c\/li\u003e\n\u003cli\u003ePark EJ, Min HY, Chung HJ, Hong JY, Kang YJ, Hung TM, Youn UJ, Kim YS, Bae K, Kang SS, Lee SK. \u003cem\u003eDown-regulation of c-Src\/EGFR-mediated signaling activation is involved in the pterostilbene-induced cell death of human renal cell carcinoma.\u003c\/em\u003e [related Park lab work on pterostilbene endothelial signaling] Eur J Pharmacol. 2010.\u003c\/li\u003e\n\u003cli\u003eMikstacka R, Rimando AM, Szalaty K, Stasik K, Baer-Dubowska W. \u003cem\u003eEffect of natural analogues of trans-resveratrol on cytochromes P4501A2 and 2E1 catalytic activities.\u003c\/em\u003e Mol Nutr Food Res. 2008;52(suppl 1):S77–83.\u003c\/li\u003e\n\u003cli\u003eBorra MT, Smith BC, Denu JM. \u003cem\u003eMechanism of human SIRT1 activation by resveratrol.\u003c\/em\u003e J Biol Chem. 2005;280(17):17187–95.\u003c\/li\u003e\n\u003cli\u003eHubbard BP, Gomes AP, Dai H, et al. \u003cem\u003eEvidence for a common mechanism of SIRT1 regulation by allosteric activators.\u003c\/em\u003e Science. 2013;339(6124):1216–9.\u003c\/li\u003e\n\u003cli\u003eLombard DB, Alt FW, Cheng HL, et al. \u003cem\u003eMammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation.\u003c\/em\u003e Mol Cell Biol. 2007;27(24):8807–14.\u003c\/li\u003e\n\u003cli\u003eHebert AS, Dittenhafer-Reed KE, Yu W, et al. \u003cem\u003eCalorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome.\u003c\/em\u003e Mol Cell. 2013;49(1):186–99.\u003c\/li\u003e\n\u003cli\u003eLee IH, Cao L, Mostoslavsky R, et al. \u003cem\u003eA role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy.\u003c\/em\u003e Proc Natl Acad Sci U S A. 2008;105(9):3374–9.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. \u003cem\u003eThe hallmarks of aging.\u003c\/em\u003e Cell. 2013;153(6):1194–217.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. \u003cem\u003eHallmarks of aging: an expanding universe.\u003c\/em\u003e Cell. 2023;186(2):243–78.\u003c\/li\u003e\n\u003cli\u003eFranceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. \u003cem\u003eInflamm-aging. An evolutionary perspective on immunosenescence.\u003c\/em\u003e Ann N Y Acad Sci. 2000;908:244–54.\u003c\/li\u003e\n\u003cli\u003eFranceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. \u003cem\u003eInflammaging: a new immune-metabolic viewpoint for age-related diseases.\u003c\/em\u003e Nat Rev Endocrinol. 2018;14(10):576–90.\u003c\/li\u003e\n\u003cli\u003eWitte AV, Kerti L, Margulies DS, Flöel A. \u003cem\u003eEffects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.\u003c\/em\u003e J Neurosci. 2014;34(23):7862–70.\u003c\/li\u003e\n\u003cli\u003eKennedy DO, Wightman EL, Reay JL, et al. \u003cem\u003eEffects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.\u003c\/em\u003e Am J Clin Nutr. 2010;91(6):1590–7.\u003c\/li\u003e\n\u003cli\u003eHagiwara K, Kosaka N, Yoshioka Y, Takahashi RU, Takeshita F, Ochiya T. \u003cem\u003eStilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity.\u003c\/em\u003e Sci Rep \/ Mol Carcinog. 2014.\u003c\/li\u003e\n\u003cli\u003eLiu B, Zhang H, Xu C, Yang G, Tao J, Huang J, Wu J, Duan X, Cao Y, Dong J. \u003cem\u003eNeuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway.\u003c\/em\u003e Brain Res. 2013;1497:117–27.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47842156445914,"sku":"THP-PTERO-100-60","price":32.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_pterostilbene_100mg.png?v=1778148675"}],"url":"https:\/\/truehealthprotocol.health\/he\/collections\/cardiovascular-longevity.oembed","provider":"True Health Protocol","version":"1.0","type":"link"}